ML031250206
| ML031250206 | |
| Person / Time | |
|---|---|
| Site: | Susquehanna  |
| Issue date: | 04/30/2003 |
| From: | Shriver B Susquehanna |
| To: | Office of Nuclear Reactor Regulation |
| References | |
| PLA-5618 | |
| Download: ML031250206 (183) | |
Text
SUSQUEHANNA STEAM ELECTRIC STATION APPENDIX A SSES ODCM/TRM Radioactive Effluent and Waste Disposal Report 2002 Annual Report PPL Susquehanna, LLC 769 Salem Boulevard Berwick, Pennsylvania 18603 April 2003
SSES MANUAL Manual Name:
ODCMANUAL Manual
Title:
OFFSITE DOSE CALCULATION MANUAL Table Of Contents Issue Date:
03/25/2003 Procedure Name ODCM-QA-001
Title:
ODCM INTRODUCTION Rev Issue Date 1
04/15/2002 Change ID Change Number PCAF ODCM-QA-002 1
03/16/2000
Title:
ODCM REVIEW AND REVISION CONTROL ODCM-QA-003 2
03/05/2003
Title:
EFFLUENT MONITOR SETPOINTS ODCM-QA-004 2
09/20/2002
Title:
AIRBORNE EFFLUENT DOSE CALCULATIe
\\ODCM-QA-005 2
e 0v
Title:
WATERBORNE EFFLUENT DOSE CALCUlaTIONS 2003-1240 2002-1194 2002-1409 2003-1239 2003-1238 2003-1237 PCAF PCAF ODCM-QA-006
Title:
TOTAL DOSE ODCM-QA-007 PCAF 09/20/2002 SYSTEMS PCAF 2003-1236 ODCM-QA-008
Title:
RADII 06/11/2002 MONITORING PROGRAM PCAF 2003-1235 ODCM-QA-009 2
03/18/2003
Title:
DOSE ASSESSMENT POLICY STATEMENTS Pagel of 1 Report Date: 03/26/03 Page I of 1
Report Date: 03/26/03
PROCEDURE CHANGE PROCESS FORM PCAF NO. 2003-V&
- 12. PAGE 1 OF 6
- 13. PROC. NO.
ODCM-QA-001 REV. 1
- 4.
FORMS REVISED R
R.R-R R__
R R
- 5.
PROCEDURE TITLE ODCM INTRODUCTION
- 6.
REQUESTED CHANGE PERIODIC REVIEW l
NO L YES INCORPORATE PCAFS El NO 1
YES # 2002-1699 REVISION LI PCAF DELETION
[](CHECK<<ONE ONLY)
- 7.
SUMMARY
OF I REASON FOR CHANGE
<g, The change being rade is the addition of the Nuclear Emergency Planning4t tIECOMMENDED REVIEWS" section on the procedure cover page.
This change to ODCM-OA-001 is an administrative correction and does not dase the level of effluent control or the accuracy and/or reliability of dose calculations or setjhit determinations as required by 1 OCFR20.1302, 40CFR1 90, 1 OCFR50.36a and 1 OCFR50 App. I.
Continued [
- 8.
DETERMINE COMMITTEE REVIEW REQUIREM ENT'S--
(Refer to Section 6.1.4)
PORC REVIEW REQ'D?
LVES
- 9.
PORCMTG#
d BLOCKS 11 THRU 16AREONPAGEYO):FOdR__
- 17.
Francis J. Hickey 3
- 18. COMMUNICATION OF CHANGE REQUIRED?
PREPARER t
DATE s NO F
YES (TYPE)
(Print or Type)
- 19.
nm-SIGNATURE ATTESTS THAT RESPONSIBLE SUPERVISOR HAS
- 19.
CONDUCTED QADR AND TECHNICAL REVIEW UNLESS OTHERWISE DOCUMENTED IN BLOCK 16 OR ATTACHED REVIEW FORMS.
.S; i'~
D Q
CROSS DISCIPUNE REVIEW (IF REQUIRED) HAS BEEN COMPLETED ESPBJER VISOR DATE BY SIGNATURE IN BLOCK 16 OR ATTACHED REVIEW FORMS.
- 20.
N/A FUM APPROVAL DATE
- 21. RESPONSIBLE APPROVER N/A
-ENTER N/A IF FUM HAS APPROVAL AUTHORITY INITIALS
- DATE AF6RM NDAP-QA-0002-8, Rev. 8, Page 1 of 2 (Electronic Form)
PROCEDURE CHANGE PROCESS FORM
- 1. PCAFNO. 2003-27,4257
- 12. PAGE20F 6
- 13. PROC.NO. ODCM-OA-001 REV. 1
- 11. This question documents the outcome of the 50.59 and 72.48 Review required by NDAP-QA-0726. Either 11 a, b, c or d must be checked 'YES' and the appropriate forrm attached or referenced.
- a. This change is an Administrative Correction for which 50.59 and 72.48 are not 3 YES 3 N/A applicable.
- b. This change is a change to any surveillance, maintenance or administrative f
YES 3 N/A procedure for which 50.59 and 72.48 are not applicable.
- c. This change is bounded by a 50.59/72.48 Screen/Evaluation, therefore, no new a YES W
N/A 50.59/72.48 Evaluation is required.
Screen/Evaluation No.
- d. 50.59 and/or 72.48 are applicable to this change and a 50.59/72.48 Fl YES l N/A Screen/Evaluation is attached.
s YES Change Request No.
- 13. Should this change be reviewed for potential effects on Training Needs or Material?
El YES
'3 NO If YES, enter an Action Item @ NIMS/Action/Gen Work Mech/PICN
- 14. Is a Surveillance Procedure Review Checklist required per NDAP-QA-0722?
[] YES 3 NO
- 15. Is a Special, Infrequent or Complex Test/Evolution Analysis Form required per C] YES 3 NO NDAP-OA-0320? (SICT/E form does not need to be attached.)
- 16. Reviews may be documented below or by attaching Document Review Forms NDAP-QA-01 01 -1.
REVIEWED BY WITH DATE REVIEW NO COMMENTS QADR TECHNICAL REVIEW REACTOR ENGINEERING/NUCLEAR FUELS
- IST**
OPERATIONS NUCLEAR SYSTEMS ENGINEERING NUCLEAR MODIFICATIONS MAINTENANCE HEALTH PHYSICS NUCLEAR TECHNOLOGY CHEMISTRY OTHER Required for changes that affect, or have potential for affecting core reactivity, nuclear fuel, core power level indication or impact the thermal power heat balance. (58)
Required for changes to Section Xl Inservice Test Acceptance Criteria.
FORM NDAP-QA-0002-8, Rev. 8, Page 2 of 2 (Electronic Form)
)
PACL.O~a PROCEDURE COVER SHEET PPL SUSQUEHANNA, LLC I NUCLEAR DEPARTMENT PROCEDURE ODCM INTRODUCTION ODCM-QA-001 Revision 1 Page 1 of 15 QUALITY CLASSIFICATION:
APPROVAL CLASSIFICATION:
O QA Prograrn 0 Non-QA Program 0 Plant C Non-Plant Instruction EFFECTIVE DATE:
PERIODIC REVIEW FREQUENCY:
N/A PERIODIC REVIEW DUE DATE:
NIA RECOMMENDED REVIEWS:
Nuclear Bpergency Flaming Procedure Owner:
Francis J. Hickey Responsible Supervisor:
Chemistry Support Supervisor-SSES Responsible FUM:
Chemistry Supervisor-SSES Responsible Approver Vice President-Nuclear Operations
'5 IA -
F-P C
A F
FORM NDAP-QA0002-1, Rev. 3, Page 1 of 1
ODCM-QA-001 Revision 1 Page 2 of 15 PROCEDURE REVISION
SUMMARY
TITLE:
ODCM INTRODUCTION The revisions described below are clarification adding detail and editorial in nature and do not change any limits or analyses. Thus, Revision 1 of ODCM-QA-001 maintains the level of radioactive effluent control required pursuant to 10CFR20.1302, 40CFR190, 10CFR50.36a and Appendix I to 10CFR50 and does not impact the accuracy or reliability of effluent, dose, or setpoint calculations.
In addition, these changes (1) do not alter the conduct of the radiological environmental monitoring program, (2) do not change the radioactive effluent controls and radiological environmental monitoring activities, and (3) do not change the information to be included in the Annual Radiological Environmental Operating and Radioactive Effluent Release Reports.
- 1. Removal of gray shading from ITS Implementation (NIMS 381803).
- 2. Added responsibilities for Supervisor - Environmental Services (Section 4.9)
(NIMS 381805).
- 3. Revised Attachment A as to content details for AE&WD Report (NIMS 381805).
- 4. Added Attachment B to include content for AREOR (NIMS 381805).
- 5. Deleted Reference 3.4, NDAP-QA-0152 as it no longer exists.
- 6. Updated position titles and minor word changes in Section 4.0.
- 7. Sections 2.1 and 2.4 minor wording changes.
- 8. Reference change for Section 5.1.
0 ULILM-UA-UU1 PAGOL $
OF. L Revision 1 Page 3 of 15 a_
TABLE OF CONTENTS SECTION PAGE 1.0 PURPOSE 4
2.0 POUCY/DISCUSSION 4.
2.1 Derived Release Concentrations and Dose Rates 4
2.2 Radioactive Effluent Control Program (RECP) 4 2.3 Annual Effluent and Waste Disposal Report 4
2.4 Annual Radiological Environmental Operating Report 5
2.5 Special Reports 5
3.0 REFERENCES
5 4.0 RESPONSIBILITIES 6
4.1 Vice President - Nuclear Operations 6
4.2 General Manager - Nuclear Engineering 6
P 4.3 General Manager - Nuclear Assurance 6
C 4.4 Chemistry Supervisor - SSES 6
A 4.5 Manager - Regulatory Affairs 6
F 4.6 Chemistry Support Personnel 6
4.7 Chemistry Support Supervisor-SSES 7
5.0 DEFINITIONS 7
6.0 PROCEDURE 7
6.1 Organization 7
7.0 RECORDS 9
ATTACHMENT PAGE A
Contents of Annual Effluent and Waste Disposal Report 10 B
Contents of Annual Radiological Environmental Operating Report 15
ODCM-QA-001 Revision I Page 4 of 15 1.0 PURPOSE The prurpose of this procedure is to describe the overall purpose and organization of the SSES Offsite Dose Calculation Manual (ODCM).
2.0 POLICYIDISCUSSION The purpose of the ODCM is to provide the parameters and methodology to be used in calculating offsite doses and effluent monitoring setpoints for the Susquehanna Steam Electric Station, Units 1 and 2. The ODCM contains the requirements of the Radiological Effluent Control Program (RECP) as described in Section 2.2 and the Radiological Environmental Monitoring Program (REMP) as defined in TR 3.11.4.
Remedial actions to be taken when program limits (TROs) are exceeded are specified in the Technical Requirements Manual (TRM). The ODCM includes methods for determining maximum individual, whole body, and organ doses due to waterbome and airborne effluents to ensure compliance with the dose limitations in the Technical Requirements (TR). Methods are also included for performing dose calculations to ensure compliance with the waterbome and airborne treatment system operability sections of the Technical Requirements. This manual includes the required inputs for inclusion in the Annual Effluent and Waste Disposal Report and the Annual Radiological Environmental Operating Report.
2.1 Derived Release Concentrations and Dose Rates The ODCM uses 10 times the concentrations of Appendix B, Table 2, Column 2 of 10CFR20.1001-20.2402 as concentration limits for liquid releases and the instantaneous release rates which are no longer referenced in 10CFR20 but
- come directly from TR 3.11.2 for gaseous releases as confirmed in the 6/93 NRC response to NUMARC.
2.2 Radioactive Effluent Control Program (RECP)
The Radioactive Effluent Control Program (RECP) is a comprehensive program as detailed in TS 5.5.4 which provides control of radioactive effluent for maintaining the dose to members of the public from radioactive effluent as low as reasonably achievable. The RECP is defined in TR's 3.6.1, 3.11.1, 3.11.2, and 3.11.3.
2.3 Annual Effluent and Waste Disoosal Report The radioactive effluent release report is titled, "Annual Effluent and Waste
-Disposal Report."
It covers the operation of the station during the previous year and-must be submitted prior to May 1 of each year in accordance with TS 5.6.3. The report is prepared in accordance with Procedure ST-099-002 and the required topics for the report are provided in Attachment A.
A
ODCM-QA-001 Revision I Page 5 of 15 2.4 Annual Radiological Environmental Operating Report
- This report, submitted prior to May 15 of each year, contains the summaries, interpretations and analyses of the results of the Radiological Environmental Monitoring Program for the previous year as spelled out in ODCM-QA-008 and the required topics for the report are provided in Attachment B.
2.5 Special Reports These reports are required to be submitted to the NRC when the limits of TR's 3.11.1.2, 3.11.1.3, 3.11.2.2, 3.11.2.3, 3.1i.2.4, 3.11.2.5, 3.11.3, and 3.11.4.1 (Condition B, C, or D) are exceeded. Special reports shall be submitted within 30 days and shall address the actions required in the TRM.
3.0 REFERENCES
3.1 TS 5.5.1, Offsite Dose Calculation Manual (ODCM) 3.2 TS 5.5.4, Radioactive Effluent Control Program 3.3 TR 2.1.1, ODCM 3.4 TR 2.1.4, Radioactive Effluent Controls 3.5 TR 3.6.1, Containment Venting or Purging 3.6 TR 3.11, Radioactive Effluents 3.7 ST-099-002, Radioactive Effluent Release Report 3.8 10CFR20 Appendix B, Annual Limits on Intake and Derived Air Concentrations of Radionuclides for Occupational Exposure; Effluent Concentrations; Concentrations for Release to Sewerage 3.9 NDAP-QA-0646, Solid Radioactive Process Control Program 3.10 Letter from T. Murley, Director, Office of Nuclear Reactor Regulations, to T. Tipton, Vice President and Director of Operations, NUMARC, 6/93 3.11 NDAP-QA-1 180, Radiological Effluent Monitoring and Control 3.12
-NDAP-00-1203, Process for Major Project Identification, Scoping and Long-Range Planning
ruswB_
ODCM-QA 001 PAG OF.
Revision 1 5Page 6 of 15.
4.0 RESPONSIBILMES 4.1 Vice President - Nuclear Operations.
4.1.1 Ensures that the ODCM is used in performance of the surveillance requirements and for compliance with the TROs stated in the TRM relative to radioactive effluent 4.1.2 Approves revisions to the ODCM.
4.2 General Manager - Nuclear Engineering c
4.2.1 Provides modification engineering and support in accordance with F
NDAP-00-1203 for equipment and systems involved with the conduct of the effluent and environmental monitoring programs at SSES.
P 4.3 General Manager-Nuclear Assurance C
4.3.1 Periodically assesses the SSES effluent, environmental and meteorological programs for compliance with the requirements of the TRM and the ODCM.
4.4 Chemistry Supervisor-SSES 4.4.1 Ensures the adequacy and correctness of methodologies described in the ODCM.
4.4.2 Is responsible for reviewing revisions to the ODCM.
4.4.3 Approves both the Annual Effluent and Waste Disposal and the Annual Radiological Environmental Operating Reports submitted to the NRG.
4.4.4 Manages the programs for the assessment of the radiological environmental impact of SSES.
P 4.5 Manager-Regulatorv Affairs A
4.5.1 Submits the required radiological effluent and environmental reports to F
the NRC.
4.5.2 Notifies the appropriate groups of NRC licensing requirements.
4.6 Chemistry Support Personnel 4.6.1 Develops methodologies used in performance of effluent dose calculations and establishment of setpoints.
PAGR.J OF.L Revision 1 Page 7 of 15 A.6.2 Performs dose calculations necessary for fulfillment of SSES Technical Requirements Surveillance.
4.6.3 Prepares and submits the Annual Effluent and Waste Disposal Report to Regulatory Affairs for submittal to the NRC.
4.6.4 Prepares and submits the Annual Radiological Environmental Operating P
Report to Regulatory Affairs for submittal to the NRC.
C A
4.7 Chemistry Supoort Subervisor-SSES F
4.7.1 Reviews Annual Effluent and Waste Disposal Report and Annual Radiological Environmental Operating Report to assure adequacy of content in accordance with Attachments A and B, respectively, 4.7.2 Ensures development of appropriate revisions to the ODCM.
5.0 DEFINmONS 5.1 ECL - Effluent Concentration Umit as defined by TRO 3.11.1.1.
5.2 Site Boundary - Is that line beyond which the land is not owned, leased or otherwise controlled by the licensee. (PPL Drawing C243786, SHI, Rev. 1,
" U-1 &2 Site Facilities and Boundary Map.")
5.3 Unrestricted Area -The area at or beyond the site boundary access to which is neither limited nor controlled by the licensee for purposes of protection of individuals from exposure to radiation and radioactive materials, or any area within the site boundary used for residential quarters or for industrial, commercial, institutional and/or recreational purposes.
6.0 PROCEDURE 6.1 Oraantzation P
Chemistry Department - SSES shall develop and maintain a set of prbcedures I c as described in the following subsections.
F A 6.1.1 ODCM-QA-001 - ODCM Introduction This procedure describes the overall purpose and organization of the ODCM.
6.1.2 ODCM-QA-002 - ODCM Review and Revision Control This procedure describes the initiation, review and processing of revisions to the ODCM and establishes responsibility for the ODCM.
IL ODCM-QA-001 Revision 1 Page 8 of 15 6.1.3 ODCM-QA-003 - Effluent Monitor Setpoints This procedure describes the policies pertaining to and the methodology used in establishing effluent monitor setpoints.
6.1.4 ODCM-QA-004 - Airborne Effluent Dose Calculations This procedure provides the methodology and parameters used in calculating air dose resulting from noble gas effluent and maximum individual, whole body, and organ doses due to airborne effluents to ensure compliance with the dose limitations in the Technical Requirements Manual.
6.1.5 ODCM-QA-005 - Waterbome Effluent Dose Calculations This procedure provides the methodology and parameters to be used in calculating maximum individual, whole body, and organ doses due to waterborne effluents to ensure compliance with the dose limitations in the Technical Requirements Manual.
6.1.6 ODCM-QA-006 - Total Dose Calculations This procedure provides the methodology and parameters to determine the total dose to a member of the public from the fuel cycle in the vicinity of the SSES site.
- 6.1.7 ODCM-QA-007 - Radioactive Waste Treatment Systems This procedure defines the operability requirements of the radioactive waste treatment systems and monitoring instruments. It also includes reporting requirements where changes are made to systems or when operability is not maintained in accordance with the TRM.
6.1.8 ODCM-QA-008 - Radiological Environmental Monitoring Program This procedure provides the methodology and parameters used to determine doses to the public resulting from inhalation, ingestion, and direct shine from radiologically contaminated environmental sampling media based on measured activity concentrations in those media. This procedure also describes the Radiological Environmental Monitoring Program (REMP), which includes the annual land use census survey and interlaboratory comparison program.
6.1.9 ODCM-QA-009 - Dose Assessment Policy Statements The purpose of this procedure is to state dose and effluent policy statements that are not directly associated with any other section of the ODCM.
ODCM-QA-001 Revision 1 Page 9 of 15 7.0 RECORDS Except for ODCM-QA-002, no records are specified by the ODCM. Records are generated in performance of other procedures that use the information contained in the ODCM. Control of these records is specified in the controlling procedures.
ODCM-QA-001(26)
Attachment A ODCM-QA-001 Revision 1 Page 10 of 15 CONTENTS OF ANNUAL EFFLUENT AND WASTE DISPOSAL REPORT (Note: All data and information is referenced to RG 1.21 unless otherwise noted.)
General Provide an estimate of total error associated with the measurement of radioactivity combining errors with sampling and measuring.
Values stated using three significant figures.
Values stated using external floating point form using 'E' to denote exponent to the base 10.
The term "not detected" should not be used.
- Annual report for previous year to be submitted prior to May I of each year (TS 5.6.3).
ODCM shall be submitted to the NRC in the format of a complete legible copy of the entire ODCM for the period of the report in which any change in the ODCM was made. Each change shall be identified by markings in the margin of the affected pages clearly indicating the area of the page that was changed, and shall indicate the date (i.e., month and year) the change was implemented (TS 5.5.1.C.3).
Liquid Radwaste Effluent Monitoring Instrumentation inoperability not corrected in a timely manner (TRM Action 3.11.1.4.F.2).
Radioactive Liquid Process Monitoring Instrumentation (Table 3.11.1.5-1) inoperability not corrected in a timely manner (TRM Action 3.11.1.5.C.1).
Explanation for Radioactive Gaseous Effluent Monitoring Instrumentation required actions and completion times not met (TRM Action 3.11.2.6.K).
Land use census identifies a new location which yields a calculated dose or dose commitment greater than the values currently being calculated (TRM Action 3.11.4.2.A).
Land use census identifies a location(s) that yields a calculated date or dose commitment (via the same exposure pathway) 20 percent greater than at a location from which samples are currently being obtained (TRM Action 3.11.4.2.B).
Identify the cause of the availability of milk or fresh leafy vegetable samples and identify the new location(s) for obtaining replacements (TRM Action 3.11.4.1.F.2).
Page 1 of 5
Attachment A ODCM-QA-001 Revision I Page 11 of 15 Liquid Effluent
- 1. Mixed Fission and Activation Products Quarterly sums of total curies of radioactive material determined to be released in liquid effluents (not including tritium, dissolved and entrained gases, and alpha-emitting material).
(See Table 2A.)
Average concentrations (pCi/ml) of mixed fission and activation products (C.1.a above) released to unrestricted areas, averaged over the quarterly periods covered by the report.
Percent of applicable limit of average concentrations released to unrestricted areas (C.1.b above). Include the limit used and the bases in the supplemental report information.
Quarterly sums of total curies for each of the radionuclides determined to be released in liquid effluents based on analyses performed. Data should be separated by type of release mode, i.e., continuous or batch. (See Table 2B.)
Average concentrations (pCi/ml) of tritium released in liquid effluents to unrestricted areas, averaged over the quarterly periods covered by the report.
Percent of applicable limit of average concentrations released to unrestricted areas (C.2.b above), i.e., percent 3 x 1 0-3pCiml. Include the limit and the bases in the supplemental report information.
- 3. Dissolved and Entrained Gases
- Quarterly sums of total curies of gaseous radioactive material determined to be released in liquid effluents.
- Average concentrations (p Ci/ml) of dissolved and entrained gaseous radioactive material released to unrestricted areas averaged over the quarterly periods covered by the report.
Percent of limit of average concentrations released to unrestricted areas. Include the limit used and the bases in the supplemental report information.
Quarterly sums of total curies for each of the radionuclides determined to be released as dissolved and entrained gases in liquid effluents.
Page 2 of 5
_I L
Attachment A ODCM-QA-001 Revision 1 Page 12 of 15
- 4. Alpha Radioactivity Quarterly sums of total curies of gross alpha-emitting material determined to be released in liquid effluents.
- 5. Volumes Quarterly sums, in liters, of total measured volume, prior to dilution, of liquid effluent released.
Quarterly sums of total determined volume, in liters, of dilution water used during the period of the report.
- 6. Stream Flow Data on the average flow of the stream during periods of effluent release should be collected and reported in the Supplemental Information section of the report.
Gaseous Effluent
- 1. Gases Quarterly sums of total curies of fission and activation gases released.
- Average release rates (pCisec) of fission and activation gases for the quarterly periods covered by the report.
Percent of limit for releases of fission and activation gases.
Quarterly sums of total curies for each of the radionuclides determined to be released based on analyses of fission and activation gases. The data should be categorized by:
(1) elevated releases, batch and continuous modes, and (2) ground-level releases, batch and continuous modes.
- 2. Iodines
- Quarterly sums of total curies of iodine-131 and iodine-1 33 released.
- Average release rate (pCilsec) of iodine-131 and iodine-133.
Percent of limit for iodine-131 and iodine-1 33.
Quarterly sums of total curies of each of the isotopes, iodine-131, iodine-133, and iodine-135 determined to be released.
Page 3 of 5
Attachment A ODCM-QA-001 Revision 1 Page 13 of 15
- 3. Particulates Quarterly sums of total curies of radioactive material in particulate form with half-lives greater than eight days determined to be released.
- Average release rate (pCilsec) of radioactive material in particulate form with half-lives greater than eight days.
Percent of limit for radioactive material in particulate form with half-lives greater than eight days.
- Quarterly sums of total curies for each of the radionuclides in particulate form determined to be released based on analyses performed.
Quarterly sums of total curies of gross alpha radioactivity determined to be released.
- 4. Tritium Quarterly sums of total curies of tritium determined to be released in gaseous effluents.
- Average release rate (pCi/sec) of tritium.
Percent of appropriate limits for tritium.
- 5. The Gaseous Effluent Table (RG Table 1.C) should list nuclides even if the total is reported as zero (NIMS 281707).
- 6. Detectable airborne radioactivity in the Low Level Radwaste Holding Facility (FSAR 11.6.11).
Solid Radwaste (SRW)
Total curie quantity and radionuclide composition for solid waste shipped for burial or disposal.
Total SRW volume in cubic meters.
Total SRW radioactivity in curies for the categories of waste specified (a) spent resins, filter sludges, evaporator bottoms, etc., (b) dry compressible waste, contaminated equipment, etc., (c) irradiated components, control rods, etc., (d) other (describe) as applicable. [Note:
Our reporting typically breaks these categories into more detail.]
Estimateof the major nuclide composition in each category of SRW.
Page 4 of 5
IL Attachment A ODCM-QA-001 Revision 1 Page 14 of 15 The disposition of SRW shipments (number of shipments, mode of transport and destination). [Note: This involves shipments that lead to burial or disposal during the year. It does not include shipments for processing.]
The disposition of irradiated fuel shipments (number of shipments, mode of transport and destination).
Licensee initiated changes to the Process Control Program to include detailed information to support rationale for changes, change did not reduce the overall conformance of the solidification waste product to existing criterion for solid radwaste, changes reviewed and recommended for approval by PORC. (FSAR 13.4.4.1)
Meteorological Data Cumulative joint frequency distribution of wind speed, wind direction and atmospheric stability.
Radiological Impact on Man Total body and significant organ doses to individuals in unrestricted areas from receiving water-related exposure pathways.
Total body and skin doses to individuals exposed at the point of maximum offsite ground-level concentrations of radioactive materials in gaseous effluents.
Organ doses to individuals in unrestricted areas from radioactive iodines and radioactive material in particulate form from all pathways of exposure.
Total body doses to individuals in unrestricted areas from direct radiation from the facility.
Calculated doses to members of the public within the Riverlands/Information Center Complex.
Supplemental Information (Per RG 1.21, Page 1.21-13)
Standards for Normal Operation (Per 40 CER 190.10)
Page 5 of 5
Attachment B ODCM-QA-001 Revision 1 Page 15 of 15 CONTENTS OF ANNUAL RADIOLOGICAL ENVIRONMENTAL OPERATING REPORT
Sampling Location Maps and Tables with Distances and Directions from SSES (TRS 3.11.4.1.1)
Tables of all Detectable Primary Analysis Results and Radiation Measurements (TRS 3.11.4.1.2 and TS 5.6.2)
Tables with a Statistical Summary of Analysis Results (TS 5.6.2)
Data Interpretation (TS 5.6.2)
Comparison of Indicator Location Data with Other Periods and Controls (TS 5.6.2)
- Trend Analyses for Detectable Results (TS 5.6.2)
Dose Evaluation with Environmental Impact Assessment (TRS 3.11.4.1.3)
Interlaboratory Comparison Results (TRS 3.11.4.3.1)
Deviations from Sampling/Analysis Requirements (TRM 3.11.4.1.A)
Non-SSES Radionuclide Activities Detected (TRM 3.11.4.1.E)
Explanation of Unavailable Monitoring Results (TS 5.6.2)
Page 1 of 1
PROCEDURE CHANGE PROCESS FORM
- 1. PCAFNO.
N/80<}
- 12. PAGE I OF 6 13 PROC. NO.
ODCM-QA-002 REV. 1
- 4. FORMS REVISED -
_R_
R R
R
-Rl
- 5. PROCEDURE TITLE ODCM REVIEW AND REVISION CONTROL
- 6. REQUESTED CHANGE PERIODIC REVIEW l
NO LI YES INCORPORATE PCAFS L NO
[D YES # 2002-1194 REVISION L
PCAF
-DELETION [J, (CmE& ONE ONLY)
- 7.
SUMMARY
OF / REASON FOR CHANGE I
hi This change is being made as the result of clarification by Nuclear Regulatory AffIAtof thefbabt that 50.59 and 72.48 screens are not needed for ODCM changes because the process for making chaniges isirealr'ady approved by the NRC in section 5.5.1 of the SSES Technical Specifications. In addition, this change alsoreplace all appropriate references to the 'Environmental Services Health Physicist (Effluents)" with 'Environmenital Services Health Physicist." Any Environmental Services Health Physicist may perform most of the tasks described id ODCM-QA-002. The "(Effluents)"
restriction is generally unnecessary, with the exception of items directly inv'ed, ith the preparation of the Annual Effluent and Waste Disposal Report. This change to ODCM-QA-0@ is adminstrative and does not decrease the level of effluent control or the accuracy and/or reliability of dose calculaton netp6* determinations as required by 10CFR20.1302. 40CFR190. 10CFR50.36a. and 10CFR50.
7 Jv AContinued
- 8. DETERMINE COMMITTEE REVIEW REQUIREMENTR (Refer to Section 6.1.4)
PORC REVIEW REQ'D?
YES.
PORCMTG
~
h.
BLOCKS 11 THRU 16 ARE ON PAGE~2b)OFFoRkM
- 17.
William A. Hill Jc-oA891 05/16/2002
- 18.
COMMUNICATION OF CHANGE REQUIRED?
PREPARER z
N`$>
DATE 3 NO F YES (TYPE)
(Print or Type)X 19 M<
AdSIGNATURE ATTESTS THAT RESPONSIBLE SUPERVISOR HAS et I s -S Ar.
k e
CONDUCTED QADR AND TECHNICAL REVIEW UNLESS OTHERWISE
~A itl Ef li S
- n DOCUMENTED IN BLOCK 16 OR A17ACHED REVIEW FORMS.
RESP LE SUPERVISOR C BY SIGNATURE IN BLOCK 16CRATTACHED REVIEW FORMS.
FUM APPROVAL DATE
- 21. RZBLEVAPPROVER
- 1 Toz-DATE
- ENTER N/A IF FUM HAS APPROVAL AUTHORITY INITIALS
--FORM NDAP-QA-0002-8, Rev. 8, Page 1 of 2 (Electronic Form)
PROCEDURE CHANGE PROCESS FORM
- 1. PCAF NO.
-47?-/q'6 5'-
- 12.
PAGE 2 OF 5
- 13.
PROC. NO. ODCM-QA-002 REV. 1
- 11.
This question documents the outcome of the 50.59 and 72.48 Review required by NDAP-QA-0726. Either II a, b, c or d must be checked 'YES" and the appropriate form attached or referenced.
- a. This change is an Administrative Correction for which 50.59 and 72.48 are not E
YES N/A applicable.
- b. This change is a change to any surveillance, maintenance or administrative J3 YES El N/A procedure for which 50.59 and 72.48 are not applicable.
-A-e a/
1W
- c. This change is bounded by a 50.59/72.48 Screen/Evaluation, therefore, no new YES 3 N/A 50.59/72.48 Evaluation is required.
Screen/Evaluation No.
- d. 50.59 and/or 72.48 are applicable to this change and a 50.59/72.48 0 YES Z N/A Screen/Evaluation is attached.
Change Request No.
- 13.
Should this change be reviewed for potential effects on Training Needs or Material?
If YES, enter an Action Item @ NIMS/Action/Gen Work Mech/PICN
- 14.
Is a Surveillance Procedure Review Checklist required per NDAP-QA-0722?
- 15.
Is a Special, Infrequent or Complex TestlEvolution Analysis Form required per NDAP-QA-0320? (SICT/E form does not need to be attached.)
M YES El YES E
NO YES Z
NO El YES Z NO
- 16. Reviews may be documented below or by attaching Document Review Forms NDAP-QA-0101-1.
REVIEWED BY WITH DATE REVIEW NO COMMENTS QADR
&4 a
7-TECHNICAL REVIEW REACTOR ENGINEERING/NUCLEAR FUELS
- IST OPERATIONS NUCLEAR SYSTEMS ENGINEERING NUCLEAR MODIFICATIONS MAINTENANCE HEALTH PHYSICS NUCLEAR TECHNOLOGY CHEMISTRY OTHER Required for changes that affect, or have potential for affecting core reactivity, nuclear fuel, core power level indication or impact the thermal power heat balance. (58)
Required for changes to Section Xl Inservice Test Acceptance Criteria.
FORM NDAP-QA-0002-8, Rev. 8, Page 2 of 2 (Electronic Form)
PROCEDURE COVER SHEET NUCLEAR DEPARTMENT PROCEDURE m
ODCM REVIEW AND REVISION CONTROL ODCM-QA-002 Revision 1 Page 1 of 8 QUALITY CLASSIFICATION:
APPROVAL CLASSIFICATION:
z QA Program D Non-QA Program E
Plant
-Plant LI Instructiqh c
EFFECTIVE DATE:
j/16/00 PERIODIC REVIEW FREQUENC 9 N/A PERIODIC REVIEW DUE pATEW N/A
'.d
-44v.,
RECOMMENDED REVIEWS:
Procedure wner M. B. Detamore Res sbe Supervisor:
Supervisor-Environmental Services Responsible FUM:
Manager-Nuclear Technology Responsible Approver General Manager-SSES I
FORM NDAP-QA-0002-1, Rev. 2, Page 1 of 1
ODCM-QA-002 Revision 1 Page 2 of 8 PROCEDURE REVISION
SUMMARY
TITLE:
ODCM REVIEWAND REVISION CONTROL
- 1.
Incorporate ITS related changes.
- 2.
Change responsibilities to recognize Supervisor - Environmental Services position.
- 3.
Revise Section 6.1 to state that changes tracked by other mechanisms (Condition Reports, Modifications) do not require use of Form ODCM-QA-002-1.
- 4.
Add a Section 6.3.4 to include the revision control requirements of Technical Specifications 5.5.1.C.3.
- 5.
Revise Section 6.6 to allow other members of Operations Technology to present ODCM revisions to PORC.
The above changes to ODCM-QA-002 have been evaluated as to not decrease the level of effluent control or the accuracy andlor reliability of dose calculations or setpoint determinations as required by IOCFR20.1302, 40CFRI90, 10CFR50.36a and 10CFR50, App. I..
In addition, these changes(') do not alter the conduct of the radiological environmental monitoring program, (2) do not change the radioactive effluent controls and radiological environmental monitoring activities, and(3) do not change the information to be included in the Annual Radiological Environmental Operating and Radioactive Effluent Release Reports.
I ODCM-QA-002
/'C4f A
n-Revision 1 0
vPage3of8 TABLE OF CONTENTS SECTION PAGE 1.0 PURPOSE 4
2.0 POLICY/DISCUSSION 4
3.0 REFERENCES
4 4.0 RESPONSIBILITIES 5
4.1 General Manager-SSES 5
4.2 Manager - Nuclear Technology 5
-4.3 Supervisor - Environmental Services 5
p C
4.4 Environmental Services - Health Physicist 5
IA 4.5 All Personnel 5
5.0 DEFINITIONS 6
6.0 PROCEDURE 6
7.0 RECORDS 7
ATTACHMENTS ATTACHMENT PAGE A
SSES ODCM CHANGE REQUEST (FORM ODCM-QA-002-1) 8
UIL ODCM-QA-002 Revision 1 Page 4 of 8 1.0 PURPOSE The purpose of this procedure is to describe the initiation, review, and processing of revisions to the ODCM and to establish responsibility for the ODCM.
This procedure constitutes part of the SSES Offsite Dose Calculation Manual (ODCM),
which is a licensing basis document.
2.0 POLICY/DISCUSSION 2.1 The ODCM is part of the Licensing Basis of SSES and is controlled by ITS 5.5.1, Offsite Dose Calculation Manual (ODCM).
2.2 The ODCM procedures are controlled as Plant Functional Unit Procedures in accordance with the requirements of NDAP-QA-0002, with the following additional guidance and controls:
2.2.1 ODCM procedures shall be numbered as follows: ODCM-QA-nnn, where nnn is a sequential number starting with 001.
2.2.2 ODCM procedures shall be reviewed and accepted by the Manager -
Nuclear Technology prior to PORC review.
2.2.3 ODCM procedures shall be approved by the General Manager - SSES.
2.2.4 Changes to the procedures comprising the ODCM require PORC review prior to approval. Changes which are solely administrative corrections or an expedited review revision are excepted. PORC review will be indicated by recording the PORC meeting number on the Procedure Change Process Form (NDAP-QA-0002-8).
2.2.5 ODCM procedures shall be issued and controlled by Nuclear Records Document Control Services (NR-DCS) in accordance with NR procedures. The distribution list shall be maintained by DCS.
2.3 Changes to the Radioactive Effluent Control Program (RECP) are controlled in
-accordance with NDAP-QA-0728, but are reported as changes to the ODCM in the Annual Effluent and Waste Disposal Report.
3.0 REFERENCES
3.1 TS 5.5.1, Offsite Dose Calculation Manual (ODCM) 3.2 NDAP-QA-0002, Nuclear Department Procedure Program 3.3 NDAP-QA-0101, Document Review
ODCM-QA-002
°,,9 4 at Revision 1 Page 5 of 8 3.4 NDAP-QA-01 52, Quality Assurance for Radiological Environmental Monitoring, Radioactive Effluents, Meteorology, The Environmental Protection Plan, and The Offsite Dose Calculation Manual 3.5 NDAP-QA-0728, SSES Technical Requirements Program 3.6 10CFR20.1302, Compliance with Dose Limits for Individual Members of the Public 3.7 40CFR190, Environmental Radiation Protection Standards for Nuclear Power Operation 3.8 1 OCFR50.36a, Technical Specifications on Effluents from Power Reactors 3.9 10CFR50, Appendix I, Numerical Guides for Design Objectives and Limiting Conditions for Operation to Meet "As Low As Is Reasonably Achievable' for Radioactive Material in Light-Water Cooled Nuclear Power Reactors 4.0 RESPONSIBILITIES 4.1 General Manager - SSES 4.1.1 Approves revisions to the ODCM.
4.2 Manager - Nuclear Technology 4.2.1 Is the Responsible Functional Unit Manager (FUM) 4.3 Supervisor-Environmental Services 4.3.1 Ensures the adequacy and correctness of methodologies described in the ODCM.
4.3.2 Is responsible for reviewing revisions to the ODCM.
P 4.4 Environmental Services '- Health Physicist C
4.4.1 Maintains the ODCM.
4.4.2 Processes revisions to'the ODCM.
4.5 All Personnel P
4.5.1 Submit comments on ODCM contents and proposed revisions to the A
appropriate Environmental Services-Health Physicist (Effluent).
F
/Cva' o:ODCM-QA-002
- ,Revision 1
Page 6 of 8 S
5.0 DEFINITIONS None.
6.0 PROCEDURE 6.1 Personnel shall submit proposed ODCM revisions on the SSES Offsite Dose Calculation Manual Change Request Form ODCM-QA-002-1. The submitter shall complete Sections 1 through 5 according to the directions on the form, including sufficient detail of the revision and technical basis of the change to support the rationale for the change and to enable the Environmental Services-Health Physicist to proceed. The submitter should provide at least one month lead time between the submittal date and the requested implementation date to permit preparation, review by interested parties, and approval of the ODCM revision. Changes tracked by other mechanisms (eg., Condition Reports and Modifications) do not require use of Form ODCM-QA-002-1.
6.2 The Environmental Services Health Physicist shall sign and date Form(s)
ODCM-QA-002-1 on receipt, and retain the form(s) in a work file created for this ODCM revision. The Environmental Services - Health Physicist (Effluent) may contact the form submitter to discuss the details of the revision.
6.3 The Environmental Services Health Physicisf or designee prepares a draft of the
- T"Cs' 0
ODCM revision based on information in Form(s) ODCM-QA-002-1.
6.3.1 The preparer shall ensure that the change does not reduce the level of effluent control or the accuracy and/or reliability of dose calculations or setpoint determinations as required by 10CFR20.1302, 40CFR1 90, 10CFR50.36a and 10CFR50, Appendix I.
6.3.2 The preparer shall include a statement to this effect in the Procedure Revision Summary.
6.3.3 If compliance to the criterion in §6.3.1 cannot be demonstrated, the preparer shall make appropriate changes to ensure compliance, else the proposed revision shall be dismissed.
6.3.4 Each change shall be identified by markings in the margin of the affected pages, clearly indicating the area of the page that was changed. The date the change is implemented is indicated on the Procedure Cover sheet.
6.4 The Environmental Services Health Physicist follows the process described in NDAP-QA-0002, Section 7.0, for plant procedures.
6.4.1 All review comments and resolutions shall be documented according to NDAP-QA-0101.
A".
66wf
°'
?
ODCM-QA-002 Revision 1 9° vPage 7 of 8 6.4.2 The review shall sustain that the change does not reduce the accuracy or reliability of dose calculations and/or setpoint determinations.
6.5 The Environmental Services Health Physicist schedules the proposed ODCM revision for PORC review in accordance with PORC procedures.
T6.6 The Supervisor - Environmental Services or Environmental Services Heat PhysicstEnt) presents the ODCM revision to PORCI along with originating information (Forms)
QA-002-1), review ocmntation (Form NDAP-QA-01 0 1 -1), 5 0. 59 t7 V M48 =Dee t e
% mD APA
-0726 5), Safety Evaluation (if required, Foa th6-1n i2, caal matmrial (calculations, studi Icessary to support the ODCM revisson, tevauioreeuired in cid appropriate signature approvals.
6.6 The Supervisor-Environmental Services H
h sEnvruental Submit Health Physicist presents the ODCM revision to PORC, along with originating information (Form(s) ODCM-OA-002-1), review documentation (Form NDAP-QA-OCo 0101-1), any technical material (calculations, studies, etc.) necessary to support lP~
the ODCM revision, the evaluation required in Section 6.3.1 and appropriate signature approvals.
6.7 The Environmental Services Health Physicist.(EfFluent) shall submit to the NRC a complete, legible copy of the revised ODCM in the Annual Effluent and Waste Disposal Report for the period of the report in which any change in the ODCM wasmade.
7.0 RECORDS The following shall be submitted to Nuclear Records in accordance with NR procedures:
7.1 Form(s) ODCM-QA-002-1, with attachments, if any.
7.2 Review package, assembled in accordance with the requirements of NDAP-QA-0002 and NDAP-QA-0101.
odcrnqaOO2(26)
1.
Attachment A ODCM-QA-002 Revision 1 Page 8 of 8 SSES OFFSITE-DOSE CALCULATION MANUAL CHANGE REQUEST
- 1. ODCM-QA-_
Submit a separate form for each ODCM procedure to be revised.
- 2. Describe proposed revisions to the SSES ODCM below. Include references to sections, figures, tables, parameters, and equations with sufficient detail to convey complete and correct information. If necessary, use additional pages. If proposed revision can be more clearly indicated on marked up copy(s) of the current ODCM, then attach these marked up pages to this form.
- 3. Reason for revision: include references to Condition Reports, Audit Services observations or findings, Licensing Issues, DCPs, etc., as applicable. If necessary, use additional pages.
- 4. Additional pages attached?
Number of additional pages No El Yes El
- 5. Requested date for implementation of revision:
Requested by:
Cost Area:
Date To be completed by Environmental Services Received by:
Date:
FORM ODCM-QA-002-1, Rev. 0, Page 1 of 1 (File R9-5)
PROCEDURE COVER SHEET PPL SUSQUEHANNA, LLC I NUCLEAR DEPARTMENT PROCEDURE 4
EFFLUENT MONITOR SETPOINTS ODCM-QA-003 Revision 2 Page 1 of 17 QUALITY CLASSIFICATION:
-APPROVAL CLASSIF'ICATION:
O QA Program D Non-QA Program E
Plant AQ-EENon-Plant
.IInstructio/
-EFFECTIVE DATE:
o PERIODIC REVIEW FREQUENCJCYEI N/A emf PERIODIC REVIEW DUE DATE:,-
N/A RECOMMENDED REVIEWS:
Nuclear Emergency Pla Procedure Francis Hickey A
Respon Supervisor:
Chemistry Supervisor - SSES Responsible FUM:
Chemistry Supervisor - SSES Responsible Approver:
Vice President - Nuclear Operations FORM NDAP-QA-0002-1, Rev. 3, Page 1 of 1
ODCM-QA-003 Revision 2 Page 2 of 17 PROCEDURE REVISION
SUMMARY
TITLE:
EFFLUENT MONITOR SETPOINTS Most of the revisions described below are editorial in nature. The changes made do not reduce or compromise the level of effluent control or the accuracy and/or reliability of dose calculations or setpoint determinations as required by 1 OCFR20.1302, 40CFR1 90, 1 OCR50.36a and 1 OCFR50, Appendix I. Additionally, the changes outlined below (1) do not alter the conduct of the radiological environmental monitoring program, (2) do not change the radioactive effluent controls and radiological environmental monitoring activities, and (3) do not change the information to be included in the Annual Radiological Environmental Operating and Radioactive Effluent Release Reports.
- 1. Section 2.4.2 was revised to provide more operational flexibility regarding effluent data retrieval and use in order to determine the compliance status of a gaseous effluent release.
ODCM-QA-003 Revision 2 Page 3 of 17 TABLE OF CONTENTS SECTION PAGE 1.0 PURPOSE 4
2.0 POLICY/DISCUSSION 4
2.1 ODCM Setpoints are Upper Limit Values 4
2.2 Waterbome Effluent Monitors 4
2.3 Airborne Effluent Monitors 5
2.4 Selection of Data for Determination of Dose Rate Compliance 5
3.0 REFERENCES
6 4.0 RESPONSIBILITIES 7
4.1 Chemistry Supervisor - SSES 7
5.0 DEFINITIONS 7
6.0 PROCEDURE 7
6.1 Liquid Effluent Monitoring 7
6.2 Airborne Effluent Monitoring - Noble Gas 11 6.3 Airborne Effluent Monitoring - Iodine and Particulate 13 6.4 Airborne Monitor Line Loss Corrections 15 7.0 RECORDS 16 ATTACHMENTS PAGE A
Parameters Used to Determine Airborne Effluent Monitor Setpoints 17
ODCM-QA-003 Revision 2 Page 4 of 17 1.0 PURPOSE This procedure discusses the methodology to be used in determining effluent monitor alarm/trip setpoints to be used to ensure compliance with the concentration and instantaneous release rate limits in the Technical Requirements Manual (Sections 3.11.1.1 and 3.11.2.1) and provides operational flexibility while giving reasonable assurance of meeting the design objectives of 10CFR50, Appendix I.
This procedure constitutes part of the SSES Offsite Dose Calculation Manual which is a licensing basis document.
2.0 POLICY/DISCUSSION 2.1
-ODCM Setpoints are UnDer Limit Values 2.1.1 Effluent monitor alarm/trip setpoints calculated in accordance with the ODCM shall be considered upper limit values. Higher (less conservative) setpoints shall not be used, however lower (more conservative) setpoints may be used as required to maximize the utility of the monitor.
2.2 Waterbome Effluent Monitors 2.2.1 A gross radioactivity monitor providing automatic termination of liquid effluent releases is present on the liquid radwaste effluent line. Flow rate measurement devices are also present on the liquid radwaste effluent line and the discharge line (cooling tower blowdown).
2.2.2 Precautions, limitations, and setpoints applicable to the operation of the SSES liquid effluent monitors are provided in the applicable plant procedures.
2.2.3 The liquid effluent monitor setpoints are determined in accordance with the methodology and parameters described in Section 6.1 and controlled as "field set" in accordance with applicable plant procedures.
2.2.4 Setpoint values are to be calculated to ensure that alarm and trip actions occur upon approaching 10 times the EC limits of 10 CFR 20, Appendix B, Table 2, Column 2 and 2E-4 jCVml for total dissolved gases at the release point to the Unrestricted Area.
2.2.5 Setpoint values for monitors used for leak detection (if set more conservatively than the EC limits) should be based on X times background values provided such values do not result in concentrations greater than the EC limits at the Unrestricted Area. The setpoint is established based on operating experience.
ODCM-QA-003 Revision 2 Page5 of 17 2.3 Airborne Effluent Monitors 2.3.1 Noble gas activity monitors, iodine samplers and monitors, and particulate samplers and monitors are present on the reactor building ventilation system (Units 1 and 2), the turbine building ventilation system (Units 1 and 2), and the standby gas treatment system exhaust vents.
Effluent system flow rate and sampler flow rate are measured on all of the systems allowing the vent monitor microprocessor to calculate release rates based on measured flow rates.
2.3.2 Precautions, limitations, and setpoints applicable to the operation of the SSES airborne effluent monitors are provided in the applicable plant procedures.
2.3.3 Setpoints are conservatively established for each effluent monitor so that the instantaneous dose rates of TRO 3.11.2.1 will not be exceeded.
2.3.4 The general methodology for establishing plant ventilation airborne effluent monitor setpoints is based upon vent release rates derived from site-specific meteorological dispersion conditions, vent flow rates, and measured or expected radionuclide mixtures in the gaseous effluents.
The vent release rate can then be converted to vent concentrations for input as setpoints for the applicable detectors. Since the vent monitors are programmed to calculate concentrations of iodine and particulate being released based on the rate of accumulation of activity on the filters, setpoints can be established for the iodine and particulate channels.
2.3.5 The main condenser offgas pre-treatment monitor provides indication of offgas activity prior to input to the holdup system. Alarm setpoints are based on the Technical Specification 3.7.5 noble gas release rate limit of 330 millicuries/second or less at the motive steam jet condenser discharge.
2.3.6 Noble gas activity monitor setpoints are established at release rates which permit some margin for corrective action to be taken before exceeding the offsite instantaneous dose rates of TRO 3.11.2.1.
2.4 Selection of Data for Determination of Dose Rate ComDliance 2.4.1 Airborne effluent monitor setpoints are maintained in accordance with Section 2.3, to alarm before the dose rate limits of the Technical Requirements Manual 3.11.2.1 are exceeded. Station alarm response procedures contain instructions for investigation and verification of monitor alarms. Because setpoint calculations must include assumptions about the composition of the monitored effluent, a monitor high alarm does not necessarily indicate that a dose rate limit has been exceeded.
ODCM-QA-003 Revision 2 Page 6 of 17 2.4.2 Valid 1 0-minute or valid 15-minute averaged data should be the primary information used to determine the compliance status of an incident.
One-minute averaged data should also be reviewed if available, but they may or may not provide additional information depending on the magnitude of the release due to the manner in which the monitors update values to be stored and associated statistical considerations. Averages over a longer period should be used only when data with higher resolution is not available. Grab sample analyses should be performed whenever possible to confirm or disprove monitor data, and to provide indication of the nuclide specific composition of the effluent. When grab sample data are available which, based on vent monitor data, are indicative of the period of elevated release, dose rate calculations should be performed using the actual effluent mix. The determination of compliance status should not be based on monitor data alone when it is possible to collect and analyze a vent sample which will be representative of the period of elevated release.
3.0 REFERENCES
3.1 TS 3.7.5, [Radioactive Effluents] Main Condenser 3.2 TR 3.11.1.1, [Radioactive Effluents] [Liquid Effluents] Concentration 3.3 TR 3.11.1.4, Liquid Radwaste Effluent Monitoring Instrumentation 3.4 TR 3.11.1.5, Radioactive Liquid Effluent Monitoring Instrumentation 3.5 TR 3.11.2.1, [Radioactive Effluents] [Gaseous Effluents] Dose Rate 3.6 TR 3.11.2.6, Radioactive Gaseous Effluent Monitoring Instrumentation 3.7 10 CFR 20.1301, Dose limits for individual members of the public 3.8 10 CFR 20 Appendix B, Annual Limits on Intake (ALls) and Derived Air Concentrations (DACs) of Radionuclides for Occupational Exposure: Effluent Concentrations; Concentrations for Release to Sewerage 3.9 40CFR1 90, Environmental radiation protection standards for nuclear power operations 3.10 1 OCFR50 Appendix I, Numerical Guides for Design Objectives and Limiting Conditions for Operation to Meet the Criterion 'As Low as is Reasonably Achievable" for Radioactive Material in Light-Water Cooled Nuclear Power Reactor Effluents 3.11 EC-RADN-1041, SSES "Expected" Liquid and Gaseous Effluent Releases, Aquatic Doses, and Atmospheric Doses - Incorporates Condensate Filtration System and Hydrogen Water Chemistry
ODCM-QA-003 Revision 2 Page 7 of 17 3.12 EC-ENVR-1 040, Evaluation of Setpoint Methodology for Airborne Iodine and Particulate Monitors 3.13 Analysis of the Effluent Sampling Line Particulate and Iodine Losses for the Susquehanna Steam Electric Station by Watts-Bar Jones February 1988 (PLI-55451 and PLI-54729) 3.14 The importance of P-32 in Nuclear Reactor Liquid Effluents, USNRC Edward F.
Branagan Jr., Charles R. Nichols, and Charles A. Willis; 1982 3.15 PPL AR# 401298, "Deletion of LRW Composite Sample P-32 Analysis 5/2002w 4.0
-RESPONSIBILITIES 4.1 Chemistry Supervisor - SSES 4.1.1 Is responsible for calibrating, functionally testing, and providing alarm responses for radiological effluent monitoring equipment.
4.1.2 Ensures adequacy and correctness of methodology used to establish setpoints.
4.1.3 Is responsible for development of methodology and calculations used to establish setpoints 5.0 DEFINITIONS 5.1 Actual Tank Activity - The sum of the products of tank concentrations and volume for each isotope.
5.2 Cs-1 37 Equivalent-Concentration equivalent of 1.OOE-06 jCV/mI ECL for Cs-1 37.
5.3 ECL - Effluent Concentration Limits as defined in 1 OCFR20, Appendix B.
6.0 PROCEDURE 6.1 Liquid Effluent Monitoring Chemistry shall develop procedures implementing the following requirements for Liquid Effluent Monitoring.
6.1.1 Discharge Termination Chemistry shall determine the setpoint concentration for the discharge termination, which limits the maximum concentration being released, as follows:
ODCM-QA-003 Revision 2 Page 8 of 17 Cy = x*C" C
(Eq. 6.1-1)
Where:
C7 = The setpoint concentration at which the discharge would be terminated (jiCiml).
X = A unitless number greater than one that is chosen to prevent spurious alarms that might result from non-uniformity in the activity concentrations of the liquid discharges.
Cf,= The concentration of isotope n in the contents of the tank to be discharged as determined by pre-release sampling and analyses.
The summation shall include gamma-emitting isotopes only (including noble gases).
The setpoint concentration is based on the activity of the isotopes to which the monitor responds, i.e., gamma-emitting isotopes only. It is used to establish the radiation monitor setpoint (count rate) in units of cpm or cps.
6.1.2 Radiation Monitor Setpoint The radiation monitor setpoint is the sum of the background count rate and the count rate equivalent of the setpoint concentration. The count rate equivalent of the setpoint concentration in units of,ICi/ml is determined by dividing the setpoint concentration by the calibration factor (igCVmVcprm).
Chemistry shall determine the radiation monitor setpoint as follows:
S=Cy+B (Eq. 6.1-2)
K Where:
S = the radiation monitor setpoint (cpm)
Cr = the setpoint concentration at which the discharge would be terminated from Eq. 6.1-1 (gCVml)
K =
the radiation monitor calibration factor (p.CimVcpm)
B = the background radiation level for the radiation monitor (cpm)
The alarm setpoint may be established at a suitable fraction of the setpoint for discharge termination.
ODCM-QA-003 Revision 2 Page 9 of 17 6.1.3 Discharge Flow Rate Limit Determination The flow rate below which tank discharges must be maintained depends on the magnitude of the dilution required to ensure compliance with the limits of TR 3.11.1.1:
Chemistry shall establish the maximum Discharge Flow Rate using the following equation:
F f -
(Eq. 6.1-3)
Y C(,cIlL, + b CNG, / 2E -4 1
n NGt Where:
f
=
The maximum discharge rate from the tank (gpm).
F
=
The minimum dilution flow rate of 5000 gpm provided by the blowdown flow from the Cooling Towers and any overflow from the spray pond (gprn).
Y
=
A unitless number that is chosen to ensure that the dilution flow is conservatively determined.
Cn
=
The concentration of isotope n in the contents of the tank to be discharged as determined by pre-release sampling and analyses. The summation shall include previous composite sample results for non-gamma emitting radionuclides such as H-3, Fe-55, Sr-89, and Sr-90 (AlCVml).
L
=
Ten (10) times the effluent concentration (EC) for isotope n per 1 OCFR20, Appendix B, Table 2, Column 2 for radionuclides other than noble gases. To maintain compatibility with other federal regulations, the maximum permissible concentration (MPC) value from 10CFR20, Appendix B, Table II, Column 2 (pre-1994 10CFR20) may be used for those isotopes for which the MPC is more restrictive than (10 x EC).
CNGI
=
The concentration of noble gas isotope i in the contents of the tank to be discharged. The summation shall include all dissolved and entrained noble gases.
JM-ODCM-QA-003 Revision 2 Page 10 of 17 Selecting values of X (Section 6.1.1) and Y (Section 6.1.3) is a matter of experience and the expected margin needed between the activity concentration and the maximum concentration limit (10 x ECL).
6.1.4 Post-Release Evaluation Chemistry shall perform post-release evaluations when the actual composite sample results for non-gamma-emitting radionuclides exceed pre-selected criteria.
6.1.5 Service Water, SDHR Service Water, and RHR Service Water The Service Water System provides screened water from the cooling tower basin for cooling plant systems and equipment. The supplemental Decay Heat Removal Service Water System (SDHR) provides decay heat removal during refueling outages when the Service Water System is shut down. The Residual Heat Removal (RHR) Service Water System provides water from the Engineered Safeguard Service Water (ESSW) spray pond to the RHR heat exchangers. In post-accident conditions, RHR Service Water can supply water for vessel and containment flooding. The Service Water, SDHR Service Water, and RHR Service Water Systems are not normal pathways for liquid effluents. Radiation monitors are in place on these systems to provide indication of leaks across heat exchangers into the service water.
The high radiation setpoints for these monitors are set at 1 E-5/cal. factor (IE-5 = 10 times the Cs-137 equivalent). Considering the radionuclides predominant in SSES liquid effluents e.g., Co-58, Co-60, Fe-59, Mn-54 and Cr-51, use of a setpoint based on the Cs-1 37 ECL is reasonable based on the following parameters:
- 1) photon abundance (85%), photon energy (0.662 MeV)
- 2) magnitude of applicable ECL (1 E-6 pCi/ml)
Because Service Water, SDHR Service Water, and RHR Service Water systems are not normal release pathways for liquid effluents, no credit should be taken for possible dilution scenarios. All service water should be maintained below 1 E-5 pCi/mI (10 times the Cs-1 37 equivalent ECL) or as established by Chemistry based on operating experience (Section 2.2.5).
If some background contribution is to be added to the calculated High and Alert setpoints, a' Downscale or Low Rad Setpoint is also required in order to minimize the chance of a change in the background of a monitor masking a significant trend in monitored activity. The alarm setpoints for Service Water, SDHR Service Water and RHR Service Water monitors are then determined as follows:
ODCM-QA-003 Revision 2 Page 11 of 17
- a. When monitor background <(1 E-5)/Cal. Factor:
Hi RAD Setpoint = 0.5 Background + (1 E-5)/Cal. Factor DOWNSCALE or LOW RAD Setpoint = 0.5 Background
- b. When monitor background >(1 E-5)/Cal. Factor:
HI RAD Setpoint = Background + 0.5 (1 E-5)/Cal. Factor DOWNSCALE or LOW RAD Setpoint = Background - 0.5 (1 E-5)/Cal.
Factor Where:
Setpoint
=
alarm threshold value to be entered into monitor (cps for Service Water and SDHR Service Water, cpm for RHR Service Water)
Background
=
monitor background at most recent background determination (cps for Service Water, and SDHR Service Water, cpm for RHR Service Water)
(1 E-5)
=
10 times the Cs-1 37 ECL (pC/ml)
Cal. Factor
=
monitor response factor per unit Cs-137 concentration determined during most recent calibration (pCi/ml per cps for Service Water and SDHR Service Water, puCiml per cpm for RHR Service Water)
The ALERT RAD setpoints for the RHR Service Water monitors are maintained at 80% of the applicable Hi RAD setpoint (cpm).
6.2 Airborne Effluent Monitoring - Noble Gas The methodology outlined in Equations 6.2-1 a and 6.2-1 b shall be utilized in implementing the following requirements for Airbome Effluent Monitoring of Noble Gas.
6.2.1 Site Limiting Release Rate - Noble Gas
- a.
The limiting total body and skin release rates are calculated as follows:
LB = QNG
- DRTB
- k DTB (Eq. 6.2-1 a)
ODCM-QA-003 Revision 2 Page 12 of 17 QL
= NG *DRs *k (Eq. 6.2-1 b)
Where:
LTB
=
limiting release rate-noble gas total body (pCimin)
Ls
= limiting release rate-noble gas skin (p.Cimin)
ONG
= total noble gas source term (Ci)
DRTB = total body dose rate limit for the noble gas effluent (500 mrem/year) (ref. TRO 3.11.2.1, I.A)
DRs
=
total skin dose rate limit for the noble gas effluent (3000 mrem/year) (ref. TRO 3.11.2.1, l.B)
D7B
=
limiting total body offsite dose resulting from the noble gas source temm ONG (mrem)
Ds
= limiting skin offsite dose resulting from the noble gas source term QNG (mrem) k
=
units conversion factor (1 E6 g+/-CVCi) * (1 yr/365 days) * (1 day/ 24 hours2.777778e-4 days <br />0.00667 hours <br />3.968254e-5 weeks <br />9.132e-6 months <br />)
- (1 hour/60 minutes)
DTB and Ds are determined in accordance with ODCM-QA-004 using the noble gas source term and dispersion parameters provided in Attachment A.
Note, ONG is the sum of the noble gas activities provided in Attachment A. The ratio of the annual source term to the corresponding total body and skin dose is used in the above equations. Thus, either the total annual release per unit or the total annual release for the site may be used.
- b.
The site limiting release rate for noble gas, LNG, shall be set as the lesser of LT8 and Ls and the site limiting release rate for noble gas implemented in the Emergency Plan. The Emergency Plan may be revised to implement the lesser of LTB and Ls to provide additional flexibility in plant operations.
6.2.2 Monitor Limiting Concentration - Noble Gas The limiting noble gas concentration shall be determined as follows:
ODCM-QA-003 Revision 2 Page 13 of 17 CNG =
(Eq. 6.2-2)
EFv Where:
=
limiting noble gas concentration (pCi/cc)
LNG
=
site limiting release rate - noble gas from §6.2.1 (pCi/min)
Fv
=
vent flow high limit for vent V (cc/min) 6.3 Airborne Effluent Monitoring - Iodine and Particulate The methodology outlined in Equations 6.3-1, 6.3-2, 6.3-3 and 6.3.4 shall be utilized in implementing the following requirements for Airborne Effluent Monitoring of iodine and particulates. Note, the methodology for determining the limiting release rate and concentration for airborne iodine and particulates is evaluated in EC-ENVR-1 040.
6.3.1 Site Limiting Release Rate - Iodine
- a.
The limiting 1-131 release rate shall be determined as follows:
,=
Q *DRp *k (Eq. 6.3-1)
Djp Where:
L
=
provisional limiting release rate-1-131 (pCi/min) 0,
=
total 1-131 source term (Ci)
DRP =
dose rate limit for 1-131, 1-133, tritium, and particulate effluent (1500 mrem/year maximum organ, inhalation)
(ref. TRO 3.11.2.1, II.A)
Dip
=
limiting (maximum) organ dose for all age groups resulting from the total 1-131 and 1-133 source term (mrem) k
=
units conversion factor (1 E6 gCVCi) * (1 yr/365 days) * (1 day/24 hours)
- (1 hour/ 60 minutes)
Dip shall be determined in accordance with ODCM-QA-004 using the iodine source term and dispersion parameters provided in Attachment A.
U ODCM-QA-003 Revision 2 Page 14 of 17 Note, 0, is the 1-131 activity provided in Attach ment A. The ratio of the annual source term to the corresponding organ dose is used in the above equations. Thus, either the total annual release per unit or the total annual release for the site may be used.
- b.
The site limiting release rate for 1-131, L,, shall be set as the lesser of L, and the site limiting release rate for 1-131 implemented in the Emergency Plan. The Emergency Plan may be revised to implement L' to provide additional flexibility in plant operations.
6.3.2 Monitor Limiting Concentration Iodine The limiting 1-131 concentration shall be determined as follows:
C L=
(Eq. 6.3-2)
ZFv Where:
C,
=
limiting 1-131 concentration (uCVcc)
L
=
limiting 1-131 release rate from §6.3.1 (pCimin)
Fv
=
vent flow high limit for vent V (cc/min) 6.3.3 Site Limiting Release Rate - Particulates
- a.
The limiting release rate for particulates shall be determined as follows:
LI = Qp *DRp *k (Eq. 6.3-3)
DP Where:
L '
=
provisional limiting release rate-particulates (Ci/min)
Qp
=
total particulate source term (Ci)
DR~p =
dose rate limit for 1-131,1-133, tritium, and particulate effluent (1500 mrem/year maximum organ, inhalation)
(ref. TRO 3.11.2.1, I.A)
Dp
=
limiting (maximum) organ dose for all age groups resulting from the source term Op (mrem)
ODCM-QA-003 Revision 2 Page 15 of 17 k
=
units conversion factor (1 E6 pCVCi) * (1 yr/365 days) * (1 day/ 24 hours2.777778e-4 days <br />0.00667 hours <br />3.968254e-5 weeks <br />9.132e-6 months <br />) *
(1 hour/ 60 minutes)
Dp shall be determined in accordance with ODCM-QA-004 using the particulate source term and dispersion parameters provided in Attachment A.
Note, 0p is the sum of the particulate activities provided in Attachment A. The ratio of the annual source term to the corresponding organ dose is used in the above equations. Thus, either the total annual release per unit or the total annual release for the site may be used.
- b.
The site limiting release rate for particulates, Lp, shall be set as the lesser of L p and the site limiting release rate for particulates implemented in the Emergency Plan. The Emergency Plan may be revised to implement L' to provide additional flexibility in plant operations.
6.3.4 Monitor Limiting Concentration - Particulates The limiting particulate concentration shall be determined as follows:
CP = Lp (Eq. 6.3-4)
Fv Where:
Cp
=
limiting particulate concentration (pCVcc)
Lp
=
limiting particulate release rate from §6.3.3 (/CVmin)
Fv
=
vent flow high limit for vent v (cc/min) 6.4 Airborne Monitor Line Loss Corrections 6.4.1 Chemistry shall apply the following correction factors to monitor data and sample analysis results in order to correct for airborne effluent monitor sample line loss in accordance with station procedures:
ODCM-QA-003 Revision 2 Page 16 of 17 CORRECTION FACTORS (Ref. 3.13)
Effluent Monitors Iodine Particulates Reactor Building Unit 1 Refuel Floor 1.5 3.2 Reactor Building Unit 1 Roof 1.0 1.0 Reactor Building Unit 2 Refuel Floor 1.5 3.2 Reactor Building Unit 2 Roof 1.0 1.0 Turbine Building Unit 1 Refuel Floor 1.6 3.6 Turbine Building Unit 1 PAVSS 1.7 4.2 Turbine Building Unit 1 Roof 1.0 1.0 Turbine Building Unit 2 Refuel Floor 1.6 3.6 Turbine Building Unit 2 PAVSS 1.7 4.3 Turbine Building Unit 2 Roof 1.0 1.0 Standby Gas Treatment; Refuel Floor 1.5 3.9 Standby Gas Treatment; PAVSS 1.6 4.4 Standby Gas Treatment; Roof 1.0 1.0 7.0 RECORDS None.
odcm-qa-003(26)
Attachment A ODCM-QA-003 Revision 2 Page 17 of 17 PARAMETERS USED TO DETERMINE AIRBORNE EFFLUENT MONITOR SETPOINTS NUCLDEs
<TOTALRELEE(1 Ar-41 2.60E+01 Kr-83m O.OOE+O0 Kr-85m 1.1 OE+01 Kr-85 2.30E+02 Kr-87 1.42E+01 Kr-88 2.22E+01 Kr-89 1.47E+02 Xe-131m 1.80E+01 Xe-1 33m O.OOE+OO Xe-1 33 2.23E+03 Xe-135m 6.70E+02 Xe-1 35 9.73E+02 Xe-1 37 4.68E+02 Xe-1 38 2.1 OE+02
-8{-*-4, 5f,-.i-p
=.("ya pear rco).
NUCLIDE~;
, ~OARELEASC1?i 1-131i'1 1.02E-01/1.23E-01 1-33'27 1.14E+00/1.45E+OO Cr-51 2.08E-05 Mn-54 5.52E-05 Fe-59 7.1 OE-06 Co-58 7.OOE-06 Co-60 1.23E-04 Zn-65 6.53E-05 Sr-89 1.25E-05 Sr-90 1.40E-07 Nb-95 1.OOE-04 Zr-95 1.81 E-05 Ru-1 03 4.21 E-05 Ag-11 Om 2.40E-08 Sb-124 1.40E-06 Cs-1 34 7.46E-05 Cs-136 7.1 OE-06 Cs-137 1.11 E-04 Ba-140 2.51 E-04 Ce-141 2.91 E-05 4
.1.
+
Annual Average Dispersion Parameters - Limiting Site Boundary (3)
Relative Concentration 1.46E-5 sec/m 3 Decayed Relative Concentration 1.46E-5 sec/m 3 Decayed, Depleted Relative Concentration 1.35E-5 secrm3 Deposition Rate 3.35E-8 m 2 Notes:
- 1. Design basis "expected" gaseous effluent releases per EC-RADN-1 041 (particulates with half-lives greater than 8 days)
- 2. Use limiting case Normal Water Chemistry/Hydrogen Water Chemistry
- 3. 1973-76 Meteorological Data Updated to 1996 Land Use Survey per EC-RADN-1 041 Page 1 of 1
PROCEDURE CHANGE PROCESS FORM
- 1.
PCAF NO. _2003-112
- 2. PAGE 1 OF 3 3, PROC.NO.
ODCM-QA-004 REV. 2 a
- 4. FORMS REVISED R.,
R R_, -
R_
R-,
-R
- 5. PROCEDURE TITLE AIRBORNE EFFLUENT DOSE CALCULATIONS
- 6.
REQUESTED CHANGE PERIODIC REVIEW 3 NO E YES INCORPORATE PCAFS ;
NO El YES #
REVISION a
PCAF 3
DELETION 2 (CHEC$>E ONLY)
- 7.
SUMMARY
OF REASON FOR CHANGE The change being rmade is the addition of the Nuclear Emergency Planning m hp1^ECOMMENDED REVIEWS" section on the procedure cover page.
This change to ODCM-QA-004 is an administrative correction and does e the level of effluent control or the accuracy and/or reliability of dose calculations or setint determnations as required by 1 OCFR20.1302, 40CFR1 90, 1 OCFR50.36a and 1 OCFR50 App v
Continued E
- 8. DETERMINE COMMITTEE REVIEW REQUIREM (Refer to Section 6.1.4)
PORC REVIEW REQ'D?
- 9.
PORCMTG#
d14 BLOCKS 11 THRU 16AREONPAGEkOFFO
$R_
- 17.
Francis J. Hickey I18.-:I24IO3
- 18. COMMUNICATION OF CHANGE REQUIRED?
PREPARER No DATE I3 NO El YES (TYPE)
(Print or Type)
-_K_
- 19.
SIGNATURE ATrESTS THAT RESPONSIBLE SUPERVISOR HAS
- 19.
,CONDUCTED QADR AND TECHNICAL REVIEW UNLESS OTHERWISE F-2,/
3 3
DOCUMENTED IN BLOCK 16 OR ATTACHED REVIEW FORMS.-
f o ESU
\\/RHoW D
,ATE CROSS DISCIPLINE REVIEW (IF REQUIRED) HAS BEEN COMPLETED BY SIGNATURE IN BLOCK 16 OR ATTACHED REVIEW FORMS.
- 20.
N/A FUM APPROVAL DATE
- 21. RESPONSIBLE APPROVER ENTER NIA IF FUM HAS APPROVAL AUTHORITY N/A INITIALS DATE
\\-.-RM NDAP-QA-0002-8, Rev. 8, Page 1 of 2 (Electronic Form)
1.
PROCEDURE CHANGE PROCESS FORM
- 1. PCAF NO. 2003-1,9
- 12. PAGE 2 OF 3
- 13. PROC. NO. ODCM-QA-004 REV. 2
- 11. This question documents the outcome of the 50.59 and 72.48 Review required by NDAP-QA-0726. Either 11 a, b, c or d must be checked 'YES' and the appropriate form attached or referenced.
- a. This change is an Administrative Correction for which 50.59 and 72.48 are not 3 YES 3 N/A applicable.
- b. This change is a change to any surveillance, maintenance or administrative Li YES 3 N/A procedure for which 50.59 and 72.48 are not applicable.
- c. This change is bounded by a 50.59/72.48 Screen/Evaluation, therefore, no new a
YES 3 N/A 50.59/72.48 Evaluation is required.
Screen/Evaluation No.
- d. 50.59 and/or 72.48 are applicable to this change and a 50.59/72.48 Li YES 1 N/A Screen/Evaluation is attached.
3 YES Change Request No.
- 13. Should this change be reviewed for potential effects on Training Needs or Material?
E YES 3 NO If YES, enter an Action Item @ NIMS/Action/Gen Work Mech/PICN
- 14. Is a Surveillance Procedure Review Checklist required per NDAP-QA-0722?
LI YES 3 NO
- 15. Is a Special, Infrequent or Complex TestlEvolution Analysis Form required per LI YES Z NO NDAP-OA-0320? (SICT/E form does not need to be attached.)
- 16. Reviews may be documented below or by attaching Document Review Forms NDAP-QA-0101-1.
REVIEWED BY WITH DATE REVIEW NO COMMENTS QADR TECHNICAL REVIEW REACTOR ENGINEERING/NUCLEAR FUELS OF 1ST OPERATIONS NUCLEAR SYSTEMS ENGINEERING NUCLEAR MODIFICATIONS MAINTENANCE HEALTH PHYSICS NUCLEAR TECHNOLOGY CHEMISTRY OTHER Required for changes that affect, or have potential for affecting core reactivity, nuclear fuel, core power level indication or impact the thermal power heat balance. (5)
Required for changes to Section Xl Inservice Test Acceptance Criteria.
FORM NDAP-QA-0002-8, Rev. 8, Page 2 of 2 (Electronic Formn)
I us
{v C
- I I
§A~ P 9
- r I.
, -.. 17 PROCEDURE COVER SHEET QUE4ANNA, LLC I NUCLEAR DEPARTMENT PROCEDURE I
Tb-,I AIRBORNE EFFLUENT DOSE CALCULATIONS ODCM-QA-004 Revision 2 Page 1 of 59 QUALITY CLASSIFICATION:
APPROVAL CLASSIFICATION.
QA Program I] Non-QA Program 0 Plant-rl Non-Plant El Instruction EFFECTIVE DATE:
JeV-oae PERIODIC REVIEW FREQUENCY:
N/A PERIODIC REVIEW DUE DATE:
N/A RECOMMENDED REVIEWS: _
A __
I Nuclear onegqy PlaenIng IC F
I I
I I
procedure Owner Responsible Supervisor Responsible FUM:
R I Responsible Approver.
Francis J. Hickey Chemistry Supervisor-SSES rhkpmistrv Suenrvisor-SSES V Vice President - Nuclear Operations FORM NDAP-0A0002-1, Rev. 3; Page 1 of I
ODCM-QA-004 Revision 2 Page 2 of 59 PROCEDURE REVISION
SUMMARY
X TITLE:
AIRBORNE EFFLUENT DOSE CALCULATIONS Most of the revisions descrilied below are editorial in nature. The changes made do not reduce or compromise the level of effluent control or the accuracy and/or reliability of dose calculations or setpoint determinations as required by 1 OCFR20.1302, 40CFR1 90, 1 OCFR50.36a and 10CFR50, Appendix I. Additionally, the changes outlined below (1) do not alter the conduct of the radiological environmental monitoring program, (2) do not change the radioactive effluent controls and radiological environmental monitoring activities, and (3) do not change the information to be included in the Annual Radiological Environmental Operating and Radioactive Effluent Release Reports.
- 1. Section 2.5.5 has been renumbered as 2.4.5 and revised for reporting of the dose contribution from insignificant pathways to be documented in the Annual Effluent Release Report as opposed to the monthly surveillance. The conservative methodology used in calculating the insignificant pathway effluent releases will continue to be utilized. Attachment D has been added to clarify the methodology utilized to evaluate effluent releases from insignificant effluent pathways. The dose contribution from the insignificant pathway has been evaluated to not challenge the limits outlined in the TRM. Insignificant pathway effluents will continue to be tracked and evaluated.
- 2. Sections 4.2 and 4.3 have been deleted and Section 4.1 revised to clarify responsibilities to support compliance with the applicable TRM sections. The methodology for gaseous effluent offsite dose assessment is provided In the ODCM and implemented via the SSES surveillance program. NEPM-QA-1 011 provides information, which is redundant with the ODCM and the monthly surveillance and thus will be deleted.
- 3. Attachment C, "SITE SPECIFIC INFORMATION USED BY THE GASPAR CODE," has been deleted due to replacement of the GASPAR computer program with Radioactive Effluent Tracking and Dose Assessment Software (RETDAS). RETDAS utilizes standard values which are outlined in Regulatory Guide 1.109 and NUREG-0133. These values are acceptable (per Regulatory Guide 1.109) to show compliance with 10CFR20.1302, 40CFR1 90, 10CFR50.36a and 10CFR50, Appendix I.
- 4. Attachment D, UODCM Maximum Pathway Dose Factors: Radionuclides Other Than Noble Gases," has been revised and renamed as Attachment C, "Dose Factors: Radionuclides Other Than Noble Gases." The RETDAS computer program utilizes standard values, which are outlined in Regulatory Guide 1.109 and NUREG-0133 in the derivation of the dose factors for radionuclides other than noble gases. As mentioned in Item 3 above, these values are acceptable (per Regulatory Guide 1.109) to show compliance with 10CFR20.1302, 40CFR1 90, 1 OCFR50.36a and 1 OCFR50, Appendix I. The resulting dose factor
ODCM-QA-004 Revision 2 Page 3 of 59 values differ from the Rev. 1 values in Attachment D due to the use of site specific data. PPL Calculation EC-ENVR-1055, Rev. 0, "Evaluation of Dose Factors for Liquid and Gaseous Effluent Releases," has been added as a reference, which supports the revised values in Attachment D and these values correspond to the values used by the RETDAS program.
- 5. The following existing sections have been deleted due to the transition from the GASPAR program to the REDTAS program and due to the dose factors as referenced in Item 4 above: 2.4, 3.10, 3.13, 3.14, 3.15, 3.16, 3.17, 3.18 and 6.3.-
- 6. Sections 2.4.5 and 2.5.1 c have been revised to include the "Batch Lube Oil Tank" and 'Noble Gases Entrained in Liquid Effluents" as an Insignificant Effluent release pathways.
- 7. Section 6.1 has been revised to more accurately correspond to the methodology outlined in Reference 3.9, NUREG-0133, Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants," October 1978.
- 8. Various sections revised to reflect SSES organizational changes.
ODCM-QA-004 Revision 2 Page 4 of 59 TABLE OF CONTENTS SECTION PAGE 1.0 PURPOSE 5
2.0 POLICY1DISCUSSION 5
2.1 Meteorological Parameters 5
2.2 Noble Gases 5
2.3 Radionuclides Other Than Noble Gases 6
2.4 Effluent Data 6
2.5 Assignment of Releases to the Reactor Units 6
3.0 REFERENCES
7 4.0 RESPONSIBILITIES 8
4.1 Chemistry Supervisor - SSES 8
5.0 DEFINITIONS 8
6.0 PROCEDURE 9
6.1 Noble Gases 9
6.2 Radionuclides Other Than Noble Gases 10 6.3 Airborne Effluent Dose Calculations Exceeding Twice the Quarterly or Annual TRM Values 11 6.4 Projected Dose from Gaseous Effluent 12 7.0 RECORDS 12 ATTACHMENTS ATTACHMENT PAGE A
Dose Factors for Noble Gases 13 B
Annual Average Dispersion Factors Used for Monthly Surveillances 14.
C ODCM Maximum Pathway Dose Factors: Radionuclides other than Noble Gases 15 D
Evaluation of Insignificant Effluent Pathway Gaseous Releases 58
ODCM-QA-004 Revision 2 Page 5 of 59 1.0 PURPOSE The purpose of this procedure is to provide the methodology and parameters used in calculating air dose resulting from noble gas effluent and maximum individual, whole body, and organ doses due to airborne effluents to ensure compliance with the dose limitations in the Technical Requirements Manual (Sections 3.11.2.2, 3.11.2.3, 3.11.2.5 and 3.11.3) and 10CFR20.1302.
This procedure constitutes part of the SSES Off site Dose Calculation Manual (ODCM) which is a licensing basis document 2.0 POLICYIDISCUSSION 2.1 Meteorological Parameters 2.1.1 The meteorological parameters are provided by the SSES meteorology program. Instrumentation and controls necessary to ensure that sufficient meteorological data are available to determine radiation doses to the public as a result of radioactive releases are specified in TR 3.3.3.
2.1.2 Annual dose calculations for the Annual Effluent and Waste Disposal Report are based on the actual meteorological conditions concurrent with the reporting year.
2.1.3 Monthly dose calculations are based on the limiting sector average annual dispersion factors based on a selected period of time. The dispersion factors currently used are provided in Attachment B.
2.1.4 Use of the no-decay-undepleted X/Q is recommended for dose computations, because it is conservative for all isotopes. Consideration for depletion of radiolodines and particulates and radioactive decay of the plume is acceptable, but not required.
2.1.5 The methodology described herein incorporates parameters outlined in Regulatory Guide 1.109, Rev. 1, October, 1977, Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purposes of Evaluating Compliance with 1 OCFR50, Appendix I, and NUREG-0133, Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants.
2.2 Noble Gases 2.2.1 The methods for sampling and analysis of continuous ventilation releases
.are given in the applicable plant procedures.
ODCM-QA-004 Revision 2 Page 6 of 59 2.3 Radionuclides Other Than Noble Gases 2.3.1 The methods for sampling and analysis of continuous ventilation releases for radioiodines and radioactive particulates are given in the applicable plant procedures and shall be performed in accordance with TR Table 3.11.2.1-1.
2.4 Effluent Data 2.4.1 The total number of Curies released for each radionuclide during the time period being evaluated is supplied by the SSES effluent monitoring program.
2.4.2 For determination of compliance with the Technical Requirernents Manual dose limits, effluent totals shall be based only on activity positively
-detected at the 95% confidence level.
2.4.3 Applicable airborne pathways at SSES include immersion, inhalation,
- ground exposure, vegetable ingestion, and cow-milk ingestion. The grass-to-meat-to-man airborne pathway is applicable depending on its identification in the annual Land Use Census Report.
2.4.4 Quarterly doses are the summation of the applicable monthly values.
2.4.5 Effluent data from the following Insignificant Effluent Pathways shall be included in the Annual Effluent Release Report Units 1 and 2 CSTs, Units 1 and 2 Main Turbine and RFPT Lube Oil Systems, Units 1 and 2 Hydrogen Seal Oil Systems, the RWST, Batch Lube Oil Tank and Noble Gases Entrained in Liquid Effluents.
The contribution from Insignificant Effluent Pathways to the total dose from all SSES effluents should be small enough that the dose from these pathways combined with the dose from Significant Effluent Pathways would not be expected to challenge the radiological effluent dose limits for the SSES. Insignificant Pathway Effluents will be tracked and evaluated quarterly.
2.5 Assignment of Releases to the Reactor Units 2.5.1 For determination of compliance with SSES radioactive effluent dose limits which are on a 'per reactor unit' basis:
- a. Effluents from the Unit 1 Reactor Building vent and the Unit 1 Turbine Building vent shall be included as Unit 1 releases. Effluent from the following Insignificant Effluent Pathways associated with Unit 1 shall also be included in the Unit 1 releases: the Unit 1 Condensate Storage Tank Vent, the Unit 1 Main Turbine and RFPT Lube Oil System vents, and the Unit 1 Hydrogen Seal Oil system vent. The Radwaste Building vent shall also be included in Unit 1 releases.
-9
ODCM-QA-004 Revision 2 Page 7 of 59
- b. Effluents from the Unit 2 Reactor Building vent and the Unit 2 Turbine Building vent shall be included as Unit 2 releases. Effluents from the following Insignificant Effluent Pathways associated with Unit 2 shall also be included in the Unit 2 releases: the Unit 2 Condensate Storage Tank vent, the Unit 2 Main Turbine and RFPT Lube Oil System vents, and the Unit 2 Hydrogen Seal Oil System vent.
- c. Effluents from the Standby Gas Treatment System vent and the following Insignificant Effluent Pathways common to both Units 1 and 2 shall be divided equally between Units I and 2 releases, or apportioned appropriately between the units if sufficient information is available: Refueling Water Storage Tank, Noble Gases Entrained in Liquid Effluents and Batch Lube Oil Tank.
3.0 REFERENCES
3.1 TR Table 3.11.2.1-1, Radioactive Gaseous Waste 'Sampling and Analysis Program 3.2 TR 3.11.2.2, [Radioactive Effluents] lGaseous Effluents] Dose-Noble Gases 3.3 TR 3.11.2.3, [Radioactive Effluents] [Gaseous Effluents] Dose-Iodine, Tritium, and Radionuclides in Particulate Form 3.4 TR 3.1 1.2.5, [Radioactive Effluents] [Gaseous Effluents] Ventilation Exhaust Treatment System 3.5 TR 3.11.3, Total Dose 3.6 TR 3.3.3, Meteorological Instrumentation 3.7 1 OCFR20 Appendix B, Annual Limits on Intake (ALls) and Derived Air Concentrations (DACs) of Radionuclides for Occupational Exposure; Effluent Concentrations; Concentrations for Release to Sewage 3.8 Regulatory Guide 1.109, Rev. 1, October, 1977, Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purposes of Evaluating Compliance with 10 CFR 50, Appendix I 3.9 NUREG-01 33, Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants, October 1978 3.10 NEPM-QA-1017, SSES Meteorological Data Processing and Reporting 3.11 ODCM-QA-006, Total Dose Calculations 3.12 PPL Calculation EC-ENVR-1 055, Rev. 0, Evaluation of Dose Factors for Liquids and Gaseous Effluent Releases"
ODCM-QA-004 Revision 2 Page 8 of 59 3.13 SSES Annual Land Use Census Report 3.14 PPL Calculation EC-ENVR-1008, Rev. 4, Unmonitored Release Analysis:
Systems Identified in PLI-77223" 4.0 RESPONSIBILITIES 4.1 Chemistry Supervisor - SSES 4.1.1 Ensures adequacy and correctness of methodology to be used in calculating doses resulting from airborne effluents as necessary for fulfillment of Technical Requirement Surveillances (3.11.2.2.1, 3.11.2.3.1, 3.11.3).
4.1.2 Ensures the cumulative dose contributions for the current calendar quarter and current calendar year are determined every 31 days in fulfillment of TRSs 3.11.2.2.1, 3.11.2.3.1, 3.11.3.
4.1.3 Ensures methodology and parameters to be used in calculating doses resulting from airborne effluents are developed to ensure compliance with the dose limitations in the Technical Requirements Manual.
5.0 DEFINITIONS 5.1 FID - Fraction of airborne radioiodine effluent that is estimated to be elemental
-iodine. The fraction of iodine deposited (FID) is assumed to be 0.5 (Regulatory Guide 1.109 (page 1.1 09-26)).
5.2 MEMBER(S) OF THE PUBLIC - Shall include all persons who are not occupationally associated with the plant. This category does not include employees of the utility, its contractors, or vendors. Also excluded from this category are persons who enter the site to service equipment or to make deliveries. This category does include persons who use portions of the site for recreational, occupational, or other purposes not associated with the plant.
5.3 UNRESTRICTED AREA - Shall be any area at or beyond the site boundary, access to which is not controlled by the licensee for purposes of protection of individuals from exposure to radiation and radioactive materials, or any area within the site boundary used for residential quarters or for industrial, commercial, institutional, and/or recreational purposes.
ODCM-QA-004 Revision 2 Page 9 of 59 6.0 PROCEDURE 6.1 Noble Gases 6.1.1 The dose rate at a specified location due to noble gases released in airborne effluents shall be determined by the following equation for whole body dose:
D,=,,
Y, (K,)(X IQ)1,(Qua )
(Eq. 1) (Ref. 3.9) i 1'
and by the following equation for skin dose:
Ds =
S
[Li+I(Mi)](XIQ)X(Q'b)
(Eq. 2) (Ref. 3.9) where:
Db
=
the annual whole body dose (mren/yr)
=
the whole body dose factor due to gamma emissions for each identified noble gas radionuclide (i) from Attachment A (mrerr/yr per pCVm3)
(X/Q)v =
the relative concentration factor for the specified location from vent release point (v) such as from Attachment B (sec/ma)
[
1
=
the release rate of radionuclide (i) from vent (v) (uCVsec)
Ds
=
the annual skin dose (mrem/yr) 4
=
the skin dose factor due to the beta emissions for each identified noble gas radionuclide (i) from Attachment A (mremfyr per pCrm3)
M
=
the air dose factor due to gamma emissions for each identified noble gas radionuclide (I) from Attachment A (mrad/yr per piC/m 3) 1.1
=
unit conversion constant of 1.1 mrad/mrem converts air dose to skin dose 16.1.2 The air dose at a specified location due to noble gases released in airborne effluents during any specified time period shall be determined by the following equation for gamma radiation:
D9 =3.17E -8 (Mi)(X/ Q)V (Q1Y)
(Eq. 3) (Ref. 3.9)
ODCM-QA-004 Revision 2 Page 1 D of 59 and by the following equation for beta radiation:
l Db =a17E-8 (N 1 )(XIQ), (Q1,)
(Eq. 4) (Ref. 3.9) where:
Dg
=
the total gamma air dose from airborne effluents for the specified time period (mrad)
Db
=
the total beta air dose from airborne effluents for the specified time period (mrad) 3.17E-8
=
the inverse of seconds in a year (yr/sec)
MI
=
the air dose factor due to gamma emissions for each identified noble gas radionuclide (i) from Attachment A (mrad/yr per pCVm3)
No
=
the air dose factor due to beta emissions for each identified noble gas radionuclide (i) from Attachment A (mrad/yr per /CVm 3)
(X/Q)V
=
the relative concentration factor for the specified location such as from Attachment B (secIM3) i=
the integrated release of radionuclide (i) from all vents (v) for a specified time period. (pCi) 6.2 Radionuclides Other Than Noble Gases 6.2.1 The dose rate at a specified location due to inhalation of radioactive materials released in airborne effluent (including 1-131 and 1-133) shall be determined by the following equation for any organ:
DC=-
S (Ri)(W,)(Q' )
(Eq. 5) (Ref. 3.9)
I v
where:
Dc=
the annual organ dose (mrem/yr)
RI=
the dose factor based on inhalation pathway for each radionuclide other than noble gases (i) for the inhalation pathway from Attachment C. (mren/yr per pCVrm3)
Wv=
the relative concentration factor for the specified location from Attachment B. (sec/m 3)
ODCM-QA-004 Revision 2 Page 11 of 59 Q,= the release rate of radionuclide (i) from vent (v) (pCi/sec) 6.2.2 The critical organ dose to an individual from radionuclides other than noble gases released in airborne effluent (including 1-131 and 1-133) during any specified time period at a specified location shall be determined by the following equation:
DC = 3.17E - 8 (Ri )(Wv ) (QJV )
(Eq. 6) where:
Dc
=
the total dose to a critical organ from radionuclides other than noble gases for a specified time period (mrem)
R
=
the dose factor based on inhalation pathway for each radionuclide other than noble gases (i) for the inhalation pathway (mrem/yr per PCVrM3) and for ingestion and ground plane pathways (mrem-m 2lyr per pCisec) from Attachment C WV
=
Relative concentration (X/Q) (sec/r 3) for the inhalation pathway and relative deposition (D/Q: m 2) for the ingestion and ground pathways such as from Attachment B
=
the integrated release of radionuclide (i) from all vents (v) for a specified time period (pCi) 3.1 7E-8 =
the inverse of seconds in a year (yr/sec)
For radioiodines, the deposition model considers only the elemental fraction of the effluent. Thus, deposition is computed only for that fraction of the effluent that is estimated to be elemental iodine. The fraction iodine deposited (FID) is assumed to be 0.5 (Regulatory Guide 1.109 (page 1.109-26)). The deposition pathway dose factors for radiolodines presented in Attachment C have been adjusted by a factor of 0.5.
6.3 Airborne Effluent Dose Calculations Exceeding Twice the Quarterly or Annual TRM Values 6.3.1 When the results of airborne dose calculations exceed twice the value of TR's 3.11.2.2.a, 3.11.2.2.b, 3.11.2.3.a, or 3.11.2.3.b, calculations shall be made which include the direct radiation contribution in accordance with ODCM-QA-006 to determine if the limits of TR 3.11.3 have been exceeded. If the limits of TR 3.11.3 have been exceeded, a special report shall be prepared and submitted to the NRC within 30 days which addresses the actions specified in TR 3.11.3.
ODCM-QA-004 Revision 2 Page 12 of 59 6.4 Projected Dose from Gaseous Effluent 6.4.1 Doses from gaseous effluents released to unrestricted areas are projected at least every 31 days as required by TRM 3.11.2.5. These projections are made by averaging the doses from previous operating history (normally the previous three months) which is indicative of expected future operations.
7.0 RECORDS None.
odcm-qa-004{26)
Attachment A ODCM-QA-004 Revision 2 Page 13 of 59 DOSE FACTORS FOR NOBLE GASES (1)
Whole Body Gamma Air Beta Air Dose Factor Skin Dose Factor Dose Factor Dose Factor K.Li M,
N.
Radionuclide (mremlyr perpCi/m3)
(mremlyr-pergCi/m 3)
(mradlyr per gCi/m 3)
(mrad/yr per pC/rn Kr-83m 7.56E-02
-1.93E+01 2.88E+02 Kr-85m 1.17E+03 1.46E+03 1.23E+03 1.97E+03 Kr-85 1.61 E+01 1.34E+03 1.72E+01 1.95E+03 Kr-87 5.92E+03 9.73E+03 6.17E+03 1.03E+04 Kr-88 1.47E+04 2.37E+03 1.52E+04 2.93E+03 Kr-89 1.66E+04
- .O E+04 1.73E+04 1.06E+04 Kr-90 1.56E+04 7.29E+03 1.63E+04 7.83E+03 Xe-131m 9.15E+01 4.76E+02 1.56E+02 1.11 E+03 Xe-1 33m
- 2.51 E+02 9.94E+02
'3.27E+02 1.48E+03 Xe-1 33 2.94E+02 3.06E+02 3.53E+02 1.05E+03 Xe-135m 3.12E+03 7.11 E+02 3.36E+03 7.39E+02 Xe-1 35 1.81 E+03 1.86E+03 1.92E+03 2.46E+03 Xe-1 37 1.42E+03 1.22E+04 1.51 E+03 1.27E+04 Xe-138 8.83E+03 4.13E+03 9.21 E+03 4.75E+03 Ar-41 8.84E+03 2.69E+03 9.30E+03 3.28E+03
- 1. The listed dose factors are for radionuclides that may be detected in airborne effluents and derived from Table B-1 in Reg. Guide 1.109.
Page 1 of 1
Attachment B ODCM-QA-004 Revision 2 Page 14 of 59 ANNUAL AVERAGE DISPERSION FACTORS USED FOR MONTHLY SURVEILLANCES ()
Type of Location Direction Distance XJQ X/Q XJQ D/O (miles)
(sec/r 3)
(sec/r
- 3)
(seclm3)
(per m 2) no decay 2.260 day 8.000 day decav-decay undepleted undepleted depleted -
Maximum Site Boufda SW 0.60 2.40E-05 2.40E-05 2.1OE-05 3.OOE-08 Closest Site Bounda S
0.34 1.40E-05 1.40E-05 1.30E-05 4.50E-08 Maximum XlQ Residence WSW 1.16 1.1OE-05
- 1. 1OE-05 9.7 E-06 1. OE-08 Maximum Dai Animal WSW 1.70 6.60E-06 6.50E-06 5.50E-06 6.1OE-09 Maximum D/Q Residence SE 0.38 4.10E-06 4.1OE-06 3.80E-06 2.20E-08 Notes:
- 1.
July, 1981, through December, 1985, meteorological data.
j I Page 1 of 1
Attachment C ODCM-QA-004 Revision 2 Page 15 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2,5.3)
Units:
AgeGroup:
Pathway:
Airborne Pathways & Tritium Ingestion: (mrerrlyr)/(pCimA3))
Deposition Pathways: (mn2 * (mrem/yr)/(uC/sec)
ADULT Grs/Goat/Milk (GMILK)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO 1.56e+03 1.56e+03 1.56e+03 1.56e+03 1.56e+03 O.OOe+OO 1.56e+03 C-14 2.63e+08 5.27e+07 5.27e+07 5.27e+07 5.27e+07 5.27e+07 0.OOe+OO 5.27e+07 NA-24 2.94e+05 2.94e+05-2.94e+05 2.94e+05 2.94e+05 2.94e+05 O.OOe+OO 2.94e+05 P-32 3.19e+09 1.28e+09 O.OOe+000.OOe+O0 O.OOe+OO 2.31e+09 0.OOe+OO 7.93e+08 CR-51 O.OOe+OO O.OOe+OO 2.05e+03 7.56e+02 4.55e+03 8.63e+05 O.OOe+O0 3.43e+03 MN-54 O.OOe+OO-1 Ole+06 0.O0e+OO 3.01e+05 0.OOe+OO 3.09e+06,0.OOe+OO 1.93e+05 MN-56 O.OOe+OO 5.07e-04 O.OOe+OO 6.44e-04 O.OOe+OO 1.62e-02 O.OOe+OO 9.00e-05 FE-55 3.27e+05 2:26e+05 O.OOe+OO O.OOe+OO 1.26e+05 1.29e+05 O.OOe+OO 5.26e+04 FE-59 3.86e+05 9.08e+05-O.OOe+OO O.OOe+OO 2:54e+05 3.03e+06 O.OOe+OO 3.48e+05 CO-58 O.OOe+OO 5.66e+05 O.OOe+OO O.OOe+OO O.OOe+OO 1.15e+07 O.OOe+OO 1.27e+06 CO-60 O.OOe+OO 1.97e+06 O.OOe+OO O.OOe+OO O.OOe+OO 3.70e+07 O.O0e+0O 4.34e+06 NI-63 8.08e+08 5.60e+07 O.OOe+OO O.OOe+OO O.OOe+0O 1.17e+07 O.OOe+OO 2.71e+07 NI-65 4.52e-0 2 5.87e-03 0.OOe+0O O.OOe+OO O.00e+OO 1.49e-01 0.OOe+OO 2.68e-03 CU-64 O.OOe+OO 2.67e+03 O.OOe+OO 6.72e+03 O.OOe+0O 2.27e+05 O.OOe+O0 1.25e+03 ZN-65 1.65e+08 5.24e+08 O.OOe+OO 3.50e+08 O.OOe+OO 3.30e+08 O.OOe+OO 2.37e+08 ZN-69 2.64e-1 3 5.04e-13 O.OOe+OO 3.28e-13'0.O0e+O0 7.58e-14 O.OOe+OO 3.51e-14 BR-83 O.OOe+OOO;OOe+OO O.OOe+OO O.OOe+OO O.OOe+00 1.71e-02 O.OOe+OO 1.19e-02 BR-84 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+00,1.65e-29 O.OOe+0O 2.10e-24
,RB-86 O.OOe+OO 3.11e+08 O.OOe+0O O.OOe+OO 0O.OOe+OO 6.14e+07 O.OOe+0O 1.45e+08 RB-88 O.OOe+00-2.99e-4 6 O.OOe+OO O.OOe+OO O.OOe+OO 4.14e-57 O.OOe+0O 1.59e-46 RB-89 O.OOe+OO 7.93e-55 O.00e+OO O.OOe+OO O.OOe+OO 4.6le-68 O.OOe+O0 5.58e-55 SR-89 3.05e+09 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 4.89e+08 0.OOe+OO 8.75e+07 SR-90
-9.83e+10 O.OOe+OO O.OOe+OO O.00e+OO O.OOe+OO 2.84e+09 O.OOe+OO 2.41e+10 SR-91 6.11e+04 O.OOe+OO O.OOe+00 O.OOe+OO O.OOe+OO 2.91e+05 O.OOe+OO 2.47e+03 SR-92 1.04e+00 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.07e+O1 O.OOe+OO 4.51e-02 Y-90 8.51e+00 O.OOe+00 O.OOe+OO O.OOe+OO O.OOe+OO 9.02e+04 O.OOe+O0 2.28e-O1 Y-91 1.03e+03 O.OOe+OO O.OOe+0O O.'OOe+O0 O.OOe+OO 5.67e+05 O.OOe+OO 2.76e+01 Y-91M 7.59e-21 O.OOe+OO O.OOe+OO O.OOe+00 O.OOe+00'2.23e-20 O.OOe+002.94e-22 Y-92 6.78e-06 O.OOe+00' O.OOe+0O O.OOe+OO O.OOe+OO 1.19e-01 O.OOe+00-1.98e-07 Y-93 2.69e-02 O.OOe+OO O.OOe+OO O.OOe+OO 0O.OOe+OO 8.54e+O O.OOe+00 7.44e ZR-95 1.13e+0 2 3.63e+01 O.OOe+OO 5.70e+O1 O.OOe+OO 1.15e+05 O.OOe+OO 2.46e+O1 ZR-97 5.21e-0 2 1.05e-02 O.OOe+OO 1.59e-02 '0.00e+O 3.26e+03 O.OOe+OO 4.8le-03 NB-95 9.91e+03 5.51e+03 O.OOe+OO 5.45e+03 O.OOe+OO 3.35e+07 O.OOe+OO 2.96e+03 NO-99 O.OOe+OO 2.98e+06'0.00e+00 6.74e+06 0.OOe+00'6.90e+06 O.OOe+OO 5.66e+05 TC-99M 4.02e-01 1.14e+00 O.OOe+OO 1.72e+O1 5.56e-01 6.72e+02 O.OOe+OO 1.44e+O1 TC-101 3.77e-61 5.44e-61 O.OOe+009.79e-60 2.78e-61 1.63e-72 O.OOe+0O 5.33e-60 RU-103 1.22e+02 O.OOe+OO O.OOe+OO 4.66e+020.00e+00 1.43e+04 O.OOe+OO 5.26e+O1 RU-105
'1.04e-0 4 O.OOe+OO O.OOe+OO 1.34e-03.O.OOe+OO 6.35e-02 O.OOe+OO 4.10e-05 I Page I of 44
Attachment C ODCM-QA-004 Revision 2 Page 16 of 59 I
Units:
AgeGroup:
Pathway:
DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)
Airborne Pathways & Tritium Ingestion: (mrem/yr)/(pCimA3))
Deposition Pathways: (m^2 * (mremnyr)/(,uCVsec)
ADULT Grs/Goat/Milk (GMILK) i Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-106 AG-llOM TE-125M TE-127 TE-127M TE-129 TE-129M TE-131 TE-131M TE-132 1-130 1-131 1-132 1-133 1-134 1-135 CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141 BA-142 LA-140 LA-142 CE-141 CE-143 CE-144 PR-143 PR-144 ND-147 W-187 NP-239 PU-239 U-235 2.45e+0' 6.99e+W 1.96e+O(
- 7. 88e+0' 5.49e+OE 3.53e-11 7.23e+0(
4.82e-34 4.34e+04 2.88e+O!
2.53e+0!
1.78e+OE
- 1. Ole-01 2.33e+06 1.27e-12 7.76e+03 1.70e+10 7.90e+08 2.21e+10 2.95e-23 5.48e-09 3.23e+06, 5.7le-47 4.12e-81 5.42e-01 2.29e-12 5.81e+02 5.00e+00 4.29e+04
- 1. 89e+Ol 8.25e-55 1.13e+01 7.83e+02 4.4le-01 3.36e+06 3.71e+08 3 0.OOe+O(
66.46e+O0 6 7.08e+0' L 2.83e+01 61.96e+O0 11.32e-13 62.70e+OE I2.02e-34 2.12e+04 1.87e+05 7.46e+05 32.54e+08 2.69e-01 4.05e+06 3.46e-12 2.03e+04 4.04e+10 t3.12e+09 3.03e+10 5.83e-23 3.91e-12 4.05e+03 4.31e-50 4.24e-84 2.73e-01 1.04e-12 3.93e+02 3.69e+03 1.79e+04 7.60e+00 3.43e-55 1.31e+01 6.55e+02 4.34e-02 4.04e+05 0.00e+0O
)0.00e+OC
- 0.00e+OC i5.88e+05 S.83e+0l 1.40e+06
- 2.7le-11 2.48e+06 3.97e-34 J-3.36e+04 2.06e+05 6.33e+07 8.33e+10 9.41e+00 5.95e.08 6.00e-11 1.34e+06 0.00e+00 0.O00e+00 0.00e+00
- 0. 00e+00 0.O00e.00 O.O00e+00 O.O00e+00 0.O00e+00
- 0. 00e+00 0.00e+00 0.O00e+O0 0.00~e+00 0.O00e+00 0.00e+00 0.00e+00 0.O00e+00
- 0. 00e+00 0.00e+00 0.00e+00
- 0. 00e+00 I 4.73e+03 1.27e+07
- 7.95e+06 L 3.21e+02
- 2.23e+07 L 1.48e-10 3.02e+07 2.11e-33 2.15e+05 1.80e+06 1.17e+06 4.36e+08 4.28e-01 7.06e+06 5.51e-12 3.26e+04 1.31e+10 1.74e+09 1.03e+10 4.29e-23 3.65e-12 1.38e+03 4.Ole-50 3.58e-84
- 0. OOe+00 0.OOe+00 1.83e+02 1.63e+00
- 1. 06e+04 4.39e+00 1.93e-55 7.64e+00 O.OOe+00 1.35e-01 3.76e+05 8.67e+07 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+0O O.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+0O
- 0. 00e+00 0.OOe+0O 0.OOe+00 O.OOe+00
- 0. OOe+O0 0.OOe+O0 4.34e+09 2.38e+08 3.42e+09 4.23e-24 2.22e-12 2.32e+03 2.45e-50 2.40e-84 0.OOe+O0 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00 O.OOe+00 0.OOe+OO 0.OOe+00 0.OOe+00 1.58e+05 0.00e+00 3.10e+02 2.64e+09 7.81e+06 6.21e+03 1.84e+07 2.66e-11 3.64e+07 6.83e-35 2.11e+06 8.82e+06 6.43e+05 6.71e+07 5.05e-02 3.64e+06 3.02e-15 2.29e+04 7.06e+08 3.54e+08 5.86e+08 2.49e-28 9.72e-09 6.64e+06 2.69e-56 0.OOe+00 2.Ole+04 7.62e-09 1.50e+06 1.38e+05 1.45e+07 8.30e+04 1.19e-61 6.27e+04 2.15e+05 8.90e+03 3.09e+05' 3.62e+07
-0.00e+00 0.00e+00 0.00e+00 0.O00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.O00e+00
- 0. 00e+00
- 0. 00e+00 0.00e+O0 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.O00e+00
- 0. 00e+00 0.O00e+00 0.00e+00
- 0. 00e+00 0.O00e+00
- 0. 00e+00 0.00e+00 0.00e+00
- 0. 00e+00 0.O00e+00 o. 00e+00 0.00e+00 0.O00e+00 O.O00e+00 o. 00e+00 0.O00e+00
- 0. 00e+00 3.84e+06 2.62e+05 1.70e+01 6.70e+05 8.59e-12 1.14e+06 1.52e-34
- 1. 77e+04 1.75e+05 2.95e+05 1.46e+08 9.41e-02 1.23e+06 1.24e-12 7.50e+03 3.30e+10 2.25e+09 1.98e+10 2.89e-23 1.60e-10 2.lle+05
- 1. 93e-48 2.59e-82 7.22e-02 2.60e-13 4.46e+01 4.09e-01 2.31e+03 9.39e-01 4.19e-56 7.82e-01 2.29e+02 2.39e-02 8.8 6e+04 2.25e+07 l Page 2 of 44
Attachment C ODCM-QA-004 Revision 2 Page 17 of 59 i
DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES I
(Ref.3.9 Ch. 5.2, 5.3)
Units:
AgeGroup:
Pathway:
Airborne Pathways & Tritium Ingestion: (mrem/yr)1(pC1/n-Vf"3))
Deposition Pathways: (rmr2 * (mrem/yr)/(uCVsec)
ADULT Ground Plane Deposition (GPD)
I Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB NA-24 1.20e+07 1.20e+07 1.20e+07 1.20e+07 1.20e+07 1.20e+07 1.39e+07 1.20e+07 CR-51 4.66e+06 4.66e+06 4.66e+06 4.66e+06 4.66e+06 4.66e+06 5.51e+06 4.66e+06 MN-54 1.39e+09 1.39e+09 1.39e+09 1.39e+09 1.39e+09 1.39e+09 1.63e4-09 1.39e+09 MN-56 9.04e+05 9.04e+05 9.04e+05-9.04e+05 9.04e+05 9.04e+05 1.07e+06'9.04e+05
.FE-59 2.72e+08 2.72e+08 2.72e+08 2.72e+08 2.72e+08 2.72e+08 3.20e+08 2.72e+08 CO-58 3.79e+08 3.79e+08 3.79e+08 3.79e+08 3.79e+08,3.79e+08 4.44e+08 3.79e+08 CO-60 2.15e+10 2.15e+10 2.15e+10 2.15e+10 2.15e+10 2.15e+10 2.15e+10 2.15e+10 NI-65
- 2.97e+05 2.97e+05 2.97e+05 2.97e+05 2.97e+05,2.97e+0 5
3.45e+05 2.97e+05 CU-64 6.07e+05 6.07e+05 6.07e+05 6.07e+05 6.07e+05 6.07e+05 6.88e+05 6.07e+05 ZN-65 7.47e+08 7.47e+08 7.47e+08 7.47e+08 7.47e+08 7.47e+08 8.60e+08 7.47e+08 BR-83 4.87e+03 4.87e+03 4.87e+03 4.87e+03 4.87e+03 4.87e+03 7.08e+03 4.87e+03 BR-84 2.03e+05-2.
0 3 e+05 2.03e+05 2.03e+05 2.03e+05 2.03e+05 2.36e+05 2.03e+05 RB-86 8.99e+06 8.99e+06 8.99e+06 8.99e+06 8.99e+06 8.99e+06 1.03e+07 8.99e+06 RB-88 3.31e+04 3.31e+04 3.31e+04 3.31e+04 3.31e+04.3.31e+0 4
3.78e+04 3.31e+04 RB-89 1.21e+05 1.21e+05 1.21e+05 1.21e+05 1.21e+05 1.21e+05 1.45e+05 1.21e+05 SR-89 2.16e+04 2.16e+04-2.16e+0 4
2.16e+04 2.16e+04 2.16e+04 2.51e+04 2.16e+04 SR-91 2.15e+06 2.15e+06 2.15e+06 2.15e+06 2.15e+06.2.15e+0 6
2.51e+06 2.15e+06 SR-92 7.77e+05 7.77e+05 7.77e+05 7.77e+05 7.77e+05 7.77e+05 8.63e+05 7.77e+05 y-90 4.49e+03 4.49e+03 4.49e+03 4.49e+03 4.49e+03 4.49e+03 5.31e+03 4.49e+03 Y-91 1.07'e+06 1.07e+06 1.07e+06 1.07e+06 1.07e+06 1.07e+06 1.21e+06 1.06e+06 Y-91M 1.OOe+05 1.OOe+05 1.OOe+05 1.OOe+05 1.OOe+05 1.OOe+05 1.16e+05 -l.OOe+05 Y-92 1.80e+05 1.80e+05 1.80e+05 1.80e+05 1.80e+05 1.80e+05 2.14e+05 1.80e+05 Y-93 1.83e+05 1.83e+05 1.83e+05 1.83e+05 1.83e+05 1.83e+05 2.51e+05 1.83e+05 ZR-95 2.45e+08 2.45e+08 2.45e+08 2.45e+08 2.45e+08, 2.45e+08 2.84e+08 2.45e+08 ZR-97 2.96e+06 2.96e+06 2.96e+06 2.96e+06,2.96e+06 2.96e+06 3.45e+06 2.96e+06 NB-95 1.37e+08 1.37e+08 1.37e+08 1.37e+08 1.37e+08 1.37e+08 1.61e+08 1.37e+08' MO-99 4.00e+06 4.00e+06 4.00e+06 4.00e+06 4.00e+06 4.00e+06 4.63e+06 4.00e+06 TC-99M 1.84e+05 1.84e+05 1.84e+05 1.84e+05 1.84e+05 1.84e405 2.l1e+05 1.84ei+05 TC-101 2.04e+04 2.04e+04 2.04e+04 2.04e+04 2.04e+04 2.04e+04 2.26e+04 2.04e+04 RU-103 1.08e+08 1.08e+08 1.08e+08 1.08e+08-1.08e+08 1.08e+08 1.26e+08 1.08e+08 RU-105 6.37e+05 6.37e+05 6.37e+05 6.37e+QO5 6.37e+05 6.37e+05 7.21e+05 6.37e+05 RU-106 4.22e+08 4.22e+08 4.22e+08 4.22e+08 4.22e+08 4.22e+08 5.07e+08 4.22e+08 AG-llOM 3.44e+09 3.44e+09 3.44e+09 3.44e+09 3.44e+09 3.44e+09 4.01e+09 3.44e+09 TE-125M 1.55e+06 1.55e+06 1.55e+06 1.55e+06 1.55e+06 1.55e+06 2.13e+06 1.55e+06 TE-127 2.98e+03 2.98e+03 2.98e+03 2.98e+03 2.98e+03 2.98e+03 3.28e+03 2.98e+03 TE-127M 9.17e+04 9.17e+04 9.17e+04 9.17e+04 9.17e+04 9.17e+04 1.08e+05 9.17e+04 TE-129 2.62e+04 2.62e+04 2.62e+04 2;62e+04 2.62e+04 2.62e+04 3.10e+04 2.62e+04 TE-129M 1.98e+07 1.98e+07 1.98e+07 1.98e+07 1.98e+07 1.98e+07 2.31e+07 1.98e+07 l Page 3 of 44
Attachment C ODCM-QA-004 Revision 2 Page 18 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3) i I Units:
AgeGroup:
Pathway:
Airborne Pathways & Tritium Ingestion: (mrem/yr)/(pCVmA3))
Deposition Pathways: (m2 * (mrem/yr)/(pCVsec)
ADULT Ground Plane Deposition (GPD)
I Nuclide Bone Liver Thyroid Kidney Lung GI-Lli, Skin TB TE-131 TE-131M TE-132 I-130 I-131 I-132 I-133 1-134 I-135 CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141 BA-142 LA-140 LA-142 CE-141 CE-143 CE-144 PR-144 ND-147 W-187 NP-239 PU-239 u-235 2.92e+04 8.03e+0 6 4.24e406 5.51e+06 1.72e+07 1.25e+06 2.45e+06 4.47e+05 2.53e+06 6.86e+09 1.51e408
- 1. 03e+10 3.59e+05 1.O06e+05 2.05e+07 4.17e+04 4.49e+04
- 1. 92e+07 7.60e+05 1.37e+07 2.31e+06 6.95e+07
- 1. 84e+03 8.3 9e+06 2.35e+06 1.71e+06 2.29e-106 9.2 8e+09 2.92e+04 8.03e+06 4.24e+06 5.51e+06 1.72e+07 1.25e+06 2.45e+06 4.47e+05 2.53e+06 6.86e+09 1.51e+08 1.03e+10 3.59e+05 1.06e+05 2.05e+07 4.17e+04 4.'49e+04 1.92e+07 7.60e+05 1.37e+07 2.31e+06 6.95e+07 1.84e+03 8.39e+06 2.35e+06 1.71e+06 2.29e+06 9.28e+09 2.92e+04 8.03e+06 4.24e.06 5.51e+06 1.72e+07 1.25e+06 2.45e+06 4.47e+05 2.53e+06 6.86e+09 1.51e+08
- 1. 03e+10 3.59e+05
- 1. 06e+05 2.O05e+07 4.17e+04 4.49e+04
- 1. 92e+07 7.60e+05
- 1. 37e+07 2.31e+06 6.95e+07
- 1. 84e+03 8.3 9e*06 2.35e+06 1.71e+06 2.29e+06 9.28e+09 2.92e+04 8.03e+06 4.24e+06 5.51e+06 1.72e+07 1.25e+06 2.45e+06 4.47e+05 2.53e+06 6.86e+09 1.51e+08 1.03e+10 3.59e+05
- 1. 06e+05 2.05e+07 4.17e+04 4.49e+04 1.92e+07 7.60e+05 1.37e+07 2.31e+06 6.95e+07 1.84e+03 8.39e+06 2.35e+06 1.71e+06 2.29e+06 9.28e+09 2.92e+04 8.03e+06 4.24e+06 5.51e+06 1.72e+07 1.25e+06 2.45e+06 4.47e+05 2.53e+06 6.86e+09 1.51e+08 1.03e+10 3.59e+05 1.06e+05 2.05e+07 4.17e+04
-4.49e+04 1.92e+07 7.60e+05 1.37e+07 2.31e+06 6.95e+07 1.84e+03 8.39e+06 2.35e+06 1.71e+06 2.29e+06 9.28e+09 2.92e+04 8.03e+06 4.24e+06 5.51e+06 1.72e+07 1.25e+06 2.45e+06 4.47e+05 2.53e+06 6.86e+09 1.51e+08 1.03e+10 3.59e+05 1.06e+05 2.05e+07 4.17e+04 4.49e+04 1.92e+07 7.60e+05 1.37e+07 2.31e+06 6.95e+07 1.84e+03 8.39e+06 2.35e+06 1.71e+06 2.29e+06 9.28e+09 3.45e+07 9.46e+06 4.98e+06 6.69e+06 2.09e+07 1.47e+06 2.98e+06 5.31e+05 2.95e+06 8.00e+09 1.71e+08 1.20e+10 4.10e+05 1.19e+05 2.35e+07 4.75e+04 5.11e+04 2.18e+07 9.12e+05
- 1. 54e+07 2.63e+06 8.04e+07 2.11e+03 1.Ole+07 2.73e+06 1.98e+06 2.23e+07 1.16e+10 2.92e+04 8.03e+06 4.24e+06 5.51e+06 1.72e+07 1.25e+06 2.45e+06 4.47e+05 2.53e+06 6.86e+09 1.51e+08 1.03e+10 3.59e+05 1.06e+05 2.05e+07 4.17e+04 4.49e+04 1.92e+07 7.60e+05 1.37e+07 2.31e+06 6.95e+07 1.84e+03 8.39e+06 2.35e+06 1.71e+06 2.29e+07 9.28e+09 I
J Page 4 of 44
Attachment C ODCM-QA-004 Revision 2 Page 19 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3) i Units:
AgeGroup:
Pathway:
Airborne Pathways & Tritium Ingestion: (mremlyr)/(pCVmrn3))
Deposition Pathways: (m'12 * (mrem/yr)/(piCVsec)
ADULT Inhalation (INHL)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO 1.26e+03 1.26e+03 1.26e+03 1.26e+03 1.26e+03 O.OOe+OO1.26e+03 C-14 1.82e+04 3.41e+03 3.41e+03 3.41e+03 3.41e+03 3.41e+03 O.OOe+OO 3.41e+03 NA-24 1.02e+04 1.02e+04 1.02e+04 1.02e+04 1:02e+04 1.02e+04 O.OOe+OO 1.02e+04 P-32 1.32e+06 7.71e+04 O.OOe+OO O.OOe+OO O.OOe+OO 8.64e+04 O.OOe+OO 5.01e+04 CR-51 O.OOe+OO O.OOe+OO 5.95e+01 2.28e+01 1.44e+04 3.32e+03 O.OOe+OO 1.OOe+02 MN-54 O.OOe+OO 3.96e+04 O.OOe+OO 9'.84e+03 1.40e+06 7.74e+04 O.OOe+OO 6.30e+03 MN-56 O.OOe+OO 1.24e+00 O.OOe+OO 1.30e+00 9.44e+03 2.02e+04 O.OOe+OO 1.83e-01 FE-55 2.46e+04 1.70e+04 O.OOe+OO O.OOe+OO 7.21e+04 6.03e+03 O.OOe+OO 3.94e+03 FE-59 1.18e+04 2.78e+04 O.OOe+OO O.OOe+OO 1.02e+06 I'.88e+05 O.OOe+OO 1.06e+04 CO-58 O.OOe+OO 1.58e+03 O.OOe+OO O.Oe+OO 9.28e+05 1.06e+05 O.OOe+OO 2.07e+03 CO-60 O.OOe+OO 1.15e+04 O.OOe+OO O.OOe+OO 5.97e+06 2.85e+05 O.OOe+OO 1.48e+04 NI-63 4.32e+05 3.14e+04 0.OOe+OO O.OOe+OO 1.78e+05 1.34e+04 O.OOe+OO 1.45e+04 NI-65 1.54e+00 2.10e-01 O.OOe+OO O.OOe+OO 5.60e+03 1.23e+04 O.OOe+O0 9.12e-02 CU-64 O.OOe+OO 1.46e+00 O.OOe+OO 4.62e+00 6.78e+03 4.90e+04 O.OOe+OO 6.15e-01 ZN-65 3.24e+04 1.03e+05 O.OOe+OO 6.90e+04 8.64e+05 5.34e+04 O.OOe+OO 4.66e+04 ZN-69 3.38e-02 6.51e-02 O.OOe+OO 4.22e-02 9.20e+02 1.63e+01 O.OOe+OO 4.52e-03 BR-83 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.32e+02 O.OOe+OO 2.41e+02 BR-84 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.64e-03 O.OOe+OO 3.13e+02 BR-85 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.28e+01 RB-86 0.Oe+OO 1.35e+05 0.OOe+OO O.OOe+OO O.OOe+OO 1.66e+04 0.OOe+OO 5.90e+04 RB-88 O.OOe+OO 3.87e+02 O.OOe+OO O.OOe+OO O.OOe+OO 3.34e-.09 O.OOe+OO 1.93e+02 RB-89 O.OOe+OO 2.56e+02 O.OOe+OO O.OOe+OO O.OOe+OO 9.28e-12 O.OOe+OO 1.70e+02 SR-89 3.04e+05 O.OOe+OO O.OOe+OO O.OOe+OO 1.40e+06 3.50e+05 O.OOe+OO 8.72e+03 SR-90 9.92e+07 O.OOe+OO O.OOe+OO O.OOe+OO 9.60e+06 7.22e+05 O.OOe+OO 6.10e+06 SR-91 6.19e+01 O.OOe+OO O.OOe+OO O.OOe+OO 3.65e+04 l.91e+05 O.OOe+OO 2.50e+00 SR-92 6.74e+00 O.OOe+OO O.OOe+OO O.OOe+OO 1.65e+04 4.30e+04 O.OOe+OO 2.91e-01 y-90 2.09e+03 O.OOe+OO O.OOe+OO O.OOe+OO 1.70e+05 5.06e+05 O.OOe+OO 5.61e+01 Y-91 4.62e+05 O.OOe+OO O.OOe+OO O.OOe+OO 1.70e+06 3.85e+05 O.OOe+OO 1.24e+04 Y-91M 2.61e-01 O.OOe+OO O.OOe+OO O.OOe+OO 1.92e+03 1.33e+00 O.OOe+OO 1.02e-02 Y-92 1.03e+01 O.OOe+OO O.OOe+OO O.OOe+OO 1.57e+04 7.35e+04 O.OOe+OO 3.02e-01 y-93 9.44e+01 O.OOe+OO O.OOe+OO O.OOe+OO 4.85e+04 4.22e+05 O.OOe+OO 2.61e+00
'ZR-95 1.07e+05 3.44e+04 O.OOe+OO 5.42e+04 1.77e+06 1.50e+05 O.OOe+OO 2.33e+04 ZR-97 9.68e+01 1.96e+01 O.OOe+OO 2.97e+01 7.87e+04 5.23e+05 O.OOe+OO 9.04e+00 NB-95 1.41e+04 7.82e+03 O.OOe+OO 7.74e+03 5'-05e+05 1.04e+05 O.OOe+OO 4.21e+03 MO-99 O.OOe+OO 1.21e+02 O.OOe+OO 2.91e+02 9.12e+04 2.48e+05 O.OOe+OO 2.30e+01 TC-99M 1.03e-03 2.91e-03 O.OOe+OO 4.42e-02 7.64e+02 4.16e+03 'O.OOe+OO 3.70e-02
-TC-101 4.18e-05 6.02e-05 O.OOe+OO 1.08e 703 3.99e+02 1.09e-11 O.OOe+OO 5.90e-04 RU-103 1.53e+03 O.OOe+OO O.OOe+OO 5.'83e+03 5.05e+05 1.lOe+05 O.OOe+OO 6.58e+02 Page 5 of 44
Attachment C ODCM-QA-004 Revision 2 Page 20 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)
I I Units:
AgeGroup:
Pathway:
Airborne Pathways & Tritium Ingestion: (mremnyr)I(pCVm"3))
Deposition Pathways: (mA2 * (mrem/yr)/(pCVsec)
ADULT Inhalation (INHL)
I Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-105 RU-106 AG-llOM TE-125M TE-127 TE-127M TE-129 TE-129M TE-131 TE-131M TE-132 I-130 1-131 1-132 I-133 1-134 I-135 CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141 BA-142 LA-140 LA-142 CE-141 CE-143 CE-144 PR-143 PR-144 ND-147 W-187 NP-239 PU-239 U-235
- 7. 90e-01 6.91e+0 4 1.08e+04 3.42e+03 1.40e4+ 0 0 1.26e+ 0 4 4.98e-02 9.76e+03 1.1lie- 0 2 6.99e+Oi
- 2. 60e+0 2 4.58e+0 3
- 2. 52e+0 4 1.16e+03
- 8. 64e+03 6.44e+ 0 2 2.68e+03 3.73e+O5 3.90e+0 4 4.78e+05 3.31e+02 9.36e-01 3.90e+04 1.00e-01 2.63e-02 3.44e402 6.83e-01
- 1. 99e+04 1.86e+02 3.43e+0 6 9.36e40 3
- 3. Ole-0 2 5.27e+0 3 8.48e+00 2.30e+0 2 1.33e+10O S. ooe+07 I
0.OOe+0O 0.00e+00 l.OOe+04 1.58e+03 6.42e-01 5.77e+03 2.39e-02 4.67e+03 5.95e-03 4.36e+01 2.15e+02 1.34e+04 3.58e+04 3.26e+03 1.48e+04 1.73e+03 6.98e+03 8.48e+05 1.46e+05 6.21e+05 6.21e+02 6.66e-04 4.90e+01 7.53e-05 2.70e-05 1.74e+02 3.10e-01 1.35e+04 1.38e+02 1.43e+06 3.75e+03 1.25e-02 6.10e+03 7.08e+00 2.03e+02 3.56e+09 O. OOe+00 0.OOe+OO 0.OOe+00 O.OOe+00 1.05e+03 1.06e+00 3.29e+03 3:90e-02 3.44e+03 9.36e-03 5.50e+01 1.90e+02 I.14e+06 1.19e+07 1.14e+05 2.15e+06 2.98e+04 4.48e+05 0.OOe+00 O.00e+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 0.0Oe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.0Oe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.0Oe+00 0.OOe+00 0.OOe+00
- 0. 00e+O0 1.02e+00 1.34e+05 1.97e+04 1.24e+04 5.10e+00 4.58e+04 1.87e-01 3.66e+04 4.37e-02 3.09e+02 1.46e+03 2.09e+04 6.13e+04 5.18e+03 2.58e+04 2.75e+03 l.lle+04 2.87e+05 8.56e+04 2.22e+05 4.80e+02 6.22e-04 1.67e+01
- 7. 00e-05 2.29e-05 0.OOe+00
- 0. 00e+00 6.26e+03 6.08e+01 8.48e+05 2.16e+03 7.05e-03 3.56e+03
- 0. OOe+00 7.00e+01 2.64e+09 1.87e+07 1.lOe+04 9.36e+06 4.63e+06 3.14e+05 6.51e+03 9.60e+05 1.94e+03 1.16e+06 1.39e+03 1.46e+05 2.88e+05 0.00e+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 9.76e+04 1.20e+04 7.52e+04 4.B6e+0l 3.76e+03 1.27e+06 1.94e+03 l.19e+03 1.36e+05 6.33e+03 3.62e+05 7.98e+04 7.78e+06 2.81e+05 1.02e+03 2.21e+05 2.90e+04 3.76e+04 1.38e+09 3.92e+08 4.82e+04 9.12e+05 3.02e+05 7.06e+04 5.74e+04 1.50e+05 1.57e+02 3.83e+05 1.84e+01 5.56e+05 5.10e+05 7.69e+03 6.28e+03 4.06e+02 8.88e+03 1.01e+00 5.25e+03 1.04e+04 1.17e+04 8.40etO3 1.86e-03 8.96e+02 2.18e+05 1.16e-07 1.57e-16 4.58e+05 2.lle+03 1.20e+05 2.26e+05 8.16e+05 2.OOe+05 2.15e-08 1.73e+05 1.55e+05 1.19e+05 3.30e+05 3.87e+06
- 0. 00e+00
- 0. 006+00 0.O00e+00 0.00e+00 0.00e+00 0.O00e+OD 0.O00e+00 0.O00e.00 0.O00e+00
- 0. 00e+00 0.00e+00 0.00e+O0
- 0. 00e+00 0.00~e+00 0.00e+00 0.00e+00 0.00e+00 0.O00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.O00e+00 o0.00e+00 0.00e+O0 0.00e+O0 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 3.1le-01 8.72e+03 5.94e+03 4.67e+02 3.lOe-0O 1.57e+03 1.24e-02 1.58e+03 3.59e-03 2.90e+01 1.62e+02 5.28e+03 2.05e+04 1.16e+03 4.52e+03 6.15e+02 2.57e+03 7.28e+05
- 1. lOe+05 4.28e+05 3.24e+02 2.74e-02 2.57e+03 3.36e-03 1.66e-03 4.58e+01 7.72e-02 1.53e+03 1.53e+01 1.84e+05 4.64e+02 1.53e-03 3.65e+02 2.48e+00 1.24e+01 6.20e+08 4.86e+06
,1)
_i I Page 6 of 44
L i Attachment C ODCM-QA-004 Revision 2 Page 21.of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)
Airborne Pathways & TrRium Ingestion: (mremlyr)/(uCVmA 3))
Deposition Pathways: (mA2 * (mren/yr)/(pC/sec)
ADULT Grs/Cow/Meat (CMEAT) l Units:
AgeGroup:
Pathway:
I I Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO 3.25e+02 3.25e+02 3.25e+02 3.25e+02 3.25e+02 O.OOe+OO 3.25e+02 C-14 2.41e+08 4.83e+07 4.83e+07 4.83e+07 4.83e+07 4.83e+07 O.OOe+0O 4.83e+07 NA-24 1.40e-03 1.40e-03 1.40e-03 1.40e-03 1.40e-03 1.40e-03 O.OOe+OO 1.40e-03 P-32 7.25e+08 2.90e+08 O.OOe+OO O.OOe+OO O.OOe+OO 5.24e+08 O.Oe+OO 1.80e+08 CR-51 O.OOe+OO O.OOe+OO 4.22e+03 1.55e+03 9.36e+03 1.77e+06 O.OOe+OO 7.05e+03 MN-54 O.OOe+OO 9.18e+06 O.OOe+OO 2.73e+06 O.Oe+OO 2.8le+07 0.00e+001.75e+06 MN-56 O.OOe+001.81e-5 3 O.OOe+OO 2.30e-53 O.OOe+OO 5.77e-52 O.OOe+OO 3.21e-54 FE-55 2.93e+08 2.03e+08 O.OOe+OO O.OOe+001.13e+0B 1.16e+08 O.OOe+OO 4.73e+07 FE-59 2.66e+08 6.24e+08 O.OOe+OO O.OOe+OO 1.75e+08 2.08e+09 O.OOe+OO 2.39e+08 CO-58 O.OOe+OO 1.82e+07 O.OOe+OO O.OOe+OO O.Oe+OO 3.70e+08 O.OOe+OO 4.09e+07 CO-60 O.OOe+OO 7.52e+07 O.OOe+OO 0.OOe+OO O.OOe+OO 1.41e+09 O.OOe+OO 1.66e+08 NI-63 1.89e+10 1.31e+09 O.OOe+OO O.OOe+DO O.OOe+OO 2.73e+08 O.OOe+OO 6.34e+08 NI-65 2.69e-52 3.50e-53 O.OOe+OO O.OOe+OO O.OOe+OO 8.87e-52 O.OOe+OO 1.60e-53 CU-64 O.OOe+OO 2.81e-07 0.00e+00 7.09e-07 O.OOe+OO 2.40e-O5 O.OOe+OO 1.32e-07 ZN-65 3.56e+08 1.13e+09 O.OOe+OO 7.57e+08 O.OOe+OO 7.13e+08 O.OOe+OO 5.12e+08-RB-86 O.OOe+OO 4.88e+08 O.OOe+OO O.OOe+OO O.OOe+OO 9.62e+07 O.OOe+OO 2.27e+08 SR-89 3.02e+08 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 4.84e+07 O.OOe+OO 8.66e+06 SR-90 1.24e+1° O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+00 3.59e+08 O.OOe+OO 3.05e+09 SR-91 1.59e-10 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 7.59e-10 O.OOe+OO 6.44e-12 SR-92 1.39e-4 9 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.76e-48 O.OOe+OO 6.03e-51 y-90 1.08e+02 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.15e+06 O.OOe+OO 2.91e+00 Y-91 1.13e+06 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 6.23e+08 O.00e+OO 3.03e+04 Y-92 1.73e-39.0.00e+00 O.OOe+OO O.OOe+OO O.OOe+OO 3.02e-35 O.OOe+OO 5.04e-41 y-93 4.91e-12 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.56e-07 O.OOe+OO 1.36e-13 ZR-95 1.87e+06 6.01e+05 O.OOe+OO 9.43e+05 O.OOe+OO 1.90e+09 O.OOe+OO 4.07e+05 ZR-97 2.12e-05 4.28e-06 O.OOe+OO 6.47e-06 O.OOe+OO 1.33e+00 O.OOe+OO 1.96e-06 NB-95 2.30e+06 1.28e+06 O.OOe+OO 1.26e+06 O.OOe+OO 7.76e+09 O.OOe+OO 6.87e+05 MO-99 O.OOe+OO 1.Ole+05 O.OOe+OO 2.28e+05 O.OOe+OO 2.33e+05 O.Oe+OO 1.92e+04 TC-99M 4.80e-21 1.36e-20 O;OOe+OO 2.06e-19 6.65e-21 8.03e-18 O.OOe+OO 1.73e-19 RU-10 3 1.05e+08 O.OOe+OO O.OOe+OO 4.02e+08 0.00e+00 1.23e+10 O.OOe+OO 4.53e+07 RU-1OS 6.40e-28 O.OOe+OO O.OOe+OO 8.27e-27 O.OOe+OO 3.91e-25 O.OOe+OO 2.53e-28 RU-106 2.80e+09 O.OOe+OO O.OOe+OO 5.40e+09 O.OOe+OO 1.81e+ll O.OOe+OO 3.54e+08 AG-llOM 6.68e+06 6.18e+06 O.OOe+OO 1.22e+07 O.OOe+OO 2.52e+09 O.OOe+OO 3.67e+06 TE-125M 3.59e+08 1.30e+08 1.08e+08 1.46e+09 O.OOe+OO 1.43e+09 O.OOe+OO 4.81e+07 TE-12 7 2.23e-10 8.00e-11 1.65e-10 9.08e-10 O.OOe+OO 1.76e-08 O.OOe+OO 4.82e-11 TE-127M 1.12e+09 3.99e+08 2.85e+08 4.53e+09 O.OOe+OO 3.74e+09 O.OOe+OO 1.36e+08 TE-129M 1.14e+09 4.23e+08 3.90e+08 4.74e+09 O.OOe+OO 5.71e+09 O.OOe+OO 1.80e+08 TE-131M 4.58e+02 2.24e+02 3.55e+02 2.27e+03 O.OOe+OO 2.22e+04 O.OOe+OO 1.87e+02 Page 7 of 44
Attachment C ODCM-QA-004 Revision 2 Page 22 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)
, Units:
AgeGroup:
Pathway:
Airborne Pathways & Tritium Ingestion: (mrem/yr)/(ICUmA3))
Deposition Pathways: (mA2 * (mren/yr)/(pCVsec)
ADULT Grs/Cow/Meat (CMEAT) l Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB TE-132 1-130 I-131 I-132 1-133 1-135 CS-134 CS-136 CS-137 BA-140 LA--140 LA-142 CE-141 CE-143 CE-144 PR-143 ND-147 w-187 NP-239 PU-239 U-235 1.43e+06 1.09e-06 5.38e+06 4.25e-5 9 1.87e-01 2.37e-17 6.58e+08
- 1. 21e+0 7 8.72e+08 2.88e+0 7 3.75e-0 2 4.59e-92
- i.
41e+0 4 2.04e-02 1.46Ge+06 2.10e+04 7.08e+03
- 2. lle-0 2 2.61-e-01 2.78e+0 7 7.47e+08 9.24e+05 3.23e-06 7.70e+06 1.14e-58 3.25e-01 6.2ie-17 1.57e+09 4.77e+07 l.19e+09 3.62e+04 1.89e-02 2.09e-92 9.51e+03 1.51e+O1 6.09e+05 8.42e+03 8.19e+03 1.76e-02 2.57e-02 3.34e+06 0.OOe+00 1.02e+06 2.73e-04 2.52e+09 3.98e-57 4.77e+01 4.09e-15 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.O00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00
- 0. 00e+00 0.00e+00 0.00e.00 o0.00e+00 0.00e+00 0.00e+00 8.90e+06 5.04e-06 1.32e+07 1.8ile-58 5.67e-01 9.96e-17 5.06e+08 2.65e+07 4.05e+08 1.23e+04 0.00e+00 0.00e+00 4.42e+03
- 6. 62e-03 3.62e+05 4.86Ge+03 4.79e+03 0.00e+00 8.Ole-02 3.11e+06 1.74e+08 0.O00e+00
- 0. 00e+00
- 0. 00e+00 0.00e+00 O.O00e+00 O.
00e+00
- 1. 68e+08 3.63e+06
- 1. 35e+08 2.07e+04 0.00Oe+00
- 0. 00e+00 o
. 00e+O0 0.00e+O0 0.O00e+00 0.O00e+00 0.O00e+00
- 0. 00e+00 0.O00e+00 0.O00e+00 0.O00e+00 4.37e+07 2.78e-06 2.03e+06 2.13e-59 2.92e-01 7.Oe-17 2.74e+07 5.41e+06 2.31e+07 5.93e+07 1.39e+03 1.52e-88 3.63e+07 5.63e+02 4.93e+08 9.20e+07 3.93e+07 5.77e+00 5.27e+03 2.56e+06 7.28e+07 0.O00e+00 0.O00e+00 0.00e+00 O.
00e+00 O.
00e+00 0.O00e+00 0.00e+00 0.00e+00 0.00e+00 O.O00e+00 0.00e+00
- 0. 00e+00 0.00e+00 0.00e+00 0.00eeOO 0.00e+00 0.00e+00 0.O00e+00 O.O00e+00 0.00e.00 0.O00e+00 8.67e+05 1.27e-06 4.41e+06 3.98e-59 9.90e-02 2.29e-17 1.28e+09 3.43e+07 7.Ble+08 1.89e+06 5.OOe-03 5.20e-93 1.08e+03 1.67e-03 7.83e+04 1.04e+03 4.90e+02 6.16e-03 1.42e-02 7.33e+05 4.53e+07 C
J l Page 8 of 44
Attachment C ODCM-QA-004 Revision 2 Page 23 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3) l Units:
Airborne Pathways & Tritium Ingestion: (mrernryr)/(CVrmA3)).
Deposition Pathways: (mA2 * (mrem/yr)/(pCVsec)
AgeGroup:
ADULT Pathway:
Grs/Cow/Milk (CMILK)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 0.O0e+OO 7.63e+02 7.63e+02 7.63e+02 7.63e+02 7.63e+02 0.OOe+00 7.63e+02 C-14 2.63e+08 5.27e+07 5.27e+07 5.27e+07 5.27e+07 5.27e+07 0.OOe+00 5.27e+07 NA-24 2.45e+06 2.45e+06 2.45e+06 2.45e+06 2.'45e+06 2.45e+06 0.OOe+O0 2.45e+06 P-32 2.66e+09 1.06e+09 0.OOe+OO 0.OOe+00 0.OOe+00 1.92e+09 0.OOe+00 6.61e+08 CR-51 0.0Oe+0O 0.OOe+00 1.71e+04 6.30e+03 3.79e+04 7.19e+06 0.OOe+0O 2.86e+04 MN-54 0.00e+00 8.41e+06 0.OOe+00 2.50e+06 0.OOe+00 2.58e+07 O.OOe+OO 1.61e+06 MN '0.OOe+00'4.23e-03 O.OOe+00 5.37e-03 0.OOe+00 1.35e-01 0.OOe+00 7.50e-04 FE-55 2.51e+07 1.74e+07 0.OOe+00 0.00e+OO 9.68e+06 9.95e+06 0.OOe+00 4.05e+06 FE-59 2.97e+07 6.98e+07 0.OOe+O0 0.OOe+00 1.95e+07 2.33e+08 0.OOe+00 2.68e+07 CO 0.00e+0O 4.71e+06 0.OOe+00 0.00e+00 0.OOe+00 9.56e+07 0.OOe+00 1.06e+07 CO-60 0.00e+00 1-.64e+07 0.OOe+OO O.OOe+00 0.OOe+00 3.08e+08 0.OOe+OO 3.62e+07 NI-63 6.73e+09 4.67e+08 0.OOe+000.OOe+00 0.OOe+00 9.74e+07 0.OOe+00 2.26e+08 NI-65 3.77e-01 4-.89e-02 0.OOe+00 0.00e+00 0.OOe+00 1.24e+00 0.OOe+00 2.23e-02 CU-64 0.00e+00 2.39e+04 0.OOe+00 6.03e+04 0.OOe+00 2.04e+06 0.00e+00 1.12e+04 ZN-65 1.37e+09 4.37e+09,0.00e+00 2.92e+09 0.00e+00 2.75e+09 0.00e+00 1.97e+09 ZN-69 2.20e-12 4.20e-12 0.OOe+00 2.73e-12 0.OOe+O0 6.31e-13 0.OOe+00 2.92e-13 BR-83 0.OOe+0O 0.OOe+00 0.OOe+00 0.00e+00 0.00e+00 1.43e-01 0.OOe+00 9.90e-02 BR-84 0.00e+00 0.OOe+O0 0.OOe+00 0.OOe+00 0.OOe+00 1.38e-28 0.OOe+00 1.75e-23 RB-86 0.OOe+OO 2.60e+09 0.00e+00 0.OOe+000.O0e+0O 5.12e+08 0.OOe+00 1.21e+09 RB 0.00e+00 2.49e-45 0.OOe+00'0.0e+O0O 0.OOe+00 3.45e-56 0.OOe+00 1.32e-45 RB-89 0.OOe+OO 6.61e-54 0.00e+00 0.OOe+00-0.00e+00 3.-84e-67 0.OOe+O0 4.65e-54 SR-89 1.45e+09 0.OOe+O0 O.OOe+00 0.OOe+00 0.OOe+00 2.33e+08 0.OOe+00 4.17e4+07 SR-90 4.68e+10 0.OOe+00 0.OOe+000.OOe+OO 0.OOe+00 1.35e+b9 0.OOe+00 1.15e+10 SR-91 2.91e+04 O.OOe+00 0.OOe+00 O.OOe+OO-O.OOe+O0 1.38e+05 0.OOe+O0 1.17e+03 SR-92 4.97e-01 0.OOe+00 0.OOe+00 0.00e+OO-0.00e+00'9.84e+00 0.OOe+O0 2.15e-02 y-90 7.09e+01 0.OOe+00-0.OOe+OO 0.OOe+00 0.OOe+00 7.52e+05 0.OOe+00 1.90e+00 Y-91 8.59e+03 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 4.73e+06 O.OOe+00 2.30e+02 Y-91M 6.32e-20 0.OOe+00 0.OOe+00 O.OOe+0O 0.OOe+00 1.86e-19 0.OOe+OO 2.45e-21 Y-92 5.65e-05 0.OOe+OO,0.OOe+00 0.OOe+00 0.OOe+00 9.90e-01 0.OOe+00 1.65e-06 y-93 2.24e-01 0.OOe+00 0.DOe+00 0.00e+00 0.OOe+00 7.12e+03 0.OOe+00 6.20e-03 ZR-95 9.43e+02 3.03e+02 0.OOe+00 4.75e+02 0.OOe+00 9.59e+05 0.OOe+O0 2.05e+02 ZR-97 4.34e-01 8.77e-02 0.00e+00 1.32e-010O.OOe+00 2.72e+04 O.OOe+O0 4.Ole-02 NB-95 8.26e+04 4.59e+04 0.OOe+00 4.54e+04 0.OOe+00 2.79e+08 0.OOe+O0 2.47e+04 MO-99 0.00e+00 2.48e+07.0.OOe+00 5.61e+07 0.OOe+00 5.75e+07 0.00e+00 4.72e+06 TC-99M 3.35e+00 9.46e+00 0.OOe+00 1.44e+02 4.63e+00 5.60e+03 0.00e+00 1.21e+02 TC-101 3.14e-60 4.53e-60 0.OOe+00 8.16e-59-2.3 le-6 0 1.36e-71 0.OOe+00 4.44e-59 RU-103 1.02e+03 0.OOe+OO 0.OOe+00 3.89e+03,0.00e+00'1.19e+05-O.OOe+00 4.39e+02 RU-105 8.66e-04 0.OOe+00 0.OOe+00 1.12e-02 0.OOe+00 5.29e-01 0.OOe+00 3.42e-04 I Page 9 of 44
Attachment C ODCM-QA-004 Revision 2 Page 24 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3) i l Units:
AgeGroup:
Pathway:
Airborne Pathways & Tritium Ingestion: (mremnyr)/(pCVm"A3))
Deposition Pathways: (me2 * (mrem/yr)/(pCisec)
ADULT Grs/Cow/Milk (CMILK)
Nuclide Bone Liver Thyroid Kidney Lung-GI-Lli Skin TB RU-106 AG-llOM TE-125M TE-127 TE-127M TE-129 TE-129M TE-131 TE-131M TE-132 1-130 1-131 1-132 1-133 I-134 1-135 CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141 BA-142 LA-140 LA-142 CE-141 CE-143 CE-144 PR-143 PR-144 ND-147 W-187 NP-239 PU-239 U-235
- 2. 04e+04 S. 82e+0 7 1.63e+0 7 6.56e+0 2 4.58e+0 7 2.94e-10 6.02e+07 4.02e-33 3.62e+05 2.40e+06
- 2. lle+05S 1.48e+08 8.38e-0 2 1.94e+06 1.06e-12 6.46e+03 5.65e+09 2.63e+08 7.38Be+0 9
- 9. 85e-2 4 4.57e-08 2.69e+07 4.76e-4 6 3.43e-80 4.52e+00
- 1. 9le-11 4.85e+03 4.16e+01 3.58e+05 1.58e+02 6.88e-54 9.42e+01 6.53e.03
- 3. 68e+00 2.80e+07 3.10e+09 0.00e+00 5.39e+07 5.90e+06 2.36e+02-
- 1. 64e+07 1.lOe-10 2.25e+07
- 1. 68e-33 1.77e+05 1.56e+06 6.22e+05 2.12e+08 2.24e-01 3.37e+06 2.89e-12
- 1. 69e+04 1.35e+10 1.04e+09 1.Ole+10 1.94e-23 3.25e-11 3.38e+04 3.59e-49 3.53e-83 2.28e+00 8.7Oe-12 3.28e+03 3.08e+04 1.50e+05 6.34e+01 2.86e-54 1.09e+02 5.46e+03 3.61e-01 3.37e+06 O.00e+00 0.O00e+00 0.O00eO00 4.90e+06 4.8 6e+02 1.17e+07 2.25e-10 2.07e+07 3.3le-33
- 2. 80e+05 1.72e.06 5.27e+07 6.94e-i10 7.84e+00 4.96e+08
- 5. OOe-11 1.12e+06 0.00~e+00 0.00e+00 0.00e+00 0.O00e+00 0.00e+00 0.O00e+O0 0.00e+00 0.00e+00 0.O00e+00 0.O00e+00 0.00e+00 0.O00e+O0 0.00e+00 0.O00e+00 0.00e+00 0.00e+00 0.00e+00 0.00~e+00 0.00e+00 0.00e+00 3.94e+04
- 1. 06e+08 6.63e+07 2.67e+03 1.86e+08 1.24e-09 2.51e+08 1.76e-32 1.79e+06 1.50e+07 9.71e+05
- 3. 63e+08 3.57e-01 5.89e+06 4.59e-12 2.71e+04 4.35e+09 5.78e+08 3.43e+09 1.43e-23 3.04e-11
- 1. 15e+04 3.34e-49 2.98e-83 0.OOe+00 0.00e+OO 1.52e+03 1.36e+01 8.87e+04 3.66e+01 1.61e-54 6.36e+01 O.OOe+00 1.13e+00 3.13e+06 7.23e+08 0.00~e+00
- 0. 00e+00 0.00~e+00 0.00e+00 0.00~e+00 0.00~e+00 0.00e+00 0.00~e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.O00e+00 0.O00e+00 1.45e+09 7.93e+07 1.14e+09 1.4le-24 1.85e-11 1.93e+04 2.04e-49 2.00e-83 0.O00e+00 0.O00e+O00 0.O00e+00 0.O00e+00 0.O00e+00 0.O00e+00 O.O00e+00 0.O00e+00
- 0. 00e.00 0.00e+00 0.0~e+ 00
- 0. 00e+00 1.32e+06 2.20e+10 6.51e+07 5.18e+04 1.54e+08 2.22e-10 3.03e+08 5.69e-34 1.76e+07 7;35e+07 5.36e+05 5.59e+07 4.21e-02 3..03e+06 2.52e-15 l.91e+04 2.35e+08 1.18e+08 1.95e+08 8.29e-29 8.10e-08 5.54e+07 2.24e-55 4.83e-98 1.67e+05 6.35e-08 1.25e+07 1.15e+06 1.21e+08 6.92e+05 9.89e-61 5.23e+05 1.79e+06 7.42e+04 2.57e+06 3.02e+08 O0. 00e+00 0.00e+00 0.00e+00 0.00e+00 0.O00e+00 0.O00e+00 O.O00e+00 o0.00e+00 0.O00e+00
- 0. O0e+00 0.00e+00 0.00e+00 0.00e+00 0.00eO00 0.00e+00 0.00e+00
- 0. 00 e-e00 0.O00e+00O
- 0. 00e+00 0.O00e+00
- 0. 00e+00 0.00~e+00 0.00e+00 0.O00e+00 0.00e+00
- 0. 00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00
- 0. O0e-00 0.00e+00 0.O00e+00 0.O00e+O0 0.O00e+00 2.58e+03 3.20e+07 2.18e+06 1.42e+02 5.58e+06 7.16e-11 9.53e+06 1.27e-33 1.47e+05 1.46e+06 2.45e+05 1.21e+08 7.84e-02 1.Q3e+06 1.03e-12 6.25e+03 1.lOe+10 7.48e+08 6.61e+09 9.63e-24 1.34e-09 1.76e+06 1.60e-47 2.16e-81 6.02e-01 2.17e-12 3.72e+02 3.41e+00 1.92e+04 7.83e+00 3.49e-55 6.51e+00 1.91e+03 1.99e-01 7.38e+05 1.88e+08 D
l Page 10 of 44
Attachment C ODCM-QA-004 Revision 2 Page 25 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)
I I Units:
AgeGroup:
Pathway.
Airborne Pathways & Tritium Ingestion: (mrem/yr)I(pCVimA3))
Deposition Pathways: (rnA2 * (mrem/yr)/(pCVsec)
ADULT Vegetation (VEG)
Nuclide. Bone Liver
-Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO 2.26e+03 2.26e+03 2.26e+03 2.26e+03 2.26e+03 O.OOe+OO 2.26e+03 C-14
-2.28e+08 4.55e+07 4.55e+07 4.55e+07 4.55e+07 4.55e+07 O.OOe+OO 4.55e+07 NA-24 2.68e+05 2.68e+05 2.68e+05 2.68e+05 2.68e+05'2.68e+05 O.OOe+OO 2.68e+05 P-32 2.18e+08 8.73e+07 O.OOe+OOO.OOe+OO O.OOe+OO 1.58e+08 O.OOe+OO 5.43e+07 CR-51 O.OOe+OO O.OOe+OO 2.78e+04-1.02e+04 6.16e+04 1.17e+07 O.OOe+00'4.64e+04 MN-54' O.OOe+OO 3.13e+08 O.0Oe+00O9.31e+07 0.00e+00 9.59e+08 O.OOe+OO 5.97e+07 MN-56 O.OOe+OO 1.55e+D1 O.OOe+OO 1.96e+O1 O.OOe+OO 4.93e+02 O.OOe+OO 2.74e+00 FE-55 2.10e+0 8 -1.45e+08 O.OOe+OO O.OOe+OO 8.08e+07' 8.31e+07 O.OOe+OO 3.38e+07 FE-59
-1.26e+08 2.96e+08 O.OOe+OO,0.OOe+OO 8.28e+07 9.88e+08 O.OOe+OO 1.14e+08 CO-58 O.OOe+003.07e+07 O.OOe+OO O.OOe+OO O.OOe+OO 6.23e+08 O.00e+O0,6.89e+07 CO-60 O.OOe+001.67e+08 O.OOe+OO0O.OOe+O0 O.OOe+00'3.14e+09 0.00e+00 3.69e+08 NI-63 1.04e+10.7.22e+08,0.00e+00 O.OOe+OO O.OOe+OO 1.51e+08 O.OOe+OO 3.49e+08 NI-65^-
5.97e+017.76e+00 0.00e+00 O.OOe+OO O.OOe+OO 1.97e+02 O.OOe+OO 3.54e+00 CU-64
-O.OOe+OO 9.15e+03 0.00e+00 2.31e+04 0.00e+00 7.80e+05 O.OOe+OO 4.30e+03 ZN-65 3.17e+08 1.Ole+09 0.00e+00 6.75e+08 O.OOe+0O 6.36e+08 O.OOe+OO 4.56e+08 ZN-69 5.08e-06 9.71e-06 O.OOe+OO 6.31e-06 O.OOe+OO 1.46e-06 O.OOe+OO 6.75e-07 BR-83 O.O0e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 4.34e+00 O.OOe+OO 3.01e+00 BR-84 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+0O 1.69e-16 O.00e+0O 2.15e-11 RB-86 O.OOe+OO 2.19e+08 O.OOe+OO O.OOe+OO O.00e+OO 4.32e+07 O.OOe+OO 1.02e+08 RB-88 O.OQe+OO 2.68e-22 0O.OOe+OO O.OOe+O0 O.OOe+OO 3.70e-33 O.OOe+OO 1.42e-22 RB-89 O.OOe+OO 1.04e-26 O.OOe+OO O.OOe+OO O.OOe+006.02e-40 O.OOe+00 7.29e-27 SR-89 9.97e+09 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1.60e+09 O.OOe+OO 2.86e+08 SR-90 6.05e+ll O.OOe+OO O.OOe+OO O.OOe+OO O:OOe+0O 1.75e+10 O.OOe+OO 1.48e+11 SR-91 3.02e+05 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+0O 1.44e+06 O.OOe+OO 1.22e+04 SR-92 4.15e+02 0.OOe+OO O.00e+OO O.OOe+OO O.OOe+OO 8.23e+03 O.OOe+OO 1.80e+O1 Y-90 1.33e+04 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 1'41e+08 O.OOe+OO 3.56e+02 Y-91 5.11e+06 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.81e+09 O.OOe+OO 1.37e+05 Y-91 4.78e-09 O.OOe+OO O.OOe+OO'O.OOe+OOO:OOe+OO1.40e-08 O.OOe+OO 1.85e-10 Y-92 8.97e-01 O.OOe+OO O.0Oe+OO O.OOe+OO O.OOe+00 1.57e+04 0.00e+00 2.62e-02 Y-93 1.68e+02 O.OOe+OO O.OOe+OOO.OOe+OO.O.OOe+OO 5.34e+06 O.OOe+OO 4.65e+00 ZR 1.17e+06 3.77e+05 O.OOe+OO 5.91e+05 O.OOe+OO 1.19e+09 O.OOe+OO 2.55e+05 ZR 3.36e+02 6.78e+O1 O.OOe+OO 1.02e+02 0.00e+00'2.10e+07 O.OOe+OO 3.10e+O1 NB-95 1.42e+05 7.92e+04 O.OOe+OO 7.83e+04 O.OOe+OO'4.81e+08 O.OOe+OO 4.26e+04 MO-99 O.OOe+OO 6.15e+06 0.OOe+OO 1.39e+07 'O.OOe+001.;43e+07 O.OOe+OO 1.17e+06 TC-99M 3.06e+0O,8.66e+00 O.OOe+OO 1.32e+02 4.24e+00 5.13e+03 O.OOe+OO 1.lOe+02 TC-101 6.02e-31 8.68e-31 O.'OOe+OO 1.56e-29 4.44e-31 2.61e-42 O.OOe+OO 8.51e-30 RU-103 4.77e+06 O.OOe+OO O.OOe+OO 1.82e+07,0.00e+00.5.57e+08 O.OOe+OO 2.06e+06 RU-105 5.30e+O1 O:Oe+OO O.OOe+OO 6.85e+02 0.00e+00 3.24e+04O.OOe+OO 2.09e+O1 Page 11 of 44
Attachment C ODCM-QA-004 Revision 2 Page 26 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)
I I Units:
AgeGroup:
Pathway:
Airborne Pathways & Tritium Ingestion: (mrem/yr)/(pCim'*3))
Deposition Pathways: (mA2 * (mrerm/yr)/(pC/sec)
ADULT Vegetation (VEG)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-106 AG-1.OM TE-125M TE-127 TE-127M TE-129 TE-129M TE-131 TE-131M TE-132 1-130 I-131 1-132 I-133 I-134 1-135 CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141 BA-142 LA-140 LA-142 CE-141 CE-143 CE-144 PR-143 PR-144 ND-147 W-187 NP-239 PU-239 U-235 1.93e+08 0.OOe+00 0.OOe+O0 1.05e+07 9.75e+06 0.OOe+O0 9.65e+07 3.50e+07 2.90e+07 5.62e+0 3 2.02e+03 4.16e+03 3.49e+08 1.25e+08 8.92e+07 7.16e-04 2.69e-04 5.49e-04 2.51e+08 9.37e+07 8.63e+07 1.26e-15 5.26e-16 1.04e-15 9.10e+05 4.45e+05 7.05e+05 4.30e+06 2.78e+06 3.07e+06 1.95e+05 5.75e+05 4.88e+07 4.04e+0 7 5.77e+07 1.89e+10 2.79e+Ol 7.46e+01 2.61e+03 1.04e+06 1.81e+06 2.66e+08 4.44e-05 1.21e-04 2.09e-03 1.93e+°4 5.05e+04 3.33e+06 4.67e+09 1.lle+10 0.OOe+O0 4.27e+07 1.68e+08 -0.00e+00 6.36e+0 9 8.70e+09 0.OOe+00 3.42e-11 6.74e-11 0.OOe+00 2.71e-02 1.93e-05.0.00e+00 1.28e+08 1.61e+05 0.OOe+00 9.05e-2 2 6.84e-25 0.OOe+00 3.96e-39 4.07e-42 0.OOe+00 1.97e+03 9.95e+02 0.OOe+0O 1.93e-04 8.77e-05 0.00e+00 1.97e+05 1.33e+05 0.00e+O0 9.96e+02 7.36e+05 0.OOe+00 3.29e+07 1.38e+07 0.OOe+00 6.26e+04 2.51e+04 0.OOe+00 2.39e-26 9.93e-27 0.OOe+0O 3.33e+04 3.85e+04 0.OOe+00 3.79e+04 3.17e+04 0.OOe+O0 1.43e+03 1.40e+02 0.OOe+00 5.81e+10 6.98e+09 0.OOe+O0 6.42e+10 O.OOe+O0 0.OOe+00 3.72e+08 1.92e+07 3.93e+08 2.29e+04 1.42e+09 3.Ole-03 1.05e+09 5.51e-15 4.51e+06 2.68e+07 8.98e+05 9.90e+07 1.19e+02 3.15e+06 1.92e-04 8.09e+04 3.59e+09 9.37e+07 2.95e+09 4.95e-11 1.80e-05 5.49e+04 6.36e-25 3.44e-42
- 0. OOe+00
- 0. OOe+00 6.19e+04 3.24e+02 8.16e+06 1.45e+04 5.60e-27 2.25e+04 0.OOe+O0 4.37e+02 6.50e+09 1.50e+10 0.00e+O0 0.O00e+00 O.O00e+O0 O.O00e+00 O.O00e+00 O.O00e+O0 O.O00e+00 O.O00e+00 0.00e+00 o. O0e+O0 0.O00e+O0 0.O00e+00 0.O00e+00
- 0. 00e+00
- 0. 00e+00 0.00e+O0
- 1. 19e+09 1.28e+07 9.81e+08 4.89e-12
- 1. lOe-05 9.24e+04 3.88e-25 2.30e-42 o0.00e+O0 0.00e+00 0.00~e+00 o. 00e+00
- 0. 00e+00 O.O00e+00 0.O00e+O0
- 0. 00e+00 0.00e+00 0.00e+00 0.00e+00
- 0. 00e+00 1.25e+10 3.98e+09 3.85e+08 4.43e+05 1.17e+09 5.40e-04 1.27e+09 1.78e-16 4.42e+07 1.32e+08 4.95e+05 1.52e+07 1.40e+01 1.63e+06 1.05e-07 5.70e+04 1.94e+08 1.91e+07 1.68e+08 2.88e-.16 4.80e-02 2.64e+08 4.26e-31 5.57e-57 7.31e+07 6.41e-01 5.10e+08 2.75e+07 1.lle+10 2.74e+08 3.44e-33 1.85e+08 1.04e+07 2.88e+07 5.34e+09 6.26e+09
- 0. 00e+O0
- 0. 00e+00 0.00e+00
- 0. 00e+00 0.O00e+00 0.O00e+00
- 0. 00e+00
- 0. 00e+00 O0.00e+00 O.
00e+00
- 0. 00e+00 0.O00e+00 0.O00e+00
- 0. 00e+00 0.00e+00 0.O00e+00 0.O00e+00 0.O00e+O0 0.O00e+00 0.O00e+00 0.O00e+00 0.O00e+00 0.00e+00 0.O00e+00 0.O00e+00
- 0. 00e+00 0.00e+00 0.O00e+O0 0.O00e+00 0.O00e+00 0.O00e+00 0.O00e+00 0.O00e+00 0.O00e+00 o0.00e+00 0.00e+00 2.44e+07 5.79e+06 1.29e+07 1.22e+03 4.26e+07 1.74e-04 3.98e+07 3.97e-16 3.71e+05 2.61e+06 2.27e+05 3.31e+07 2.61e+01 5.51e+05 4.31e-05 1.86e+04 9.08e+09 1.21e+08 5.70e+09 3.34e-11 7.93e-04 B.41e+06 3.05e-23 2.49e-40
- 2. 63e+02 2.19e-05 1.51e+04 8.15e+01 1.77e+06 3.10e+03 1.22e-27 2.3Oe+03
- 1. lle+04 7.73e+01 1.53e+09 3.90e+09 C
C I Page 12 of 44
Attachment C ODCM-QA-004 Revision 2 Page 27 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 52, 5.3)
I Units:
Airborne Pathways & Tritium Ingestion: (mremlyr)/(CVnmA3))
Deposition Pathways: (mn2 * (mrernlyr)f(uCVsec)
TEEN Grs/GoatIMilk (GMILK)
AgeGroup:
Pathway:
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.OOe+OO 2.03e+03 2.03e+03 2.03e+03 2.03e+03 2.03e+03 O.OOe+OO 2.03e+03 C-14 4.86e+0B 9.72e+07 9.72e+07 9.72e+07 9.72e+07 9.72e+07O0.00e+00 9.72e+07 NA-24 5.12e+05-5.12e+05 5.12e+05 5.12e+05 5.12e+05 5;312e+05 O.00e400 5.12e+05 P-32 5.88e+09 2.35e+09 O.OOe+OOO.OOe+OO O.OOe+003.18e+09 O.OOe+OO 1.47e+09 CR-51 O.OOe+OO O.OOe+OO 3.33e+03 1.31e+03 8.55e+03 1.01e+06 O.OOe+OO 5.99e+03 MN-54 0.OOe+OO 1.68e+06 O.OOe+OO 5.02e+05 0.OOe+OO 3.45e+06 0.00e+00 3.34e+05 NN-56 O.OOe+OO 8.99e-04 O.OOe+00 1.14e-03 O.OOe+OO 5.92e-02 O.OOe+OO,1.60e-04 FE-55 5.79e+05 4.11e+05 O.OOe+OO O.OOe+OO 2.60e+05 1.78e+05 O.OOe+OO 9.57e+04 FE-59 6.74e+05 1.57e+06 O.00e+OO O.OOe4OO 4.96e+05 3.72e+06 O.OOe+00 6.07e+05 C0-58
-0.OOe+OO 9.52e+05 O.OOe+OO O.00e+00 O.OOe+OO 1.31e+07 O.OOe+OO 2.20e+06 CO-60 O.Oe+OO 3.34e+06 O.OOe+OO O.OOe+OO O.OOe+OO 4.35e+07 O.OOe+OO 7.52e+06 NI-63 1.42e+09 1.OOe+08 O.Oe+OO O.OOe+OO O.OOe+OO 1.60e+07 O.00e+OO 4.81e+07 NI-65 8.27e-02 1.06e-02 O.Oe+OO O.OOe+OO 0.OOe+OO 5.73e-01 O.OOe+OO 4.82e-03 CU-64 O.OOe+OO 4.75e+03 O.Oe+OO 1.20e+04 O.OOe+OO 3.68e+05 O.OOe+OO 2.23e+03 ZN-65 2.53e+08 8.78e+08 O.OOe+OO 5.62e+08 O.OOe+OO 3.72e+08 O.OOe+OO 4.10e+08 ZN-69
-4.86e-13 9.25e-13 O.OOe+OO 6.04e-13 O.Oe+00 1.70e-12-O.OOe+O0 6.47e-14 BR-83 O.O0e+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2219e-02 BR-84 O.OOe+OO O.OOe+OO O.OOe+OO -O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+00 3.76e-24 RB-86 O.OOe+OO 5.68e+08 O.OOe+OO O.OOe+OO O.OOe+00 8.40e+07 O.OOe+OO 2.67e+08 RB-88 O.O~e+OO 5.44e-46 O.OOe+OO O.OOe+OO O.OOe+OO 4.66e-53-O.OOe+O0 2.90e-46 RB-89 O.Oe+OO 1.40e-54 O.OOe+OO O.OOe+OO O.OOe+OO 2.15e-63 O.OOe+OO 9.93e-55 SR-89 5.62e+09 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 6.69e+08 O.OOe+OO 1.61e+08 SR-90 1.39e+ll O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+00 3.90e+09 O.OOe+00-3.43e+1C SR-91 1.12e+05 O.OOe+OO O.00e 4 OO O.OOe+OO O.OOe+OO 5.09e+05 O.OOe+004.46e+03 SR-92 l.91e+00O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 4.86e+O1 O.OOe+OO 8.14e-02 Y-90 1.56e+O1O.OOe+OO O.00e+OO O.OOe+OO O.OOe+OO 1.29e+05 O.OOe+OO 4.21e-01 Y-91 1.90e+03 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 7.77e+05 O.OOe+OO 5.08e+01 Y-91M 1.39e-20 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 6.56e-19O0.OOe+O0 5.31e-22 Y-92 1'.25e-0 5 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+00 3.-44e-01 O.OOe+OO 3.63e-O7 y-93 4.97e-02 0.00e+00 O.OOe+OO O.OOe+OO O.OOe+OO 1.52e+03 O.OOe+OO 1.36e-03 ZR-95 1.98e+02 6.25e+O1 O.OOe+OO 9.18e+O1 O.OOe+OO 1.44e+05 O.OOe+OO 4.30e+01 ZR-97 9.49e-02 1.88e-02 O.OOe+OO 2.85e-02 O.OOe+00 5.08e+03 O.OOe+008.65e-O3 NB-95 1.69e+04 9.37e+03 0.00e+00 9.08e+03 O.OOe+OO 4.Ole+07 O.OOe+OO 5.16e+03 MO-99 O.OOe+OO 5.37e+06 O.OOe+OO 1.23e+07 O.OOe+OO 9.62e+06 O.OOe+OO 1.02e+O0 TC-99M 6.97e-01 1.94e+00 O.OOe+OO 2.89e+O1 1.08e+00 1.28e+03 O.OOe+OO 2.52e+01 TC-101 6.90e-61 9.81e-61 O.OOe+OO 1.77e-59 5.98e-61 1.68e-67
.0;00e+00 9.64e-6(
RU-103 2.17e+02 O.OOe+OO O.OOe+OO 7.66e+02 O.OOe+OO 1.82e+04 O.OOe+OO 9.29e+Ol RU-105 1.90e-04 O.OOe+OO O.OOe+OO 2.39e-03 O.OOe+OO 1.53e-01 O.OOe+OO 7.36e-O!
I I
L I Page 13 of 44
Attachment C ODCM-QA-004 Revision 2 Page 28 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)
I Units:
Airborne Pathways & Tritium Ingestion: (mrem/yr)/(pCinmA3))
Deposition Pathways: (mA2 * (mrem/yr)/(uCVsec)
TEEN Grs/Goat/Milk (GMILK)
AgeGroup:
Pathway:
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-106 AG-llOM TE-125M TE-127 TE-127M TE-129 TE-129M TE-131 TE-131M TE-132 1-130 I-131 I-132 1-133 1-134 I-135 CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141 BA-142 LA-140, LA-142 CE-141 CE-143 CE-144 PR-143 PR-144 ND-147 W-187 NP-239 PU-239 U-235 4.50e+03 1.16e+0 7 3.61e+06 1.46e+0 2 1.Ole+07 6.49e-1l
- 1. 32e+07 B. 82e-34 7.90e+04 5.15e+05 4.45e+05 3.22e+08 1.78e-01 4.25e+06 2.27e-12 1.38e+04 2.95e+10 1..35e+0 9 4.02e+10 5.36e-23
- 1. Ole-OS 5.82e+06
- 1. 05e-46 7.46e-81 9.74e-01 4.14e-12
- 1. 07e+03 9.18e+00 7.90e+04 3.48e+Ol 1.52e-54 2.18e+0l
- 1. 43e+03 S. 42e-Ol 4.58e+06 6.82e+08
- 0. 00e+00
- 1. 09e+07
- 1. 30e+06 5.17e+Ol
- 3. 59e+06 2.42e-11
- 4. 90e+06 3.63e-34 3.79e+04 3.26e+05
- 1. 29e+06 4.51e+08 4.67e-01 7.21e+06
- 6. 0 Oe-12 3.55e+04 6.93e+10 5.29e+09 5.34e+10
- 1. 03e-22 7.13e-12 7.14e+03 1.83e-50 7.46e-84 4.78e-01
- 1. 84e-12 7.12e+02
- 6. 68e+03 3.27e+04 1.39e+01 6.23e-55 2.36e+Ol
- 1. 17e+03 7.94e-02 5.56e.05 0.00e+00 0.00e+O0 0.00e+00 1 Ole+06 1.Ole+02 2.41e+06
- 4. 64e-11 4.26e+06 6.79e-34 5.70e+04 3.44e+05 1.05e+08 1.32e+11 1.57e+01
- 1. Ole+09
- 1. OOe-10 2.28e+06
- 0. 00e+00 0.00e+00 0.00e+00 0.O00e+00 0.00e+00 O. 00e+00
- 0. 00e+00 0.00e+00
- 0. 00e+O0 O. 00e+00
- 0. 00e+O0
- 0. 00e+00
- 0. OOe+O0
- 0. 00e+00
- 0. OOe+O0 0.00e+00
- 0. 00e+00 0.00e+00 O.OOe+OO 0.00e+00 8.68e+03 2.09e+07 0.OOe+00 5.91e+02 4.lle+07 2.72e-10 5.53e+07 3.86e-33 3.95e+05 3.13e+06 1.98e+06 7.77e+08 7.35e-01 1.27e+07 9.46e-12 5.60e+04 2.20e+10 2.88e+09 1.82e+10 7.59e-23 6.72e-12 2.42e+03 7.27e-50 6.31e-84 0.OOe+OO 0.OOe+00 3.35e+02 3.00e+00 1.95e+04 8.08e+QO 3.57e-55 1.39e+01 0.OOe+OO 2.49e-01 5.13e+05
- 1. 60e+08 0.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+O0 O.OOe+O0 0.OOe+O0 0.OOe+00 0.OOe+00 O.OOe+O0 0.OOe+00 8.41e+09 4.54e+08 7.06e+09 8.84e-24 4.92e-12 4.80e+03 5.36e-50 4.96e-84 0.OOe+00 0.OOe+00 o.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 2.16e+05 3.07e+09 1.06e+07 1.13e+04 2.52e+07 3.55e-10 4.96e+07 7.24e-35 3.04e+06 1.03e+07 9.89e+05 8.93e+07 2.03e-01 5.46e+06 7.91e-14 3.93e+04 8.62e+08 4.26e+08 7.60e+08 4.67e-26 9.04e-08 8.98e+06 2.24e-52 2.29e-92 2.75e+04 5.60e-08 2.04e+06 2.Ole+05 1.99e+07 1.15e+05
- 1. 68e-57 8.53e+04 3.16e+05 1.28e+04 4.22e+05 4.95e+07 0.00e+00 0.00e+00 0.O00e+00 0.00e+00 0.O00e+00 0.00e+00 0.00e+00 0.00e+00 O.O00e+00 0.O00e+00 0.O00e+00 0.O00e+00 0.O00e+00 0.00e+00 0.00e+00
- 0. OOe-00 0.00e+00
- 0. 00e+O0 0.00e+00 0.00e+00
- 0. 00e+00
- 0. 00e+00 0.O00e+00 0.O00e+00 0.O00e+00 0.00e+00 o. 00e+00 0.00e+00 0.O00e+00 O. 00e+00
- 0. 00e+O0
- 0. 00e+00
- 0. 00e+00 0.00e+00 0.00e+00 0.00e+00 5.67e+02 6.65e+06 4.82e+05 3.14e+01 1.20e+06 1.58e-11 2.09e+06 2.76e-34 3.16e+04 3.07e+05 5.14e+05 2.43e+08 1.67e-01 2.20e+06 2.16e-12 1.32e+04 3.22e+10 3.55e+09 1.86e+10 5.14e-23 2.95e-10 3.75e+05 3.50e-48 4.59e-82 1.27e-01 4.58e-13 8.18e+01 7.46e-01 4.25e+03 1.73e+00 7.71e-56 1.42e+00 4.09e+02 4.41e-02 1.20e+05
- 4. 15e+07 I Page 14 of 44
Attachment C ODCM-QA-004 Revision 2 Page 29 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2,5.3)
I Units:
AgeGroup:
Pathway:
Airborne Pathways & Tritium Ingestion: (mrem/yr)y(uCVmA3)) -
Deposition Pathways: (mA2 * (mrern/yr)/(uCi/sec)
TEEN Ground Plane Deposition (GPD) l Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB-
+--i NA-24 CR-51 MN-54 MN-56 FE-59 CO-58 CO-60 NI CU-64 ZN-65 BR-83 BR-84 RB-86 RB-88 RB-89 SR-89 SR-91 SR-92 Y-90 Y-91 Y-91M Y-92 Y-93 ZR-95 ZR-97 NB-95 MO-99 TC-99M TC-101 RU-103 RU-105 RU-106 AG-llOM TE-125M TE-127 TE-127M TE-129 TE-129M 1.20e+07 4.66e+06 1.39e+09 9.04e+05 2.72e+08 3.79e+08 2.15e+10 2.97e+05 6.07e+05
.7.47e+08 4.87e+03 2.03e+05 8.'99e+06 3.31e+04 1.21e+05 2.16e+04 2.15e+06 7.77e+05 4.49e+03 1.07e+06
,l.
OOe+05 1.80e+05 1.83e+05 2.45e+08 2.96e+06 1.37e+08
-4.00e+06 1.84e+05 2.04e+04 1.08e+08 6.37e+05 4.22e+08 3.44e+09 1.55e+06 2.98e+03 9.16e+04 2.62e+04 1.98e+07 1.20e+07 1.20e+07
'4.66e+06 4.66e+06 1.39e+09 1.39e+09 9.04e+05 9.04e+05 2.72e+08 2.72e+08-3.79e+08 3.79e+08 2.15e+10 2.15e+10 2.97e+05 2.97e+05 6.07e+05 6.07e+05 7.47e+08 7.47e+08 4.87e+03 4.87e+03 2.03e+05 2.03e+05 8.99e+06 8.99e+06 3.31e+04 3.31e+04 1.21e+05 1.21e+05 2.16e+04 2.16e+04 2.15e+06 2.15e+06 7.77e+05 7.77e+05 4.49e+03 4.49e+03 1.07e+06 1.07e+06 1.OOe+05 1.OOe+05 1.80e+05 1.80e+05 1.83e+05 1.83e+05 2.45e+08 2.45e+08 2.96e+06 2.96e+06-1.37e+08-1.37e+08 4.00e+06 4.00e+06 1.84e+05-1.84e+05-2.04e+04-2.04e+04 1.08e+08 1.08e+08 6.37e+05 6.37e+05 4.22e+08 4.22e+08 3.44e+09 3.44e+09 1.55e+06 1.55e+06 2.98e+03 2.98e+03 9.16e+04 9.16e+04 2.62e+04 2.62e+04 1.98e+07 1.98e+07 1.20e+07 4.66e+06 1.39e+09 9.04e+05 2.72e+08 3.79e+08 2.15e+10 2.97e+05 6.07e+05 7.47e+08 4.87e+03 2.03e+05 8.99e+06 3.31e+04 1.21e+05 2.16e+04 1.20e+07 4.66e+06 1.39e+09 9.04e+05 2.72e+08 3.79e+08 2.15e+10 2.97e+05 1.20e+07 4.66e+06 1.39e+09 9.04e+05 2.72e+08 3.79e+08 2.15e+10 2.97e+05 6.07e+05. 6.07e+05 7.47e+08 7.47e+08 4.87e+03.4.87e+03.
2.03e+05 2.03e+05 8.99e+06 8.99e+06 3.31e+04 3.31e+04 1.21e+05 1.21e+05 2.16e+04 2.16e+04 2.15e+06.2.15e+06.2.15e+06 7.77e+05 7.77e+05 7.77e+05 4.49e+03 4.49e+03 4.49e+03 1.07e+06-1.07e+06 1.07e+06, 1.OOe+05-1.00e+05 1.OOe+05 1.80e+05 1.80e+05 1.80e+05 1.83e+05-1.83e+05.1.83e+05 2.45e+08 2.45e+08 2.45e+08 2.96e+06 2.96e+06.2.96e+06 1.37e+08 1.37e+08 1.37e+08 4.00e+06 4.00e+06 4.00e+06
-1.84e+05 1.84e+05 1.84e+05 2.04e+04 2.04e+04 2.04e+04 1.08e+08 1.08e+08 1.08e+08 6.37e+05 6.37e+05 6.37e+05 4.22e+08 4.22e+08 4.22e+08 3.44e+09 3.44e+09 3.44e+09 1.55e+06 1.55e+06 1.55e+06 2.98e+03 2.98e+03 2.98e+03 9.16e+04 9.16e+04 9.16e+04 2.62e+04 2.62e+04 2.62e+04 1.q9P+07 1.98e+07 1.98e+07 1.39e+07 1.20e+07 5.51e+06 4.66e+06 1.63e+09 1.39e+09 1.07e+06 9.04e+05 3.20e+08 2.72e+08 4.44e+08 3.79e+08 2.53e+10 2.15e+10 3.45e+05 2.97e+05 6.88e+05 6.07e+05 8.60e+08 7.47e+08 7.08e+03 4.87e+03 2.36e+05 2.03e+05 1.03e+07 8.99e+06 3.78e+04 3.31e+04 1.45e+05 1.21e-+05 2.51e+04 2.16e+04 2.51e+06 2.15e+06 8.63e+05 7.77e+05 5.31e+03 4.49e+03 1.21e+06 1.07e+06 1.16e+05 1.OOe+05 2.14e+05 1.80e+051 2.51e+05 1.83e+05 2.84e+08 2.45e+08 3.45e+06 2.96e+06 1.61e+08 1.37e+08 4.63e+06 4.00e+06
-2.11e+05 1.84e+05 2.26e+04 2.04e+04 1.26e+08 1.08e+08 7.21e+05 6.37e+05 5.07e+08 4.22e+08 4.01e+09 3.44e+09 2.13e+06 1.55e+06 3.28e+03 2.98e+03 1.08e+05 9.16e+04 3.10e+04 2.62e+04 2.31e+07 1.98e+07 I Page 15 of 44
Attachment C ODCM-QA-004 Revision 2 Page 30 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3) i I Units:
AgeGroup:
Pathway:
Airborne Pathways & Tritium Ingestion: (mrem,/yr)/(uCVmA3))
Deposition Pathways: (mA2 * (mrem/yr)/(uClsec)
TEEN Ground Plane Deposition (GPD)
I Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB TE-131 TE-131M TE-132 I-130 1-131 I-132 I-133 1-134 1-135 CS-134 CS-136, CS-137 CS-138 BA-139 BA-140 BA-141, BA-142 LA-140, LA-142 CE-141 CE-143 CE-144 PR-144 ND-147 W-187 NP-239 PU-239 U-235
- 2. 92e+0 4 8.03e+06 4.24e+06 5.51e+06 1.72e+07 1.25e+06
- 2. 45e+0 6 4.47e+05 2.53e+0 6
- 6. 86e+09 1.51e+08
- 1. 03e+10 3.59e+05 1.06e+05 2.05e+07 4.17e+04 4.49e+04 1.92e+07 7.6G~e+05 1.37e+0 7 2.31e+06 6.95e+07
- 1. 84e+03 8.39e+06 2.35e+06 1.71e+06 2.29e+06 9.28e+09 2.92e+04 2.92e+04 8.03e+06 8.03e+06 4.24e+06 4.24e+06 5.51e+06 5.51e+06 1.72e+07 1.72e+07 1.25e+06 1.25e+06 2.45e+06 2.45e+06 4.47e+05 4.47e+05 2.53e+06 2.53e+06 6.86e+09 6.86e+09 1.51e+08 1.51e+08 1.03e+10 1.03e+10 3.59e+05 3.59e+05 1.06e+05 1.06e+05 2.05e+07.2.05e+07 4.17e+04.4.17e+04 4.49e+04. 4.49e+04 2.92e+04 8.03e+06 4.24e+06 5.51e+06 1.72e+07 1.25e+06 2.45e+06 4.47e+05 2.53e+06 6.86e+09 1.51e+08 1.03e+10 3.59e+05 1.06e+05 2.05e+07 4.17e+04 4.49e+04 1.92e+07 7.60e+05 1.37e+07 2.31e+06 6.95e+07
- 1. 84e+03 8.39e+06 2.35e+06 1.71e+06 2.29e+06 9.28e+09 2.92e+04 8.03e+06 4.24e+06 5.51e+06 1.72e+07 1.25e+06 2.45e+06 4.47e+05 2.53e+06 6.86e+09 1.51e+08 1.03e+10 3.59e+05 1.06e+05 2.05e+07 4.17e+04 4.49e+04 1.92e+07 7.60e+05 1.37e+07 2.31e+06 6.95e+07 1.84e+03 8.39e+06 2.35e+06 1.71e+06 2.29e+06 9.28e+09 2.92e+04 8.03e+06 4.24e+06 5.51e+06 1.72e+07 1.25e+06 2.45e+06 4.47e+05 2.53e+06 6.86e+09 1.51e+08 1.03e+10 3.59e+05 1.06e+05 2.05e+07 4.17e+04 4.49e+04 1.92e+07 7.60e+05 1.37e+07 2.31e+06 6.95e+07 1.84e+03 8.39e+06 2.35e+06 1.71e+06 2.29e+06 9.28e+09 3.45e+07 9-.46e+06 4.98e+06 6.69e+06 2.09e+07 1.47e+06 2.98e.06 5.31e+05 2.95e+06 8.00e.09 1.71e.08 1.20e+10 4.10e+05
- 1. 19e+05 2.35e+07 4.75e+04 5.ll1e+04 2.18e+07 9.12e+05 1.54e+07 2.63e+06 8.04e+07 2.ll1e+03
- 1. Ole+07 2.73e+06 1.98e+06 2.23e+07
- 1. 16e+10 2.92e+04 8.03e+06 4.24e+06 5.51e+06 1.72e+07 1.25e+06 2.45e+06 4.47e+05 2.53e+06 6.86e+09 1.51e+08 1.03e+10 3.59e+05 1.06e+05 2.05e+07 4.17e+04 4.49e+04 1.92e+07 7.60e+05 1.37e+07 2.31e,06 6.95e+07 1.84e+03 8.39e+06 2.35e+06 1.71e+06 2.29e+06 9.28e+09 1.92e+07 7.60e+05
- 1. 37e+07 2.31e+06 6.95e+07
- 1. 84e+03 8.39e+06 2.35e+06 1.71e+06 2.29e+06 9.28Be+09 1.92e+07 7.60e+05 1.37e+07 2.31e+06 6.95e+07 1.84e+03 8.39e+06 2.35e+0'6 1.71e+06 2.29e+06 9.28e+09 I0 l Page 16 of 44
Attachment C ODCM-QA-004 Revision 2 Page 31 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)
IUnits:
AgeGroup:
Pathway:
Airborne Pathways & Tritium Ingestion: (mrernlyr)/(PCVmA3))
Deposition Pathways: (mA2 * (mremfyr)/(pCisec)
TEEN Inhalation (INHL) l Nuclide Bone Liver Thyroid -Kidney Lung GI-Lli Skin TB H-3 C-14 NA-24 P-32 CR-51 MN-54 MN-56 FE-55 FE-59 CO-58 CO-60 NI-63 Ni-65 CU-64 ZN-65 ZN-69 BR-83 BR-84 BR-85 RB-86 RB-88 RB-89 SR-89 SR-90 SR-91 SR-92 Y-90 Y-91 Y-91M Y-92 Y-93 ZR-95 ZR-97 NB-95 MO-99 TC-99M TC-101 RU-103 O.00e+00 2.60e+04 1.38e+04
- 1. 89e+0 6
- 0. 00e+00
- 0. 00e+00 0.00e+0 0
- 3.34e4-0 4 1.59e+04 O. 00e4-00 0.O00e+00 5.80e+05 2.18e+00 o 200e+00
- 3. 86e+04 4.83e-02 O '00e+00 0.O00e+00 0.O00e+00 0.O00e+00 0.00Oe+00
- 0. 00e+00 4.34e+05
- 1. 08e+08 8.8 0e4-01 9.52e+00 2.9 Be+0 3 6.61e+05 3.70e-01 1.47e+01 1.35e+02 1.46e+05 1.38e+02 1.86e+04 0.00e+00 1.38e-03 5.92e-05 2.10e+03 1.27e+03 4.87e+03 1.38e+04 1.10e+05 O.O00e+00 5.11e+04 1.70e+O0 2.38e+04 3.70e+04 2.07e+03 1.51e+04 4.34e+04 2.93e-01 2.03e+00 1.34e+05
'9.20e-02 O.O00e+00 0.00e+O0 0.00~e+00 1.90e+05 5.46e+02 3.52e+02 0.00e+00
- 0. 00e+00
- 0. 00e+00 0.O00e+00 0.00Oe+00
- 0. 00e+00 0.O00e+00
- 0. 00e+00 0.0e+00
- 4. 58e+~04 2.72e+01
- 1. 03e+~04
- 1. 69e+02 3.8 6e-03 8.40e-05
- 0. 00e+00 1.27e+03 1.27e+03 1.27e+03 1.27e+03 4.87e+03 4.87e+03 4.87e+03 4.87e+03 1.38e+04 1.38e+04 1.38e+04 1.38e+04 0.OOe+00 0.OOe+00 0.OOe+00 9.28e+04 7.50e+01 3.07e+01 2.10e+04, 3.00e+03 0.OOe+00 1.27e+04 1.98e+06 6.68e+04 0.OOe+00 1.79e+00 1.52e+04 5.74e+04 0.OOe+00 0.OOe+00 1.24e+05 6.39e+03 0.OOe+00 0.OOe+00 1.53e+06 1.78e+05 0.OOe+000.OOe+00 1.34e+06 9.52e+04 0.OOe+00 0.OOe+00 8.72e+06 2.59e+05 0.OOe+00 0.OOe+00 3.07e+05 1.42e+04 0.OOe+00 O.OOe+00 9.36e+03J3.67e+04 0.OOe+00 6.41e+00 1.lle+04 6.14e+04 0.OOe+00 8.64e+04 1.24e+06 4.66e+04 0.OOe+00 6.02e-02 1.58e+03 2.85e+02 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.00e+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+0O 0.OOe+00 0.00e+000.00e+00 1.77e+04 0.Oe+00 0.OOe+00 0.OOe+00 2.92e-05 0.OOe+00 0.OOe+00 0.OOe+00 3.38e-07 0.00e+00 0.OOe+00 2.42e+06 3.71e+05 0.OOe+00 0.00e+00 1.65e+07 7.65e+05 0.OOe+0 0.OOe+00 6.07e+04 2.59e+05 0.OOe+0O 0.00e+00 2.74e+04 1.19e+05 0.OOe+0O 0.OOe+00 2.93e+05 5.59e+05 0.OOe+OO 0.OOe+00 2.94e+06 4.09e+05 0.OOe+0O 0.OOe+00 3.20e+03 3.02e+01 0.OOe+00 0.OOe+00 2.68e+04 1.65e+05 0.OOe+00-0.00e+Q0'8.32e+04 5.79e+05 0.OOe+00 6.74e+04'2.69e+06 1.49e+05 0.OOe+00 4.12e+01 1.30e+05 6.30e+05 0.OOe+00 1.OOe+04 7.51e+05 9.68e+04 0.00e+00 4.11e+02 1.54e+05 2.69e+05 0.OOe+00 5.76e-02 1.15e+03 6.13e+03 0.OOe+00 1.52e-03--6.67e+02 8.72e-07 O.00e+00 7.43e+03 7.83e+05 1.09e+05 0.00e+O0 0.O00e+00
- 0. 00e+00 0.00e+00
- 0. 00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.O00e+00 0.00e+O0 0.00e+00 0.00e+00 0.00e+00 0.00e+00
- 0. 00e+00
- 0. 00e+00 0.00e+00 0.00e+00 0.00e+00
- 0. 00e+00 0.00e+00 0.00e4-00 0.00e+00 0.00e+00
- 0. 00e+00
- 0. 00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.0 0e400 0.00e+00
- 0. 00e4-00 o.boe+00 0.00e+00 0.00e+00 1.27e+03 4.87e+03 1.38e+04 7.16e+04 1.35e+02 8.40e+i03 2.52e-01 5.54e+03 1.43e+04 2.78e+03
- 1. 98e+04
- 1. 98e+04 1.27e-01 8.48e-01 6.24e+04 6.46e-03 3.44e+02 4.33e+02 1.83e+02.
8.40e+04 2.72e+02 2.33e+02
- 1. 25e+04 6.68e+06 3.51e+00 4.06e-01
- 8. 00e+01 1.77e+04 1.42e-02 4.29e-01 3.72e+00
- 3. 15e+04 1.2 6e+01 5.66e+03 3.22e+O1 4.99e-02 8.24e-04 8.96e4-02 I Page 17 of 44
Attachment C ODCM-QA-004 Revision 2 Page 32.of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Oh. 5.2, 5.3)
I Units:
Airborne Pathways & Tritium Ingestion: (mrenlyr)/(pCVmA3))
Deposition Pathways: (mA2 * (mrem/yr)/(pCVsec)
TEEN Inhalation (INHL)
AgeGroup:
Pathway:
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-105 RU-106 AG-llOM TE-125M TE-127 TE-127M TE-129 TE-129M TE-131 TE-131M TE-132 1-130 1-131 1-132 1-133 1-134 I-135 CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141 BA-142 LA-140 LA-142 CE-141 CE-143 CE-144 PR-143 PR-144 ND-147 W-187 NP-239 PU-239 U-235 1.12e+00 9.84e+04 1.38e+04 4.88e+03 2.Ole+00 1.80e+04 7.10e-02
- 1. 39e+04 1.58e-02 9.84e+01 3.60e+02 6.24e+03 3.54e+04 1.59e+03 1.22e+04 8.88e+02 3.70e+03 5.02e+05 5.15e+04 6.70e+05 4.66e+02 1.34e+00 5.47e+04 1.42e-01 3.70e-02 4.79e+02 9.60e-01 2.84e+04 2.66e+02 4.89e+06 1.34e+04 4.3Oe-02 7.86e+03 1.20e+01 3.38e+02 1.38e+10 1.14e+08 O.OOe+00 0.OOe+0O
- 1. 31e+04 2.24e+03 9.12e-01 8.16e+03 3.38e-02 6.58e+03 8.32e-03 6.Ole+01 2.90e+02 1.79e+04 4.91e+04 4.38e+03 2.05e+04 2.32e+03 9.44e+03 1.13e+06 1.94e+05 8.48e+05 8.56e+02 9.44e-04 6.70e+01 1.06e-04 3.70e-05, 2.36e+02 4.25e-01 1.90e+04 1.94e+02 2.02e+06 5.31e+03 1.76e-02 8.56e+03 9.76e+00 2.88e+02 8.96e+09 0.OOe+00
- 0. 00e+00 0.O00e+00
- 0. 00e+00 1.40e+03 1.42e+00 4.38e+03 5.18e-02 4.58e+03 1.24e-02 7.25e-+01 2.46e+02 1.49e+06 1.46e+07
- 1. 51e+05 2.92e+06' 3.95e.04 6.21e+05 0.00e+00 0.00e+O0 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.0 0e+00 0.00e+00 O.
00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00
- 1. 41e+00 1.90e+05
- 2. 50e+04 0.O00e+00
- 7. 28e+O0 6.54e+04 2.66e-01 S. 19e+04 6.18e-02 4.39e+02
- 1. 95e+93 2.75e+04 8.40e.04 6.92e+03 3.59e+04 3.66e+03
- 1. 49e+04 3.75e+05 1.10e+05 3.04e+05 6.62e-i02 8.88e-04 2.28e+01
- 9. 84e-05 3.14e-05 0.O00e+00 0.00e+00
- 8. 88e+03
- 8. 64e+O1
- 1. 21e+06 3.09e+03
- 1. Ole-02 5.02e+03 0.00Oe+00 1.O00e+02 2.75e+09 2.67e+07 1.82e+04 1.61e+07 6.75e+06 5.36e+05 1.12e+04 1.66e+06 3.30e+03 1.98e+06 2.34e+03 2.38e+05 4.49e+05 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+00 1.46e+05 1.78e+04 1.21e+05 7.87e+01 6.46e+03 2.03e+06 3.29e+03 1.91e+03 2.14e+05 1.02e+04 6.14e+05 1.30e+05 1.34e+07 4.83e+05 1.75e+03 3.72e+05 4.74e+04 6.49e+04 2.34e+09 6.75e+08 9.04e+04 9.60e+05 2.73e+05 7.50e+04 8.08e+04 1.59e+05 1.62e+03 4.05e+05 1.51e+01 6.21e+05 4.63e+05 9.12e+03 6.49e+03 1.27e+03 1.03e+04 2.04e+01 6.95e+03 9.76e+03 1.09e+04 8.48e+03 2.70e-01 6.45e+03 2.29e+05 7.46e-04 4.79e-10 4.87e+05 1.20e+04 1.26e+05 2.55e+05 8.64e+05 2.14e+05 2.35e-04 1.82e+05 1.77e+05 1.32e+05 3.50e+05 4.10e+05 0.O00e+00 0.00e+00
- 0. 00e+00 0.O00e+O0 0.00e+00 0.00e+00
- 0. 00e+00 0.00eO00 0.00e+00 0.O00e+00 0.00e+00 0.00e+00 0.O00e+00 0.00e+00 0.00e+00 0.00e+00 0.O00e+00 0.00e+00 0.00e+O0 0.00e+00
- 0. 00e+00 0.O00e+00 0.00e+00 0.00~e+00 0.00e+00 0.00~e+00
- 0. 00e+00 0.00~e+O0 0.00~e+00
- 0. 00e+00 0.00e+00 0.00e+00 0.00~e+O0 0.O00e+00 0.00e+00 0.00~e+00 0.00~e+00 4.34e-01 1.24e+04 7.99e+03 6.67e+02 4.42e-01 2.18e+03 1.76e-02 2.25e+03 5.04e-03 4.02e+01 2.19e+02 7.17e+03 2.64e+04 1.58e+03 6.22e+03 8.40e+02 3.49e+03 5.49e+05 1.37e+05
- 3. 11e+05 4.46e+02 3.90e-02 3.52e+03 4.74e-03 2.27e-03 6.26e+01 1.06e-01 2.17e+03 2.16e+01 2.62e+05 6.62e+02 2.18e-03
- 5. 13e+02 3.43e+00 1.77e+01 6.44e+08 6.94e+06 I Page 18 of 44
Attachment C ODCM-QA-004 Revision 2 Page 33 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3) l Units: Airborne Pathways & Tritium Ingestion: (mremlyr)/I(CUiA3))
Deposition Pathways: (mA2 * (mrem/yr)/(pCVsec)
AgeGroup:
TEEN Pathway:
Grs/Cow/Meat (CMEAT)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 O.00e+OO 1.94e+02 1.94e+02 1.94e+02 1.94e+02 1.94e+02 O.OOe+OO 1.94e+02 C-14 2.04e+08 4.08e+07 4.08e+07 4.08e+07 4.08e+07 4.08e+07 O.OOe+OO 4.08e+07 NA-24 1.12e-03 1.12e-03 1.12e-03 1.12e-03 1.12e-03 1.12e-03 O.OOe+OO 1.12e-03 P-32 6.13e+08 2.44e+08 O.OOe+OO O.OOe+OO O.OOe+OO 3.31e+08 O.OOe+OO 1.53e+08 CR-51 O.OOe+OO O.OOe+OO 3.13e+03 1.24e+03 8.05e+03 9.48e+05 O.OOe+OO 5.64e+03 MN-54 O.OOe+OO 7.00e+06 O.OOe+OO 2.09e+06 O.OOe+OO 1.44e+07 O.OOe+OO 1.39e+06 MN-56 O.OOe+OO 1.47e-53 0.09e+0D 1-86e-53 O.OOe+OO 9.67e-52 O.OOe+OO 2.61e-54 FE-55 2.38e+08 1.69e+08 O.OOe+OO O.OOe+OO 1.07e+08 7.31e+07 O.OOe+OO 3.94e+07 FE-59 2.12e+08 4.96e+08 O.OOe+OO O.OOe+OO 1.56e+08 1.17e+09 O.OOe+OO 1.91e+08 CO-58 O.OOe+OO 1.41e+07 O.OOe+OO O.OOe+OO O.OOe+OO 1.94e+08 O.OOe+OO 3.24e+07 CO-60 O.OOe+OO 5.84e+07 O.OOe+OO O.OOe+OO O.OOe+OO 7.60e+08 O.OOe+OO 1.31e+08 NI-63 1.52e+10 1.07e+09 O.OOe+OO O.OOe+OO O.OOe+OO 1.71e+08 O.OOe+OO 5.15e+08 NI-65 2.26e-52 2.88e-53 O.OOe+OO O.00e+OO O.OOe+OO 1.56e-51 O.OOe+OO 1.31e-53 CU-64 O.OOe+OO 2.30e-07 O.OOe+OO 5.81e-07 O.OOe+OO 1.78e-05 O.OOe+OO 1.08e-07 ZN-65 2.50e+08 8.69e+08 O.ODe+OO 5.56e+08 O.OOe+OO 3.68e+08 O.OOe+OO 4.05e+08 RB-86 O.OOe+OO 4.07e+08 O.OOe+OO O.OOe+OO O.OOe+OO 6.02e+07 O.OOe+OO 1.91e+08 SR-89 2.55e+08 O.OOe+OO 0O00e+OO O.OOe+OO O.OOe+OO 3.03e+07 O.OOe+OO 7.29e+06 SR-90 8.05e+09 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.26e+08 O.OOe+OO 1.99e+09 SR-91 1.34e-10 O.OOe+OO O.OOe+OO O.OOe+OO O.00e+OO 6.08e-10 O.OOe+OO 5.33e-12 SR-92 1.17e-49 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 2.98e-48 O.OOe+OO 4.98e-51 Y-90 9.12e+O1 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 7.53e+05 O.OOe+OO 2.46e+00 Y-91 9.54e+05 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 3.91e+08 O.OOe+OO 2.56e+04 Y-92 1.46e-39 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 4.01e-35 O.OOe+OO 4.22e-41 y-93 4.14e-12 O.OOe+OO O.00e+00 O.OOe+OO O.OOe+OO 1.27e-07 O.OOe+OO 1.14e-13 ZR-95 1.50e+06 4.73e+05 O.OOe+OO 6.96e+05 O.OOe+OO 1.09e+09 O.OOe+OO 3.26e+05 ZR-97 1.77e-05 3.50e-06 O.OOe+OO 5.31e-06 O.OOe+OO 9.49e-01 O.OOe+OO 1.61e-06 NB-95 1.80e+06 9.96e+05 O.OOe+OO 9.65e+05 O.OOe+OO 4.26e+09 O.OOe+OO 5.48e+05 MO-99 O.OOe+OO 8.33e+04 O.OOe+OO 1.91e+05 O.OOe+OO 1.49e+05 O.OOe+OO 1.59e+04 TC-99M 3.81e-21 1.06e-20 O.OOe+OO 1.58e-19 5.90e-21 6.98e-18 O.OOe+OO 1.38e-19 RU-103 8.57e+07 O.OOe+OO O.OOe+OO 3.02e+08 O.OOe+OO 7.16e+09 O.OOe+OO 3.66e+07 RU-105 5.35e-28 O.OOe+OO O.OOe+OO 6.75e-27 O.OOe+OO 4.32e-25 O.OOe+OO 2.08e-28 RU-106 2.36e+09 O.OOe+OO O.OOe+OO 4.55e+09 O.OOe+OO 1.13e+11 O.OOe+OO 2.97e+08 AG-llOM 5.06e+06 4.79e+06 O.OOe+OO 9.13e+06 O.OOe+OO 1.35e+09 O.OOe+OO 2.91e+06 TE-125M 3.03e+08 1.09e+08 8.47e+07 O.OOe+OO O.OOe+OO 8.95e+08 O.OOe+OO 4.05e+07 TE-127 1.89e-10 6.70e-11 1.30e-10 7.66e-10 O.OOe+OO 1.46e-08 O.OOe+OO 4.07e-11 TE-127M 9.42e+08 3.34e+08 2.24e+08 3.82e+09 O.OOe+OO 2.35e+09 *0.00e+00 1.12e+08 TE-129M 9.51e+08 3.53e+OB 3.07e+08 3.98e+09 O.OOe+OO 3.57e+09 O.OOe+OO 1.50e+08 TE-131M 3.82e+02 1.83e+02 2.75e+02 1.91e+03 O.OOe+OO 1.47e+04 O.OOe+OO 1.53e+02 l Page 19 of 44
Attachment C ODCM-QA-004 Revision 2 Page 34 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES K> l (Ref.3.9 Ch. 5.2, 5.3)
Units: Airborne Pathways & Tritium Ingestion: (mremlyr)I(pCVm"3))
Deposition Pathways: (mA2 * (mrern/yr)/(uCVsec)
AgeGroup:
TEEN Pathway:
Grs/Cow/Meat (CMEAT)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB TE-132 I-130 I-131 1-132 I-133 I-135 CS-134 CS-136 CS-137 BA-140 LA-140 LA-142 CE-141 CE-143 CE-144 PR-143 ND-147 w-187 NP-239 PU-239 U-235 1.17e+06 8.81e-07, 4.47e+06 3.45e-59 1.56e-01 1.93e-17 5.23e+08 9.41e+06 7.24e+08 2.38e+0 7 3.09e-02 3.79e-92 1.18e+04 1.71e-02 1.23e+06 1.77e+04 6.24e+03 1.76e-02 2.28e-01 1.74e+07 7.40e+05 7.80e+05 2.55e-06 2.08e-04 6.26e+06 1.83e+09 9.03e-59, 3.04e-57 2.65e-01 3.70e+01 4.97e-17 3.20e-15 1.23e+09 0.OOe+00 3.70e+07 0.OOe+00 9.63e+08 O.OOe+00 2.92e+04 0.OOe+O0 1.52e-02 0.00e+00 1.68e-92 O.OOe+00 7.88e+03 O.OOe+00 1.25e+01 0.OOe+O0 5.08e+05 0.60e+00 7.05e+03 0.OOe+00 6.79e+03 0.OOe+O0 1.44e-02 0.00e+00 2.15e-02 0.OOe+00 2.11e+06 0.OOe+00 7.10e+06-0.00e+00 2.34e+07 0.OOe+OO,6.97e+05 3.92e-06 0.OOe+O0 1.96e-06 0.OOe+00 1.02e-06 1.08e+07 0.00e+O0 1.24e+06 0.OOe+00 3.36e+06 1.42e-58 O.OOe+00 3.93e-59O0.00e+00 3.24e-59 4.65e-01 0.OOe+00 2.00e-01 0.OOe+O0 8.08e-02 7.84e-17 0.OOe+00 5.50e-17 O.OOe+00 1.84e-17 3.91e+08 1.49e+08 1.53e+07 O.OOe+O0 5.71e+08 2.02e+07 3.18e+06 2.98e+06 0.OOe+00 2.49e+07-3.28e+08 1.27e+08 1.37e+07 0.OOe+00 3.36e+08-9.88e+03 1.96e+04'3.67e+07 O.OOe+00'1.53e+06 O.OOe+0O 0.OOe+00 8.71e+02 0.OOe+00 4.04e-03 O.OOe+00 0.OOe+00,5.13e-88 O.OOe+00-4.19e-93 3.71e+03 0.00e+00 2.25e+07 O.OOe+O0 9.05e+02 5.59e-03 0.OOe+O0 3.75e+02 0.OOe+00 1.39e-03 3.04e+05 O.OOe+00 3.09e+08 0.OOe+00 6.60e+04 4.1Oe+03 0.OOe+00 5.81e+07 0.OOe+00 8.79e+02 3.99e+03 0.00e+0O 2.45e+07 0.OOe+00'4.07e+02 0.OOe+00 0.O0e+00-3.89e+00O0.00e+00 5.04e-03 6.76e-02 0.00e+00 3.46e+03 O.OOe+00 1.20e-02 1.94e+06-0.00e+00 1.60e+06 O.OOe+O0 4.56e+05 1.47e+08 O.OOe+00 4.56e+07 0.00e+00 3.82e+07 6.28e4-OB 0.00e+00 0.00e+UU I Page 20 of 44
Attachment C ODCM-QA-004 Revision 2 Page 35 of 59 I
DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)
'VN l Units: Airborne Pathways & Tritium Ingestion: (mrerm/yr)/(uCVm't3))
Deposition Pathways: (mA2 * (mrem/yr)/(,uCVsec)
AgeGroup:
TEEN Pathway:
Grs/Cow/Milk (CMILK)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 C-14 NA-24 P-32 CR-51 MN-54 MN-5 6 FE-55 FE-59 CO-58 CO-60 NI-63 NI-65 CU-64 ZN-65 ZN-69 BR-83 BR-84 RB-86 RB-88 RB-89 SR-89 SR-90 SR-91 SR-92 Y-90 Y-91 Y-91M Y-92 Y-93 ZR-95 ZR-97 NB-95 MO-99 TC-99M TC-1001 RU-103 RU-105 O.OOe+OO 4.86e+08 4.27e+06 4.90e+09 O.OOe+OO 0.OOe+OO 0.OOe+OO 4.45e+07 5.18e+07 0.OOe+OO O.OOe+OO 1.18e+10 6.90e-01 O.OOe+OO
- 2. lle+09 4.05e-12 O.OOe+OO 0.OOe+OO 0.OOe+0O O. OOe+OO
- 0. OOe+OO,
- 2. 68e+09 6.61e+10 5.34e+04 9.09e-01 1.3Oe+02 1.58e+04 1.16e-19 1.04e-04 4.14e-01 1.65e+03 7.91e-01 1.41e+05 0.OOe+OO 5.80e+00 5.75e-60 1.81e+03 1.58e-03 9.94e+02 9.72e+07 4.27e+06 1.96e+09 0.0Oe+00 1.40e+07 7.49e-03 3.16e+07 1.21e+08 7.94e+06 2.78e+07 8.35e+08 8.81e-02 4.26e+04 7.32e+09 7.7le-12 0.OOe+00 0.OOe+00 4.73e+09 4.53e-45
,1.17e-53 0.OOe+00 0.OOe+00 0.OOe+O0 0.0O0e+0O 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 5.21e+02 1.57e-01 7.81e+04 4.48e+07 1.62e+01 8.18e-60 0.OOe+00 0.OOe+00 9.94e+02 9.72e+07 4.27e+06 0.OOe+00 2.77e+04 0.OOe+00 O. Oe+0O 0.OOe+00
,O.OOe+00 0.OOe+OO
- 0. OOe+00 0.OOe+00 0.OOe+0O 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+O0
- 0. OOe+00
- 0. OOe+00 0.OOe+0O
- 0. OOe+O0
- 0. OOe+00 O.OOe+O0
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+OO 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+OO
- 0. OOe+OO 0.OOe+00 0.OOe+00 9.94e+02 9.72e+07 4.27e+06
- 0. OOe+00 1.09e+04 4.18e+06 9.48e-03 0.OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00
- 1. 08e+05
- 4. 68e+09 5.04e-12 O. OOe+O0 0.OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+OO
- 0. 00e+00 0.OOe+00
- 0. OOe+00 0.OOe+00 7.65e+02 2.37e-01 7.57e+04 1.02e+08 2.41e+02 1.48e-58 6.38e+03 1.99e-02 9.94e+02 9.72e+07 4.27e+06 0.OOe+0O 7.13e+04 0.OOe+00
- 0. OOe+00 2.00e+07
- 3. 82e+07 0.OOe+00 0.OOe+00
- 0. 00e+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+O0
- 0. OOe+O0 0.OOe+00 0.0Oe+00
- 0. OOe+00
- 0. Oe+00
- 0. OOe+O0
- 0. OOe+00 0.OOe+00 0.0Oe+00 8.99e+00 4.98e-60
- 0. OOe+0O
- 0. OOe+OO 9.94e+02 9.72e+07 4.27e+06 2.65e+09 8.39e+06 2.88e+07 4.93e-01 1.37e+07 2.86e+08 1.09e+08 3.62e+08 1.33e+08 4.78e+00 3.31e+06 3.10e+09 1.42e-1l 0.OOe+O0
- 0. OOe+00 7.00e+08 3.88e-52 1.79e-62 3.19e+08 1.86e+09 2.42e+05 2.32e+01 1.08e+06 6.48e+06 5.46e-18 2.87e+00 1.26e+04 1.20e+06 4.24e+04 3.34e+08 8.02e+07 1.06e+04 1.40e-66 1.51e+05 1.28e+00 0.OOe+00 0.OOe+00 0.OOe+0O O.OOe+00 0.OOe+0O 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 O.OOe+00 0.OOe+0O O.OOe+0O 0.OOe+0O 0.OOe+00 O.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+OO 0.OOe+O0 0.OOe+00 0.OOe+O0 0.OOe+00 O. OOe+00 O.OOe+00 O.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+O0 0.OOe+00 0.OOe+00 0.OOe+00 9.94e+02 9.72e+07 4.27e+06 1.22e+09 4.99e+04 2.78e+06 1.33e-03 7.36e+06 4.67e+07 1.83e+07 6.26e+07
- 4. Ole+08 4.Ole-02 2.Ole+04 3.41e+09 5.39e-13 1.83e-01 3.14e-23 2.22e+09 2.42e-45 8.28e-54 7.66e+07 1.63e+10 2.12e+03 3.88e-02 3.51e+00 4.24e+02 4.42e-21 3.02e-06 1.14e-02 3.58e+02 7.21e-02 4.30e+04 8.54e+06 2.10e+02 8.03e-59 7.74e+02 6.14e-04 l Page 21 of 44
I Attachment C ODCM-QA-004 Revision 2 Page 36 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)
Units: Airborne Pathways & Tritium Ingestion: (mremlyr)/(PCVmA3))
Deposition Pathways: (mA2 * (mrem/yr)/&JC'sec)
AgeGroup:
TEEN Pathway:
Grs/Cow/Milk (CMILK)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli' Skin TB RU-106 3.75e+04 0.00e+00 AG-110M 9.63e+07'9.l1e+07 TE-125M 3.00e+07 1.08e+07 TE-127 1.22e+03 4.31e+02 TE-127M 8.44e+0 7 2.99e+07 TE-129 5.41e-10 2.02e-10 TE-129M 1.lOe+08 4.09e+07 TE-131 7.35e-3 3 3.03e-33 TE-131M 6.58e+0 5 3.16e+05 TE-132 4.30e+06 2:72e+06 1-130 3.71e+05 1.07e+06 1-131 2.69e+08 3.76e+08 I-132-1.49e-01 3.89e-01 1-133 3.54e+0 6 6.Ole+06 1-134 1.89e-12 5.00e-12 1-135 1.15e+04 2.96e+04 CS-134 9.82e+09 '2.31e+10 CS-136 4.48e+08 1.76e+09 CS-137 1.34e+10 1.78e+10 CS-138 1.79e-2 3 '343e-23 BA-139 8.45e-08,5.94e-11 BA-140
- 4.85e+0 7 5.95e+04 BA-141-8.74e-4 6 6.53e-49 BA-142 6.22e-80 6.22e-83 LA-140 8.11e+00 3.99e+00 LA-142 3.45e-11 1.53e-11 CE-141 8.88e+03 5.93e+03 CE-143 7.65e+Ol 5.57e+04 CE-144 6.58e+05 2.72e+05 PR-143 2.90e+02 1.16e+02 PR-144 1.27e-5 3 5.19e-54 ND-147 1.81e+02 1.97e+02 W-187 1.19e+0 4 9.73e+03 NP-239 7.02e+00 6.62e-01 PU-239 3.82e+07 4.63e+06 U-235 5.68e+09 0.Oe+O0 0.OOe+00 O. OOe+00
-8.39e+06 8.39e+02 2.01e+07 3.86e-10 3.55e+07 5.66e-33 4.75e+05 2.87e+06 8.75e+07 1.lOe+ll 1.31e+01 8.39e+08 8.34e-11 1.90e+06 0.OOe+0O 0.00e+OO 0.OOe+00 0.OOe+0O O.OOe+00 0.OOe+O0 0.0e+00 0.OOe+00 0.OOe+O0
- 0. OOe+O0 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+00 O.OOe+0O 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+OO 0.OOe+00 7.24e+04 1.74e+08 0.OOe+00 4.93e+03 3.42e+08-2.27e-09 4.61e+08 3.21e 3.29e+06 2.61e+07 1.65e+06 6.48e+08 6.12e-01 1.05e+07 7.89e-12 4.67e+04 7.34e+09 9.60e+08 6.06e+09 2.53e-23 5.60e-11 2.02e+04 6.06e-49 5.26e-83 0.OOe+00 0.OOe+00 2.79e+03 2.50e+O1 1.63e+05 6.73e+01 2.98e-54
-1.16e+02
- 0. OOe+00 2.08e+00 4.27e+06 1.33e+09 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0-.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 2.80e+09 1.51e+08 2.35e+09 2.95e-24 4.lOe-11 4.00e+04 4.47e-49 4.14e-83 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 1.80e+06 2.56e+10 8.86e+07 9.39e+04 2.10e+08 2.96e-09 4.13e+08 6.03 e-34 2.53e+07 8.61e+07 8.24e+05 7.44e+07
- 1. 69e-01 4.55e+06 6.59e-14 3.28e+04 2.87e+08
- 1. 42e+08 2.53e+08 1.56e-26
- 7. 53e-07 7.49e+07 1.86e-51
.1.91e-91 2.29e+05 4.67e-07 1.70e+07 1.67e+06 1.66e+08 9.55e+05 1.40e-56 7.lle+05 2.63e+06 1.06e+05 3.52e+06 0.0Oe+OO O.OOe+OO O.OOe+OO O.OOe+00
- 0. OOe+00 O.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00 O.O00e+OO 4.73e+03 5.54e+07 4.02e+06 2.62e+02 1.OOe+07 1.32e-10 1.74e+07 2.30e-33 2.63e+05 2.56e+06 4.28e+05 2.02e+08 1.40e-01 1.83e+06 1.80e-12 1.lOe+04 1.07e+10 1.19e+09 6.2Oe+09 1.72e-23 2.46e-09 3.13e+06 2.92e-47 3.83e-81 1.06e+00 3.82e 6.81e+02 6.22e+00 3.54e+04 1.44e+01 6.43e-55
- 1. 18e+01 3.41e+03 3.67e-01
- 1. OOe+06 3.46e+08 0.00e+00-4.13e+08 I Page 22 of 44
Attachment C ODCM-QA-004 Revision 2 Page 37 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3) loaf I Units:
AgeGroup:
Pathway:
Airborne Pathways & Tritium Ingestion: (mrem/yr)/(uCimA3))
Deposition Pathways: (mA2 * (mrernryr)/(pClsec)
TEEN Vegetation (VEG)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 C-14 NA-24 P-32 CR-51 MN-54 MN-56 FE-55 FE-59 CO-58 CO-60 NI-63 NI-65 CU-64 ZN-65 ZN-69 BR-83 BR-84 RB-86 RB-88 RB-89 SR-89 SR-90 SR-91 SR-92 Y-90 Y-91 Y-91M Y-92 Y-93 ZR-95 ZR-97 NB-95 MO-99 TC-99M TC-101 RU-103 RU-105 O.OOe+0(
3.69e+Ol 2.38e+O!
2.50e+01
- 0. OOe+0(
O.OOe+O(
O.00e+0(
3.26e+O0 1.79e+O0
- 0. OOe+OC 0.OOe+OC
- 1. 61e+1C 5.56e+01 0.OOe+00 4.24e+08 4.75e-06 0.OOe+00 0.0Oe+00 0.00e+00
- 0. OOe+00
- 0. OOe+00 1.51e+10 7.51e+11 2.83e+05 3.87e+02 1.24e+04 7.83e+06 4.45e-09 8.43e-01
- 1. 58e+02 1.72e+06 3.lle+02 1.92e+05 0.OOe+00 2.70e+00 5.60e-31 6.82e+06 4.92e+01 0 2.59e+0 3 7.38e+02 5 2.38e+O0 3 9.97e+0 0.OOe+O(
04.54e+0E 01.39e+01 B 2.31e+OE I 4.19e+OE I 4.36e+07 I 2.49e+08 I 1. 14e+09 7.lle+00 8.29e+03 1.47e+09 9.06e-06
- 0.
OOe+00
- 0. 00e+00 2.74e+08 2.47e-22 9.33e-27 O.OOe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 5.43e+05 6.15e+01 1.07e+05 5.64e+06 7.54e+00 7.97e-31
- 0. OOe+00 0.0O0e+00 32.59e+03 7 7.38e+07 5 2.38e+05 0.OOe+00 3.43e+04 B 0.OOe+00 0.OOe+00 3 0.OOe+00 I 0.OOe+00 70.OOe+00 30.OOe+00 1 0.OOe+00
) 0.OOe+00 0.OOe+00
- 0.
OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0.
OOe+00
- 0.
OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.0Oe+00 0.OOe+00 0.OOe+00 0.0O0e+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.0Oe+00 0.OOe+00 0.OOe+00 0.0Oe+00 0.OOe+00 2.59e+03 7.38e+07 2.38e+05 0.OOe+00 1.35e+04 1.36e+08 1.76e+01 0.0Oe+00 0.0Oe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.0Oe+00 2.10e+04 9.42e+08 5.92e-06 0.OOe+00 O.OOe+00 O.OOe+00 O.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O. OOe+OO 0.OOe+00 0.OOe+00
- 0. OOe+0O 7.98e+05 9.33e+01 1.03e+05 1.29e+07 1.12e+02 1.44e-29 2.40e+07 6.21e+02 2.59e+03 7.38e+07 2.38e+05
- 0. OOe+0O 8.80e+04 0.OOe+00 0.OOe+00 1.47e+08 1.32e+08
- 0. OOe+0O
- 0. OOe+0O
- 0. OOe+O0 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 O.OOe+00 O.OOe+00
- 0. OOe+0O
- 0. OOe+O0
- 0. OOe+0O 0.OOe+O0 0.0Oe+0O 0.OOe+00 O.OOe+00
- 0. OOe+0O O. OOe+0O 0.00e+OO O.OOe+0O
- 0. OOe+0O
- 0. OOe+00
- 0. OOe+0O 0.OOe+00 0.OOe+00 4.19e+00 4.86e-31
- 0. OOe+00 O.OOe+00 2.59e+03 7.38e+07 2.38e+05 1.35e+08 1.04e+07 9.32e+08 9.18e+02
- 1. OOe+08 9.90e+08 6.Ole+08 3.24e+09 1.81e+08 3.85e+02 6.43e+05 6.23e+08 1.67e-05 O.OOe+O0 O.OOe+00 4.05e+07 2.12e-29 1.43e-35
- 1. 80e+09 2.lle+10 1.28e+06 9.85e+03 1.02e+08 3.21e+09 2.lOe-07 2.31e+04 4.82e+06 1.25e+09 1.67e+07 4.56e+08 1.Ole+07 4.95e+03 1.36e-37 5.70e+08 3.97e+04
- 0. 00e+00 0.O00e+00 0.O00e+00 0.O00e+00 0.O00e+00 0.O00e+00 0.O00e+00 0.O00e+00 O.O00e+00 0.00e+00 0.00e+00 O. 00e+00
- 0. 00e+00 0.O00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 o. 00e+00 o. 00e+00 0.O00e+00 0.O00e+00
- 0. 00e+00
- 0. 00e+O0 0.00e+00 0. 00e+00 0.O00e+00 0.00e+00
- 0. 00e+00 O.O00e+00 0.O00e+00 0.O00e+00 O. 00e+00 0.O00e+O0 O.O00e+00 O.O00e+00 0.O00e+00 2.59e+03 7.38e+07 2.38e+05 6.24e+07 6.17e+04 9.Ole+07 2.48e+00 5.39e+07 1.62e+08
- 1. OOe+08 5.60e+08 5.45e+08 3.24e+00 3.90e+03 6.87e+08 6.34e-07 2.82e+00 1.96e-11 1.29e+08 1.32e-22 6.60e-27 4.34e+08 1.85e+11 1.12e+04 1.65e+O1 3.34e+02 2.10e+05 1.70e-10 2.44e-02 4.33e+00 3.73e+05 2.83e+01 5.87e+04 1.08e+06 9.77e+01 7.83e-30 2.91e+06 1.91e+01 0
I Page 23 of 44
Attachment C ODCM-QA-004 Revision 2 Page 38 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)
I I Units:
AgeGroup:
Pathway:
Airborne Pathways & Tritium Ingestion: (mrerm/yr)/(pCVm"3))
Deposition Pathways: (mA2 * (mremfyr)/(ICisec)
TEEN Vegetation (VEG)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-106 AG-llOM TE-125M TE-127 TE-127M TE-129-TE-129M-TE-131 TE-131M TE-132 1-130 1-131 I-132 -
1-133-I-134 I-135.
CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141 BA-142 LA-140 LA-142 CE-141 CE-143 CE-144 PR-143 -
PR-144 ND-147 W-187 NP-239 PU-239 U-235 3.10e+Ol 1.52e+O0 1.48e+0l 5.30e+0-5.51e+O0 6.70e-04 3.62e+0E
- 1. 17e-J.
8.42e+O0 3.91e+06 1.74e+O0 3.84e+07 2.51e+01 9.65e+05
- 4. Ole-05 1.74e+04 7.l0e+09 4.37e+07
- 1. Ole+10 3.15e-11 2.55e-02 1.38e+08 8.46e-22
- 3. 65e-39 1.8Oe+03 1.77e-04 2.83e+05 9.31e+02 5.27e+07 7.00e+04 2.24e-26
.3.62e+04 3.53e+04 1.38e+03 6.95e+10 1.04e+11 0.OOe+00 1.43e+07 5.34e+07 1.88e+03 1.96e+08 2.50e-04 1.'34e+08 4.82e-16 4.04e+05 2.47e+06 5.05e+05 5.38e+07
- 0. OOe+00 0.OOe+00 4.14e+07 3.65e+03 1.31e+08 4.79e-04 1.17e+08
- 9. Ole-16 6.08e+05 2.61e+06 4.1le+07 1.57e+10 6.58e+01 2.22e+03 i1. 64e+06 1.06e-04 4.48e+04
- 1. 67e+10 1.72e+08 1.35e+10 6.05e-11 1.79e-05
- 1. 69e+05 6.3le-25 3.65e-42 8.86e+02 7.86e-05
- 1. 89e+05 6.77e+05 2.18e+07
- 2. 79e+04 9.18e-27 3.94e+04 2.8 8e+04
- 1. 31e+02 8.44e+09 0.00e+00 2.29e+08 1.77e-03 2.88e+06 o0.00e+00 0.00e+00, 0.00e+00 0.00e+00
- 0. 00e+O0 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.O00e+00 0.00e+O0 0.-.00e+00 0.00e+00 0 -0e+00 0.00e+00 0.00e+00 0.00e+00
'O.
00e+00 0.00e+00 0.00e+00 5.97e+08 2.74e+07 0.0Oe+OO 2.15e+04 2.24e+09
- 2. 81e-03 1.51e+09 5.1le-15 4.21e+06 2.37e+07 7.77e+05 9.26e+07 1.04e+02
,2.87e+06 1.68e-04 7.08e+04 5.31e+09 9.36e+07 4.59e+09 4.47e-11 1.69e-05
,5.74e+04 5.86e-25 3.08e-42.
0.OOe+OO 0.OOe+OO 8.89e+04 3.04e+02 1.30e+07 1.62e+04 5.27e-27 2.31e+04 0.OOe+00 4.10e+02 7.79e+09 2.43e+10 0.OOe+00 1.48e+10 0.OOe+0O 4.03e+09 O.OOe+0O 4.37e+08 O.OOe+00 4.09e+05 0.OOe+00 1.37e+09 0.OOe+00 3.66e-03 0.00e+00 1.36e+09 0.OOe+00 9.60e-17 0.OOe+00 3.24e+07 0.OOe+00 7.83e+07 0.OOe+O0 3.88e+05 O.OOe+00b1.06e+07 0.OOe+00 2.87e+01 0.00e+00 1.24e+06 O.OOe+00 1.40e-06 0.OOe+00 4.97e+04 2.03e+09 2.08e+08 1.48e+07 1.38e+07 1.78e+09 1.92e+08 5.20e-12 2.74e-14 1.24e-05 2.27e-01 1.14e+05 2.13e+08 4.32e-25-1.80e-27 2.43e-42 1.12e-50 0.OOe+00 5.09e+07 0.00e+00 2.39e+00 0.OOe+00 5.40e+08 O.OOe+00[2.04e+07 O.-OOe+00 1.33e+10 0.OOe+O00,2.30e+08 0.OOe+O0 2.47e-29 0.OOe+O0 1.42e+08 0.OOe+00 7.78e+06 O.OOe+00 2.10e+07 0.OOe+00 6.42e+09 0.OOe+00 7.53e+09
- 0. OOe+00 0.OOe+00 0.0O0e+00 O.OOe+OO 0.OOe+00
- 0. OOe+OO 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+O
- 0. OOe+00 0.OOe+00 0.OOe+OO O.OOe+0O 0.OOe+00 0.OOe+O0 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00.
- 0. OOe+00 0.OOe+00
- 0. OOe+00 O.OOe+00 0.OOe+00
- 0. OOe+0O 0.OOe+OO O.OOe+00 O.OOe+00 0.OOe+0O 0.OOe+0O 0.OOe+00 3.90e+07 8.72e+06 1.98e+07 1.14e+03 6.56e+07 1.63e-04 5.72e+07 3.66e-16 3.37e+05 2.33e+06 2.02e+05 2.89e+07, 2.36e+01 5.00e+05 3.82e-05
- 1. 66e+04 7.75e+09 1.16e+08 4.70e+09 3.02e-11 7.42e-04 8.89e+06 2.82e-23 2.24e-40 2.36e+02 1.96e-05 2.17e+04 7.57e+01 2.83e+06 3.48e+03 1.14e-27 2.36e+03 1.Ole+04 7.25e+01 1.83e+09 6.31e+09 I Page 24 of 44
Attachment C ODCM-QA-004 Revision 2 Page 39 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)
I Units:
AgeGroup:
Pathway:
Airborne Pathways & Tritium Ingestion: (mrem/yr)I(pCVmA3))
Deposition Pathways: (mA2 * (mrem/yr)/(pClsec)
CHILD Grs/GoatVMilk (GMILK)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 C-14 NA-24 P-32 CR-51 MN-54 MN-56 FE-55 FE-59 CO-58 CO-60 NI-63 NI-65 CU-64 ZN-65 ZN-69 BR-83 BR-84 RB-86 RB-88 RB-89 SR-89 SR SR-91 SR-92 Y-90 Y-91 Y-91M Y-92 Y-93 ZR-95 ZR-97 NB-95 MO-99 TC-99M TC-101 RU-103 RU-105 O. OOe+OC 1.20e+O0 1.07e+O0
- 1. 45e+IC
- 0. OOe+OC O.OOe+OC
- 0. OOe+OC 1.45e+06 1.56e+06 0.OOe+0O 0.OOe+00 3.56e+09
- 2. 02e-01
- 0. OOe+OO 4.96e+08 1.19e-12 0.OOe+OO 0.OOe+00 O.OOe+00 0.OOe+OO
- 0. 0Oe+O0 1.39e+10 2.35e+11 2.75e+05
- 4. 66e+00 3.87e+01 4.68e+03 3.39e-20
- 3. 08e-05 1.22e-01
- 4. 60e+02 2.31e-01 3.82e+04
- 0. OOe+00 1.60e+00
- 1. 69e-60 5.14e+02 4.63e-04 3.20e+03 2.39e+08 51.07e+06 P 4.37e+09 0 O.OOe+00 2.52e+06 I1.57e-03 7.71e+05 2.53e+06 1.46e+06 5.18e+06 1.91e+08 1.91e-02 8.35e+03 i1.32e+09
- 1. 73e-12
- 0. O.e+00 0.OOe+00 1.05e+09 l.OOe-45 2.46e-54 0.00 e+00 0.OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 l.Ole+02 3.34e-02 1.49e+04 9.77e+06 3.13e+00 1.77e-60 0.OOe+00 0.0Oe+00 3.20e+03 2.39e+08 1.07e+06
- 0. OOe+00 6.78e+03 0.OOe+00 0.OOe+00 0.OOe+OO 0.OOe+00
- 0. OOe+O0 0.OOe+00 0.OOe+00 0.OOe+00 0.00e+00
- 0.
OOOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 3.20e+03 2.39e+08 1.07e+06
- 0. OOe+00 1.85e+03
- 7. 06e+05 1.90e-03 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00 2.02e+04 8.33e+08 1.05e-12
- 0. OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 1.45e+02 4.79e-02 1.40e+04 2.09e+07 4.55e+01 3.02e-59 1.29e+03 4.07e-03 3.20e+03 2.39e+08 1.07e+06
- 0. OOe+00 1.24e+04 0.OOe+00 0.OOe+00 4.36e+05 7.33e+05 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 1.59e+00 9.36e-61 0.OOe+00
- 0. OOe+00 3.20e+03 2.39e+08 1.07e+06 2.58e+09 6.48e+05 2.11e+06 2.27e-01 1.43e+05 2.63e+06 8.49e+06 2.87e+07 1.28e+07 2.33e+00 3.92e+05 2.32e+08 l.09e-10 0.0Oe+00 0.OOe+00 6.77e+07 4.9le-47 2.15e-56 5.38e+08 3.16e+09 6.08e+05
- 8. 83e+01 1.lOe+05 6.24e+05 6.65e-17
- 8. 89e-01 1.82e+03
- 1. 05e+05 5.05e+03 2.75e+07 8.08e+06 1.78e+03 5.63e-60 1.33e+04 3.02e-01 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+O0
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.0Oe+00 0.OOe+00 0.00e+00 0.00e+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.00e+00 0.OOe+0O 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.00e+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.00e+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 3.20e+03 2.39e+08 1.07e+06 3.60e+09 1.22e+04 6.70e+05 3.54e-04 2.39e+05 1.26e+06 4.45e+06 1.53e+07 1.21e+08 1.lle-02 5.04e+03 8.22e+08 1.59e-13 5.38e-02 8.51e-24 6.47e+08 6.95e-46 2.19e-54 3.97e+08 5.95e+10 1.04e+04 1.87e-01 1.04e+00 1.25e+02 1.23e-21 8.80e-07 3.35e-03 9.00e+01 1.97e-02 1.06e+04 2.42e+06 5.19e+01 2.24e-59, 1.98e+02 1.68e-04 l Page 25 of 44
Attachment C ODCM-QA-004 Revision 2 Page 40 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3) i Units:
AgeGroup:
Pathway:
Airborne Pathways & Tritium Ingestion: (mrem/yr)I(uC'mA3))
Deposition Pathways: (mA~2 * (mrem/yr)/(pCVsec)
CHILD Grs/Goat/Milk (GMILK)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-106 AG-llOM TE-125M TE-127.-
TE-127M TE-129 TE-129M TE-131 TE-131M TE-132 1-130 I-131 1-132 1-133 1-134 I-135 CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141 BA-142 LA-1 40 LA-142 CE-141 CE-143 CE-144 PR-143 PR-144 ND-147 W-187 NP-239 PU-239 U-235 1.lle+0 4 2.51e+07 8.85e+06 3.59e+02
-2.50e+07 1.60e-1o 3.26e+07 2.16e-33 1.92e+05 1.23e+06
- 1. 04e+06 7.82e+08 4.22e-01
- 1. 03e+07 5.36e-12 3.26e+04 6.79e+10 3.04e+09
,9.67e+10 1.30e-22 2.49e-08 1.41e+07 2.58e-46 1.80e-80 2.33e+00' 1.OOe-ll 2.63e+03 2.25e+01 1.95e+05
- 8. 62e+01 3.76e-54 5.34e+01 3.47e+03 2.07e+00 6.37e+06
- 1. 69e+09 O.OOe+00 0.OOe+00,1.50e+04 1.69e+07 0.OOe+O0 3.15e+07
.2.40e+06 2.49e+06 0.OOe+00 9.68e+01 2.48e+02 1.02e+03 6;72e+06 5.97e+06 7.12e+07 4.47e-11 1.14e-10 4.68e-10 9.10e+06 1.05e+07.9.56e+07 6.60e-34 1:66e-33 6.54e-33 6.65e+04 1.37e+05-6.44e+05 5.45e+05 7.93e+05 5.06e+06 2.10e+06 2.32e+08 3.14e+06 7.87e+08 2.60e+11 1.29e+09 7.75e-01 3.60e+01 l.l9e+00 1.28e+07 2.37e+09 2.13e+07 9.96e-12 2.29e-10 1.52e-11 5.87e+04 5.20e+06 9.00e+04 1.12e+11 0.00e+00 3.45e+10 8.35e+09 O.OOe+00 4.44e+09 9.26e+10 0.OOe+00 3.02e+10 1.81e-22 0.00e+00 1.27e-22 1.33e-11 0.OOe+00 1.16e-11 1.23e+04 0.00e+00 4.'Ole+03 1.44e-49 0.OOe+00 1.25e-49 1.30e-83 0.OOe+00 1.05e-83 8.15e-01 0.00e+00'0.OOe+00 3.19e-12 0.OOe+00 O.OOe+00 1.31e+03 0.OOe+00 5.74e+02 1.22e+04-0.00e+00 5.12e+00 6.lle+04 0.OOe+O0 3.38e+04 2.59e+O1 0.OOe+00'1.40e+01 1.16e-54 0.OOe+00'6.16e-55 4.32e+01 0.OOe+00 2.37e+01 2.06e+03 0.OOe+000.OOe+00 1.49e-01 0.OOe+00 4.30e-01 6.81e+05 0.OOe+0O-6.02e+05 0.OOe+00 0.OOe+0O 2.77e+08 0.OOe+00 0.OOe+00
,0.OOe+00 0.OOe+O0 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+OO
'.OOe+00
'O.OOe+OO 0O.
00e+00 O.'OOe+OO 0.00e+00 0.OOe+00 0.OOe+O0 0.00e+O0 0.00e+00 1.24e+10 6.'63e+08 1.09e+10 1.37e-23 7.82e-12 7.34e+03 8.49e-49 7.62e-84
- 0. OOe+00 0.0Oe+00 0.OOe+00 O. OOe+00 O.OOe+00
.0. 00+0O 0.Oee+00 0.OOe+00 0.OOe+00 1.73e+05 0.OOe+00 2.Ole+09,0.00e+00 8.54e+06 0.OOe+00 1.40e+04, 2.02e+07 9.97e-09 3.97e+07 1.14e-32 2.70e+06 5.48e+06
.9.
83e+05 7.00e+07 9.12e-01
'5.15e+06 6.61e-12 4.47e+04 6.Ole+08 2.93e+08 5.80e+08 8.32e-23 1.44e-06 7.12e+'06 1.47e-46 2.35e-82 2.27e+04 6.32e-07
- 1. 63e+06 1.79e+05 1.59e+07 9.30e+04 2.51e-51 6.85e+04 2.89e+05 0.OOe+00 0.OOe+00 0.OOe+0O 0.OOe+00 0.OOe+0O 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O;OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+00
,O.OOe+00 O.'OOe+OO
- 0. OOe+00 0.OOe+O0 O. OOe+O0
- 0. OOe+00 O.'O0e+00 0.OOe+O0 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+O0 0.OOe+OO 0.OOe+00 1.38e+03 1.35e+07 1.18e+06 7.7Oe+01 2.96e+06 3.80e-11 5.06e+06 6.44e-34 7.08e+04 6.58e+05 1.08e+06 4.47e+08 3.56e-01 4.83e+06 4.58e-12 2.78e+04 2.35e+10 5.40e+09 1.37e+10 1.15e-22 7.22e-10 8.21e+05 8.40e-48 1.Ole-81 2.75e-01 9.98e-13
- 1. 94e+02 1.77e+00 1.04e+04 4.28e+00 1.89e-55 3.35e+00 9.23e+02 1.05e-01 1.63e+05 1.02e+08
'O.OOe+001.lOe+04 0.OOe+00'3.38e+05 0.OOe+00'3.96e+07 I Page 26 of 44
Attachment C ODCM-QA-004 Revision 2 Page 41 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)
I Units:
AgeGroup:
Pathway:
Airborne Pathways & Tritium Ingestion: (mrem/yr)I(pCi/nmt3))
Deposition Pathways: (mA2 * (mremfyr)/(uCi/sec)
CHILD Ground Plane Deposition (GPD)
I I
IJ I)
I]
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB NA-24 1.20e+07 1.20e+07 1.20e+07 1.20e+07 1.20e+07 1.20e+07 1.39e+07 1.20e+07 CR-51 4.66e+06 4.66e+06 4.66e+06 4.66e+06 4.66e+06 4.66e+06 5.51e+06 4.66e+06 MN-54 1.39e+09 1.39e+09 1.39e+09 1.39e+09 1.39e+09 1.39e+09 1.63e+09 1.39e+09 MN-56 9.04e+05 9.04e+05 9.04e+05 9.04e+05 9.04e+05 9.04e+05 1.07e+06 9.04e+05 FE-59 2.72e+08 2.72e+08 2.72e+08 2.72e+08 2.72e+08 2.72e+08 3.20e+08 2.72e+08 C0-58 3.79e+08 3.79e+08 3.79e+08 3.79e+08 3.79e+08 3.79e+08 4.43e+08 3.79e+08 CO-60 2.15e+10 2.15e+10 2.15e+10 2.15e+10 2.15e+10 2.15e+10 2.53e+10 2.15e+10 NI-65 2.97e+0 5 2.97e+05 2.97e+05 2.97e+05 2.97e+05 2.97e+05 3.45e+05 2.97e+05 CU-64 6.07e+05 6.07e+05 6.07e+05 6.07e+05 6.07e+05 6.07e+05 6.88e+05 6.07e+05 ZN-65 7.47e+08 7.47e+08 7.47e+08 7.47e+08 7.47e+08 7.47e+08 8.60e+08 7.47e+08 BR-83 4.87e+03 4.87e+03 4.87e+03 4.87e+03 4.87e+03 4.87e+03 7.08e+03 4.87e+03 BR-84 2.03e+05 2.03e+05 2.03e+05 2.03e+05 2.03e+05 2.03e+05 2.36e+05 2.03e+05 RB-86 8.99e+06 8.99e+06 8.99e+06 8.99e+06 8.99e+06 8.99e+06 1.03e+07 8.99e+06 RB-88 3.31e+04 3.31e+04 3.31e+04 3.31e+04 3.31e+04 3.31e+04 3.78e+04 3.31e+04 RB-89 1.21e+05 1-21e+05 1.21e+05 1.21e+05 1.21e+05 1.21e+05 1.45e+05 1.21e+05 SR-89 2.16e+04 2.16e+04 2.16e+04 2.16e+04 2.16e+04 2.16e+04 2.51e+04 2.16e+04 SR-91 2.15e+06 2.15e+06 2.15e+06 2.15e+06 2.15e+06 2.15e+06 2.51e+06 2.15e+06 SR-92 7.77e+05 7.77e+05 7.77e+05 7.77e+05 7.77e+05 7.77e+05 8.63e+05 7.77e+05 Y-90 4.49e+03 4.49e+03 4.49e+03 4.49e+03 4.49e+03 4.49e+03 5.31e+03 4.49e+03 Y-91 1.07e+06 1.07e+06 1.07e+06 1.07e+06 1.07e+06 1.07e+06 1.21e+06 1.07e+06 Y-91M 1.OOe+05 1.OOe+05 1.0Oe+05 1.OOe+05 1.OOe+05 1.OOe+05 1.16e+05 1.OOe+05 Y-92 1.80e+0 5 1.80e+05 1.80e+05 1.80e+05 1.80e+05 1.80e+05 2.14e+05 1.80e+05 Y-93 1.83e+05 1.83e+05 1.83e+05 1.83e+05 1.83e+05 1.83e+05 2.51e+05 1.83e+05 ZR-95 2.45e+08 2.45e+08 2.45e+08 2.45e+08 2.45e+08 2.45e+08 2.84e+08 2.45e+08 ZR-97 2.96e+06 2.96e+06 2.96e+06 2.96e+06 2.96e+06 2.96e+06 3.45e+06 2.96e+06 NB-95 1.37e+08 1.37e+08 1.37e+08 1.37e+08 1.37e+08 1.37e+08 1.61e+08 1.37e+08 MO-99 4.00e+06 4.00e+06 4.00e+06 4.00e+06 4.00e+06 4.00e+06 4.63e+06 4.00e+06 rC-99M 1.84e+05 1.84e+05 1.84e+05 1.84e+05 1.84e+05 1.84e+05 2.11e+05 1.84e+05 TC-101 2.04e+04 2.04e+04 2.04e+04 2.04e+04 2.04e+04 2.04e+04 2.26e+04 2.04e+04 RU-103 1.08e+08 1.08e+08 1.08e+08 1.08e+08 1.08e+08 1.08e+08 1.26e+08 1.08e+08 RU-105 6.37e+05 6.37e+05 6.37e+05 6.37e+05 6.37e+05 6.37e+05 7.21e+05 6.37e+05 RU-106 4.22e+08 4.22e+08 4.22e+08 4.22e+08 4.22e+08 4.22e+08 5.07e+08 4.22e+08
%G-11OM 3.44e+09 3.44e+09 3.44e+09 3.44e+09 3.44e+09 3.44e+09 4.01e+09 3.44e+09 TE-125M 1.55e+06 1-55e+06 1.55e+06 1.55e+06 1.55e+06 1.55e+06 2.13e+06 1.55e+06 rE-127 2.98e+03 2.98e+03 2.98e+03 2.98e+03 2.98e+03 2.98e+03 3.28e+03 2.98e+03 PE-127M 9.17e+04 9.17e+04 9.17e+04 9.17e+04 9.17e+04 9.17e+04 1.08e+05 9.17e+04 LE-129 2.62e+04 2.62e+04 2.62e+04 2.62e+04 2.62e+04 2.62e+04 3.lOe+04 2.62e+04 7E-129M 1.98e+07 1.98e+07 1.98e+07 1.98e+07 1.98e+07 1.98e+07 2.31e+07 1.98e+07
-)
I Page 27 of 44
Attachment C ODCM-QA-004 Revision 2 Page 42 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)
I I Units:
AgeGroup:
Pathway:
Airborne Pathways & Tritium Ingestion: (mrem/yr)I(pCVmA3))
Deposition Pathways: (mA2 * (mren/yr)/(pCVsec)
CHILD Ground Plane Deposition (GPD)
Nuclide -Bone
-Liver Thyroid Kidney Lung GI-Lli Skin TB TE-131
'TE-131M TE-132 I-130 1-131 I-132 I-133 I-134 1-135 CS-134 CS-136 CS-137 cS-138 BA-139 BA-140' BA-141 BA-142 LA-140 LA-142 CE-141 CE-143 CE-144 PR-144 ND-147 W-187 NP-239 PU-239,
u-235 2.92e+04 2.92e+04 8.03e+06 8.03e+06 4.24e+06,4.24e+06 5.51e+065.51e+06 1.72e+07 1.72e+07 1.25e+06 1.25e+06
-2.45e+06 2.45e+06 4.47e+05 4.47e+05 2.53e+06 2.53e+06 6.86e+09 6.86e+09 1.51e+08,1.51e+08 1.03e+10 1.03e+10 3.59e+05 3.-59e+05
-1.06e+05 1.06e+05 2.05e+07 2.05e+07 4.17e+04 4.17e+04 4.49e+04 4.49e+04 1.92e+07 1.92e+07 7.60,+05 7.60e+05 1.37e+07 1.37e+07 2.31e+06 2.31e+06 6.95e+07 6.95e+07 1.84e+03 1.84e+03 8.39e+06 8.39e+06 2.35e+06 2.35e+06, 1.71e+06 1.71e+06 2.29e+06 2.29e+06 9.28e+09 9.28e+09 2.92e+04 -2.92e+04 2.92e+04 8.03e+06 4.24e+06 5.51e+06 8.03e+06 8.03e+06 4.24e+06 4.24e+06 5.51e4-O6 5.51e.06 2.92e+04 8.03e+06 4.24e+06 5.51e+06 1.72e+07 -1.72e+07 1.72e+07 1.72e+07 1.25e+06 1.25e+06 1.25e+06 1.25e+06 2.45e+06 2.45e+06 2.45e+06 2.45e+06 4;47e+05 4.47e+05 4.47e+05 4.47e+05 2.53e+06 2.53e+06 2.53e+06 2.53e+06
,6.86e+09 6.86e+09 6.86e+09 6.86e+09
-1.51e+08 1.51e+08 1.51e+08 1.51e+08 1.03e+10 1.03e+10 1.03e+10 1:03e+10 3.59e+05 3.59e+05 3.59e+05 3.59e+05 1.06e+05 1.06e+05 1.06e+05 1.06e+05 2.05e+07 2.05e+07 2.05e+07 2.05e+07 4.17e+04 4.17e+04 4.17e+04 4,17e+04 4.49e+04 4.49e+04 4.49e+04 4.49e+04 1.92e+07 1.92e+07 1.92e+07 1.92e+07 7.60e+05 7.60e+05 7.60e+05 7.60e+05 1.37e+07 1.37e+07 1.37e+07 1.37e+07 2.31e+06 2.31e+06 2.31e+06 2.31e+06 6.95e+07 6.95e+07 6.95e+07 6.95e+07 1.84e+03 1.84e+03 1.84e+03 1.84e+03 8.39e+06 8.39e+06 8.39e+06-8.39e+06 2.35e+06 2.35e+06 2.35e+06'2.35e+06 1.71e+06 1.71e+06 1.71e+06 1.71e+06 2.29e+06 2.29e+06 2.29e+06 2.29e+06 9.28e+09 9.28e+09 9.28e+09 9.28e+09 3.45e+07'2.92e+04 9.46e+06 8.03e+06 4.98e+06 4.24e+06 6.69e+06 5.51e+06 2.09e+07 1.72e+07, 1.47e+06 1.25e+06 2.98e+06 2.45e+06 5.31e+05 4.47e+05 2.95e+06 2.53e+06 8.00e+09 6.86e+09 1.71e+08 1.51e+08 1.20e+10 1.03e+10 4.10e+05 3.59e+05 1.19e+05'1.06e+05 2.35e+07 2.05e+07 4.75e+04 4.17e+04 5.11e+04 4.49e+04 2.18e+07 1.92e+07 9.12e+05 7.60e+05 1.54e+07,1.37e+07 2.63e+06 2.31e+06 8.04e+07 6.95e+07 2.11e+03 1.84e+03 1.Ole+07 8.39e+06 2.73e+06 2.35e+06 1.98e+06 1.71e+06 i2.23e+07 1.16e+10 2.29e+06..'
9.28e+09 -
I Page 28 of 44
Attachment C ODCM-QA-004 Revision 2 Page 43 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)
I l Units: Airborne AgeGroup:
Pathway:
Pathways & Tritium Ingestion: (mrem/yr)/(pCVmriA3))
Deposition Pathways: (mA2 * (mrem/yr)/(pCi/sec)
CHILD Inhalation (INHL)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 C-14 NA-24 P-32 CR-51 MN-54 MN-56 FE-55 FE-59 CO-58 CO-60 NI-63 NI-65 CU-64 ZN-65 ZN-69 BR-83 BR-84 BR-85 RB-86 RB-88 RB-89 SR-89 SR-90 SR-91 SR-92 Y-90 Y-91 Y-91M Y-92 Y-93 ZR-95 ZR-97 NB-95 MO-99 TC-99M TC-101 RU-103 0.OOe+00 3.59e+04 1.61e+04
- 1. 15e+09 0.OOe+00 O.OOe+00 0.OOe+00 4.74e+04 2.07e+04 0.OOe+00
- 0. 00e+00 8.21e+05 2.99e+00
- 0. OOe+00 4.26e+04 6.70e-02 0.OOe+00 0.OOe+00 0.OOe+00 0.00 e+00
- 0. OOe+00 0.OOe+00 5.99e+05 1.Ole+08 1.21e+02 1.31e+01 4.11e+03 I 9.14e+05 (
5.07e-01 I 2.04e+01 4 1.87e+02 (
1.90e+05 4 1.88e+02 2 2.35e+04 9 0.OOe+00 3 1.78e-03 3 8.10e-05 8 2.79e+03 0
- 1. 13e+03 6.73e+03
- 1. 61e+04
- 1. 14e+05
- 0. 00~e+00 4.29e-i04
- 1. 66e+00 2.52e+04 3.35e+04
- 1. 77e+03 1.31e+04 4.63e+04 2.96e-01 1.99e+00 1.13e+05
- 9. 66eL02
- 0. 00e+00 0.00e+00 0.O00e+00
- 1. 98e+05 S. 62e+02 3.45e+02
- 0. 00e+00 O.O00e+00 0.O00e+00-
- 0. 00e+00 0.O00e+00 D. 00e+00
).O00e+O0 00Oe+004 00Oe+00 4 I.
18e+04
.72e+O1
.18e+03
- .72e+02(
- .48e-03 C
.51e-05 C 00Oe+00 C 1.13e+03 6.73e+03
- 1. 61e+04 0.00e+00 8.55e4-01
- 0. 00e+00
- 0. 00e+00 0.00~e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.O00e+00 0.00e+00 0.00e+00 0.00e+00 0.O00e+00 0.00e+00 0.00e+00 0.00Oe+00 0.00e+00
- 0. 00e+00 0.00e+00 0.O00e+00
- 0. 00e+00 0.00e+00
- 0. 00e+00 D. 00e+00 D.00e+00
). 00e+O0
).00e+00
).00e+00 00Oe+00 00Oe+00
).00e+00
).
00e+00 P. 00e+00 1.13 e+03 6.73e+03
- 1. 61e+04
- 0. 00e+00 2.43e+01
- 1. OOe-+04
- 1. 67e+00 0.00e+O0 0.O00e+00 0.00e+00 0.O00e+00
- 0. 00e+00
- 0. 00e+00 6.03e+00 7.14e+04 S. 85e-02 0.O00e+O0 0.O00e+00
- 0. 00e+O0 0.O00e+00 0.O00e+00 0.O00e+O0 0.O00e+00 0.O00e+00
- 0. 00e+00
- 0. O0e+00 0.O00e+00
- 0. 00e+00 0.O00e+00 0.O00e+00
- 0. 00e+00 5.96e+04 3.89e+01
- 8. 62e+03 3.92e+02 5.07e-02 I 45e-03 7.03e+03 1.13e+03 6.73e+03 1.61e+04
- 0.
OOe+00 1.70e+04 1.58e+06 1.31e+04 1.lle+05 1.27e+06 1.lle+06 7.07e+06 2.75e+05 8.18e+03 9.58e+03 9.95e+05 1.42e+03
- 0. OOe'+00 O.OOe+00 O.OOe+00 0.OOe+00 0.OOe+00 0.00e+00 2.16e+06 1.48e+07 5.33e+04-2.40e+04 2.62e+05 2.63e+06 2.81e+03 2.39e+04 7.44e+04 2.23e+06 1.13e+05 6.14e+05 1.35e+05 9.51e+02 5.85e+02
- 6. 62e+05 1.13e+03 6.73e+03 1.61e+04 4.22e+04 1.08e+03 2.29e+04 1.23e+05 2.87e+03 7.07e+04 3.44e+04
- 9. 62e+04 6 :33e+03 8.40e+04 3.67e+04 1.63e+04
- 1. 02e+04 0.OOe+00
- 0. OOe+00 0.OOe+00 7.99e+03 1.72e+01 1.89e+00
- 1. 67e+05 3.43e+05 1.74e+05 2.42e+05 2.68e+05
- 1. 84e+05 1.72e+03 2.39e+05 3.89e+05 6.11e+04 3.51e+05 3.70e+04 1.27e+05 4.81e+03
- 1. 63e+01 4.48e+04 O.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 O. OOe+00
- 0. OOe+00 O.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+0O O. Oae+OO O.OOe+00 O.OOe+00 0.00e+00
- 0. OOe+OO 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00 1.13e+03 6.73e+03 1.61e+04 9.88e+04 1.54e+02 9.51e+03 3.12e-01 7.77e+03 1.67e+04 3.16e+03 2.26e+04 2.80e+04 1.64e-01
- 1. 07e+00 7.03e+04 8.92e-03 4.74e+02 5.48e+02 2.53e+01
- 1. 14e+05 3.66e+02 2.90e+02 1.72e+04 6.44e+06 4.59e+00 5.25e-01 1.lle+02 2.44e+04 1.84e-02 5.81e-01 5.11e+00 3.70e+04 1.60e+01 6.55e+03 4.25e+01 5.77e-02 1.08e-03 1.07e+03 Page 29 of 44
Attachment C ODCM-QA-004 Revision 2 Page 44 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)
I Units: Airborne AgeGroup:
Pathway:
Pathways & Tritium Ingestion: (mrem/yr)/(PCVmA3))
Deposition Pathways: (m^2 * (mremlyr)/(pCisec)
CHILD Inhalation (INHL)
Nuclide Bone Liver -
Thyroid 'Kidney Lung
, GI-Lli Skin TB1 RU-105 1.53e+00 0.OOe+00 O.OOe+OO 1.34e+00 1.59e+04 9.95e+04 0.OOe+O0 5.55e-01 RU-106 1.36e+05 O.OOe+OO O.00e+001.84e+05 1.43e+07 4.29e+05 O.OOe+00 1.69e+04 AG-llOM 1.69e+04 1.14e+04 O.OOe+OO 2.12e+04 5.48e+06 l.OOe+05,0.00e+00 9.14e+03 TE-125M 6.73e+0 3 2.33e+03 1.92e+03 O.OOe+OO 4.77e+05 3.38e+04 O.OOe+0O 9.14e+02 TE-127 2.77e+00 9.51e-01 1.96e+00 7.07e+00 1.OOe+04 5.62e+04 0.OOe+0O 6.1le-01 TE-127M 2.49e+04 8.55e+03 6.07e+03 6.36e+04 1.48e+06 7.14e+04 O.OOe+00 3.02e+03 TE-129 - 9.77e-0 2 3.50e-02 7.14e-02 2.57e-01 2.93e+03 2.55e+04 O.OOe+O0 2.38e-02 TE-129M 1.92e+04 6.85e+03 6.33e+03'?5.03e+04-1.76e+06 1.82e+05 O.OOe+0O 3.04e+03 TE-131 2.17e- 0 2 8.44e-03 1.70e-02 5.88e-02,2.05e+03 1.33e+03 0.OOe+00-6.59e-03 TE-131M 1.34e+02 5.92e+01 9.77e+01 4.00e+02 2.06e+05 3.08e+05 0.00e+00 5.07e+01l TE-132 4.81e+02 2.72e+02 3.18e+02 1.77e+03 3.77e+05-1.38e+05 0.OOe+00 2.63e+02 I-130 8.18e+03 1.64e+04 1.85e+06 2.45e+04 O.Oe+OO 5.11e+03 O.OOe+0O 8.44e+03 I-131 4.81e+04 4.81e+04 1.62e+07 7.88e+04 0.OOe+OO 2.84e+03 0.OOe+O0 2.73e+04 I-132 2.12e+0 3 4.07e+03 1.94e+05 6.25e+03 0.OOe+O0 3.20e+03 O.OOe+O0 1.88e+03 I-133 1.66e+04 2.03e+04 3.85e+06 3.38e+04 0.OOe+OO 5.48e+03 O.OOe+O0 7.70e+03 I-134 1.17e+03 2.16e+03 5.07e+04 3.30e+03 O.OOe+OO 9.55e+02 O.00e+00 9.95e+02 I-135 4.92e+0 3 8.73e+03 7.92e+05 1.34e+04-0.OOe+O0 4.44e+03 0.OOe+0O 4.14e+03 CS-134 6.51e+05 1.Ole+06 O.OOe+OO 3.30e+05 1.21e+05 3.85e+03 O.OOe+0O 2.25e+05 CS-136 6.51e+0 4 1.71e+05 O.OOe+OO 9.55e+04 1.45e+04 4.18e+03 O.OOe+OO 1.16e+05 CS-137 9.07e+05 8.25e+05 O.OOe+OO 2.82e+05 1.04e+05 3.62e+03 O.OOe+OO 1.28e+05 CS-138 6.33e+0 2 8.40e+02 O.OOe+O0 6.22e+02,6.81e+O1 2.70e+02 O.OOe+O0 5.55e+02 BA-139 1.84e+00 9.84e-04 O.OOe+O0 8.62e-04 5.77e+03 5.77e+04 O.OOe+O0 5.37e-02 BA-140 7.40e+04 6.48e+01 0.OOe+O0 2.11e+01 1.74e+06 1.02e+05 O.OOe+00 4.33e+03 BA-141 1.96e-01 1.09e-04O0.00e+00 9.47e-05 2.92e+03 2.75e+02 O.OOe+00 6.36e-03 BA-142 5.00e-02 3.60e-05 O.OOe+00 2.91e-05 1.64e+03 2.74e+00 O.OOe+00 2.79e-03 LA-140 6.44e+0 2 2.25e+02 O.OOe+OO O.OOe+OO 1.83e+05 2.26e+05 O.OOe+O0 7.55e+01 LA-142 1.29e+0° 4.11e-01 O.OOe+O0 O.OOe+O0 8.70e+03 7.59e+04 O.OOe+00 1.29e-01 CE-141 3.92e+04 1.95e+04 O.OOe+O0 8.55e+03 5.44e+05 5.66e+04 0.OOe+O0 2.90e+03 CE-143 3.66e+02 1.99e+02 O.OOe+OO 8.36e+01 1.15e+05 1.27e+05 O.OOe+O0 2.88e+01 CE-144 6;77e+06 2.12e+06 O.OOe+OO 1.17e+06 1.20e+07, 3.89e+05,0.OOe+O0 3.62e+05 PR-143 1.85e+04 5.55e+03 0.OOe+O0 3.00e+03 4.33e+05 9.73e+04 O.OOe+OO 9.14e+02 PR-144 5.96e-0 2 1.85e-02 O.OOe+OO 9.77e-03 1.57e+03 1.97e+02 0.OOe+OO 3.00e-03 ND-147 1.08e+04 8.73e+03 0.OOe+00 4.81e+03.3.28e+05 8.21e+04 O.OOe+O0 6.81e+02 W-187 1.63e+01 9'66e+00 O.'OOe+O0 O.OOe+00-4.11e+04 9.10e+04 O.OOe+O0 4.33e+'00 NP-239 4.66e+02 3.01e+02 O.OOe+0O 9.73e+01 5.81e+04 6.40e+0410.00e+00 2.35e+01 PU-239 1.03e+10 6.22e+09 O.OOe+O0 1.77e+09 2.12e+09 1.57e+05 0.OOe+O0 4.74e+08 U-235 1.58e+08 0.OOe+OO 0.OOe+OO 2.59e+07 6.03e+08 1.84e+05 O.OOe+00 9.58e+06 PeN IPage 30 of 44
Attachment C ODCM-QA-004 Revision 2 Page 45 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)
I Units:
AgeGroup:
Pathway:
Airborne Pathways & Tritium Ingestion: (mrerr/yr)/(pCVmA3))
Deposition Pathways: (mA2 * (mren/yr)/(pCVsec)
CHILD Grs/Cow/Meat (CMEAT)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 C-14 NA-24 P-32 CR-51 MN-54 MN-56 FE-55 FE-59 CO-58 CO-60 NI-63 NI-65 CU-64 ZN-65 RB-86 SR-89 SR-90 SR-91 SR-92 Y-90 Y-91 Y-92 Y-93 ZR-95 ZR-97 NB-95 MO-99 TC-99M RU-103 RU-105 RU-106 AG-llOM TE-125M TE-127 TE-127M TE-129M TE-131M O.OOe+O(
3.83e+0l 1.78e-0O 1.15e+05
- 0. OOe+OC 0.0Oe+O(
0.0Oe+OC 4.57e+OE 3.77e+OE
- 0. OOe+OC 0.0Oe+OC 2.91e+10 4.22e-52
- 0. OOe+00 3.76e+08 0.OOe+00 4.82e+08 1.04e+10 2.52e-10 2.l8e-49 1.73e+02 1.80e+06 2.74e-39 7.78e-12 2.66e+06 3.29e-05 3.10e+06 0.OOe+00 6.69e-21 1.55e+08 9.99e-28 4.44e+09 8.39e+06 5.69e+08 3.56e-10 1.78e+09 1.79e+09 7.lle+02
)2.34e+0.'
3 7.67e+0j i1. 78e ?3.48e+OE
)0.O00e+OC
- 8. Ole+OE
)1.96e-53 I2.43e+OE I6.09e+OE I1. 64e+0'7 I6.93e.0'7 1.56e.09 3.97e-53 3.08e-07 1.00e+09
- 5.77e+08 0.00~e+00 0.00e+00 0.00e+00 0.00Oe+00
- 0. 00e+00 0.00e+00 0.00e+00 0.00Oe+00 5.86e+05 4.76e-06 1.21e+06 1.16e+05 1.3le-20 0.O00e+00 0.00~e+00 0.00e+00 5.67e+06 1.54e+08 9.59e-11 4.78e+08 5.O00e+08 2.46e+02 2.34e+0~
- 7. 67e+0'j I-1. 78e-02 I 0.O00e+OC I4.88e+02; 0.O00e+OC 0.00e+OC I0.O00e+OC 0.O00e+OC 0.O00e+00 0.O00e+00 0.O00e+00 0.O00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.O0e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.O00e+00 0.00e+00 0.00~e+00 0.O00e+00 0.O00e.00 0..00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00
- 1. 60e+08 2.46e-10 4.24e+08 5.78e+08 S. 05e+02 2.34e+02 7.67e+07 1.78e-03 I 0.OOe+00 31.33e+03 I 2.25e+06
)2.37e-53 0.OOe+00 I0.OOe+00 0 O.OOe+00 0.0Oe+00 0.OOe+00 0.OOe+00 7.45e-07 6.30e+08
- 0.
OOe+00 0.OOe+00 0.OOe+00
- 0.
OOe+00
- 0.
OOe+00
- 0.
OOe+00
- 0.
OOe+00 0.00e+00
- 0.
OOe+00 8.38e+05 6.83e-06 1.13e+06 2.47e+05 1.90e-19 3.90e+08 8.78e-,7 5.99e+09 1.06e+07 0.00e+0O 1.Ole-09 5.06e+09 5.26e+09 2.38e+03 2.34e+02 7.67e+07 1.78e-03 0.OOe+00 8.91e+03
- 0. OOe+00 0.0Oe+00 1.37e+08 1.77e+08 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.0Oe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 6.66e-21 0.OOe+00 0.OOe+00 0.OOe+00 0.0Oe+00 0.OOe+00 0.OOe+00
- 0. OOe+O0 0.0O0e+00 0.OOe+00 2.34e+02 7.67e+07 1.78e-03
- 2. 05e+08 4.66e+05 6.72e+06
- 2. 84e-51 4.49e+07 6.34e+08 9.58e+07 3.84e+08 1.05e+08 4.86e-51 1.45e-05 1.76e+08 3.71e+07 1.87e+07 1.40e+08 5.55e-10 4.13e-48 4.92e+05 2.40e+08 7.92e-35 1.16e-07 6.lle+08 7.21e-01 2.23e+09
- 9. 58e+04 7.46e-18 4.Ole+09 6.52e-25 6.90e+10 6.74e+08 5.49e+08 1.39e-08 1.44e+09 2.19e+09 9.97e+03 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+0O O.OOe+0O
- 0. OOe+O0 O.OOe+00 0.OOe+O0 0.OOe+0O 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+O0 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 O.OOe+00 O.OOe+00 O.OOe+00 O.OOe+00 O.OOe+00 O.OOe+00 0.OOe+00 2.34e+02 7.67e+07 1.78e-03 2.86e+08 8.80e+03 2.13e+06 4.42e-54 7.51e+07 3.04e+08 5.03e+07 2.04e+08 9.91e+08 2.32e-53 1.86e-07 6.22e+08 3.55e+08 1.38e+07 2.64e+09 9..49e-12 8.75e-51 4.62e+00 4.82e+04 7.84e-41
- 2. 14e-13 5.21e+05-2.8le-06 8.62e+05 2.87e+04
- 2. 17e-19 5.96e+07 3.63e-28 5.54e+08 4.53e+06 7.59e+07 7.63e-11 2.lle+08 2.78e+08 2.62e+02 0_
I Page 31 of 44
Attachment C ODCM-QA-004 Revision 2 Page 46 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)
(
I Units:
AgeGroup:
Pathway:
Airborne Pathways & Tritium Ingestion: (mremfyr)/f(CimA3))
Deposition Pathways: (mnA2 * (mrem/yr)/(uCVsec)
CHILD Grs/Cow/Meat (CMEAT)
Nuclide Bone Liver Thyroid-Kidney Lung GI-Lli Skin TB TE-132 1-130 1-131 1-132 I-133 1-135 CS-134 CS-136 CS-137 BA-140 LA-140 LA-142 CE-141 CE-143 CE-144 PR-143 ND-147 W-187, NP-2 39 PU-239 U-235 2.13e+06 1.58e-06 8.30e+06 6.24e-5 9 2.90e-01 3.49e-17
.9.22e+08
- 1. 62e+ 0 7 1.33e+09 4.39e+07 5.65e-02 7.00Oe-9 2 2.22e+0 4 3.2le-02 2.32e+06 3.34e+04
- 1. 17e+04 3.27e-02 4.30e-01
- 1. 85e+07 1.19e+09 9.44e+05 1.38e+06 8.77e+06 O.Oe+00 3.18e-06 3.51e-04 4.76e-06 0.OOe+00 8.34e+06 2.76e+09 1.37e+07 O.OOe+00 1.15e-58 5.32e-57 1.75e-58 0.OOe+00 3.59e-01 6.66e+O1 5.98e-01 0.OOe+00 6.29e-17 5.57e-15 9.64e-17 O.OOe+00 1.51e+09 0.OOe+00 4.69e+08 1.68e+08 4.47e+07 0.OOe+00 2.38e+07 3.55e4+06 1.28e+09 0.OOe+00 4.16e+08 1.50e+08 3.85e+04 O.OOe+00 1.25e+04 2.29e+04 1.98e-02 0.OOe+00 0.OOe+00 0.OOe+00 2;23e-92 0.OOe+00 O.OOe+00 0.OOe+00 1.lle+04 0.OOe+00 4.86e+03 0.OOe+00 1.74e+O1 0.OOe+00 7.31e-03 0.OOe+00 7.26e+05 O.OOe+00 4.02e+05 0.00e+00 1.OOe+04 0.OOe+00 5.44e+03 O.OOe+00 9.48e+03 0.OOe+00 5.20e+03 0.00e+00 1.94e-02 0.00e+00 0.OOe+00 O.OOe+00 3.08e-02 0.OOe+00 8.92e-02 0.00e+00 1.98e+06 0.OOe+00 1.75e+06 0.OOe+00 0.OOe+00 0.OOe+00 1.95e+08 O.OOe+00 9.50e+06 1.49e-06 7.43e+05 1.35e-58 1.45e-01 4.79e-17 8.16e+06 1.57e+06 7.99e+06 2.22e+07 5.51e+02 4.42e-87 1.38e+07 2.55e+02 1.89e+08
- 3. 61e+07 1.50e+07 2.72e+00 2.28e+03
- 9. 80e+05 2.79e+07 0.OOe+00 1.14e+06 O.OOe+00 1.64e-06 0.OOe+00 4.74e+06 0.OOe+00 5.27e-59 O.OOe+00 1.36e-01 O.OOe+00 2.97e-17 O.OOe+00 3.19e+08 O.OOe+00 2.89e+07 0.OOe+00 1.88e+08 0.OOe+00 2.56e+06 0.OOe+00 6.66e-03 0.OOe+00 6.99e-93 O.OOe+00 1.65e+03 0.OOe+00 2.52e-03 0.OOe+00 1.24e+05 O.OOe+00 1.66e+03 0.OOe+00 7.34e+02 0.OOe+00 8.69e-03 0.OOe+0O 2.17e-02 O.OOe+00 4.74e+05 0.OOe+00.7.19e+07 I Page 32 of 44
Attachment C ODCM-QA-004 Revision 2 Page 47 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)
,I I Units:
AgeGroup:
Pathway:
Airborne Pathways & Tritium Ingestion: (mrem/yr)/(pC/mA3))
Deposition Pathways: (mA2 * (mren/yr)/(uCVsec)
CHILD Grs/Cow/Milk (CMILK)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 C-14 NA-24 P-32 CR-51 MN-54 MN-56 FE-55 FE-59 CO-58 CO-60 NI-63 NI-65 CU-64 ZN-65 ZN-69 BR-83 BR-84 RB-86 RB-88 RB-89 SR-89 SR-90 SR-91 SR-92 Y-90 Y-91 Y-9lM Y-92 Y-93 ZR-95 ZR-97 NB-95 MO-99 TC-99M TC-101 RU-103 RU-105
- 0. OOe+0(
1.20e+0'
- 8. 88e+OE 1.21e+1(
0.OOe+OC O.OOe+OC 0.OOe+OC 1.12e+OE 1.20e+OE 0.OOe+0C O.OOe+OC 2.97e+1C 1.69e+0O O.OOe+00 4.13e+09 9.95e-12 0.0Oe+00 O.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 6.62e+09 1.12e+11 1.3le+05 2.22e+00 3.23e+02 3.90e+04 2.83e-19 2.56e-04 1.02e+00 3.83e+03 1.92e+00 3.18e+05 O.OOe+00 1.33e+01 1.41e-59 4.28e+03 3.86e-03
) 1.57e+03 9 2.39e+08 68.88e+06 03.64e+09 0.OOe+00 D2.10e+07 D1.31e-02 35.93e+07 I 1;-95e+08 P 1.21e+07 I 4.32e+07 1.59e+09 I 1.59e-01 7.49e+04 1 l.lOe+10 1.44e-11 0.OOe+00 0.OOe+00 8.77e+09 8.34e-45 2.05e-53
- 0.
OOe+00 0.OOe+00 iO.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00 8.42e+02 2.78e-01 1.24e+05 8.14e+07 2.61e+01 1.48e-59
- 0. OOe+00
- 0. OOe+00 1.57e+03 2.39e+08 8.88e+06 0.OOe+00 5.65e+04 0.OOe+00
!O.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.0Oe+00 0.O0e+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.0Oe+00 O.OOe+00 O. OOe+00 0.OOe+00
- 0. OOe+00 0.0Oe+00 0.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.0O0e+00 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+00
- 0. OOe+00 0.00e+00 O. OOe+00 3 1.57e+03 2.39e+08 8.88e+06 0.OOe+00 1.54e+04 l 5.88e+06 1.58e-02 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 1.81e+05 6.94e+09 8.72e-12 IO.OOe+00 IO.OOe+00 0.00e+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.00e+00
- 0. OOe+0O 0.OOe+00 1.21e+03 3.99e-01 1.16e+05 1.74e+08 3.79e+02 2.52e-58 1.08e+04 3.39e-02 1.57e+03 2.39e+08 8.88e+06 0.OOe+00
- 1. 03e+05 0.OOe+00
- 0. OOe+00 3.35e+07 5.64e+07 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00
- 0. OOe+O0 0.OOe+00 0.0Oe+O0 0.OOe+00 0.0Oe+00 0.OOe+00 O.OOe+0O 0.OOe+00
- 0. OOe+0O 1.33e+01 7.80e-60 0.OOe+00 0.OOe+00 1.57e+03 2.39e+08 8.88e+06 2.15e+09 5.40e+06 1.76e+07
- 1. 89e+00 1.lOe+07 2.03e+08 7.07e+07 2.39e+08
- 1. 07e+08
- 1. 94e+O1 3.52e+06
- 1. 93e+09 9.06e-10 0.OOe+0O 0.OOe+0O 5.64e+08 4.09e-46 1.79e-55 2.56e+08 1.51e+09 2.89e+05 4.2Oe+Ol 9.18e+05 5.20e+06 5.54e-16 7.41e+00 1.52e+04 8.79e+05 4.21e+04 2.29e+08 6.74e+07 1.49e+04 4.69e-59 1.lle+05 2.52e+00 0.OOe+00 0.OOe+OO 0.OOe+00 0,OOe+00 O.OOe+O0 0.OOe+OO 0.OOe+O0 0.OOe+OO 0.OOe+0O 0.00e+00 0.OOe+00 0.OOe+00 0.OOe+0O
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00 O.OOe+0O 0.OOe+00 0.OOe+0O
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+O0 0.OOe+00 O.OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+0O 1.57e+03 2.39e+08 8.88e+06 3.00e+09 1.02e+05 5.59e+06 2.95e-03 1.84e+07 9.69e+07 3.71e+07 1.27e+08 1.Ole+09 9.27e-02 4.53e+04 6.85e+09 1.33e-12 4.49e-01 7.09e-23 5.39e+09 5.79e-45 1.83e-53 1.89e+08 2.83e+10 4.95e+03 8.90e-02 8.63e+00 1.04e+03 1.03e-20 7.34e-06 2.79e-02 7.50e+02 1.64e-01 8.85e+04 2.02e+07 4.33e+02 1.87e-58 1.65e+03 1.40e-03
__ s I
I Page 33 of 44
Atachment L ODCM-QA-004 Revision 2 Page 48 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES f
I (Ref.3.9 Ch. 5.2, 5.3)
I Units:
AgeGroup:
Pathway:
Airborne Pathways & Tritium Ingestion: (mrem/yr)/I(.Cilm3))
Deposition Pathways: (mA2 * (mrem/yr)/(pCi/sec)
CHILD Grs/Cow/Milk (CMILK)
Le Liver Thyroid Kidney Lung GI-Lli Nuclide Bor Skin TB RU-106 AG-llOM TE-125M TE-127 TE-127M TE-129 TE-129M TE-131 TE-131M TE-132 1-130 1-131 I-132 I-133 1-134 I-135 CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141 BA-142 LA-140 LA-142 CE-141 CE-143 CE-144 PR-143 PR-144 ND-147 W-187 NP-239 PU-239 U-235 9.24e+04 2.09e+08 7.38e+07 2.99e+03 2.08e+08 1.33e-09 2.71e+08 1.80e-32 1.60e+06 1.03e+07
- 8. 67e+05 6.52e+08 3.5le-01
- 8. 61e+06 4.47e-12 2.72e+04 2.26e+10 1.Ole+09 3.22e+10 4.33e-23 2.08e-07 1.17e+08 2.15e-45 1.50e-79 1.94e+01 8.33e-11 2.19e+04 1.88e+02 1.62e+06 7.18e+02 3.14e-53 4.45e+02 2.89e+04 1.73e+01 5.31e+07 1.41e+10
- 0. 00e+OO 1.41e+08 2.00e+07 8.07e+02 5.60e+07
.3.72e-10 7.58e+07 5.50e-33 5.54e+05 4.54e+06 1.75e+06 6.56e+08 6.46e-01
- 1. 06e+07 8.30e-12 4.89e+04 3.72e+10 2.78e+09 3.09e+10 6.02e-23 1.lle-10 1.03e+05 1.20e-48 1.08e-82 6.79e+00
- 2. 66e-11 1.09e+04
- 1. 02e+05 5.09e+05 2.16e+02 9.70e-54
- 3. 60e+02 1.71e+04 1.24e+00 5.68e+06 O.OOe+O0 O.OOe+0O 1.25e+05 0.OOe+00 0.OOe+00 2.63e+08 0.OOe+O0 2.07e+07 0.OOe+00 0.OOe+O0 2.07e+03 8.51e+03 0.OOe+OO 4.97e+07 5.93e+08 0.OOe+0O 9.52e-10 3.90e-09 0.00e+00 8.75e+07 7.97e+08 O.00e+O0 1.38e-32 5.45e-32 0.OOe+O0 1.14e+06 5.36e+06 0.OOe+00 6.61e+06 4.21e+07 O.00e+00 1.93e+08 2.62e+06 0.00e+00 2.17e+11 1.08e+09 0.00e+00 3.00e+01 9.89e-01 0.00e+00 1.98e+09 1.77e+07 0.00e+00 1.91e-10 1.27e-11 O.OOe+00 4.33e+06 7.50e+04 0.OOe+O0 O.00e+00 1.15e+10 4.13e+09 0.OOe+00 1.48e+09 2.21e+08 0.OOe+00 1.Ole+10 3.62e+09 0.00e+00 4.23e-23 4.56e-24 0.OOe+00 9.68e-11 6.52e-11 O.OOe+O0 3.34e+04 6.12e+04 0.00e+00 1.04e-48 7.07e-48 O.00e+00 8.73e-83 6.35e-83 0.OOe+00 O.OOe+00 0.OOe+00 O.OOe+0O O.OOe+O0 0.OOe+00 O.OOe+OO 4.78e+03 0.00e+00 0.OOe+OO 4.27e+O1 0.00e+0O 0.OOe+00 2.82e+05 O.OOe+00 0.OOe+00 1.17e+02 O.OOe+O0 O.OOe+O0 5.13e-54 0.OOe+00 0.OOe+O0 1.98e+02 0.00e+00 0.OOe+O0 0.00e+O0 0.OOe+00 O.OOe+00 3.59e+00 O.00e+00 0.OOe+00 5.02e+06 0.OOe+O0 O.OOe+O0 2.31e+09 0.00e+OO 1.44e+06 1.68e+10 7.12e+07 1.17e+05 1.69e+08 8.31e-08 3.31e+08 9.47e-32 2.25e+07 4.57e+07 8.19e+05
- 5. 84e+07 7.60e-01 4.29e+06 5.50e-12 3.73e+04 2.00e+08 9.77e+07 1.93e+08 2.77e-23 1.20e-05 5.94e+07 1.22e-45 1.96e-81 1.89e+05 5.27e-06 1.36e+07 1.49e+06
- 1. 33e+08 7.75e+05 2.09e-50 5.71e+05 2.41e+06
-9.18e+04
- 2. 82e+06
-3.30e+08 0.O00e+00 0.00e+O0 0.O00e+00
-0.0O0e+00 0.00e+O0 0.00e+O0 O.O00e+00 0.00e+O0 0.O00e+00
-0.
00e+00 0.00e+O0 O.O00e+O0 0.00e+O0
- 0. 00e+00 O.O00e+00
- 0. 00e+00 0.00e+00 0.O00e+00 0 :00e+00 O.O00e+00
- 0. 00e+00 0.O00e+00
- 0. 00e+00 O.O00e+O0 0.O00e+00 0.O00e+00 0.O00e+00 0.O00e+00 o. 00e+00 0.00e+00 0.00e+O0 0.00e+00 0.00e+00 0.00e+O0 0.00e+00 O.O00e+00 1.15e+04 1.13e+08 9.84e+06 6.41e+02 2.47e+07 3.17e-10 4.21e+07 5.37e-33 5.90e+05 5.48e+06 9.03e+05 3.73e+08 2.97e-01 4.03e+06 3.82e-12 2.32e+04 7.84e+09 1.8Oe+09 4.56e+09 3.82e-23 6.02e-09 6.84e+06 7.00e-47 8.37e-81 2.29e+00 8.32e-12
- 1. 62e+03 1.47e+01 8.66e+04 3.56e+01 1.58e-54 2.79e+O1
.7.69e+03 8.72e-01 1.36e+06 8.52e+08 Page 34 of 44
Attachment (;
ODCM-QA-004 Revision 2 Page 49 of 59*
'I I Units:
DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)
Airborne Pathways & Tritium Ingestion: (mrem/yr)/(pCilmA3))
Deposition Pathways: (mA2 * (mrem/yr)/(pCisec)
CHILD Vegetation (VEG)
AgeGroup:
Pathway:
I Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 C-14 NA-24 P-32 CR-51 MN-54 MN-56 FE-55 FE-59 CO-58 CO-60 NI-63 NI-65 CU-64 ZN-65 ZN-69 BR-83 BR-84 RB-86 RB-88 RB-89 SR-89 SR-90 SR-91 SR-92 Y-90 Y-91 Y-91M Y-92 Y-93 ZR-95 ZR-97 NB-95 MO-99 TC-99M TC-101 RU-103 RU-105 O.OOe+OO 8.89e+08 3.71e+05 5.23e+0 8 0.OOe+OO 0.OOe+0O 0.OOe+OO 8.O1e+08 3.97e+08 0.OOe+OO 0.OOe+OO 3.95e+10 1.02e+02 0.OOe+OO 8.13e+08 8.77e-06 0.OOe+OO O.OOe+OO 0.OOe+0O 0.OOe+OO 0.OOe+OO 3.60e+10 1.24e+12 5.20e+05 7.09e+02 2.31e+04 1.86e+07 8.15e-09 1.55e+00 2.91e+02 3.86e+06 5.68e+02 4.10e+05 0.OOe+OO 4.65e+00 1.03e-30 1.53e+07 9.O0e+01 4.Ole+03 1.78e+08 3.71e+05 1.58e+08 0.OOe+OO 6.65e+08 1.82e+01 4.25e+08 6.43e+08 6.44e+07 3.78e+08 2.12e+09
- 9. 61e+00 l.09e+04 2.17e+09 1.27e-05
- 0. OOe+0O
- 0. OOe+0O 4.52e+08 3.41e-22 1.23e-26
- 0. OOe+00 0.OOe+00 0.OOe+0O 0.OOe+0O 0.OOe+0O 0.0Oe+00 0.OOe+00 O. OOe+00 0.OOe+00 8.48e+05 8.20e+Ol 1.60e+05 7.70e+06 9.13e+00 1.08e-30 0.OOe+0O 0.OOe+00 4.Oe+03 1.78e+08 3.71e+05 0.OOe+00 6.50e+04
- 0.
OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+0O 0.OOe+00
- 0. OOe+0O
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+0O O.00e+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+0O 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 4.Ole+03 1.78e+08 3.71e+05 0.OOe+00 1.78e+04 1.86e+08 2.21e+O0 0.OOe+O0 0.OOe+00 0.OOe+O0 O.OOe+00 0.OOe+00
- 0. OOe+00 2.64e+04 1.36e+09 7.69e-06 O. OOe+00 O. OOe+O0 O. OOe+O0 0.00 e+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+0O
- 0. OOe+00 O.OOe+00 1.21e+06
- 1. 18e+02 1.50e+05 1.65e+07 1.33e+02
- 1. 84e-29 3.86e+07 7.92e+02 4.Ole+03 1.78e+08 3.71e+05 0.OOe+00 1.19e+05 0.OOe+O0
- 0. 00e+00 2.40e+08 1.86e+08 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.0Oe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00 0.0Oe+00 0.0Oe+00 0.0Oe+00 0.OOe+0O 0.OOe+00 0.OOe+O0 0.OOe+00 0.OOe+00 4.63e+00 5.70e-31 0.OOe+0O 0.OOe+00 4.O1e+03 1.78e+08 3.71e+05 9.31e+07 6.21e+06 5.58e+08 2.64e+03 7.87e+07 6.70e+08 3.76e+08 2.10e+09 1.43e+08 1.18e+03 5.13e+05 3.80e+08 7.99e-04 0.OOe+00 0.OOe+00 2.91e+07 1.67e-23 1.07e-28 1.39e+09 1.68e+10
- 1. 15e+06 1.34e+04 6.56e+07 2.48e+09
- 1. 60e-05 4.48e+04 4.34e+06 8.84e+08 1.24e+07 2.95e+08 6.37e+06 5.19e+03 3.43e-30 3.96e+08
- 5. 88e+04 O.00e+00 0.0Oe+0O 0.OOe+O0 0.OOe+00 O.OOe+OO 0.OOe+0O 0.OOe+00 0.OOe+00 0.OOe+0O 0.OOe+00 0.OOe+00 O.OOe+O0 O.OOe+00 0.OOe+00 0.OOe+00 0.OOe+OO 0.OOe+00 0.OOe+00 0.OOe+O0 0.OOe+00 O.OOe+00 O.OOe+00 0.OOe+0O 0.OOe+00 0.OOe+00 0.OOe+O0 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+0O 0.OOe+00 O. OOe+00 0.OOe+00 0.OOe+00 4.Ole+03 1.78e+08 3.71e+05 1.30e+08 1.17e+05 1.77e+08 4.12e+00 1.32e+08 3.20e+08 1.97e+08 1.12e+09 1.35e+09 5.61e+00
- 6. 60e+03 1.35e+09 1.17e-06 5.21e+00 3.33e-11 2.78e+08 2.37e-22 l.09e-26 1.03e+09 3.15e+11 1.96e+04 2.84e+01 6.17e+02 4.99e+05 2.97e-10
- 4. 44e-02 7.99e+00 7.55e+05 4.84e+01 1.14e+05 l.91e+06 1.51e+02 1.37e-29 5.89e+06 3.27e+01 I Page 35 of 44
ODCM-QA-004 Revision 2 I
.Page 50 of 59
^ DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES I
(Ref.3.9 Ch. 5.2, 5.3)
Units:
AgeGroup:
Pathway:
Airbome Pathways & Tritium Ingestion: (mrem/yr)/(CuCnIA3))
Deposition Pathways: (mA2 * (mren/yr)(u/CVsec)
CHILD Vegetation (VEG)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-106 AG-llOM TE-125M TE-127 TE-127M TE-129 TE-129M TE-131 TE-131M TE-132 1-130 I-131' I-132 I-133 I-134 I-135 CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141' BA-142, LA-140 -
LA-142 CE-141 CE-143 CE-144 PR-143, PR-144 ND-147 W-187 NP-239 PU-239 U-235 7.45e+08 O.OOe+OO O.OOe+00 'l.Ole+09 O.OOe+0 1.16e+10 3.21e+07'2.17e+07 0.00e+00-4.04e+07 O.OOe+OO 2.58e+09 3.50e+08 9.50e+07 9.84e+07 O.OOe+OO 0.OOe+O0 3.38e+08 9.77e+03 2.64e+03 6.76e+03 2.78e+04 O.OOe+00,3.82e+05 1.32e+09 3.5 6 e+08 3.16e+08 3.77e+09 O.OOe+OO 1.07e+09 1.24e-03 3.46e-04 8.85e-04 3.63e-03--0.OOe+00 7.72e-02 8.41e+08 2.35e+08 2.71e+08'2.47e+09 0.OOe+OO 1.03e+09 2.15e-15 6.-57e-16 1.65e-15 6.51e-15 O.OOe+O0 1.13e-14 1.54e+06 5.32e+05 1.09e+06 5.15e+06 0.'00e+00 2.16e+07 7:00e+06 3.10e+06 4.51e+06 2.88e+07 0.OOe+00-3.12e+07 3.06e+05 6.18e+05 6.81e+07 9.24e+05 O.OOe+00 2.89e+05 7.14e+07 7:19e+07 2.38e+10 1.18e+08 0.OOe+OO 6 140e+06-4.46e+O1 8.20e+01 3.81e+03 1.26e+02 0.OOe+OO 9.66e+O1 1.76e+06 2.18e+06 4.04e+08 '3.63e+06 O.OOe+00 8.77e+05 7.13e-05 1.32e-04-3.05e-03 2.02e-04 O.0Oe+00'8.78e-05 3.09e+04 5.57e+04 4.93e+06 8.54e+04 O!OOe+0O 4.24e+04 1.60e+1° 2.63e+10 0.OOe+00 8.15e+09 2.93e+09 1.42e+08 8.24e+07 2.26e+08 0.OOe+00 1.21e+08 1.80e+07 7.96e+06 2.39e+10 2.29e+10 O.'OOe+O0 7.46e+09 2.69e+09 1.43e+08 5.73e-11 7.97e-11 0.OOe+00 5.60e-11 6.03e-12 3.67e-11 4.70e-02 2.51e-05 O.OOe+00 2.19e-05 1.47e-05 '2.71e+00 O.OOe+OO 9.30e+07 0.00e+00'1.73e+07 0.OOe+00 4.67e+07 O.OOe+OO 2.10e+03 O.OOe+OO 1.57e+08 0.OOe+0O 2.95e-04 O.OOe+OO 1.31e+08 0.OOe+OO 6.41e-16 O.OOe+00 5.66e+05 0.OOe+00 3.74e+06-O.OOe+OO 3.19e+05-O.OOe+O0 4.08e+07 O.OOe+0O 3.77e+O1 0.OOe+OO 8.24e+05 0.OOe+OO 6.09e O.OOe+O0 2.63e+04 0.OOe+O0 5.55e+09 O.OOe+OO 1.47e+08 0.OOe+OO 3.38e+09 0.OOe+O0 5.05e-11 O.OOe+OO 1.36e-03 O.'OOe+00 1.61e+07 0.OOe+OO 5.08e-23 0.OOe+0O 3.68e-40 0.OOe+00'3.82e+02 0.OOe+OO 3.20e-05 0.OOe+0O 4.86e+04' 0.OOe+00-1.35e+02-0.OOe+00 6.78e+06 0.OOe+00 7.22e+03 0.OOe+0O 2.10e-27 O.OOe+00 4.48e+03 O.0Oe+00 1.71e+04 O.OOe+00 1.29e+02 O.OOe+OO 2.43e+09 O.OOe+00.1.52e+10
- 2.77e+0 8
1.56e-21
- 6. 60e-39 3.24e+03 3.21e-04 6.56e+05 1.71e+03 1.27e+08 1.46e+05 4.17e-26 7.14e+04
'6.
42e+04 2.56e+03 9.48e+10 2.51e+11 2.42e+05 8.74e-25 4.75e-42
'1.13e+03 1.02e-04 3.27e+05 9.29e+05 3.98e+07 4.37e+04 1.29e-26 5.79e+04 3.80e+04 1.84e+02 1.Ole+10 0.0Oe+OO 0.00e+00-7.89e+04 0.00e+00-7.56e-25 0.00e+00 3.84e-42 0.00e+00-0.00e+00 o. 00e+00 o0.00e+00
- 0. 00e+O0 0.O00e+00 0.O00e+00
- 0. 00e+O0 0.O00e+00 0.00e+00 0-. 0e+00 0.00e+00 0.00e+00 O.OOe+00 1.43e+05 3.90e+02 2.21e+07 2.37e+04 6.81e-27 3.17e+04
- 0. OOe+OO
,5.3le+02 8.97e+09 4.12e+10 1.44e+05 5.14e-24 2.79e-42 o0.00e+00-0.00e+00 O.
00e+00 o. 00e+00 0.O00e+O0
-0.00e+00 0.00e+00 0.00e+00
- 0. 00e+00 0.O00e+00 0.00e+00 0.00e+00 1.40e+08 8.90e-22 8.60e-41 3.16e+07 2.03e+01 4.08e+08 1.36e+07 1.04e+10 1.57e+08 2.77e-23 9.16e+07 5.34e+06 1.36e+07
- 5. 04e+09 5.90e+09 Page 36 of 44
Attacnment L; ODCM-QA-004 Revision 2 Page 51 of 59 Al""WI Units:
AgeGroup:
Pathway:
DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)
Airborne Pathways & Tritium Ingestion: (mrernyr)l(uCVmA3))
Deposition Pathways: (mA2 * (mrenmyr)/(uCVsec)
INFANT Grs/GoatVMilk (GMILK)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 C-14 NA-24 P-32 CR-51 MN-54 MN-5 6 FE-55 FE-59 CO-58 CO-60 NI-63 NI-65 CU-64 ZN-65 ZN-69 BR-83 BR-84 RB-86 RB-88 RB-89 SR-89 SR-90 SR-91 SR-92 Y-90 Y-91 Y-91M Y-92 Y-93 ZR-95 ZR-97 NB-95 MO-99 TC-99M TC-101 RU-103 RU-105 O.OOe+OO 2.34e+09 1.86e+06 1.92e+1l O.OOe+OO O. OOe+OO 0.OOe+OO 1.76e+06 2.92e+06 O.OOe+OO
- 0. OOe+OO 4.19e+09 4.28e-01 0.OOe+OO 6.66e+08 2.54e-12 O.OOe+OO 0.OOe+OO 0.OOe+OO 0.OOe+OO O.OOe+OO 2.64e+10 2.55e+11 5.73e+05 9.91e+00 8.18e+0l 8.79e+03 I 7.20e-20 t 6.54e-05 2.60e-01 8.17e+02 I 4.89e-01 E 7.12e+04 2 0.OOe+0O 2 3.32e+00 6 3.59e-60 4 1.04e+03 0 9.77e-04 0 4.86e+03
- 5. 00e+08 1.86e+06 1.13e+10 0.OOe+00 4.68e+06
.3.84e-03 1.14e+06 5.10e+06 2.91e+06 1.06e+07 2.59e+08 4.85e-02 2.08e+04 2.29e+09 4.58e-12 0.OOe+00 O. 00e+OO 2.67e+09 2.62e-45 6.02e-54 O.OOe+O0 0.0Oe+O0 O.OOe+00
- 0. OOe+00 D.OOe+00 O.OOe+00 O.OOe+00
).OOe+00
).00e+00
- l.
99e+02 3.39e-02 2.93e+04 250e+07 6.85e+00
.52e-60 OOe+0O
.OOe+00 4.86e+03 5.00e+08 1.86e+06 0.OOe+00 1.26e+04 0.OOe+0O 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+OO 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+0O 0.OOe+0O 0.00e+OO 0.OOe+O0 0.OOe+0O 0.0Oe+00 0.0Oe+OO 0.OOe+00 0.OOe+00 0.0Oe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.0Oe+00
- 0. OOe+00 0.0Oe+0O O.OOe+00 O.OOe+0O O.OOe+00 O.OOe+00 O.OOe+00
).OOe+00 4.86e+03 5.00e+08 1.86e+06 0.OOe+00
,2.76e+03 1.04e+06 3.30e-03 0.OOe+00 0.00e+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 3.51e+04 1.lle+09 1.90e-12 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.0Oe+00 0.0Oe+00 0.OOe+00 0.OOe+00 0.OOe+00 2.15e+02 8.46e-02 2.10e+04 3.73e+07 7.37e+01 5.37e-59 2.17e+03 7.18e-03 4.86e+03
- 5. 00e+08 1.86e+06 0.OOe+00 2.46e+04 0.OOe+00 0.OOe+00 5.55e+05 1.51e+06
- 0. OOe+00 0.OOe+00
- 0. OOe+00 O.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+0O
- 0. OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 3.58e+00 2.47e-60 0.OOe+00 0.OOe+00 4.86e+03 5.00e+08
- 1. 86e+06 2.60e+09 5.64e+05 1.72e+06 3.49e-01 1.44e+05 2.43e+06 7.25e+06 2.52e+07 1.29e+07 3.69e+00 4.26e+05 1.93e+09 3.73e-10
- 0. 00e+00 0.OOe+00 6.84e+07 2.55e-45 2.05e-54 5.43e+08 3.19e+09 6.79e+05 1.07e+02 1.13e+05 6.30e+05 2.40e-16 1.25e+00 2.05e+03 9.91e+04 5.35e+03 2.48e+07 8.23e+06 1.99e+03 7.68e-58 1.27e+04 3.89e-01 0.OOe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00
- 0.
OOe+00 0.0Oe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+O0 0.OOe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 O.OOe+00
- 0. OOe+00 O.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 4.86e+03 5.00e+08 1.86e+06 7.46e+09 1.94e+04 1.06e+06 6.62e-04 3.03e+05 2.Ole+06 7.26e+06 2.50e+07 1.46e+08 2.21e-02
- 9. 61e+03 1.05e+09 3.41e-13
- 1. 14e-01
- 1. 64e-23
- 1. 32e+09 1.44e-45 4.15e-54 7.58e+08 6.50e+10 2.08e+04
- 3. 68e-01 2.19e+00 2.34e+02 2.45e-21
- 1. 84e-06 7.08e-03 1.41e+02 3.83e-02 1.70e+04 4.87e+06 8.83e+01 4.47e-59 3.48e+02 3.29e-04 I Page 37 of 44
Auacnl L
ODCM-QA-004 Revision 2 Page 52 of 59 I
DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)
Units:
AgeGroup:
Pathway:
Airborne Pathways & Tritium Ingestion: (mrem/yr)/(uCVmA3))
Deposition Pathways: (m'2 * (mrern/yr)/(uCVsec)
INFANT Grs/GoatlMilk (GMILK)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-106 AG-lilOM TE-125M TE-127 TE-127M TE-129 TE-129M TE-131 TE-131M TE-132 1-130 1-131 1-132 1-133 1-134 1-135 CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141 BA-142 LA-140 LA-142 CE-141 CE-143 CE-144 PR-143 PR-144 ND-147 W-187 NP-239 PU-239 U-235 2.28e+04 0.OOe+OI 4.63e+07 3.38e+O' 1.81e+07 6.05e+Ol 7.62e+02 2.55e+0; 5.05e+07 1.68e+0, 3.39e-10 1.17e-1l 6.69e+07 2.29e+0 4.59e-33 1.69e-3 4.06e+05 1.63e+0' 2.53e+06 1.26e+0(
2.14e+06 4.70e+O(
1.63e+09 1.92e+05 8.75e-01 1.78e+0(
2.18e+07 3.18e+07 1.lle-ll 2.28e-11 6.79e+04 1.35e+05 1.O9e+11 2.04e+11 5.93e+09 1.74e+0C 1.54e+1l 1.81e+11 2.74e-22 4.45e-22 5.30e-08 3.5ie-11 2.89e+07 2. 89e+04 5.48e-46 3.75e749 3.79e-80 3.15e-83 4.87e+00 1.92e+00 2.10e-11 7.71e-12 5.20e+03 3.17e+03 4.77e+01 3.17e+04 2.79e+05 1.14e+05 1.78e+02 6.67e+O0 8.00e-54 3.09e-54 1.06e+02 1.09e+02 7.31e+03 5.08e+03 4.38e+00 3.92e-01 6.81e+06 7.65e+05 2.31e+09 0.OOe+00 0
7 2
7 7
- 0. OOe+00 0.OOe+00 6.09e+06 6.20e+02 1.46e+07 2.84e-10 2.57e+07 4.09e-33 3.31e+05 1z.
85e+06 5.27e+08 6.32e+11 8.33e+01 5.78e+09 5.3le-10 1.21e+07 0.OOe+00 O.OOe+OO O.OOe+00 O.OOe+00 2.70e+04 4.84e+07 0.00e+00 1.8 6e+03 1.24e+08 8:45e-10
- 1. 67e+08 1.17e 32 1.12e+06 7.85e-t06 5.17e+06 2.25e+09 1.98e+00 3.73e+07 2.55e-11 1.50e+05 5.25e+10 6.95e'+09
- 4. 85e+10' 2.22e-22 0.OOe+O0 0.OOe+00 0.OOe+00 0.OOe+O0
- 0. OOe+00 0.OOe+O0 0.OOe+00 0.OOe+O0 0.OOe+O0
- 0. OOe+00 0.OOe+00 O.OOe+00 O.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 2.15e+10 1.42e+09 1.96e+10 3.47e-23, 2.13e'-11 1.78e+04 2.28e-49 1.91e-83 0.OOe+00
- 0. OOe+00-0.OOe+00 0.OOe+00 0.OOe+0OO 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+O0
- 0. OOe+0O 0.OOe+O0 0.OOe+00 1.73e+05 1.75e+09 8.62e+06 1.60e+04 2.04e+07 2.71e-08 3.99e+07 1.85e-31 2.75e+06 4.64e+06 l.Ole+06 6.87e+07 1.44e+00 5.37e+06 2.35e-11 4.88e+04 5.54e+08 2.65e+08 5.65e+08 7.12e-22 3.36e-06 7.11e+06 6.69e-45 1.56e-79 2.26e+04 1.31e-06 1.64e+06 1.85e+05 1.60e+07 9.41e+04 1.44e-49 6.89e+04 2.99e+05 1.13e+04 3.41e+05 4.00e+07 0.OOe+OO 0.OOe+00 0.0 Oe+OO 0.OOe+O0 O.OOe+O0 0.OOe+O0 0.OOe+OO 0.OOe+O0 0.OOe+OO 0.OOe+OO 0.OOe+O0 0.OOe+O0 O.OOe+O0 0.OOe+O0 O.OOe+OO O.OOe+00 O.OOe+00 O.OOe+OO 0.OOe+0O O.OOe+00 O.OOe+00 O.OOe+O0 O.OOe+00 O.OOe+O0 O.OOe+O0 0.OOe+0O 0.OOe+O0 0.OOe+O0 0.OOe+0O
- 0. OOe+00 0.OOe+00 O.OOe+0O 0.OOe+0O 0.OOe+OO 0.OOe+O0 O. OOe+0O 2.85e+03 2.24e+07 2.45e+06 1.64e+02 6.12e+06 7.92e-11 1.03e+07 1.29e-33 1.35e+05 1.17e+06 1.89e+06 8.46e+08 6.33e-01 9.30e+06 8.10e-12 4.92e+04 2.06e+10 6.51e+09 1.28e+10 2.16e-22 1.53e-09 1.49e+06 1.73e-47 1.87e-81 4.94e-01 1.85e-12 3.74e+02 3.61e+00 1.56e+04 8.84e+00 4.03e-55 6.66e+00 1.76e+03 2.21e-O1 1.75e+05 1.76e+08, O.OOe+00-2.l1e-11 O.00e+00 6.87e+03 0.OOe+00 2.26e-49 0.OOe+O0 1.81e-83 0.OOe+000.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00 9.79e+02 0.OOe+00 9.22e+00 0.OOe+00 4.62e+04 O.OOe+00 2.48e+01 0.OOe+00 1.12e-54 O.00e+OO 4.19e+01 0.OOe+00 0.OOe+00
,0.OOe+00 7.81e-01 0.OOe+O0 6.32e+05 0.OOe+00 4.90e+08 l Page 38 of 44
Attachment C ODCM-QA-004 Revision 2 Page 53 of 59 I
Units:
DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)
\\
Airborne Pathways & Tritium Ingestion: (mrerr/yr)/(uCi/mA3))
Deposition Pathways: (mA2 * (mremlyr)/(uCisec)
INFANT Ground Plane Deposition (GPD)
AgeGroup:
Pathway:
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB NA-24 CR-51 MN-54 MN-56 FE-59 CO-58 CO-60 NI-65 CU-64 ZN-65 BR-83 BR-84 RB-86 RB-88 RB-89 SR-89 SR-91 SR-92 Y-90 Y-91 Y-91M Y-92 Y-93 ZR-95 ZR-97 NB-95 MO-99 TC-99M TC-101 RU-103 RU-105 RU-106 AG-llOM TE-125M TE-127 TE-127M TE-129 TE-129M 1.20e+0 '
4.66e+0(
1.3 9e+O0 9.04e+0' 2.72e+OE 3.79e+0E 2.15e+1C 2.97e+O0 6.07e+O0 7..47e+0E 4.87e+03
- 2. 03e+05 8.99e+06 3.3le+04 1.21e+05 2.16e+04 2.15e+06 7.77e+05 4.49e+03 1.07e+06 1.OOe+05 1.80e+05 1.83e+05 2.45e+08 2.96e+06 1.37e+08
- 4. 00e+06 1.84e+05 2.04e+04 1.08e+08-6.37e+05 4.22e+08 3.44e+09 1.55e+06 2.98e+03 9.17e+04
- 2. 62e+04 1.98e+07 7 1.20e+0O 5 4.66e+OE 91.39e+05 59.04e+05 B2.72e+OE B3.79e+08
)2.15e+1C
- 2.97e+05
- 6.07e+05 37.47e+08 4.87e+03 2.03e+05 8.99e+06 3.31e+04 1.21e+05 2.16e+04
- 2. 15e+06 7.77e+05 4.49e+03 1.07e+06 1.OOe+05 1.80e+05 1.83e+05 2.45e+08 2.96e+06 1.37e+08 4.00e+06 1.84e+05 2.04e+04 1.08e+08 6.37e+05 4.22e+08 3.44e+09 1.55e+06 2.98e+03 9.17e+04 2.62e+04 1.98e+07 71.20e+07 64.66e+OE 3 1.39e+09 i9.04e+05 32.72e+08 33.79e+08 I 2.15e+10 2.97e+05 6.07e+05 7.47e+08 4.87e+03 2.03e+05 8.99e+06 3.31e+04 1.21e+05 2.16e+04 2.15e+06 7.77e+05 4.49e+03 1.07e+06 1.0Oe+05 1.80e+05 1.83e+05 2.45e+08 2.96e+06 1.37e+08
- 4. 00e+06 1.84e+05 2.04e+04 1.08e+08 6.37e+05 4.22e+08 3.44e+09 1.55e+06 2.98e+03 9.17e+04 2.62e+04 1.98e+07 1.20e+07 4.66e+06 3 1.39e+09 9.04e+05 2.72e+08 3.79e+08 2.15e+10 2.97e+05 6.07e+05 7.47e+08 4.87e+03 2.03e+05 8.99e+06 3.3le+04 1.21e+05 2.16e+04 2.15e+06 7.77e+05 4.49e+03 1.07e+06 1.OOe+05 1.80e+05 1.83e+05 2.45e+08 2.96e+06 1.37e+08
- 4. 00e+06 1.84e+05 2.04e+04 1.08e+08 6.37e+05 4.22e+08 3.44e+09 1.55e+06 2.98e+03 9.17e+04
- 2. 62e+04 1.98e+07 1.20e+07 4.66e+06 1.39e+09 9.04e+05 2.72e+08 3.79e+08 2.15e+10 2.97e+05 6.07e+05 7.47e+08 4.87e+03 2.03e+05 8.99e+06 3.31e+04 1.21e+05 2.16e+04 2.15e+06 7.77e+05 4.49e+03
- 1. 07e+06 1.OOe+05 1.80e+05 1.83e+05 2.45e+08 2.96e+06 1.37e+08 4.00e+06 1.84e+05 2.04e+04
- 1. 08e+08 6.37e+05 4.22e+08 3.44e+09 1.55e+06 2.98e+03 9.17e+04
- 2. 62e+04 1.98e+07 1.20e+07
- 4. 66e+06 1.39e+09 9.04e+05 2.72e+08 3.79e+08 2.15e+10 2.97e+05 6.07e+05 7.47e+08 4.87e+03
- 2. 03e+05 8.99e+06 3.31e+04 1.21e+05 2.16e+04 2.15e+06 7.77e+05 4.49e+03
- 1. 07e+06
- 1. 0Oe+05
- 1. 80e+05
- 1. 83e+05 2.45e+08 2.96e+06 1.37e+08
- 4. 00e+06
- 1. 84e+05 2.04e+04
- 1. 08e+08 6.37e+05 4.22e+08 3.44e+09 1.55e+06 2.98e+03 9.17e+04 2.62e+04 1.98e+07 1.39e+07 5.51e+06 1.63e+09 1.07e+06 3.20e+08 4.44e+08 2.53e+10 3.45e+05 6.88e+05 8.60e+08 7.08e+03 2.36e+05
- 1. 03e+07 3.78e+04 1.45e+05 2.51e+04 2.51e+06 8.63e+05 5.31e+03 1.21e+06 1.16e+05 2.14e+05 2.51e+05 2.84e+08 3.45e+06 1.61e+08 4.63e+06 2.11e+05 2.26e+04 1.26e+08 7.21e+05 5.07e+08 4.Ole+09 2.13e+06 3.28e+03 1.08e+05 3.10e+04 2.31e+07 1.20e+07 4.66e+06 1.39e+09 9.04e+05 2.72e+08 3.79e+08 2.15e+10 2.97e+05 6.07e+05 7.47e+08 4.87e+03 2.03e+05 8.99e+06 3.31e+04 1.21e+05 2.16e+04 2.15e+06 7.77e+05 4.49e+03 1.07e+06 1.OOe+05 1.80e+05 1.83e+05 2.45e+08 2.96e+06 1.37e+08 4.00e+06 1.84e+05 2.04e+04
- 1. 08e+08 6.37e+05 4.22e+08 3.44e+09 1.55e+06 2.98e+03 9.17e+04
- 2. 62e+04 1.98e+07 I Page 39 of 44
Atracnmeni u ODCM-QA-004 Revision 2 Page 54 of 59 I
I Units:
DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2,15.3)
Airborne Pathways & Tritium Ingestion: (mrem/yr)/(,uCimA3))
Deposition Pathways: (mA2 * (mrem/yr)/(uCVsec)
INFANT Ground Plane Deposition (GPD)
AgeGroup:
Pathway:
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli.
Skin TB TE-131 TE-131M TE-132 1-130 1-131 1-132 1-133 1-134 1-135 CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141-BA-142 LA-140 LA-142 CE-141 CE-143 CE-144 PR-144 ND-147 W-187 NP-239 PU-239 U-235 2.92e+0 4 8.03e+0 6 4.24e+06 5.51e+0 6 1.72e+07
,1.
25e+06 2.45e+06 4.47e+05 2.53e+06 6.8 6e+09 1.51e+08 1.03e+10 3.59e+05 1.0 6e+05 2. 05e4-07 4.17e+04 4.49e+04 1.92e+07.
7.60e+05 1.3 7e+07 2.,31L-+06 6.95e+07
- 1. 84e+03 8.39e+06 2.35e+06 1.71e+06 2.29e+06 9.2 8e+09 2.92e+04 8.03e+06 4.24e+06 5.51e+06 1.-72e+07 1.25e+06 2.45e+06 4.47e+05 2.53e+06 6.86e+09 1.51e+08 1.03e+10 3.59e+05 1.06e+05 2.05e+07 4.17e+04 4.49e+04 1.92e+07 7.60e+05 1.37e+07 2.31e+06 6.95e+07 1.84e+03 8.39e+06 2.35e+06 1.71e+06 2.29e+06 9.28e+09 2.92e+04-2.92e+04 2.92e+04 8.03e+06'8.03e+06 8.03e+06 4.24e+06'4.24e+06 4.24e+06 5.51e+06 5.51e+06 5.51e+06 1.72e+07 1.72e+07 1.72e+07 1.25e+06-1.25e+06 1.25e+06 2.45e+06 2.45e+06'2.45e+06 4.47e+05 4.47e+05 4.47e+05 2.53e+06 2.53e+06 2.53e+06 6.86e+09 6.86e+09 6.86e+09 1.5le+08 1.51e+08 1.51e+08 1.03e+10 1.03e+10 1.03e+10 3.59e+05 3.59e+05 3.59e+05 1.06e+05 1.06e+05 1.06e+05 2.05e+07 2.05e+07 2.05e+07 4.17e+04 4.17e+04'4.17e+04 4.49e+04 4.49e+04 4.49e+04 1.92e+07 1.92e+07 1.92e+07 7.60e+05 7.60e+05 7.60e+05 1.37e+07 1.37e+07 1.37e+07 2.31e+06 2.31e+06 2.31e+06 6.95e+07 6.95e+07 6.95e+07 1.84e+03 1.84e+03 1.84e+03 8.39e+06 8.39e+06 8.39e+06 2.35e+06 2.35e+06 2.35e+06 1.71e+06 1.71e+06 1.71e+06 2.29e+06 2.29e+06 2.29e+06 9.28e+09 9.28e+09 9.28e+09 2.92e+04 8.03e+06 4.24e+06 5.51e+06 1.72e+07 1.25e+06 2.45e+06 4.47e+05 2.53e+06 6.86e+09 1.51e+08 1.03e+10 3.59e+05 1.06e+05 2.05e+07 4.17e+04 4.49e+04 1.92e+07 7.60e+05 1.37e+07 2.31e+06 6.95e+07 1.84e+03 8.39e+06 2.35e+06 1.71e+06 i2.29e+06 9.28e+09 3.45e+07 9.46e+06 4.98e+06 6.69e+06 2.09e+07 1.47e+06 2.98e+06 5.31e+05 2.95e+06 8.00e+09 1.71e+08 1.20e+10 4.10e+05 1.19e+05 2.35e+07 4.75e+04 5.11e+04 2.18e+07 9.12e+05 1.54e+07 2.63e+06
-8.04e+07
-2.11e+03 1.Ole+07 2.73e+06 1.98e+06
-2.23e+07 1.16e+10 2.92e+04 8.03e+06 4.24e+06 5.51e+06 1.72e+07 1.25e+06 2.45e+06 4.47e+05 2.53e+06 6.86e+09 1.51e+08 1.03e+10 3.59e+05 1.06e+05 2.05e+07 4.17e+04 4.49e+04 1.92e+07 7.60e+05 1.37e+07
-2.31e+06 6.95e+07 1.84e+03 8.39e+06 2.35e+06 1.71e+06 2.29e+06 9.28e+09 a
lPage 40 of 44
Attachment C ODCM-QA-004 Revision 2 Page 55 of 59 I Units:
AgeGroup:
Pathway:
DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 5.2, 5.3)
Airborne Pathways & Tritium Ingestion: (mrem/yr)l(pCuVmA3))
Deposition Pathways: (mA2 * (mrem/yr)/(uCfsec)
INFANT Inhalation (INHL)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 C-14 NA-24 P-32 CR-51 MN-54 MN-56 FE-55 FE-59 CO-58 CO-60 NI-63 NI-65 CU-64 ZN-65 ZN-69 BR-83 BR-84.
BR-85 RB-86 RB-88 RB-89 SR-89 SR-90 SR-91 SR-92 Y-90 Y-91 Y-91M Y-92 Y-93 ZR-95 ZR-97 NB-95 MO-99 TC-99M TC-101 RU-103 O.t0e+0 2.65e+0' 1.06e+02 2.03e+01
- 0. OOe+Ol 0.OOe+0O 0.OOe+0O 1.97e+0' 1.36e+04
- 0. OOe+O(
0.OOe+O(
3.39e+05 2.39e+0C 0.OOe+OC 1.93e+04 5.39e-02
- 0. OOe+OC
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. 00e+00 3.98e+05
- 4. 09e+07 9.56e+01 1.05e+01 3.29e+03 5.88e+05 4.07e-01
- 1. 64e+01 1.50e+02 1.15e+05 1.50e+02 1.57e+04 0.OOe+00 1.40e-03 6.51e-05 2.02e+03 0 6.47e+0; 4 5.31e+0.
4 1.06e+02 6 1.12e+0!
)0.OOe+O(
0 2.53e+04
) 1.54e+0(
1 1.18e+04 4 2.35e+04 01.22e+03 08.02e+03 52.04e+04
)2.84e-01 I1.88e+OC a 6.26e+04 9.67e-02 0 O.OOe+00 0 O.OOe+00 0.OOe+00 1.90e+05 5.57e+02 3.21e+02 0.OOe+00 0.OOe+00 0.00e+00 0.OOe+00 0.00e+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 2.79e+04 2.56e+01 6.43e+03 1.65e+02 2.88e-03 8.23e-05 0.OOe+00 6.47e+02 6.47e+02 5.31e+03-5.31e+03 I 1.06e+04 5 0.OOe+OC 05.75e+03 I 0.OOe+OC
)O 0.OOe+OC I 0.00e+OC I 0.OOe+OC I 0.OOe+00 0.OOe+00 0.OOe+00 LO.OOe+00 0.OOe+00 0.OOe+00
- 0.
OOe+00 0.OOe+00
- 0.
OOe+00 0.0Oe+00
- i.
OOOe+00 0.OOe+00
- 0.
OOe+00 0.OOe+00 0.OOe+00
- 0. O.e+00
- 0. O.e+00 0.OOe +00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.0O0e+00 0.OOe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00 I 1.06e+04 0.OOe+00 1.32e+01 I 4.98e+03 I 1.lOe+00 I0.OOe+00 I 0.OOe+00 0.00e+00 0.OOe+00
- 0.
OOe+00
- 0.
OOe+00 3.98e+00 3.25e+04 4.02e-02
- 0.
OOe+00 I. OOOe+00 0.OOe+00
- 0.
OOe+00
- 0.
OOe+00
- 0. 00e+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+O0
- 0. OOe+00 0.OOe+00
- 0. OOe+00 O. OOe+00 0.OOe+00 3.11e+04 2.59e+01 4.72e+03 2.65e+02 3.lle-02 9.79e-04 4.24e+03 6.47e+02 5.31e+03 1.06e+04 0.OOe+00 1.28e+04
- 1. OOe+06 1.25e+04 8.69e+04 1.02e+06 7.77e+05 4.51e+06 2.09e+05 8.12e+03 9.30e+03 6.47e+05 1.47e+03
- 0. OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 2.03e+06 1.12e+07 5.26e+04 2.38e+04
- 2. 69e+05 2.45e+06 2.79e+03 2.45e+04
- 7. 64e+04 1.75e+06 1.lOe+05 4.79e+05 1.35e+05 8.11e+02 5.84e+02 5.52e+05 6.47e+02 5.31e+03 1.06e+04 1.61e+04 3.57e+02 7.06e+03 7.17e+04 1.lOe+03 2.48e+04
- 1. lle+04 3.19e+04 2.42e+03
- 5. Ole+04 1.50e+04
- 5. 14e+04 1.32e+04
- 0. OOe+00 0.OOe+00
- 0. OOe+00 3.04e+03 3.39e+02 6.82e+01 6.40e+04 1.31e+05 7.34e+04 1.40e+05
- 1. 04e+05 7.03e+04 2.35e+03 1.27e+05 1.67e+05 2.17e+04 1.40e+05 1.27e+04 4.87e+04 2.03e+03 8.44e+02 1.61e+04 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+0O 0.OOe+00 0.OOe+00 0.OOe+O0 0.OOe+0O 0.OOe+0O 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+O0 0.OOe+00 0.OOe+00 0.OOe+O0 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.00e+00 0.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+O0 0.OOe+00 0.OOe+O0 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 6.47e+02 5.31e+03 1.06e+04 7.74e+04 8.95e+01 4.98e+03 2.2le-01 3.33e+03 9.48e+03 1.82e+03 1.18e+04 1.16e+04 1.23e-01 7.74e-01 3.11e+04 7.18e-03 3.81e+02 4.00e+02 2.04e+01 8.82e+04 2.87e+02 2.06e+02 1.14e+04 2.59e+06 3.46e+00 3.91e-01 8.82e+01 1.57e+04 1.39e-02 4.6le-01 4.07e+00 2.03e+04 1.17e+01 3.78e+03 3.23e+01 3.72e-02 8.12e-04 6.79e+02 I Page 41 of 44
Altacn~nmenv ODCM-QA-004 Revision 2 Page 56 of 59 n!DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES L I
~(Ref.3.9 Ch. 5.2, 5.3)
I Units:
Airborne Pathways & Tritium Ingestion: (mrem/yr)I(pCVmA3))
Deposition Pathways: (m"2 * (mrenmfyr)/(pCisec)
INFANT Inhalation (INHL)
AgeGrOUP:
Pathway:
I Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB I
I e---
RU-105 RU-106 AG-llOM TE-125M TE-127 TE-127M TE-129 TE-129M TE-131 TE-131M TE-132 I-130 I-131 1-132 I-133 I-134 I-135 CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141 BA-142 LA-140 LA-142 CE-141 CE-143 CE-144 PR-143 PR-144 ND-147 W-187 NP-239 PU-239 U-235 1.22e+00 8.68e+04 0.O00e+00 IO
.'00e+00 9.98e+03 7.22e+03 4.76e+03 1.99e+03 2.23e+00 9.53e-01 1.67e+04,6.90e+03 7.88e-02 3.47e-02 1.41e+04 6.09e+03 1.74e-02 8.22e-03 1.07e+02 5.50e+01 3.72e+02 2.37e+02 6.36e+03 1.39e+04 3.79e+0 4 4.44e+04 1.69e+03 3.54e+03 1.32e+04 1.92e+04 9.21e+02.1.88e+03 3.86e+03 7.60e+03 3.96e+05 7.'03e+05 0.00~e+00 0.06+O00 0.00e+O0
- 1. 62e+03
- 1. 85e+00 I4.87e+03 4.83e+04 5.49e4-05 5.05e4-0 2 1.48e+00 5.60e+04
- 1. 57e-01 3.98e-02 5.05e+02
- 1. 03e+00 2.77e+04 2.93e+02 3.19e+06 1.40e+04
,4.79e-02 7.94e+03 1.30e+Ol 3.71e+02 4.l10e+0 9
- 7. Ole+07 1.35e+05 6.12e+05
- 7. 81e+02 9.84e-04 5.60e+01 1.08e-04 3.30e-05 2.00e+02 3.77e-01
- 1. 67e+04 1.93e+02 1.21e+06 5.24e+03 1.85e-02 8.13e+03 9.02e+00 2.98e+02 2.46e+09 0.OOe+00 6.75e-02 5.4?e+03 1.58e-02
- 8. 93e+01 2.79e+02
- 1. 60e+06 1.48e+07
- 1. 69e+05 3.56e+06 4.45e+04 6.96e+05 0.00e+00 0.O00e+00 0.00e+00 0.O00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00
- 0. 00e+00
- 0. 00e+00
- 0. 00e+00 0.00e+00 0.00e+00 0.00e+00 0.O0e+00 0.00e+00 0.00e+00 0.O00e+00
- 0. 00e+00 8.99e-01 1.57e+04 4.84e+04 0.OOe+00 1.07e+05 1.16e+07 1.64e+05 0.OOe+00 1.09e+04 3.67e+06 3.30e+04 0.OOe+00 0.OOe+00 4.47e+05 1.29e+04 0.00e+00 4.86e+00 1.04e+04 2.44e+04 0.OOe+00 3.75e+04 1.31e+06 2.73e+04 0.00e+00 1.75e-01 3.00e+03 2.63e+04 O.OOe+00 3.18e+04 1.68e+06 6.90e+04 0.OOe+O0 3.99e-02 2.06e+03 8.22e+03 0.OOe+00 2.65e+02 1.99e+05 1.19e+05 0.OOe+00 1.04e+03 3.40e+05 4.41e+04 0.OOe+0O 1.53e+04 0.OOe+00 1.99e+03 0.OOe+00 5.18e+04 0.00e+00 1.06e+03 0.OOe+OO 3.95e+03 0.OOe+00 1.90e+03 0.OOe+O0 2.24e+04-O.OOe+00 2.16e+03 0.OOe+00 2.09e+03 0.OOe+00 1.29e+03 0.OOe+00 8.47e+03 0.OOe+00 1.83e+03 0.00e+00 1.90e+05 7.97e+04 1.33e+03 0.OOe+00 5.64e+04 1.18e+04 1.43e+03 0.OOe+00 1.72e+05 7.13e+04 1.33e+03 0.00e+00 4.lOe+02 6.54e+01 8.76e+02 0.OOe+00 5.92e-04 5.95e+03 5.10e+04 0.OOe+00 1.34e+01 1.60e+06 3.84e+04 0.OOe+00 6.50e-05 2.97e+03 4.75e+03 0.OOe+00 1.90e-05 1.55e+03 6.93e+02 0.OOe+00 0.OOe+00 1.68e+05 8.48e+04 0.OOe+00 0.OOe+00 8.22e+03 5.95e+04 0.OOe+00 5.25e+03 5.17e+05 2.16e+04 0.OOe+00 5.64e+01 1.16e+05 4.97e+04 0.OOe+00 5.38e+05 9.84e+06 1.48e+05 0.OOe+00 1.97e+03.4.33e+05 3.72e+04 0.OOe+00 6.72e-C3 1.61e+03 4.28e+03 0.OOe+00 3.15e+03 3.22e+05 3.12e+04 0.OOe+00 0.OOe+00 3.96e+04 3.56e+04 0.OOe+O0 6.62e+01. 5.95e+04 2.49e+04 0.OOe+00 6.93e+08 1.19e+09 5.99e+04 0.OOe+00 1.41e+07 4.59e+08 7.03e+07 0.OOe+00 4.10~e-01 1.09e+04 5.00e+03 6.58e+02 4.89e-01 2.07e+03 1.88e-02 2.23e+03 5.OOe-03 3.63e+01 1.76e+02 5.57e+03 1.96e+04 1.26e+03 5.60e+03 6.65e+02 2.77e+03 7.45e+04 S.29e+04 4.55e+04 3.98e+02 4.30e-02 2.90e+03 4.97e-03 1.96e-03 5.15e+01 9.04e-02
- 1. 99e+03 2.21e+01 1.76e+05 6.99e+02 2.41e-03
- 5. 00e+02 3.12e+00 1.88e+01 1.88e+08 4.93e+06 I Page 42 of 4
12-Attachment C ODCM-QA-004 Revision 2 Page 57 of 59 DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES (Ref.3.9 Ch. 52, 5.3) i I
Units:
AgeGroup:
Pathway:
Airborne Pathways & Tritium Ingestion: (mrem/yr)/(uCi/rrm^3))
Deposition Pathways: (mA2 * (mremlyr)/(pCVsec)
INFANT Grs/Cow/Milk (CMILK)
I Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 C-14 NA-24 P-32 CR-51 MN-54 MN-56 FE-55 FE-59 CO-58 CO-60 NI-63 NI-65 CU-64 ZN-65 ZN-69 BR-83 BR-84 RB-86 RB-88 RB-89 SR-89 SR-90 SR-91 SR-92 Y-90 Y-91 Y-91M Y-92 Y-93 ZR-95 ZR-97 NB-95 MO-99 TC-99M TC-101 RU-103 RU-105 0.OOe+OO 2.38e+03 2.38e+03 2.34e+09 5.00e+08 5.00e+08 1.55e+07 1.55e+07 1.55e+07 1.60e+ll 9.43e+09 0.OOe+00 0.OOe+OO 0.0Oe+00 1.05e+05 0.OOe+OO 3.90e+07 0.OOe+OO 0.OOe+00 3.20e-02 0.00e+00 1.35e+08 8.73e+07 0.OOe+00 2.24e+08 3.92e+08 0.OOe+00 0.OOe+O0 2.43e+07 0.OOe+00 0.OOe+OO 8.82e+07 0.OOe+00 3.50e+10 2.16e+09 0.OOe+00 3.57e+00 4.04e-01 0.OOe+0O 0.OOe+0O 1.86e+05 0.OOe+00 5.55e+09 l.90e+10 0.OOe+00 2.12e-11 3.81e-11 0.OOe+0O O.OOe+OO 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+O0 0.OOe+00 2.23e+10 0.OOe+00 0.OOe+00 2.19e-44 0.OOe+00 0.OOe+00 5.02e-53 0.OOe+00 1.26e+10 0.OOe+00 0.OOe+00 1.22e+1 0.OOe+00 O.OOe+00 2.73e+05 0.OOe+00 0.OOe+00 4.72e+00 0.OOe+00 0.OOe+00 6.82e+02 0.OOe+00 0.OOe+0O 7.33e+04 0.OOe+00 0.OOe+00 6.00e-19 O.00e+00 0.OOe+00 5.45e-04 0.OOe+00 0.OOe+00 2.17e+00 0.OOe+00 0.OOe+0O 6.81e+03 1.66e+03 O.OOe+00 4.07e+00 6.99e-01 0.OOe+00 5.94e+05 2.44e+05 0.OOe+00 0.OOe+00 2.08e+08 0.OOe+00 2.77e+01 5.71e+01 O.OOe+00 2.99e-59 3.77e-59 0.00e+00 8.67e+03 0.OOe+00 0.OOe+00 8.14e-03 0.OOe+00 O.OOe+00 2.38e+03 5.00e+08 1.55e+07 0.OOe+00 2.30e+04 8.64e+06 2.75e-02 0.OOe+00 0.OOe+00 0.OOe+00 0.0O0e+00 0.OOe+O0 0.0Oe+00 3.15e+05 9.23e+09 1.58e-11 0.OOe+0O 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.0Oe+00 0.OOe+00 0.OOe+00 0.0Oe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 1.79e+03 7.05e-01 1.75e+05 3.11e+08 6.15e+02 4.48e-58 1.80e+04 5.98e-02 2.38e+03 5.00e+08 1.55e+07 0.0O0e+00 2.05e+05 0.OOe+00 0.OOe+00 4.27e+07 1.16e+08
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.0Oe+00 0.0Oe+00 0.OOe+00 0.OOe+00 0.0Oe+00 0.OOe+0O 0.OOe+00 0.0O0e+00 0.0O0e+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 2.99e+01 2.05e-59 0.OOe+00 0.OOe+00 2.38e+03 5.00e+08 1.55e+07 2.17e+09 4.70e+06 1.43e+07 2.91e+00 1.lle+07 1.87e+08 6.04e+07 2.10e+08
- 1. 08e+08 3.08e+01 3.82e+06 1.61e+10 3.lle-09 0.OOe+00 0.OOe+00 5.70e+08 2.13e-44 1.71e-53 2.59e+08 1.52e+09 3.23e+05 5.09e+01 9.42e+05 5.25e+06 2.OOe-15
- 1. 04e+01 1.71e+04 8.26e+05 4.46e+04 2.06e+08 6.86e+07
- 1. 66e+04 6.40e-57 1.06e+05 3.24e+00 0.OOe+00 0.OOe+00 0.OOe+00 0.0O0e+00 0.OOe+00 0.OOe+O0 0.OOe+00 0.0O0e+00 0.OOe+00
- 0. OOe+00 0.0Oe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+O0
- 0. OOe+O0 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+O0 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+O0 0.OOe+00 O.O00e+OO 2.38e+03 5.00e+08 1.55e+07 6.21e+09 1.61e+05 8.84e+06 5.51e-03 2.33e+07 1.55e+08 6.05e+07 2.08e+08 1.21e+09-
- 1. 84e-01 8.62e+04 8.78e+09 2.84e-12 9.52e-01 1.37e-22 1.lOe+10 1.20e-44 3.46e-53 3.61e+08 3.10e+10 9.88e+03 1.75e-01 1.83e+01 1.95e+03 2.04e-20 1.53e-05 5.90e-02 1.18e+03 3.19e-01 1.41e+05 4.06e+07 7.36e+02 3.73e-58 2.90e+03 2.74e-03 I
Page 43 of 44
Attachment C ODCM-QA-004 Revision 2 Page 58 of 59 1
DOSE FACTORS: RADIONUCLIDES OTHER THAN NOBLE GASES
- I (Ref.3.9 Ch. 5.2, 5.3)
I Units:
AgeGroup:
Pathway:
Airborne Pathways & Tritium Ingestion: (mremlyr)/(pC~nIA3))
Deposition Pathways: (n^M
- (mrem/yr)/IpCVsec)
INFANT Grs/Cow/Milk (CMILK)
I Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-106 AG-110M TE-125M TE-127 TE-127M TE-129 TE-129M TE-131 TE-131M TE-132 1-130 1-131 1-132 1-133 I-134 1-135 CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141 BA-142 LA-140 LA-142 CE-141 CE-143 CE-144 PR-143 PR-144 ND-147 W-187 NP-239 Pu-239 u-235 1.90e+05 3.86e+08 1.51e+08 6.35e+03 4.21e+08 2.83e-09 5.57e+08 3.82e-32 3.3 8e+06 2.11le+07 1.78e+06 1.3 6e+09 7.29e-01
- 1. 82e+07 9.27e-12 5.65e+04
- 3. 65e+10 1.98e+09 5.1.5e+10 9.13e-23 4.42e-07 2.41e+08 4.57e-4 5 3.16e-7 9 4.06e+01 1.75e-10 4.34e+04 3.98e+02 2.33e+0 6 1.49e+03 6.66e-53 8.81e+02 6.09e+04 3.65e+Ol 5.68e+0 7 1.92e+10
- . OOOe+00 2.82e+08 5.04e+07 2.13e+03 1.40e+08 9.75e-10 1.91e+08 1.41e-32 1.36e+06 1.05e+07 3.92e+06 1.60e+09 1.48e+00 2.65e+07 1.90e-11 1.13e+05 6.80e+10 5.81e+09 6.02e+10 1.48e-22 2.93e-10 2.41e+05 3.13e-48 2.62e-82 1.60e+01 6.43e-11
- 2. 65e+04 2.64e+05 9.52e+05 5.56e+02 2.58e-53 9.05e+02 4.24e+04 3.27e+00 6.38e+06 0.OOe+00 0.OOe+00 0.00e+00 5.07e+07 5.17e+03 1.22e+08 2.37e-09 2.14e+08 3.41e-32 2.76e+06 1.54e+07 4.39e+08 5.27e+11 6.94e+01 4.81e+09 4.43e-10 1.Ole+07 0.00e+00 0.OOe+00 0.0Oe+00 0.00e+00
- 0. OOe+0O
- 0. OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 0.0Oe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.00e+00 0.OOe+00 0.OOe+00 0.OOe+00 0:OOe+00 0.OOe+00 2.25e+05 4.03e+08 0.OOe+00 1.55e+04
- 1. 04e+09 7.04e-09 1.39e+09 9.78e-32 9.37e+06 6.54e+07 4.3le+06 1.87e+09 1.65e+00 3.1le+07 2.12e-11 1.25e+05 1.75e+10 2.32e+09 1.62e+10 7.40e-23 1.76e-10 5.72e+04 1.88e-48 1.51e-82 0.OOe+00 0.OOe+00 8.16e+03 7.68e+01 3.85e+05 2.07e+02 9.34e-54 3.49e+02 0.00e+00 6.51e+00 5.27e+06 4.09e+09 0.00e+00 0.O00e+00 0.00e+00 0.00e+00 0.O00e+00 0.O00e+00 0.O00e+00 0.O00e+00 0.O00e+00 0.O00e+00
- 0. 00e+00 0.O00e+00 0.O00e+00 0.O00e+00 0.O00e+00 0.00e+00 7.18e+09 4.74e+08 6.55e+09
- 1. 16e-23 1.78e-10 1.48e+05 1.90e-48 1.59e-82 0.00e+00 0.00e+00 0.00e+00
- 0. 00e+00 0.00e+O0 0.O00e+00
- 0. 00e+O0
- 0. 00e+00 0.00Oe+00 0.00e+00 O0.00e+00 0.00e+00 1.45e+06 1.46e+10 7.18e+07 1.33e+05 1.70e+08 2.26e-07 3.33e+08 1.55e-30 2.29e+07 3.87e+07 8.40e+05 5.72e+07 1.2Oe+00 4.48e+06 1.96e-11 4.07e+04 1.85e+08 8.83e+07
- 1. 88e+08 2.37e-22 2.80e-05 5.92e+07 5.58e-44 1.30e-78 1.88e+05
- 1. 09e-05 1.37e+07
- 1. 54e+06 1.33e+08 7.84e+05 1.2Oe-48 5.74e+05 2.49e+06 9.44e+04, 2.84e+06 3.33e+08 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.0Oe+00 0.0Oe+00 0.0Oe+00 0.0Oe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00 0.0O0e+00 0.0Oe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 2.38e+04 1.86e+08 2.04e+07 1.37e+03 5.10e+07 6.60e-10 8.58e+07 1.07e-32 1.12e+06 9.76e+06 1.57e+06 7.05e+08 5.27e-01 7.75e+06 6.75e-12 4.10e+04 6.87e+09 2.17e+09 4.27e+09 7.20e-23 1.28e-08 1.24e+07 1.44e-46 1.55e-80 4.12e+00 1.54e-11 3.lle+03 3.Ole+01 1.30e+05 7.37e+01 3.36e-54 5.55e+01 1.46e+04 1.85e+00 1.46e+06 1.46e+09 l Page 44 of 44
Attachment D ODCM-QA-004 Revision 2 Page 59 of 59 EVALUATION OF INSIGNIFICANT EFFLUENT PATHWAY GASEOUS RELEASES (Ref. 3.14)
The following calculation is utilized for evaluation of gaseous effluent releases from insignificant effluent gaseous release pathways as identified in Section 2.4.5. The offsite dose is calculated via the methodology outlined in Sections 6.1 or 6.2 by inputting the Insignificant Effluent Pathway Release Rate (uCiCsec) calculated as follows:
Release Rate (uCi/sec) = Concentration (pCVcc) x TC x Evap. Rate (cc/min or cc/sec)
Where:
Release Rate
=
Gaseous effluent release rate (uCisec) from sources defined in Section 2.4.5.
Concentration
=
Radionuclide concentration (gOCVcc) in Chemistry samples from sources defined in Section 2.4.5.
=
Coolant-Condensate Transfer Coefficient (unitless; see values below)
Evap. Rate
=
Evaporation Rate of Insignificant Effluent Source Volume (see values below)
TC Values; Tritium (H-3) = 1.0 Noble Gases = 1.0 lodines
= 0.02 All Others
= 0.001 Evap. Rate:
RWST = 8.052 cc/min CST (U1 & U2) = 26.22 cc/min Main Turbine/RFPT Lube Oil Release Rate = 12.66 cc/sec Hydrogen Seal Oil Vapor Release Rate = 10.05 cc/sec Total Vapor Release Rate (CST & Oil) = 1388.82 cc/min If a Release Flow-rate (cfm) is desired to evaluate Activity Released, then, if Evaporation Rate = cc/sec, then Evaporation Rate/472 = Flow-rate (cfm) or, if Evaporation Rate = cc/min, then Evaporation Rate x 2.1 9e-3 = Flow-rate (cfm)
Page 1 of 1
PROCEDURE CHANGE PROCESS FORM PCAF NO. 2
- 12. PAGE 1 OF 4
- 3. PROC. NO. ODCM-QA-005 REV. 2 (4. FORMS REVISED
- __R-
.R
,-_R R_
R R
- 5. PROCEDURE TITLE WATERBORNE EFFLUENT DOSE CALCULATIONS
- 6. REQUESTED CHANGE PERIODIC REVIEW
§3 NO D YES INCORPORATE PCAFS DI NO Z
YES
- 2002-1696 #
REVISION
[1 PCAF 3
DELETION
[
(CHEW ONLY)
- 7.
SUMMARY
OF IREASON FOR CHANGE The change being made is the addition of the Nuclear Emergency Planning op thefECOMMENDED REVIEWS" section on the procedure cover page.
This change to ODCM-OA-005 is an administrative correction and does not he level of effluent control or the accuracy and/or reliability of dose calculations or setiri* deten~iations as required by 10CFR20.1302, 40CFR190, 10CFR50.36a and 10CFR50 App 17
,Continued D
- 8. DETERMINE COMMITTEE REVIEW REQUIREM (Refer to Section 6.1.4)
PORC REVIEW REQ'D?
ED KI
- 9.
PORC MTG#
4l BLOr.CKS 11 THRU 16AREONPAGE FeFORP,
- 17.
Francis J. Hickey I
- 18. COMMUNICATION OF CHANGE REQUIRED?
PREPARER DATE 3 NO
[: YES (TYPE)
(Print or Type)
- 19.
jSSIGNATURE ATrESTS THAT RESPONSIBLE SUPERVISOR HAS CONDUCTED QADR AND TECHNICAL REVIEW UNLESS OTHERWISE DOCUMENTED IN BLOCK 16 OR ATTACHED REVIEW FORMS.-
ER DATE CROSS DISCIPLINE REVIEW (IF REQUIRED) HAS BEEN COMPLETED RF~8P0NSIBL¢iUEtSOR DATE BY SIGNATURE IN BLOCK 16 OR ATTACHED REVIEW FORMS.
- 20.
N/A FUM APPROVAL DATE.
- 21. RESPONSIBLE APPROVER
-ENTER N/A IF FUM HAS APPROVAL AUTHORITY N/A -
INITIALS DATE ArORM NDAP-QA-0002-8, Rev. 8, Page 1 of 2 (Electronic Form) i[R %IN 0 IN R1 DGCUM-F.N CONTROL SERViCES-SSES
PROCEDURE CHANGE PROCESS FORM r
I 1. PCAF NO. 2003-3?
- 12. PAGE2OF 4 I
- 13.
PROC. NO. ODCM-QA-005 REV. 2 U
- 11. This question documents the outcome of the 50.59 and 72.48 Review required by NDAP-QA-0726. Either 11 a, b, c or d must be checked 'YES' and the appropriate form attached or referenced.
- a. This change is an Administrative Correction for which 50.59 and 72.48 are not 3 YES 3 N/A applicable.
- b. This change is a charige to any surveillance, maintenance or administrative l YES 3 N/A procedure for which 50.59 and 72.48 are not applicable.
- c. This change is bounded by a 50.59172.48 Screen/Evaluation, therefore, no new E] YES E N/A 50.59172.48 Evaluation is required.
Screen/Evaluation No.
- d.
50.59 and/or 72.48 are applicable to this change and a 50.59172.48 fa YES 3 N/A Screen/Evaluation is attached.
Z YES Change Request No.
- 13. Should this change be reviewed for potential effects on Training Needs or Material?
[ YES 3 NO If YES, enter an Action Item @ NIMS/Action/Gen Work Mech/PICN
- 14. Is a Surveillance Procedure Review Checklist required per NDAP-QA-0722?
[1 YES 3 NO
- 15. Is a Special, Infrequent or Complex Test/Evolution Analysis Form required per
[] YES 3 NO NDAP-QA-0320? (SICTIE form does not need to be attached.)
- 16. Reviews may be documented below or by attaching Document Review Forms NDAP-QA-0101-1.
REVIEWED BY WITH DATE REVIEW NO COMMENTS QADR TECHNICAL REVIEW REACTOR ENGINEERING/NUCLEAR FUELS
- IST*
OPERATIONS NUCLEAR SYSTEMS ENGINEERING NUCLEAR MODIFICATIONS MAINTENANCE HEALTH PHYSICS NUCLEAR TECHNOLOGY CHEMISTRY OTHER Required for changes that affect, or have potential for affecting core reactivity, nuclear fuel, core power level indication or impact the thermal power heat balance. (5)
Required for changes to Section Xl Inservice Test Acceptance Criteria.
sk FORM NDAP-QA-0002-8, Rev. 8, Page 2 of 2 (Electronic Form)
Vv,4 -1 I
PROCEDURE COVER SHEET PPL SUSQUEHANNA LLC INUCLEAR DEPARTMENT PROCEDURE
-f WATERBORNE EFFLUENT DOSE CALCULATIONS ODCM-QA-005 Revision 2 Page 1 of 48 QUALITY CLASSIFICATION:
APPROVAL CLASSIFICATION:'
O QA Program D Non-QA Program 0
Plant
[] Non-Plant E
Instruction EFFECTIVE DATE:
9-________
PERIODIC REVIEW FREQUENCY:
N/A PERIODIC REVIEW DUE DATE:
N/A RECOMMENDED REVIEWS:
Nucleaz i
nergcy Plu'ning Procedure Owner:
Francis J. Hickey Responsible Supervisor
-Chemistry Supervisor - SSES Responsible FUM:
-Chemistry Supervisor - SSES Responsible Approver Vice President - Nuclear Operations If F,
II FORM NDAP-OA-0002-1, Rev. 3, Page 1 of I
ODCM-QA-005 Revision 2 Page 2 of 48 PROCEDURE REVISION
SUMMARY
TITLE:
WATERBORNE EFFLUENT DOSE CALCULATIONS Most of the revisions described below are editorial in nature. The changes made do not reduce or compromise the level of effluent control or the accuracy and/or reliability of dose calculations or setpoint determinations as required by 1 OCFR20.1302, 40CFR1 90, 1 OCFR50.36a and 1 OCFR50, Appendix I. Additionally, the changes outlined below (1) do not alter the conduct of the radiological environmental monitoring program, (2) do not change the radioactive effluent controls and radiological environmental monitoring activities, and (3) do not change the information to be included in the Annual Radiological Environmental Operating and Radioactive Effluent Release Reports.
Various sections have been revised and/or deleted to incorporate the change in the computer program used by PPL Susquehanna, LLC in support of offsite dose assessment (LADTAP replaced by RETDAS) from routine liquid and gaseous effluents.
- 1.
Removed redundant steps and gray shading incorporated for the transition to ITS.
- 2.
Section 4.2 has been deleted and Section 4.1 revised to clarify responsibilities to support compliance with the applicable TRM sections. The methodology for liquid and gaseous effluent offsite dose assessment is provided in the ODCM and implemented via the SSES surveillance program. NEPM-QA-1011 and NEPM-QA-1 012 provide information which is redundant with the ODCM and the surveillance program and thus both procedures will be deleted.
N
- 3.
Added references to Section 3.0 and identified the applicable references for parameters and tables in Attachments A through I.
- 4.
Deleted the Approval and Date stamp at the bottom of each page due to no longer required per ODCM-QA-002, Rev. 1.
- 5.
Revised Section 6.0 (resulting in revision to Section 6.1 and deletion of existing Sections 6.2 and 6.3) to reflect the actual dose calculation methodology of Regulatory Guide 1.109. Added Attachment G which is a consolidated description of the dose calculation methodology-of Regulatory Guide 1.109. Attachment G provides an efficient method for calculation of offsite dose from liquid effluents and reflects the metholdology utilized by the RETDAS computer program.
- 6.
Revised existing Section 6.4 (renumbered as 6.2) to more accurately reflect and enhance compliance with TRM 3.11.1.3 and to incorporate the capability to perform a liquid effluent dose projection via the methodology utilized by the RETDAS computer program.
Renamed Attachments F and G as Attachments H and 1.
- 7.
Revised Attachments A, B, and E (renamed as Attachments A, B and C) to list values defined as "Pathway Dose Commitment Factors." The values are derived from standard parameters outlined in Regulatory Guide 1.109 except P-32 (bone) which is derived based on the methodology in Reference 3.17. The derivation of the dose commitment factors is outlined in Attachment G. PPL Calculation EC-ENVR-1 055, Rev. 0, Evaluation of Dose
ODCM-QA-005 Revision 2 Page 3 of 48 Factors for Liquid and Gaseous Effluent Releases,' has been added as a reference which supports the values in Attachments A, B, and C and these values correspond to the values used by the RETDAS program.
- 8.
The following existing sections have been deleted and/or re-named due to changes in the dose calculation methodology and the transition from the LADTAP II program to the RETDAS program: 2.2,3.10,3.11,3.13,3.14,6.1,6.2,6.3,6.5, Attachments A-H.
- 9.
Revised potable water dilution factor on Attachment F to correspond with added Reference 3.12.
- 10.
Added Section 2.1.4 to recognize the SSES Sewage Treatment Plant as an Insignificant Effluent Release Pathway.
- 11.
Various sections revised to reflect SSES organizational changes.
ODCM-QA-005 Revision 2 Page 4 of 48 TABLE OF CONTENTS SECTION PAGE 1.0 PURPOSE 5
2.0 POLICY/DISCUSSI ON 5
2.1 Applicable Pathways 5
2.2 Effluent Data 5
2.3 Projected Dose 6
2.4 Assignment of Releases to the Reactor Units 6
3.0 REFERENCES
6 4.0 RESPONSIBILITIES 7
4.1 Chemistry Supervisor - SSES 7
5.0 DEFINITIONS 8
6.0 PROCEDURE 8-6.1 Liquid Effluent Dose Calculation 8
6.2 Projected Dose from Liquid Effluent 9
6.3 Waterbome Effluent Dose Calculations Exceeding Twice the TRM Values 10 7.0 RECORDS 10 ATTACHMENTS ATTACHMENT PAGE A
Dose Commitment Factors for Potable Water Pathway 11 B
Dose Commitment Factors for Fish Pathway 19 C
Dose Commitment Factors for Shoreline Pathway 27 D
Radioactive Decay Constants 35 E
Dilution Factors and Transit Times for SSES Effluents to Danville, PA 36 F
Site Specific Information
.38 G
Consolidated Dose Calculation 39 H
Maximum Hypothetical Composite Dose Factors 42 I
Maximum Hypothetical Water Ingestion Dose Factors - Infant 48
ODCM-QA-005 Revision 2 Page 5 of 48 i
1.0 PURPOSE The purpose of this procedure is to provide the methodology and parameters to be used in calculating maximum individual, whole-body and organ doses due to waterbome effluents to ensure compliance with the dose limitations in the Technical Requirements Manual (Sections 3.11.1.2, 3.1 1.3) and 1 OCFR20.1302.
This procedure constitutes part of the SSES Offsite Dose Calculation Manual (ODCM) which is a licensing basis document.
2.0 POLICY/DISCUSSION 2.1 Applicable Pathways 2.1.1 The calculations of dose received by the hypothetical maximally exposed individual are based on ingestion of fish and drinking water and exposure on the shoreline. Drinking water is taken from the nearest public drinking water intake location (Danville Water Authority). Shoreline and fish ingestion are associated with the SSES river outfall (edge of initial mixing zone).
2.1.2 Methodology for calculating dose to the maximum hypothetical offsite individual has been developed for composite (fish, drinking water and I
shoreline exposure) liquid effluent pathways. This methodology incorporates shore width, usage, dilution, and transit parameters specific to the SSES site. Any revision to these parameters should be reviewed against FSAR Table 11.2-15.
2.1.3 Calculated dose contributions from the three waterborne effluent pathways are summed to obtain the total dose to a member of the public from liquid effluent.
2.1.4 Effluent data from the following Insignificant Pathway shall be evaluated for inclusion in the Annual Effluent Release Report; Sewage Treatment Plant.
2.2 Effluent Data 2.2.1 The total number of curies released for each radionuclide during the time period being evaluated is supplied by the SSES radiation monitoring program.
2.2.2 For determination of compliance with SSES Technical Requirements Manual dose limits, effluent totals shall be based only on activity positively detected at the 95% confidence level.
I
ODCM-QA-005 Revision 2 Page 6 of 48 2.3 Projected Dose 2.3.1 The projected quarterly dose contribution from batch releases for which radionuclide concentrations are determined by periodic composite sample analysis, as stated in TR Table 3.11.1.1-1 may be approximated by assuming an average concentration based on the previous monthly (rolling 31-day) or quarterly composite analysis.
2.3.2 The calculated dose contributions from these radionuclides shall be based on the actual composite analysis. The cumulative dose commitment to the total body or any organ for a quarterly or annual analysis shall be based on the summation of isotopic activities and average cooling tower blowdown from all releases occurring during that time period.
2.4 Assignment of Releases to the Reactor Units 2.4.1 For determination of compliance with SSES radioactive effluent dose limits which are on a Oper reactor unit" basis:
- a.
Waterborne effluents shall be equally divided between Unit 1 and Unit 2 release totals. (Ref. 3.1 1)
3.0 REFERENCES
3.1 TR Table 3.11.1.1-1, Radioactive Liquid Waste Sampling and Analysis Program.
3.2
-TR 3.11.1.2 [Liquid Effluent] Dose 3.3 TR 3.11.3 Total Dose 3.4 1 OCFR20.1302, Compliance with the Dose Limits for Individual Members of the Public 3.5 10 CFR 20 Appendix B, Annual Limits on Intake (ALls) and Derived Air Concentrations (DACs) of Radionuclides for Occupational Exposure; Effluent Concentrations; Concentrations for Release to Sewerage.
3.6 1 OCFR50 Appendix I, Numerical Guides for Design Objectives and Limiting Conditions for Operation to Meet the Criterion uAs Low as is Reasonably Achievable" for Radioactive Material in Light-water Cooled Nuclear Power Reactor Effluents.
3.7 4OCFR1 90, Environmental radiation protection standards for nuclear power operations.
3.8 Regulatory Guide 1.109, Rev. 1, October, 1977, Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purposes of Evaluating Compliance with 10 CFR 50, Appendix I.
SUM VE abs>
Revision 2 PAGC L OFE....2Z Page 7 of 48 3.9 SSES License Action Request 97-002, Clarificaton of Specifications 3.11.12 and 3.11.1.3, 1/20197.
3.10 FSAR Table 11.2-15, Input Data for Aquatic Dose Calculations.
3.11 NUREG-01 33 Preparation of Radiological Effluent Technical Specifications for Nuclear Power Plants, October 1978.
3.12 "Study of Travel Time and Mixing Characteristics for the Susquehanna River Below the Susquehanna Steam Electric Station,' The Sutron Corporation, Sutron Report No. SCR85-0007, November, 1985.
3.13 Kocher, D. C., "Radioactive Decay Tables," DOE/TIC Report 11026, Oak Ridge National Laboratory, Oak Ridge, TN, 1981.
3.14 PPL Calculation EC-RADN-1 041, Rev. 5, "SSES 'Expected' Liquid and Gaseous Effluent Aquatic Doses and Atmospheric Doses - NWC/CFSIHWC."
3.15 PPL Calculation EC-ENVR-1055, Rev. 0, "Evaluation of Dose Factors for Uquid and Gaseous Effluent Releases.'
3.16 PPL Calculation EC-ENVR-0501 (OT-93-RKB-019),.Uquid Dose Factor Calculations - Liquid Pathway Dose Factors for SSES ODCM.
3.17 Importance of P-32 in Nuclear Reactor Liquid Effluents," Edward F. Branagan, Jr., Charles R. Nichols and Charles A. Willis, USNRC June 1982.
3.18 PPL AR No. 401298 "Deletion of LRW Composite SampleP-32 Analysis,"
May 2002.
4.0 RESPONSIBILITIES c
A 4.1 Chemistry Supervisor - SSES F
4.1.1 Ensures adequacy and correctness of methodology used in calculating doses resulting from waterbome effluents as necessary for fulfillment or Technical Requirement Surveillances (Sections 3.11.1.2.1 and 3.1 1.3.1).
4.1.2 Ensures dose calculations necessary for fulfillment of Technical Requirement Surveillances (Sections 3.11.1.2.1 and 3.11.3.1) are performed.
4.1.3 Ensures methodology and parameters to be used in calculating doses resulting from waterbome effluents are developed to ensure compliance with the dose limitations in the Technical Requirements Manual.
ODCM-QA-005 Revision 2 Page 8 of 48 5.0 DEFINITIONS None.
6.0 PROCEDURE 6.1 Liquid Effluent Dose Calculation The dose due to radionuclides released in liquid effluent to unrestricted areas is calculated via equations 1, 2 and 3 as outlined below. The equations incorporate the methodology as described in Regulatory Guide 1.109. A consolidated version of the Regulatory Guide 1.109 dose calculation methodology is outlined in Attachment G.
RIpj = 1 1 19 MPUwz Qi Did e-"'tP Potable Water (1)
R~~j1119F IQDj~~t Rapj=1119MPa PQiBipDai.e"P Fish(2)
F i
Rpj=1119 PT Dipj l[el-A'PI[1 - 6lb]
Shoreline (3)
Where:
B
=
Equilibrium bioaccumulation factor for nuclide i in pathway p, expressed as the ratio of the concentration in biota (pCi/kg) to the radionuclide concentration in water (pCi/liter), i.e., liter/kg (Ref. 3.8 Table A-1)
Daipi
=
Dose factor specific to a given age group a, radionuclide i, pathway p, and organ j, which can be used to calculate the radiation dose from ingestion of a radionuclide or from standing on contaminated ground. (Ref. 3.8 Table E-6, E-11 through E-14)
(mrem/pCi ingested or mrem/hr per pCVm2)
F
=
Flow rate in the liquid effluent (cooling tower blowdown flow in ft.3/sec)
Mp
=
Mixing ratio at the point of withdrawal of drinking water or point of harvest of fish
=
Reciprocal of the dilution factor DFp (Attachment E)
=
1/DFp
.=
Release rate of nuclide i (CVyr)
R
=
Total annual dose to organ j of individuals of age group a from all radionuclides in the pathway p (mrem/yr)
ODCM-QA-005 Revision 2 Page 9 of 48 tp
=
Total time elapsed between release of the nuclides and ingestion of food or water (Attachment F) (hr)
Uap
=
Usage factor that specifies the intake rate or exposure rate for an individual of age group a associated with pathway p (Attachment F) (kg/yr, Vyr or hr/yr)
Ax
=
Radioactive decay constant of nuclide i (Attachment D) (hr')
1119
=
Factor to convert from (Ci/yr)/(ft3/sec) to pCi/lter (Reg Guide 1.109 lists 1100 which is 1119 rounded to nearest hundreth) 111,900 =
Factor to convert from (Ciyr)i(ft3/sec) to pCi/liter and to account for proportionality constant (100 liter/m2-day) used in sediment radioactivity model (Reg. Guide 1.109 lists 110,000 which is 111,900 rounded to the nearest ten thousandth)
W
=
shoreline width factor (Attachment F) (dimensionless) t
=
Period of time shoreline is exposed to contaminated water (Attachment F) (hr)
T
=
Radioactive half-life of nuclide i (days).
It should be noted that although the same notation is used for all three
-pathways, Mp, U p and tp have different values, because the assumed point of withdrawal of drinking water is not the same as the assumed point of fish harvest or shoreline exposure.
6.2 Projected Dose from Liquid Effluent 6.2.1 Doses from liquid effluents released to unrestricted areas are projected at least every 31 days as required by TRM 3.1 1.1.3. These projections are made by averaging the doses from previous operating history (normally the previous three months) which is indicative of expected future operations. The dose projection from Liquid Effluents Released to Unrestricted Areas can also be performed by the following equation:
RapJ-=z[Kaipj *Ci *V*k]
Eq. 4 Where:
api=
Total projected dose during period to organ j from fish, water ingestion and shoreline exposure to individuals of age group a from all radionuclides in pathway p (mrem);
ODCM-QA-005 Revision 2 Page 10 of 48 Kipj=
Composite dose conversion factor (adult, teen, child) or water ingestion dose factor (infant) to organ j of individuals to age group a from radionuclide i in pathway p (mremJCi released: Attachment H for Maximum Hypothetical Composite Dose Factors, Attachment I for Maximum Hypothetical Water Ingestion Dose Factors);
Ci
=
Average concentration of radionuclide i in undiluted liquid effluent during batch release from radwaste (Ci/ml).
V
=
Total undiluted batch volume released from radwaste (gallons).
k Conversion factor (3.785E3 ml/gallon).
6.3 Waterborne Effluent Dose Calculations Exceeding Twice the TRM Values 6.3.1 When the results of waterborne dose calculations exceed twice the value of the TR 3.11.1.2.a or 3.11.1.2.b), calculations shall be made including the direct radiation contribution to determine if the limits of TR 3.11.3 have been exceeded. If the limits of TR 3.11.3 have been exceeded, a special report shall be prepared and submitted to the NRC within 30 days addressing the actions specified in TR 3.11.3.
7.0 RECORDS None.
Odcmqa-00526)
Attachment A ODCM-QA-005 Revision 2 Page 11 of 48 DOSE COMMITMENT FACTORS FOR THE POTABLE WATER PATHWAY (Ref. 3.15)
Release Type:
Units:
Age Group:
Pathway:
Liquid (mrem/hr) / (pCi/ml))
ADULT Potable Water (PWtr)
Nuclide -Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 C-14 NA-24 P-32 CR-51 MN-54 MN-56 FE-55 FE-59 CO-SB C060 NI -63 NI-65 CU-64 ZN-65 ZN-69 BR-83 BR-84 BR-85 RB-86 RB-88 RB-89 SR-89 SR-90 SR-91 SR-92 Y-90, Y-91 Y-91M Y-92 Y-93 ZR-95 ZR-97 NB-95 MO-99 TC-99M0 o.0ooe+00 2.3 6e+02 1.41le+0 2 2.50e+03'
.ooe+00
- o. 00e4-00
'O. 00e4-00 2.29e+02
,,3.61e+0 2 0.O00e+00 0.00e+00
- 1.
08e+04 4.39e+O1 0.0 0e+O0 4.03e+02
- 8.57e-01
'0.00e+00 0.00~e+O0 0.O00e+O0 0.O00e+00 0.OO0e+00
- 0. O0e+00 2.56e+04
- 6.31e+05 I 4.72e+02 I
- 1. 79e4-02 S. Ole-01 1.17e+O1 C
- 7.56e-03 C 7.03eC-0 2, C 2.23e- 0 31 C 2.53e+0O0 S 1.40e-01 2 5.18e-01 2 0.00e+00 3 2.06e-0 2 5
8.74e+OC 4.73e+O1 1.41e+O' 9.99e+0; 0.00e+OC 3.80e+O~i 9.57e+OC 1.58e+02 8.4 9e+02 6.20e+01 1.78e+02
- 7. 50e+02 S. 71e+00 6.93e+00 1.28e+03 1.64e+O0
- 0. 00e+O0 0.00e+00 0.00e+00 1.76e+03 5.03e+OD 3.34e+O0 D.00~e+00 D.00e+00 00Oe+00 00Oe+O0
).0Oe+00
).00e+00
). 00e+00 KO00e+00 1.00~e+00 K.ile-01
'82e'02
- 59e+02
. Ble'-02
)8.74e+OC L4.73e+OJ 1.41e+OZ 0.O00e+OC 1.32e-03 0.O00e+OC I 0. 00e+OC 0.00e+OC 0.O00e+OC 0.O00e+0C
- 0. 00e+OC 0.O00e+00 0.O00e+O0
- 0. 00e+O0 O. 00e+00 0.O00e+O0 0.O00e+'00 0.O00e+00 o; 00e+O0 0.O00e+00 0.00e+00 O.O00e+00
- 0. 00e+00 o
. 00e+60 O' 00e+00
- 0. 00e+O0 o O0e+00 O. 00e+00
- 0. 0-Oe+O0
- 0. 00e+00 0.00e+00 0.O00e+00
- 0. 00e+O0 0.00e+00
- 0. 00e+00
- 0. 00e+O0 o0.00e+00 0.00e+00 08.74e+00 8.74e+00 L4.73e+01 4.73e+01 21.41e+02'1.41e+02 DO.OOe+O0 O.OOe+OO 4.88e-02 2.94e-01 1.13e+02 O.OOe+O0 I 1.22e+01 O.OOe+00 I 0.OOe+0O 8.82e+01 0.OOe+00 2.37e+02 O.OOe+00 0.OOe+0O 0.OOe+00 O.OOe+00 O.OOe+0O O.OOe+00 0.OOe+00 0.OOe+00 1.75e+01 0.OOe+0O 8.57e+02 0.OOe+O0 1.07e+00 0.OOe+OO
-O.OOe+O0 O.OOe+0O 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+OO 0.OOe+00 O.OOe+0O O.OOe+00 0.OOe+00 0.OOe+00 O.OOe+OO 0.OOe+00 O.OOe+00 O.OOe+O0 0.OOe+O0 0.OOe+00 0.OOe+0O 0.OOe+00 0.OOe+OO 0.OOe+00 O.OOe+O0 0'00e+00 O.OOe+0O 0.OOe+O0 O.OOe+0O O.OOe+O0 0.OOe+00 0.OOe+O0 '0.OOe+0O 1.27e+00 0.OOe+OO
'4.26e-02'0.00e+00 2.85e-O1'O.OOe+OO 8.12e+02 O.'OOe+00 8.82e-01 2.85e-02 5.48e-01 1.56e-02 5.88e+01O0.00e+00 8.74e+00 4.73e+01
-1.41e+02 1.81e+03 5.57e+01 1.17e+03
- 3. 05e+02 9.07e+01 2.83e+03 1.26e+03 3.35e+03 1.56e+02 1.45e+02 5.91e+02
- 8. 07e+02 2.46e-01 4.82e+00 3.40e-05
- 0. OOe+OO 3.46e+02 6.96e-l1l 1.94e-13 4.11e+03
- 1. 82e+04 2.25e+03 3.55e+03 8.49e+03 6.46e+03 2.22e-02 1.23e+03 7.07e+03 2.57e+03 8.74e+03
'1.75e+03 8.31e+02 3.44e+01 9.15e-14 1.80e+03 o. 00e+00 0.00e+.00 o0;00e+00 0.00e+00 o0.00e+00 0.00e+00 o
. 00e+00 O.O00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 o. 00e+00
- 0. 00e+00 Q.
00e+00 Q. 00e+00
- 0. 00e+00 0.00~e+00 o. 00e+00 0.00e+00 o. 00e+00 O.
00e+O0 O. 00e+00 o. 00e+O0 O.O00e+00 0.00e+00 O.
00e+00 0.00~e+00 0O. 00e+O0
- 0. 00e+O0 0.00e+00 0.00e+00 0.O00e+00 O;.00e+O0
- 0. 00e+00 0.00e+00 8.74e+00 4.73e+O1 1.41e+02 6.21e+02 2.2le-01 7.26e+O1 1.70e+00 3.69e+01.
3.25e+02 1.396.i.02 3.93e+02 3.63e+~02 2.60e+00 3.25e+O00 5.79e+02 1.14e-01 3.35e+00 4.34e+00 1.78e 8.18e+02 2.67e+i-00 2.35e+O0 7.36e+02
- 1. 55e+05'
- 1. 91e+O1 7.74e4-00 2.15e-02 3.14e-01 2.93e-04
-2.06e-03 6.16e~-03 5.4.9e:-Ol 1.29e-02 1.55eL01 6.82e4-O1 7.40e-01 2.99e-O01 6.636+00 TC-101 2.11e-02 3.05e-02 RU-103 1.54e+01 O.OOe+O0
(')Ingestion dose factor (for bone) used in calculation of Dose Commitment Factor for P-32 derived In accordance with information supplied in Reference 3.17. The teen and child bone dose ingestion dose factors were derived by the ratio of the adult bone ingestion dose factors in Reg. Guide 1.109 and 'The Importance of P-32 in Nuclear Reactor Liquid Effluents,' Branagan, E. F., Nichols, C.R., and Willis, C. A.,
USNRC, 6/82 (Ref 3.17).
Page 1 of 8
Attachment A ODCM-QA-005 Revision 2 Page 12 of 48 I
DOSE COMMITMENT FACTORS FOR THE POTABLE WATER PATHWAY (Ret. 3.15)
Release Type:
Units:
Age Group:
Pathway:
Liquid
((mrem/hr) / (lci/ml))
ADULT Potable Water (PWtr)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-105 -1.28e+Oi
. RU-106 AG-llOM TE-125M
- TE-127 TE-127M TE-129 TE-129M TE-131 TE-131M TE-132 1-130 I-131 1-132 1-133 1-134 1-135 CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141 BA-142 2.29e+0, 31.33e+0:
2.23e+OZ
- 9. 15e+OC S. 63e+0,
2.61e+OC 9.57e+02
- 1. 64e+OC 1.44e+02 2.l0e+02 6.29e+02 3.46e+02
- 1. 69e+0l
- 1. 18e+02 B. 82e+00
- 3. 69e+01 S. 18e+03 5.42e+02
- 6. 63e+03
- 4. 59e+00 8.07e+00
- 1. 69e+03 3.92e+00
- 1. 77e+00 2.08e-01
- 1. 07e-02
- 4. 06e+01 7.66~e-01 2.50e-03 5.23e-01 8.57e+00 9.90e-02
)0. 00e+01 2 0. 00e+O(
IL1. 23e+0' B. 08e+0:
3.2 9e+OC
- 2. 01e+OZ
- 1. 3 6e+02
- l.
86e+02 4.95e+02
- 4. 52e+02
- 2. 06e+02 2.40e+02 9.65e+01 1.23e+04 2.14e+03 9.07e+03
- 9. 07e+00 5.75e-03 2.12e+00 2.96e-03 1.82e-03 1.05e-01
- 4. 84e-03 5.27e-01
- l.
02e+02 1.70e+01 3.07e-01 1.04e-03 6.O5e-01 7.17e+00 9.74e-03 D0.00e+01 D 0.00e+OC L 0.00e+0(
L 6. 71e+0:
) 6.78e+0(
I1.44e+OZ L2.01e+OC 3.29e+O; L.35e+OC
.1.12e+02 t1.50e-02
- l.
57e+04 1.62e+05 I.S8e+03 3.02e+04 4.15e+02 6.3 7e+03 0.00~e+00 0.00e+00 0.00e+00 o0.00e.00 0.00e+00 0.O~e+QO 0.00Oe+00 0.O00e+00 b.00e+00 0.00e+00
- o. 00e+00 0.00e+00 0.00~e+00 0.00~e+00
- 6. 00e+00
- 0. 00e+00 0.00e+00 0.00e+00
- 1. 66e+01 4.42e+02 2.42e+0J.
IL9.07e+02
)3.73e+01
!2.29e+03
)1. 1e+01.
!3.99e+03 I 7.18e+00 7.13e+02 1.31e+03 2.90e+02 8.49ei.02 7.20e+01 3.59e+02 3. 81e+01
- 1. 55e+02 3.99e+03
- 1. 19e+03 3.08e+03 6.67e+00 5.38e-03 7.22e-01.
2.75e-03 1.54e-03
- 0. 00e+00 0.00e+00 2.45e-01 4.47e-02
- a.
01e+o1 1.77e-el
- 5. 87e-04 3.54e-01 0.00e+00 3.04e-02 0.O00e+00 0.00e+00 0.00e+00
- 0. 00e+00 0.00e+00
-0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.O00e+00
- 0. 00e+00 0.00e+00
- 0. 00e+00 0.O00e+00 0.00e+00
- 0. 00e+00 1.32e+03 1.63e+02
- l.
02e+03
- 6. 5 e-01 3.2 6e-03 1.22e+00
- 1. 68e-03
- 1. 03e-03 0.00~e+00
- 0. Ode+00
- 0. 00e+00 0.00~e+00
- 0. 00e+00 0.O00e+00 0.00Oe+00 0.O00e+00 0.00e+00 0.00e+00 7.84e+02 1.48e+04
- 5. 03e+03 8.90e+02 7.22e+02 1.89e+03
- 1. 97e+00 4.82e+03 2.32e-01 6.99e+03 6.42e+03 1.60e+02 1.31e+02 8.49e+00
- 1. 85e+02 2.09e-02
- 1. 09e+02 2.16e+02 2.43e+02 1.76e+02 3.87e-05 1.43e+01 3.48e+03
- 1. 85e-09 2.50e-18 7.70e+03 3.54e+01
- 2. 01e+03 3.79e+03 1.37e+04 3.35e+03 3.60e-10 2.90e+03 2.35e+03
- 2. 00e+03
- 0. 00e+00 0.00e+O0 0.00e+60 O.O00e+00 0.00e+00 0.00e+00 0.O00e+e00 0.O00e+00
-0.00e+00
- 0. 00e+00
- 0. O0e+00 o. Oe+00 0.00e+00
- 0. 00e+00 0.O00e+00
- 0. 00e+00 0.00e+00 0.00e+00 0.00e+00
- 0. 00e+00 0.O00e+00 0.00e+00
- 0. 00e+00 0.O00e+00 0.00e+00 0.00e+00
- 0. 00e+00
- 0. 00e+00 0.O00e+00
- 0. 00e+00 0.00~e+00 0.O00e+00 0.O00e+00 0.00e+00 o. 00e+00 5.06e-01 2.90e+01 7.32e+00 2.99e+01 1.98e+00 6.87e+O1 6.37e-01 i.S1e+02 5.18e-01 5.87e+01 1.27e+02 7.32e+01 2.84e+02 1.58e+01 6.27e+01 8.57e+00 3.56e+01 i.Ol1e+04
- 1. 54e+03 5.94e+03 4.49e+00 2.36e-01
- 1. 11e+02 1.32e-01 1.12e-01
- 2. 77e-02 2.21e-03 5.98e-02 1.12e-02 2.18e+00
~3.79e-02 1.27e-04 3.62e-02 2.50e+00 5.37e-03 LA-140 LA-142 CE-141 CE-143 CE-144 PR-143 PR-144 ND-147 W-187 NP-239 Page 2 of 8
Attachment A ODCM-QA-005 Revision 2 Page 13 of 48 DOSE COMMITMENT FACTORS FOR THE POTABLE WATER PATHWAY (Ref. 3.15)
Release Type:
Units:
Age Group:
Pathway:
Nuclide Bone Liquid
( (mrem/hr)
/ OCi /ml1)
TEEN Potable Water (PWtr)
T.iver Thvroid Kidnev Lung GI-Lli Skin TB H-3 C-14 NA-24 P-32 CR-51 MN-54 MN-56 FE-55 FE-59 Co-58 CO-60 NI-63 NI-65 CU-64 ZN-65 ZN-69 BR-83 BR-,84 BR-85 RB-86 RB-88 RB-89 SR-89 SR-90 SR-91 SR-92 Y-90 Y-91 Y-91M Y-92 Y-93 ZR-95 ZR-97 NB-95 MO-99 TC-99M TC-101 RU-103 0-.00e4-OC 2.36e+02
- l.34e+02 2.50e+0 3 o.ooe+oc
- 0. 00e+OC 0.00~e+0 0
'2.20e+02 3.41e+02 0.00e+00 o.ooe+0 0
- 1. 03e+0 4 4.3se+O 1 0.00e+00 3.3 5e+02 s.55e-01
- o. ooe+00 o0.00e+00
- 0. 00e.+00 o.0ooe+00 0.O00e+00 00Oe+00 2.56e+04
- 4. 83e+05
- 4. 69e+02
- 1. 77e+02 7.97e-01 I-' 37e+O1 7.50e-6 3
- 7. 03e-0 2 2.23e-01 2.40e+00
-. 1.38e-0 1 4.78e-01
- o. ooe+00
- 1. 93e-0 2
- 2. 09e-0 2 1.48e+O1 6.16e+OC 4.72e+03 1.34e+02 9.94 e+02 0.00e+OC I3.43e+02 I9.19e+OC 1.56e+02 7.97e+02 5.65e+02
- 1. 63e+02 7.27e+02 5.56e4-00 6.69e+00
- 1. 16e+03 l63e+00 0.00e+00
- 0. 00e+00 0.00e+00 1.73e+03 4.95e+00 3.20e+00 0.00e+00 o0.00e+00 0.00e+00 0.00e+00
- 0. 00e+O0 0.00e+00 0.00e+00 0.00e.00 O.00e+00 7.56e-01 2.73e-02 2.65e-01 3.51e+02 5.38e-02 2.98e-02 0.00e+00 6.16e+00 4.72e+01 2.34e+02
- 0. 00e+00 I1l.16e-01 0.00e+0O
- 0. 00e+00
- 0. 00e+00 O. 00e+O0
- 0. 00e+00 0.00~e+00 0.00e+00 0.O00e+00 0.O00e+00 O. O0e+0O
- 0. 00e+00 0.00e+00 O. 00e+00
- 0. 00e+00 0.00e+00 0.00e+00
- 0. 00e+00
- 0. 00e+00 0.00~e+00 0.00e+O0 0.O00e+O0
- 0. 00e+00 0.00e+00 O. 00e+00
- 0. 00e4-00 O0.0e+O0 0.O00e+O0
- 0. 00e+00
- 0. 00e+00
- 0. 00e+00 0.O00e+00 0.O00e+00
- 0. 00e+00 6.16e+00 6.16e+00 4.72e+01 4.72e+01 1.34e+02 1.34e+02 0.OOe+00 0.OOe+00 4.59e-02 2.99e-01 2102e+02 O.OOe+00 1.16e+01 0.00e+00 0.OOe+00 9.88e+01 0.OOe+00 2.51e+02 0.OOe+00 0.OOe+O0 O.00e+.00 0.OOe+00 0.OOe+0O 0.OOe+00 O.00e+00 0.OOe+00 1.69e+01 0.OOe+00 7.44e+02 0.OOe+00 1.06e+00 0.OOe+00 0:OOe+00 O.OOe+00 0.00e+0O O.OOe+00 0.OOe+O0 0.OOe+OO O.OOe+00 0.OOe+O0 0.00e+000.OOe+O0 0.OOe+00 0.OOe+00 0.00e+00-0.OOe+00 0.OOe+OO 0.OOe+00 0.00e+00 0.Oe+00 0.OOe+0O 0.00e+00 0.OOe+00 0.OOe+0O O.OOe+00 O.OOe+00 O.OOe+00 0.OOe+00 0.00e+00 0.OOe+00 0O.00e+OO 0.OOe+00 1.lle+0O 0.OOe+00 4.13e-02 0.OOe+0O 2.57e-01 0.00e+00 8.02e+02 0.00e+00 8.02e-01 2.99e-02 5.38e-01.1.81e-02 5.23e+01 0.OOe+0O 6.16e+00 4.72e+01 1.34e+02 1.35e+03 3.52e+01 7.03e+02
- 6. 05e+02 6.74e+01 1.88e+03 7.79e+02 2.13e+03 1.16e+02 3.02e+02 5.19e+02 4.92e+02
- 3. 00e+00 0.OOe+0O 0.OOe+00 0.0Oe+00 2.56e+02 4.24e-U7 4.90e-09 3.05e+03 1.35e+04 2.13e+03 4.52e+03 6.57e+03, 4.79e+03 3.54e-01 1.93e+03 6.80e+03 1.74e+03 7.38e+03 1.13e+03 6.28e+02 3.53e+01 5.09e-09 1.24e+03 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.O00e+00 0.00e+00
- 0. 00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 o. 00e+00 0.00e+O0
- 0. 00e+00 0.00e+00 0.00e+00 0.00Oe+00 0.00e+00 0.00e+00 0.O00e+00 0.00e+00 0.00e+00 0.00~e+00 O. 00e+00 0.O00e+00 0.O00e+O0 0.00~e+00 0.O00e+00 0.00e+00 0.00e+00
- 0. 00e+00 0.00e+00
-0.00e+00 0.00e+00 0.O00e+00 0.00e+O0 0.00e+00 O. 00e+O0 6.16e+00 4.72e+01 1.34e+02 6.22e+02 2.09e-01 6.80e+01 1.63e+00 3.63e+01 3.08e+02 1.30e+02 3.68e+02 3.49e+02 2.53e+00 3.15e+00 5.42e+02 1.14e-01 3.34e+00 4.20e+00 1.77e-01 8.14e+02 2.64e+00 2.26e+00 7.33e+02 1.19e+05 1.87e+01 7.56e+00 2.15e-02 3.13e-01 2.87e-04 2.03e-03 6.10e-'03 5.20e-01 1.26e-02 1.46e-01 6.69e+01 6.98e-01 2.92e-01 6.34e+00 O)Ilngestion dose factor (for bone) used in calculation of Dose Commitment Factor for P-32 derived in accordance with information supplied in Reference 3.17. The teen and child bone dose Ingestion dose factors were derived by the ratio of the adult bone ingestion dose factors in Reg. Guide 1.109 and 'The Importance of P-32 in Nuclear Reactor Liquid Effluents," Branagan, E. F., Nichols, C.R.,
and Willis, C. A., USNRC, 6/82 (Ref 3.17).
Page 3 of 8
Attachment A ODCM-QA-005 Revision 2 Page 14 of 48 DOSE COMMITMENT FACTORS FOR THE POTABLE WATER PATHWAY (Ref. 3.15)
Release Type:
Units:
Age Group:
Pathway:
Nuclide Bone Liquid
((mrem/hr)/(pCi/ml))
TEEN Potable Water (PWtr)
Liver Thyroid Kidney Lung GI-Lli Skin TB RU-105 RU-106 AG-llOM TE-125M TE-127 TE-127M TE-129 TE-129M TE-131 TE-131M TE-132 I-130 1-131 1-132 I-133 I-134 1-135 CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141 BA-142 LA-140 LA-142 CE-141 CE-143 CE-144 PR-143 PR-144 ND-147 W-187 NP-239 1.27e+0C 2.28e+OZ'
- 1. 19e+O1 2.23e+0; 9.19e+0C
- 5. 62e+02 2.60~e+OC 9.4 8e+0 2 1.62e+0O 1.42e+02 2.03e+02 5.99e+O1
- 3. 40e+02
- 1. 62e+O1
- 1. 17e+02 8.49e+00 3.55e.O1 4.87e*03 4.99e+02 6.5Sle+03 4.S1e+00
- 8. oBe+O0
- 1. 65e+03 3.90e+00 1.74e+00 2.02e-01
- 4. 05e+01 7.62e-01
- 2. 50e-03 5.45e-01 8.4 9e+00
- 1. 02e-01 0.00e+00 O.00e+00 0.00e+00O.00e+00 L1.13e+01
- 8. 02e+01 I 3.26e+0O
- l. 99e+02 I9.7le-02 3.52e+02 I6.69e-01
- 6. 80e+i01 1.2 8e+02
- 1. 73e+02 4.76e+02 4.24e+01 1.98e+02 2.25e+O1 9.13e+O1
- 1. 15e+04
- 1. 97e+03 8.66e+03 8.66e+OO 5.69e-03 2.02e+00 2.9le-03 1.74e-03 9.94e-02
- 4. 62e-03 5.16e-01 9.94e+01 1.67e+01 3.04e-01
- 1. 02e-03
- 5. 93e-01 6.92e+00
- 9. 65e-03 0.00e+00
- 6.22e+01 6.34e+00 1.34e+02
- 1.
86e+00 3.06e+02 1.25e+00
- 1. 02e+02 1.3Se+02 1.41e+04 1.39e+i05 1.43e4-03 2.. 77e+04 3.7Se+02 S.87e+03 o0.00e+00 o0.00e+00 0.00~e+00 0.00e+O0 o. 00e+O0 0.00e+O0 0.00e+00 o0.00e+00 o. 00e+O0 0.00e+00 0.00e+00 0.00e+00 o0.00e+O0 0.00e+O0 o0.00e+00
- 0. 00e+00 0.00e+00
- 0. 00e+O0 1.60e+01 4.40e+02 2.15e+01
- 0.
OOe+O0 3.72e+01 2.28e+03
- 1. 09e+01 3.97e+03 7.09e+00 7.09e+02 1.23e+03 2.67e+02 8.20e+02 6.69e+01 3.48e+02 3.55e+01 1.44e+02 3.64e+03 1.07e+03 2.95e+03 6.40e+00 5.36e-03 6.86e-01 2.70e-03 1.47e-03 O.OOe+00
- 0. OOe+00 2.43e-01 4.46e-02 l.OOe+01 1.77e-01
- 5. 87e-04 3.48e-01 0.OOe+O0 3.03e-02 O.OOe+O0 O.OOe+O0
- 0. OOe+O0
- 0. OOe+O0
- 0. OOe+O0 0.OOe+00 O.OOe+OO O.OOe+OO O.OOe+0O O. OOe+00 0.OOe+0O 0.OOe+OO
- 0. OOe+0O O.OOe+00
- 0. OOe+OO 0.OOe+O0
- 0. OOe+OO 1.39e+03 1.69e+02 1.15e+03 7.44e-01 3.92e-03 1.36e+00 1.99e-03 1.16e-03 0.00e+00
- 0. OOe+O0
- a. OOe+00 O. OOe+O0 O. OOe+OO 0.OOe+0O
- 0. OOe+OO 0.OOe+0O O.OOe+OO O. OOe+00
- 1. 02e+03
- 1. 09e+04
- 3. 17e+03 6.57e+02 7.09e+02 1.40e+03 1.42e+01 3.56e+03 1.33e-01 5.46e+03 4.07e+03 1.33e+02 9.42e+O1
- 1. 85e+01 1.50e+02 2.97e-01
- 1. 01e+02 1.42e+02 1.58e+02 1.23e+02 3.93e-03 7.21e401 2.55~e+03 8.3 le-06 5.34e-12 5.71e+03 1.41e+02 1.4 8e.03 2.99e.03
- 1. 02e+04 2.51e+03 2.76e-06 2.14e+03
- 1. 87e+03 1.55e+03 O;00e+bO 0.OOe+OO 0.OOe+00 0.OOe+O0 O.OOe+OO 0.OOe+00 0.OOe+00 O.OOe+OO 0.OOe+00 0.OOe+00 O. 00e+00
- 0. OOe+OO O.OOe+00 O.00e+OO O. OOe+0O O.OOe+00 O.OOe+OO O.OOe+00 0.OOe+OO O.OOe+0O O.OOe+O0 O.OOe+O0 0.OOe+O0 O.OOe+00 O.OOe+O0 0.OOe+O0 O.OOe+00 0.OOe+0O O.OOe+OO O.00e+OO O.OOe+0O O.OOe+OO O.OOe+O0 O.OOe+OO O.OOe+OO 4.92e-01
- 2. 87e+01 6.86e+00-2.98e+O1 1.98e+O0 6.69e+O1 6.34e-01 1.50e+02
- 5. 07e-01 S. 67e+O1 1.21e+02 6.92e+O1 2.56e+02 1.52e+01
- 6. 05e+O2.
B.0O8e+00 3.38e+01 S.31e+03 1.32e+03 3.02e+03 4.33e+00 2.35e-01
- 1. 06e+02 1.30e-01
- 1. 07e-01 2.65e-02 1.15e-03 5.93e-02 1.11e-02
- 2. 17e+O0 3.79e-02 1.27e-04 3.55e-02 2.42e+00 S.36e-03
_ I Page 4 of 8
Attachment A ODCM-QA-005 Revision 2 Page 15 of 48 DOSE COMMITMENT FACTORS FOR THE POTABLE WATER PATHWAY (Ref. 3.1 5)
Release Type:
Units:
Age Group:
Pathway:
Liquid
((mrem/hr) / (yCi/ml))
CHILD Potable Water (PWtr)
Nuclide Bone Liver
- Thyroid Kidney Lung I GI-Lli Skin TB H-3 C-14 NA-24 P-32 CR-51 MN-54 MN-56 FE-55 FE-59 CO-58 CO-60 NI-63 NI -65 CU-64 ZN-65 ZN-69 BR-83 BR-84 BR-85 RB-86 RB-88 RB-89 SR-89 SR-90 SR-91 SR-92 Y-90 Y-91 Y-91M Y-92 Y-93 ZR-95 ZR-97 NB-95 MO-99 TC-99M TC-101 RU-103 o.o0e+01 7.03e+0:
3.37e+0:
7.44e+0.
- 0. 00e+01 0.0Oe+o0 0.OOe+O(
6.69e+0O 9.59e+0Z
- 0. OOe+OC 0.0Oe+OC 3.13e+04 1.29e+02 0.OOe+OC 7.97e+02 22.55e+OC
- 0. OOe+OO
- 0. OOe+OO O. 006+00 0.OOe+00
- 0. OOe+00
!0. OOe+00 7.67e+04 9.88e+05 1.40e+03 5.25e+02 2.39e+00 3.50e+01 2.22e-02 2.09e-01 6.63e-01 6.74e+00 4.06e-01 1.31e+00 0.OOe+00 5.37e-02 6.22e-02 4.25e+01 D 1.18e+03 2 1.41e+02 2 3.37e+02 3.2.24e+03
) 0.00e+OC
) 6.22e+02
) l.94e+01 I3.55e+02
!,1.55e+03
)1.05e+02
)3.08e+02 i1. 67e+03
!1.22e+01 I1.42e+01 t2.12e+03 3.68e+00 I0.O00e+00 I0.O00e+00
- 0.
00e+00 3.90e+03
-1.,10e+O1 6.80Oe+00
- 0. 00e+00
- 0. 00e+00
- 0. 00e+00 0.00~e.00
- 1. O5e-01 6.51e-02 0.00e+00 1.18e+01 1.18e+01 1.41e+02,1.41e+02 3.37e+02 3 0.OOe+00 I 2.87e-01 0.OOe+00 L 0.OOe+00 0.00e+00
- 0. OOe+00
- 0. OOe+00 0.00e+00
- 0. OOe+0O 0.OOe+00 0.OOe+00 0.OOe+00 0.00e+00 0.OOe+00 0.0Oe+00 0.OOe+00 0.OOe+00 0.0Oe+00 0.OOe+00
- 0. 00e+0O 0.OOe+00 0.0Oe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.0Oe+00
- 0. OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.00e+00 0.OOe+00 3.37e+02 0.OOe+00 7.85e-02 1.74e+02 2.35e+01
- 0. OOe+00 0.OOe+00 O.OOe+00
- 0. OOe+00 O. OOe+00
- 0. OOe+00 3.44e+01 1.-34e+03 2.23e+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.0Oe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 2.12e+00 8.43e-02 4.78e-01 1-. 65e+03 1.53e+00 1.18e+01 1.18e+01 1.41e+02 1.41e+02 3.37e+02.3.37e+02 0.OOe+00 1.33e+03 5.24e-01 2.74e+01 0.OOe+00 5.22e+02 0.OOe+00 2.Ble+03 2.01e+02 6.57e+01 4.50e+02 1.62e+03 0.OOe+00 6.10e+02 0.OOe+00 1.70e+03 0.OOe+00 1.13e+02 0.OOe+00 1.49e+03 0.0OOe+00,6.69e+02 0.OOe+00 3.73e+02 0.OOe+00 2.32e+02 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+0O 2.5le+02 0.OOe+00 5.42e-01 0.OOe+00 5.93e-02 0.00e+00 2.97e+03 0.OOe+00 1.33e+04 0.Ooe+00 3.08e+03 0.OOe+00 9.94e+03 0.OOe+00 6.80e+03 0.OOe+00 4.66e+03 0.OOe+00 4.35e+01 0.OOe+00 6.05e+03 0.OOe+00 9.88e+03 0.0Oe+00 1.55e+03 0.OOe+00 8.90e+03 0.OOe+00 9.42e+02 0.OOe+00 6.40e+02 5.34e-02 5.99e+01 0.O00e+.00
- 0. 00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+O0 0.00e+00 0.O0e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00
,0.00e+00
,,O O0e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 1.18e+01 1.41e+02 3.37e+02
- 1. 85e+03 5.17e-01
- 1. 66e+02 4.38Be+00,
~1. 10e+02 -
7.73e+02 3.20e+02 9.07e.02 1.O06e+03 7.09e+00 8.60e+O0 1.32e+03 3.40e-01 9.94e+00 1zl5e+01 5.30e-01 2.40e+03 7.67e+00-6.O05e+00 2.19e+03 2.51e+05 5.27e+01 2.10e+01 6.40e-02 9.36e-01 8.08e-04 5.99e-03 1.82e-02 0.ooe+00 1.32e+00 0.00e+00 3.47e-02
.0.OOe+00,3.64e-01
.0.OOe+00 1.91e+02 0.OOe+00 1.74e+00 0.ooe+00 8.26e-01 0.OOe+00 1.63e+01 1.11e+00' 3.44e-02 1.07e+02 0.00e+00 2.07e-01
- l. lOe+03 O1)lngestion dose factor (for bone) used in calculation of Dose Commitment Factor for P-32 derived In accordance with information supplied in Reference 3.17. The teen and child bone dose ingestion dose factors were derived by the ratio of the adult bone ingestion dose factors in Reg. Guide 1.109 and uThe Importance of P-32 in Nuclear Reactor Liquid Effluents," Branagan, E. F., Nichols, C.R.,
and Willis, C. A., USNRC, 6/82 (Ref 3.17).
Page 5 of 8
Attachment A ODCM-QA-005 Revision 2 Page 16 of 48 DOSE COMMITMENT FACTORS FOR THE POTABLE WATER PATHWAY I
(Ref. 3.15)
Release Type:
Units:
Age Group:
Pathway:
Liquid
((mrem/hr)/(,tCi/ml))
CHILD Potable Water (PWtr)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-105 RU-106 AG-11OM TE-125M TE-127 TE-127M TE-129 TE-129M TE-131 TE-131M TE-132 I-130 I-131 1-132 I-133 1-134 1-135 CS-134 CS-136 CS-13.7 CS-138 BA-139 BA-140 BA-141 BA-142 LA-140 LA-142 CE-141 CE-143 CE-144 PR-143 PR-144 ND-147 W-187 NP-239 3.75e+0
- 6. 80e+0
- 3. 13e+0 6.63e+0 2.74e+0 1.68e+0 7.79e+0C 2.83e+0:
- 4. 83e+OC 4.19e+0;
- 5. 87e+02
- 1. 70e+0 2 1.0Oe+03 4.65e+02 3.44e+02 2.44e+0l 1.02e+02 1.3 6e+04 1.37e+03 1.90e+04 1.33e+01 2.41e+01 4.83e+03 1.16e+01 5.08e+00 5.87e-01 3.05e-02 2.31e+00 4.06e-01 1.21e+02 2.28e+00 7.50e-03 1.62e+00 2.49e+01 3.05e-01 0.00e+O000.O00e+OC 0.00e+00 0.00e+OC 2.12e.01'0O.00e+OC 2 1.80e+O L 7.38e+0(
3-4.52e+O2 02.17e+OC I 7.91e+02 D1.47e+OC 21.45e+02 2 2.60e+02 3.43e+02 3 1.Ole+03 L 8.55e+01 4.26e+02 4.52e+01 1.83e+02 2.23e+04 3.76e+03 1.82e+04
- 1. 84e+01 1.28e-02 4.23e+00 6.51e-03 3.66e-03 2.05e-01 9.71e-03 1.15e+00 2.20e+02 3.79e+01 6.86e-01 2.32e-03 1.31e+00 1.48e+01 2.19e-02
- 1. 86e+02 31.90e+03 4.02e+02 5.56e+00 9.13e+02 I 3.69e+00 2.98e+02 3.78e+02
- 3. 78e+04 3.33e+05 3.97e+03 7.91e+04 1.04e+03
- 1. 62e+04 0.00e+00 0.00~e+00
- 0. 00e+00 0.00e+00 0.00e+00 0.00e+O0 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.O00e+00 0.O00e+O0
- 0. 00e+O0
- 0. 00e+00 0.00e+O0 0'.
00e+00 O.
00e+00
- 0. 00e+00 3.30e+01 9.19e+02 I 3.94e+01 o.ooe+OC 7.79e+01 4.79e+03 I 2.28e+01 8.31e+03 1.46e+01 1.40e+03 2.41e+03 5.13e+02 1.65e+03 1.31e+02 7.09e+02 6.92e+01 2.81e+02 6.92e+03 2.00e+03 5.93e+03 1.30e+01 1.12e-02 1.38e+00
- 5. 63e-03 2.96e-03
- 0. OOe+00 0.0Oe+00 5.05e-01 9.24e-02
- 2. 10e+01 3.72e-01 1.23e-03 7.21e-01
- 0. OOe+00 6.34e-02
- 0.00e+00
- 0.00e+00
- 0.00e+00 0.00e+00
- 0.O00e+00 0.00e+00
- 0. O0e+00
- 0. 00e+00
- 0. 00e+00 0.00e+00 0.00e+00 0.00~e+00 0.00e+00 0.00e+O0
- 0. O0e+00 0.00e+00 0.00e+00 2.48e+03
- 2. 98e+02
- 2. 13e+03 1.40e+00 7.56e-03 2.52e+O0 3.83e-02
- 2. 15e-03 0.00e+00
- 0. 00e+O0
- 0. 00e+00 0.00e+00 0.00e+O0
- 0. 00e+00
- 0. 00e+00
- 0. 00e+O0
- 0. 00e+00
- 0. 00e+O0 2.45e+03 1.06e+04 2.52e-i03'
- 6. 40e+02-
- 1. 07e-i03 1.36e+03 4.85e+02 3.45e+03 2.53e+O1 5.87e+03
- 2. 62e+03
- 1. 60e+02 8.95e+01 1.Ole+02 1.72e+02 3.00e-i01 1.40e+02 1.20e+02 1.32e+02 1.14e+02 8.49e+O0 1.39e+03 2.45e+03 6.63e+00 6.63e-02 5.72e+03
- 1. 92e+03 1.44e+03 3.23e+03
- 9. 88e+03 2.47e+03 4.99e+00
- 2. 08e403
- 2. 08e+03
- l. 62e+03 0.00e+00 0.00~e+00 0.00e+00 0.00e+00 O.O00e+00 0.00e+00 0.00e+00 0.00e+00
- 0. 00e.00
- 0. 00e+00 0.00e+00
- 0. O0e+00 0.00e+O0 0.00e+00 0.00e+00 0.00e+O0 0.00e+00 0.00e+00 0.00~e+00 0.00e+00 0.00e+00
- 0. 00e+00 0.00e+00 0.O00e+00 0.00e+00 0.00e+00
- 0. 00e+00 0.00e+00 0.00e+O0
- 0. O0e+00
- 0. 00e+00 0.00e+00 0.00e+00
- 0. 00e+00
- 0. 00e+00 1.36e+00
- 8. 49e+01
- 1. 69e+01
- 8. 84e+01
- 5. 87e+00
- 1. 99e+02
- 1.
85e+00 4.40e+02 1.44e+O0 1.54e+02 3.14e+02
- 1. 77e+02 S.72e+02 3.93e+O1
- 1. 61e+02
- 2. 08e+01
- 8. 66e+01 4.71e+03 2.43e+03 2.69e+03
- 1. 17e+01 6.98e-01
- 2. 82e+02 3.78e-01 2.84e-01 6.92e-02
- 3. 04e-03 1.7le-01 3.19e-02 6.45e+00 1.13e-01.
3.77e-04 1.02e-01
- . 63e+00 1.54e-02 Page 6 of 8
Attachment A ODCM-QA-005 Revision 2 Page 17 of 48 DOSE COMMITMENT FACTORS FOR THE POTABLE WATER PATHWAY I
(Ref. 3.15)
Release Type:
Units:
Age Group:
Pathway:
Liquid
((mrem/hr) / (uCi/ml))
INFANT Potable Water (PWtr)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 C-14 NA-24 P-32 CR-51 MN-54 MN-56 FE-55 FE-5s9 CO-SB CO-60 NI-63 NI-65 CU-64 ZN-65 ZN-69 BR-83 BR-84 BR-85 RB-86 RBi-88 RB-89 SR-89 SR-90 SR-91 SR-92 Y-90 Y-91 Y-9lM Y-92 Y-93 ZR-95 ZR-97 NB-95 MO-99 TC-99M TC-101 RU-103 o.ooe+OO 1.16e+02 8.92e+02 1.90e+02 3.80e+02 3.80e+02 6.40e+04 3.76e+03 o.ooe+OO 0.00e+00 0.OOe+OO 7.49e+02 o.ooe+OO 3.08e+01 5.23e+02 3.38e+02 1.16e+03 2.02e+03 0.00e+OO 1.35e+02 0.00e+OO 4.06e+02 2.39e+04 1.47e+03 1.77e+02 2.00e+01 0.00e+OO 2.29e+01 6.92e+02 2.37e+03 3.51e+00 6.32e+00 o.oOe+00 0.OOe+0O O.OOe+OO 0.OOe+0O O.OOe+OO O.OOe+O0 1.16e+01 1.16e+01
!.90e+02 l.90e+02 3.80e+02 3.80e+02 0.OOe+00 0.OOe+O0 3.46e-01 7.56e-02 O.OOe+0O 1.66e+02 0.OOe+00 2.64e+01
!0.OOe+0O 0.OOe+00 O.OOe+00 0.OOe+0O O.OOe+O0 0.OOe+0O O.OOe+00 O.OOe+OO 0.OOe+00 0.OOe+O0 0.OOe+0O 0.OOe+OO 0.OOe+00 3.87e+01 0.OOe+00 1.15e+03 0.OOe+00 2.63e+00 0.OOe+0O 0.OOe+00 0.OOe+OO O.OOe+O0 0.OOe+O0 0.OOe+O0 0.OOe+0O 0.OOe+O0 0.OOe+00 O.OOe+00 0.OOe+O0 0.OOe+O0 O.OOe+O0 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+0O 0.OOe+00 0.OOe+00 0.OOe+OO 0.OOe+00 O.OOe+00 0.OOe+00 0;OOe+00 0.OOe+OO 0.OOe+00 0.OOe+0O 0.OOe+00 0.OOe+00 0.OOe+00 2.04e+00 0.OOe+00 9.63e-02 0.OOe+00 4.66e-01 0.OOe+O0 l.91e+03 0.OOe+00 1.60e+00 0.00e+00 1.28e+00 0.00e+00 1.16e+02 1.16e+01 1.90e+02 3.80e+02 0.00e+0O 6.73e-01 0.OOe+OO 0.OOe+00 1.65e+02 5.98e+02
-0.0Oe+0O
- 0. OOe+0O 0.OOe+0O
- 0. OOe+0O 0.OOe+00
- 0. OOe+0O 0.OOe+00 0.OOe+0O 0.OOe+0O 0.OOe+OO O. OOe+0O
- 0. OOe+00
- 0. OOe+00 O. OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+OO
- 0. OOe+0O
- 0. OOe+O0
- 0. OOe+00
- 0. OOe+O0 0.OOe+00
- 0. OOe+00 O.OOe+00 O.OOe+00 7.79e-02
- 5. 87e-02
- 0. OOe+00
- 1. 16e+01
- 1. 90e+02 3.80e+02 I8.65e+02
- 1. 55e+01 2.75e+02 2.80e+03 4.29e+01 9.67e+02 3.37e+02 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+O0
- 0. OOe+O0
- 0. OOe+00 0.OOe+0O 0.OOe+00 0.OOe+O0 0.Ooe+00 9.67e+02 0.00e+00 7.34e+01 0.OOe+0O 1.52e+03 -0.OOe+00 4.70e+02 0.OOe+0O
-2.01e+03 0.00e+00 5.15e+02-0.OOe+00 o.00ee-O0 o..00e+00
- o. o~e+00 9.44e+04
-6.99e+05 1.88e+0 3 7.22e+02 3.27e+00 4.25e+01
- 3. 05e-0 2
- 2. 88e-01 9.14e-01
- 7. 75e+00 S. 57e-01' 1.58e+00
- 0. 00e+00 7.22e-02 8.54e-02 5.57e+01 6.40e+03 1.87e+01
- 1. 08e+01 0.OOe+0O O.OOe+00
-0.OOe+00 0.OOe+O0 0.OOe+00 O.OOe+00 0.OOe+O0 0.0Oe+00 0.OOe+00 1.89e+00 9.56e-02 6;51e-01 1.28e+03 1.49e-01 1.08e-01 0.OOe+00 0.OOe+00 0.OOe+O0 0.OOe+00
- 1. 64e+02
- 1. 82e+01 3.66e+00 1.94e+03 8.69e+03 2.23e+03 7.79e+03 4.51e+03 3.05e+03
-1. 02e+02 5.49e+03 7.22e+03 9.40e+02 6.09e+03 5.49e+02 4.21e+02 4.33e+01 1.83e+01 6.77e+02 0.OOe+00 0.OOe+O0 0.OOe+0O O. OOe+00
- 0. OOe+0O 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 1.16e+01 1.90e+02
- 3. 80e+02 2.4 8e+e03 S.30e-01
- 1.70e+02 5.30e+00
- 9. 03e+Oi 7.98e+02 3.38e+02 9.59e+02 8.28e+02
- 9. 10e+00 2.O0Ge+0 I
- 1. 09e+03 4.70e-01 1.37e+01
,1.44e+01 7.30e-01 3.16e+03
- 1. 03e+02.
7.41e+00 2.71e+03 1.77e+05
- 6. 81e+01 2.68e+O1 8.77e-02
- 1. 13e+O0 1.04e-03 8.09e-03 2.49e-02 1.34e+00 4.36e-02 3.76e-01.
2.49e+02 1.92e+00 1.06e+00
- 1. 86e+01 Page 7 of 8
Attachment A ODCM-OA-005 Revision 2 Page 18 of 48 I
DOSE COMMITMENT FACTORS FOR THE POTABLE WATER PATHWAY (Ref. 3.15)
Release Type:
Units:
Age Group:
Pathway:
Liquid
((mrem/hr)/(juCi/ml))
INFANT Potable Water (PWtr)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-105 RU-106 AG-llOM TE-125M TE-127 TE-127M TE-129 TE-129M TE-131 TE-131M TE-132 1-130 1-131 1-132 1-133 1-134 I-135 CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141 BA-142 LA-140 LA-142 CE-141 CE-143 CE-144 PR-143 PR-144 ND-147 W-187 NP-239
- 5. 12e+01 9.07e+0:
3.75e+0' 8.77e+0; 3.76e+0:
2.20e+0'
- 1. 07e+0]
3.76e+03 6.62e+OC 5.72e+O;
- 7. 82e+O; 2.26e+02 1.35e+03 6.24e+01 4.70e+02 3.27e+01 1.37e+02 1 42e+04 1.73e+03
- 1. 96e+04
- 1. 81e+01 3.31e+01 6.43e+03
- 1. 60e+01 6.92e+00 7.94e-01 4.14e-02 2.96e+00 5.57e-01 1.12e+02
- 3. 06e+00 1.03e-02 2.08e+00 3.40e+01 4.18e-01 D0.00e+OC 2 0.00e+OC L 2.73e+03 2.2. 93e+02 L 1.26e+03 3 7.30e+02 L 3.68e+00 I 1.29e+03 2.45e+00 2.30e+02 3.87e+02 4.97e+02 1.59e+03
- 1.27e+02
- 6. 85e+02
- 6.70e+01 2.72e+02 2.64e+04
- 5. 08e+03 2.30e+04 2.94e+01 2.20e-02 6.43e+00 1.09e-02 S. 76e-03 3.13e-01 1.52e-02 1.81le+00 3.69e+02 4.59e+01
- 1. 14e+00 3.99e-03
- 2. 14e+O0 2.36e+02
- 3. 74e-02 0.O00e+00 0.00e+00 0.O00e+00 2.95e+02 3.06e+01 6.36e+02 S. 895e+00 1.44e+03 5.91e+00 4.66e+02
- 5. 72e+02 5.57e+04 5.23e+05 S.94e+03
- 1. 25e+05 1.56e+03 2.44e+04
- 0. 00e+00
- 0. 00e+00
- 0. 00e+00 0.00e+00 0.00~e+00
- 0. 00e+00 0.00e+00 o0.00e+00 0.O00e+00 0.O00e+00
- 0. 00e+00
- 0. 00e+00
- 0. 00e+00
- 0. 00e+00
- 0. 00e+00
- 0. 00e+00
- 0. 00e+00
- 0. 00e+00 3.76e+01
- 1. 07e+03 3.91e+01 0.00e+00 9.18e+01 5.42e+03 2.66e+01 9.40Oe+03
- 1. 69e+O1 1.58e+03 2.42e+03 5.45e+02 1.86e+03 1.41e+02
- 8. 05e+02 7.49e+01 3.04e+02
- 6. 81e+03 2.02e+03 6.17e+03 1.47e+01 1.32e-02 2.53e+00 6.58e-03 3.31e-03
- 0. 00e+00 0.00e+00 5.57e-01 1.08e-01
- 1. 85e+01 4.25e-01 1.44e-03 8.24e-01 0.00e+00 7.45e-02
- 0. 00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.O00e.00 0.00e+00
- 0. 00e+00 0.00e+00
- 0. 00e+00
- 0. 00e+00 o0.00e+00 0.00e+00
- 0. 00e+00 0.O00e+00 0.00e+00 2.79e.03 4.14e+02
- 2. 50e+03 2.29e+00 1.33e-02
- 3. 95e+00 6.66e-03 3.4 8e-03
- 0. 00e+00
- 0. 00e+00
- 0. 00e+00 0.O00e+00 0.00Oe+00 0.00Oe+00
- 0. 00e+00
- 0. 00e+00
- 0. 00e+00
- 0. 00e+00 2.04e+03 6.88e+03 1.42e+03 4.18e+02 7.90e+02 8.88e+02 8.54e+02 2.25e+03 2.67e+02 3.87e+03 1.43e+03 1.06e+02 5.68e+01 1.03e+02 1.16e+02 6.92e+01 9.86e+01 7.19e+01 7.71e+01 7.19e+01 4.70e+01 2.10e+03 1.58e+03 1.95e+02 2.86e+01 3.68e+03 2.58e+03 9.33e+02 2.16e+03 6.43e+03 1.61e+03 1.85e+02 1.35e+03 1.39e+03 1.08e+03
- 0. 00e+00
- 0. 00e+00 0.00~e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.O00e+00
- 0. 00e+00 0.O00e+00
- 0. 00e+00
- 0. 00e+00
- 0. 00e+00
- 0. 00e+00 0.00e+00 0.00e+00 0.O00e+00
- 0. 00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00~e+00 0.00e+00
- 0. 00e+00
- 0. 00e+00 0.00e+00
- 0. 00e+00 0.00e+00 0.00e+00 0.00~e+00 0.O00e+00
- 0. 00e+00 0.00e+00
- 0. 00e+00 1.72e+00 1.13e+02 1.81e+01 1.19e+02 8.09e+00 2.66e+02 2.49e+00 5.79e+02 1.86e+00 1.90e+02
- 3. 62e+02 1.99e+02 7.00e+02
- 4. 51e+01
- 2. 01e+02 2.38e+01 9.93e+01 2.67e+03
- 1. 90e+03
- 1. 63e+03 1.43e+01 9.59e-01 3.3le+02
- 5. 04e-01 3.41e-01 8.05e-02 3.64e-03 2.13e-01 4.21e-02 6.28e+00 1.52e-01 5.19e-04 1.3le-01 8.16e+00
- 2. 1le-02 Page 8 of 8
Attachment B ODCM-QA-005 Revision 2 Page 19 of 48 DOSE COMMITMENT FACTORS FOR THE FISH PATHWAY (Ref. 3.15)
Release Type:
Units:
Age Group:
Pathway:
Liquid
((mrem/hr)/(yCi/mi))
ADULT Fresh Water Fish -
Sport (FFSP)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB Hi-3 C-14 NA-24 P-32 CR-51 MN-54 MN-56 FE-55 FE-59 CO-58 CO-60 NI-63 NI-65 CU-64 ZN-65 ZN-69 BR-83 BR-84 BR-85 RB-86 RB-88 RB-89 SR-89 SR-90 SR-91 SR-92 Y-90 Y-91 Y-9lM Y-92 Y-93 ZR-95 ZR-97 NB-95 MO-99 TC-99M TC-101 RU-103 o.OOe+00 3.13e+04 4.07e+02 2.15e+05 o.OOe+00 0.OOe+O0 O.OOe+00 6.58e+02
- 1. 04e+03 0.OOe+O0
- 0. OOe+00 3.11e+04 1.26e+02 0.OOe+00 2.32e+04 4.93e+01 O.OOe+00 0.OOe+00 O. OOe+00 O.00e+00 0.00e+00 0.OOe+00 2.21e+04 5.44e+05
- 4. 07e+02
- 1. 54e+02 5.76e-01 8.44e+00 5.44e-03
- 5. 06e-02 1.60e-01 2.40e-01 1.33e-02 4.47e+02 0.OOe+00 8.87e-03 9.12e-03 4.43e+00 2.26e-01 6.26e+03 4.07e+02 B. 62e+04 0.O00e+00 4.3 8e+03
- 1. 10e+02 4.55e+02 2.44e+03 8.92e+01 2.56e+02 2.16e+03 1.64e+01 9.97e+00 7.37e+04 9.43e+i01 0.00e+00 0.O00e+00
- 0. 00e+00
- 1. 01e+05 2.90e+02 2.26e-01 2.26e-01 6.26e+03 6.26e+03 4.07e+02 4.07e+02 2.26e-01 2.26e-01 6.26e+03 6.26e+03 4.07e+02 4.07e+02 0.00e+00
- 7. 61e-01.
0.O00e+O0 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00~e+00 0.00e+00 0.00e+00 0.00~e+00 0.O00e+00
- 0. 00e+00 0.00~e+00 0.00e+00 0.00e+00 0.OOe+00 0.OOe+0O 1.56e+05 2.81e-01 1.69e+00 3.20e+02 1.30e+03 0.00e+00 1.34e+04 1.40e+02 0.OOe+O0 3.51e+03 0.OOe+OO 2.54e+02 2.61e+02 0.OOe+0 6.82e+02 8.14e+03 O.OOe+00 0.OOe+00 1.81e+03 0.OOe+00 0.OOe+00 4.81e+03 0.OOe+00 0.OOe+00 4.50e+02 0.OOe+00 0.OOe+00 4.17e+02 2.51e+01 0.OOe+00 8.50e+02 4.93e+04 0.OOe+00 4.64e+04 6.13e+01 0.OOe+00 1.42e+01 0.OOe+O0 0.OOe+00 5.82e+01 0.OOe+00 0.OOe+00 4.11e-04 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 1.99e+04 0.OOe+00, 0.OOe+00 4.00e-09 0.00e+00 0.OOe+O0 1.12e-11 0.OOe+00 0.OOe+00 3.55e+03 0.OOe+00 0.OOe+00 1.57e+04 0.00e+00 0.00e+00 1.94e+03 0.OOe+00 0.OOe+00 3.06e+03 0.oOe+00 0.OOe+00 6.10e+03 0.OOe+00 0.OOe+00 4.64e+03 0.OOe+00 0.OOe+00 1.60e-02 0.OOe+00 0.OOe+00 8.86e+02 0.OOe+00 0.OOe+00 5.09e+03 1.21e-01 0.OOe+00 2.44e+02 4.04e-03 0.OOe+0O 8.30e+02 2.46e+02 0.OOe+00 1.51e+06 2.34e+02 0.OOe+0O 2.39e+02 3.81e-01 1.23e-02 1.48e+01 2.37e-01 6.72e-03 3.95e-14 1.69e+01 0.OOe+00 5.17e+02 O.O00e+00 0.O00e+00 0.O00e+00 O. O0e+00
- 0. 00e+00 0.O00e+00
- 0. 00e+00 0.O00e+00 0.O00e+O0 I0.O00e+00 0.O00e+00
- 0. 00e+00
- 0. O0e+00 0.00e+00 0.O00e+00
- 0. 00e+06 I0.O00e+00 1.92e+02-0.00e+00 0.00e+00,0.00Oe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O. OOe+00 0.OOe+00 0.OOe+00 7.70e-02 2.68e-03 2.48e+02
- 1. 03e+02 2.51e-02 1.31e-02 0.OOe+00 0.00e+00 0.00e+00 0.00~e+00 0.00e+00
- 0. 00e+00
,0.00e+00 0.00e+O0
- 0. 00e+00 0.00e+00 0.00e+00 0.O00e+00 0.00e+00 0.00~e+00 0.00e+00 0.00e+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+00
- 0. OOe+OO O. OOe+00 O.O00e+OO 2.26e-01 6.26e+03 4.07e+02 5.36e+04 1.27e+00 8.35e+02 1.95e+01 I.06e+02 9.36e+02
- 2. 00e+02 5.65e+02 1.04e+03 7.49e+00 4.68e+00 3.33e+04 6.56e+00 4.04e+01 5.24e+01 2.15e+00 4.71e+04 1.54e+02
- 1. 35e+02 6.35e+02 1.34e+05 1.64e+01 6.68e+00 1.54e-02 2.26e-01 2.11e-04 1.48e-03 4.43e-03 5.21e-02 1.22e-03 1.34e+02 1.96e+01 3.19e-01 1.29e-01 l.91e+00 1Ingestion dose factor (for bone) used in calculation of Dose Commitment Factor for P-32 derived in accordance with information supplied in Reference 3.17. The teen and child bone dose ingestion dose factors were derived by the ratio of the adult bone ingestion dose factors in Reg.
Guide 1.109 and *The Importance of P-32 in Nuclear Reactor Liquid Effluents," Branagan, E. F.,
Nichols, C.R., and Willis, C. A., USNRC, 6/82 (Ref 3.17).
Page 1 of 8
Attachment B ODCM-QA-005 Revision 2 Page 20 of 48 DOSE COMMITMENT FACTORS FOR THE FISH PATHWAY I
(Ref. 3.15)
Release Type:
Dose Factor:
Age Group:
Pathway:
Liquid
((mrem/hr) / (ftCi/ml))
ADULT Fresh Water Fish -
Sport (FFSP)
Nuclide Bone RU-105 RU-106 AG-llOM TE-125M TE-127 TE-127M TE-129 TE-129M TE-131 TE-131M TE-132 1-130 1-131 1-132 1-133 I-134 1-135 CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141 BA-142 LA-140 LA-142 CE-141 CE-143 CE-144 PR-143 PR-144 ND-147 W-187 NP-239 3.69e-0 6.58e+C 8.81e-0 2.57e+0
- 1. 05e+0 6.48e+O
- 3. 01e+0 1.lOe+O 1.89e+0 1.66e+0 2.41e+0 2.71e+0 1.49e+0 7.29e+0 5.10e+0 3.81e+01 1.59e+0:
2-.98e+0!
3.12e+0O 3.82e+0!
2.64e+0 9.29e-0 1.94e+0 4.51e-0 2.04e-0 1.50e-01 7.66e-0:
2.24e-0:
3.95e-0O
- 1. 17e+OC 5.51e-03 1.80e-03 3.76e-02 2.96e+02 2.85e-02 Liver Thyroid Kidney Lung GI-Lli Skin TB 1 O.OOe+00 0.OOe+00 4.76e+00 O.OOe+00 2.26e+02 0.OOe+00 1.46e-01 1 0.OOe+00 0.OOe+O0 1.27e+02 0.OOe+00 4.26e+03 0.OOe+00 8.33e+00 1 8.15e-01 0.OOe+00 1.60e+00 0.OOe+O0 3.33e+02 0.OOe+00 4.84e-01 3 9.30e+02 7.72e+02 1.04e+04 0.OOe+00 1.02e+04 0.OOe+0O 3.44e+02 2 3.78e+01 7.80e+01 4.29e+02 0.OOe+00 8.31e+03 0.OOe+00 2.28e+01 3 2.32e+03 1.66e+03 2.63e+04 0.OOe+00 2.17e+04 0.OOe+0O 7.90e+02 1 1.13e+01 2.31e+01 1.26e+02 0.OOe+00 2.27e+01 0.OOe+0O 7.33e+00 4 4.11e+03 3.78e+03 4.60e+04 0.OOe+00 5.55e+01 0.OOe+0O 1.74e+03 17.88e+00 1.55e+01 8.26e+01 0.OOe+O0 2.67e+00 0.OOe+00 5.96e+00 3 8.10e+02 1.28e+03 8.21e+03 0.OOe+00 8.04e+04 0.OOe+00 6.75e+02 3 1.56e+03 1.72e+03 1.50e+04 0.OOe+00 7.38e+04 0.OOe+0O 1.47e+03 1 8.01e+01 6.79e+03 1.25e+02 0.00e+00 6.89e+01 0.OOe+00 3.16e+01 2 2.14e+02 7.00e+04 3.66e+02 0.OOe+00 5.64e+01 0.OOe+00 1.22e+02 0 1.95e+01 6.82e+02 3.11e+01 0.OOe+0O 3.66e+00 0.OOe+00 6.82e+00 1 8.87e+01 1.30e+04 1.55e+02 0.OOe+OO 7.97e+01 0.OOe+00 2.70e+01 0 1.03e+01 1.79e+02 1.64e+01 0.OOe+00 9.01e-03 0.OOe+O0 3.70e+00 1 4.17e+01 2.75e+03 6.68e+01 O.OOe+00-4.70e+01 0.OOe+00 1.54e+01 5 7.09e+05 0.OOe+00 2-.29e+05 7.61e+04 1.24e+04 0.OOe+00 5.79e+05 4 1.23e+05 0.OOe+00 6.85e+04 9.38e+03 1.40e+04 0.OOe+0O 8.86e+04 5 5.22e+05 0.OOe+00 1.77e+05 5.89e+04 1.Ole+04 0.OOe+0O 3.42e+05 2 5.22e+02 0.OOe+00 3.84e+02 3.79e+01 2.23e-03 0.OOe+00 2.59e+02 L 6.62e-04 0.Oe+00 6.19e-04 3.75e-04 1.65e+00 0.OOe+00 2.72e-02 2 2.44e-01 O.OOe+00 8.31e+00 1.40e-01 4.00e+02 O.OOe+0O 1.27e+01 1 3.41e-04 0.OOe+00 3.17e-04 1.93e-04 2.13e-10 0.OOe+00 1.52e-02 L 2.10e-04 0.OOe+00 1.77e-04 1.19e-04 2.87e-19 0.OOe+00 1.28e-02 L 7.54e-02 0.OOe+00 0.OOe+00 0.OOe+00 5.54e+03 0.OOe+O0 1.99e-02 3 3.48e-03 0.OOe+O0 0.OOe+00 0.OOe+00 2.54e+01 0.OOe+00 8.68e-04 21.52e-02 0.OOe+O0 7.04e-03 0.OOe+00 5.79e+01 0.OOe+00 1.72e-03 32.92e+00 O.DOe+00 1.29e-03 0.OOe+0O 1.09e+02 0.OOe+00 3.23e-04 I 4.88e-01 0.OOe+O0 2.90e-01 0.OOe+00 3.95e+02 0.OOe+00 6.27e-02 L 2.21e-01 0.OOe+00 1.27e-01 0.OOe+O0 2.41e+03 0.OOe+00 2.73e-02 3 7.48e-04 0.OOe+00 4.22e-04 0.OOe+00-2.59e-10 0.OOe+O0 9.16e-05 L 4.35e-01 0.OOe+00 2.54e-01 0.OOe+00 2.09e+03 0.OOe+00 2.60e-02 2.47e+02 0.OOe+00 0.OOe+00 0.OOe+00 8.10e+04 0.OOe+0O 8.65e+01 2.80e-03 0.OOe+00 8.74e-03 0.OOe+00 5.75e+02 0.OOe+00 1.54e-03 Page,2 of 8
Attachment B ODCM-QA-005 Revision 2 Page 21 of 48 DOSE COMMITMENT FACTORS FOR THE FISH PATHWAY (Ref. 3.1 5)
I Release Type:
Units:
Age Group:
Pathway:
Liquid
((mrem/hr)/(j(Ci/m1))
TEEN Fresh Water Fish -
Sport (FFSP)
TAutv Thvroid Kidnev Lunq GI-Lli
-Skin TB Nuclide
,n r
=WA&_
CR-51 MN-54 MN-56 FE-55 FE-59 CO-58 CO-60 NI-63 NI-65 CU-64 ZN-65 ZN-69 BR-83 BR-84 BR-85 RB-86 RB-88 RB-89 SR-89 SR-90 SR-91 SR-92 Y-90 Y-91 Y-91M Y-92 Y-93 ZR-95 ZR-97 NB-95 MO-99 TC-99M TC-101 RU-103 0.00e+00 1.74e-01 3.41e4-04 6.81e+03 4.20e+02 4.20e+02 2.35e+OS 9.36e+04 0.00e+OO 0.00e+0O 0.00e+00 4.30e+03 0.00e+00 1.15e+02 6.89e+02 4.89e+02 1.07e+03 2.50e+03 o.00e+00 8.86e+O1 0.00e+00 2.56e+02 3.23e+04 2-.28e+03 1.37e+02 1.75e+01 o.ooe+00 1.05e+01 2.10e+04 7.30e+04 5.36e+O1 1:02e-+02 0.00e+00 0.00e+00 0.O0e+00 0.O0e+00 O.O0e+00 0.00e+00 o.ooe400 1.09e+05 o.00e+00 3.lle402 o.ooe+00 2.01e+02 2.41e+04 0.00e+00 4.54e+05 0.00e*00 4.42e+02 0.00e4-00 i.67e+02 0.00e+00 6.25e-01 0.00e+00 9.17e+00 0.00e+00 5.88e-03 0.00e+00 5.52e-02 0.00e+00 1.75e-01 0.00e+00 2.48e-01 7.-82e-02 1.43e-02 -2.82e-03 4.50e+02 2.50e+02 0.00e+00 1.10e+02 9.08e-03 2.53e-02 9.85e-03 1.40e-02 4.65e+00 0.00e+00 1.74e-01
- 6. Ble+03 4.20e+02 0.00e+00
- 7.30e-01 0.00e+00 0.00e+00 0.00e+00
- 0. 00e+00 0.00e+00
- 0. 00e+00 0.O00e+O0 0.00e+00 0.00e+00 0.00e+00 0.00e+00
- 0. 00e+00 0.O00e+00 0.O00e+00 0;00e+O0
- 0. 00e+00 0.00e+00 0.00e+00
- 0. 00e+00 o. 00e+00 0.O00e+00 0.00e+00 0.00e+00 0.DOe+00 o. 00e+00 0O. 00e+00 0.O00e+00 0O.'00e+00
.,0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 1.74e-01 6.81e+03 4.20e+02 0.OOe+00 2.88e-01 1.28e+03 1 46e+02 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00
,0.OOe+00 2.65e+01 4.67e+04 6.68e+01 0.OOe+00 0.0 0e+00
- 0. OOe+00 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+00 O. OOe+00 0.OOe+00 1.15e-01 4.28e-03 2.42e+02 2.52e+02 3.78e-01 2.53e-01 1.64e+01 1.74e-01 6.81e+03 4.20e+02 0.OOe+00 1.88e+00
-0.OOe+00 0.OOe+00 3.10e+02
- 7. 88e+02
- 0. OOe+00
- 0. OOe+00 0.OOe+00 O. OOe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. 00e+00
- 0. OOe+00 0.00e+00 0.OOe+00
- 0. 00e+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.00e+00 0.OOe+00 O. OOe+00
- 0. OOe+00 0.OOe+00 0.Ooe+00 1.41e-02 8.54e-03 0.OOe+00 1.74e-01 0.OOe+00 6.81e+03 0.OOe+00 4.20e+02 0.OOe+00 1.27e+05 0.OOe+00 2.21e+02 0.OOe+00 8.83e+03 0.OOe+0O 7.59e+03 0.OOe+00 2.12e+02 0.OOe+00 5.91e+03 0.OOe+00 1.22e+03 0.OOe+00 3.34e+03 0.OOe+00 3.63e+02 0.OOe+00 9.47e+02 0.OOe+00 8.14e+02 0.OOe+00
-3.09e+04 0.OOe+00 1.88e+02 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00-0.OOe+00 1.61e+04 0.OOe+00 2.66e-05 0.00e4-00 3.08e-07 0.OOe+00 2.87e+03 0.OOe+O0 1.27e+04 0.OOe+00 2.00e+03 0.OOe+00 4.25e+03 0.OOe+00 5.15e+03 O.OOe+00 3.76e+03 0.OOe+00 2.78e-01 0.OOe+00 1.51e+03 0.OOe+00 5.34e+03 0.00e+00 1.81e+02 0.OOe+00 7.64e+02 0.OOe+00 1.07e+06 0.OOe+00 1.97e+02 0.OOe+00 1.66e+01 0.OOe+00 2.39e-09 0.OOe+00 3.89e+02 0.OOe+00 1.74e-01 6.81e+03 4.20e+02 5.86e+04-1.31e+00 8.54e+02 2.O05e+01
- 1. 14e+02 9.65e+02 2.04e+02 5.77e+02-
- 1. 09e+03 7.95e+00 4.93e+00 3.40e+04
- 7. 15e+00 4.40e+01 S.5S3e+01 2.34e+00 S.11e+04
- 1. 66e+02 1.42e+02
- 6. 89e+02 1.12e+O5 1.76e+01
- 7. lle+00 1.68e'-02 2.46e-01 2.25e-04 1.60e-03 4.79e-03 5.38e-02
-1.30e-03 1.37e+02
- 2. 10e+02.
3.28e-01 1.38e-01
- 1. 99e+00 VW,
"')lngestion dose factor (for bone) used in calculation of Dose Commitment Factor for P-32 derived in accordance with information supplied in Reference 3.17. The teen and child bone dose ingestion dose factors were derived by the ratio of the adult bone ingestion dose factors in Reg.
Guide 1.109 and *The Importance of P-32 in Nuclear Reactor Liquid Effluents,: Branagan, E. F.,
Nichols, C.R., and Willis, C. A., USNRC, 6/82 (Ref 3.17).
Page 3 of 8
Attachment B ODCM-QA-005 Revision 2 Page 22 of 48 DOSE COMMITMENT FACTORS FOR THE FISH PATHWAY I
- (Ref. 3.15)
Release Type:
Units:
Age Group:
Pathway:
Liquid
((mrem/hr)/(,iCi/m1))
TEEN Fresh Water Fish -
Sport (FFSP)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-105 RU-106 AG-1OM TE-125M TE-127 TE-127M TE-129 TE-129M TE-131 TE-131M TE-132 I-130 I-131 I-132 I-133-I-134 I-135 CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141 BA-142 LA-140 LA-142 CE-141 CE-143 CE-144 PR-143 PR-144 ND-147 W-187 NP-239 3.98e-01 O.OOe+OO O.OOe+0O 7.15e+01 O.OOe+OO O.OOe+O0 8.60e-01 8.14e-01 O.OOe+O0 2.79e+03 1.Ole+03 7.81e+02 1.15e+02 4.09e+01 7.95e+01 7.06e+03 2.50e+03 1.68e+03 3.27e+01 1.22e+01 2.33e+01 1.19e+04 4.41e+03 3.84e+03 2.04e+01 8.39e+00 1.57e+01 1.78e+03 8.54e+02 1.28e+03 2.55e+03 1.61e+03 1.70e+03 2.82e+01. 8.15e+01 6.65e+03 1.60e+02 2.24e+02 6.54e+04 7.63e+00 2.00e+01 6.73e+02 5.50e+01 9.33e+01 1.30e+04 3.99e+00 1.06e+01 1.76e+02 1.67e+01 4.30e+01 2.76e+03 3.05e+05 7.19e+05 O.OOe+OO 3.13e+04 1.23e+05 O.OOe+OO 4.09e+05 5.44e+05 O.OOe+0O 2.83e+02 5.44e+02 O.OOe+OO l.Ole+OO 7.14e-04 O.OOe+OO 2.07e+02 2.54e-01 O.0Oe+OO 4.90e-01 3.66e-04 O.OOe+O0 2.18e-01 2.18e-04 O.OOe+O0 1.59e-01 7.80e-02 O.OOe+OO 8.16e-03 3.63e-03 O.OOe+OO 2.43e-02 1.62e-02 O.OOe+OO 4.29e'-03 3.12e+00 0.OOe+OO 1.27e+00 5.25e-01 O.OOe+OO 5.97e-01 2.38e-01 O.OOe+OO 1.96e-03 8.03e-04 O.OOe+O0 4.28e-01 4.65e-01 O.OOe+OO 3.20e+02 2.60e+02 O.OOe+O0 3.21e-02 3.03e-03 O.OOe+OO
- 5. 02e+00 1.38e+02 1.55e+00
- 0. OOe+OO 4.67e+02
- 2. 86e+04 1.37e+02 4.98e+04 8.90e+01 8.90e+03 1.55e+04 1.26e+02 3.86e+02
- 3. 15e+01 1.64e+02
- 1. 67e+01 6.79e+01 2.28e+05 6.71e+04
- 1. 85e+05
- 4. 01e+02 6.73e-04 8.61e-02 3.39e-04 1.85e-04 O. OOe+O0 O. OOe+00 7.62e-03 1.40e-03 3.14e-01 1.39e-01 4.61e-04 2.73e-01 O. OOe+O0 9.50e-03 O.OOe+OO O.OOe+OO O.OOe+O0 O.OOe+OO O.OOe+O0 O.OOe+OO O.OOe+O0 O.0Oe+00 O.OOe+O0 O.OOe+O0 O.OOe+OO O.0Oe+OO O.OOe+O0 O.OOe+O0 O.OOe+OO O.OOe+O0 O.OOe+O0 8.72e+04 1.06e+04 7.19e+04 4.67e+01 4.92e-04 1.71e-01 2.50e-04 1.45e-04 O.OOe+0O 0.OOe+00 O.OOe+O0 0.OOe+OO 0.OOe+OO
- 0. OOe+O0 O. OOe+O0 0.OOe+00 O.OOe+00 0.OOe+00 3.21e+02 3.43e+03 2.29e+02 8.24e+03 8.90e+03 1.76e+04 1.79e+02 4.47e+04 1.67e+00 6.85e+04
- 5. 11e+04 6.27e+01 4 :43e+01 8.70e+00 7.06e+01 1.40e-01 4.76e+01 8.94e+03 9.92e+03 7.73e+03 2.47e-01
- 9. 05e+00 3.20e+02 1.04e-06 6.70e-13 4.48e+03
- 1. lOe+02 4.63e+01 9.38e+01 3.19e+02 1.97e+03 2.16e-06
- 1. 68e+03 7.05e+04 4.87e+02 0.O00e+00 O.00e+-0O 0.00e+O0
- 0. 00e+O0 O.O00e+00 0.O00e+00 0.00e+O0 0.00e+00 0.00e+00 o0.00e+00 0.00e+00 0.00e+00
- 0. 00e+O0 o0.00e+00 0.00e+00 o0.00e+00 0.00e+00 0.00e+00 0.00e+O0 o. 00e+00 o. 00e+00 o. O0e+00 o0.00e+O0
- 0. 00e+00 0.00e+00 0.00e+00 0.00e+O0 o. 00e+O0 0.00e+O0 o0.00e+00
- 0. 00e+O0 0.00e+00 0.00e+00 o. O0e+00
- 0. 00e+O0 1.54e-01 9.01e+00 4.95e-01 3.74e+02 2.48e+01 8.39e+02 7.95e+00 1.88e+03 6.36e+00 7.12e+02 1.52e+03 3.26e+01 1.20e+02 7.17e+00 2.85e+01
- 3. 80e+00 1.59e+01 3.33e+05 8.28e+04 1.89e+05 2.72e+02 2.95e-02 1.34e+01 1.63e-02 1.34e-02 2.07e-02 9.03e-04
- 1. 86e-03 3.48e-04 6.82e-02 2.97e-02 9.94e-05 2.79e-02 9.13e+01 1.68e-03
-I~
Page 4 of 8
Attachment B ODCM-QA-005 Revision 2 Page 23 of 48 DOSE COMMITMENT FACTORS FOR THE FISH PATHWAY (Ref. 3.15)
Release Type:
Units:
Age Group:
Pathway:
Liquid
((mrem/hr)/(j(Ci/ml))
CHILD Fresh Water Fish -
Sport (FFSP)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB H-3 C-14 NA-24 P-32 CR-51 MN-54 MN-56 FE-SS FE-59 CO-58 CO-60 NI-63 NI-65 CU-64 ZN-65 ZN-69 BR-83 BR-84 BR-85 RB-86 RB-88 RB-89 SR-89 SR-90 SR-91 SR-92 Y-90 Y-91 Y-91M Y-92 Y-93 ZR-95 ZR-97 NB-95 MO-99 TC-99M TC-101 RU-103
- 0.
o0e4-00 4.38e+04 4.s6e+02
- 3. 02e+OS 0.00e+00 0.00~e+00 0.O0e+00
- 9. 05e+02
- 1. 3 oe+03 0.0 0e+00
- 0. 00e+00 4.23e+04 1.75e+02
- 0. O0e+00 2.16e+04
-6.
89e+01
- 0. 00e+00
- 0. O0e+0 0
- 0. 00e+00
- 0. 00e+00 0.O0e+00
- 0. 00e+00
- 3. 11e+04 4.01e+0S S. 66e+02 2.13e+02
- 8. O8e-01
- 1. 18e+01-7.S1e-03 7.08e-02 2.24e-01 3.01e-01
- 1. 81e-02 S.31e+02' 0.00e+00 1.09e-02 1.26e-02 S.75e+00 1.44e-01 S. 76e+03
'4.56e+02 9.lIle+04 0.O00e+00 3.37e+03
,1 0e+02 4.80e+02 2.3l0e+03 7.08e+02
,208e+02 2.27e+03
- 1. 64e+01 9.64e+00 5.74e+04 9:96e+01 O.200e+00 0.00e+00 0.0Oe+00 1.O05e+05 2.99 e+02 1.84e+02
- 0. 00e+00 0.00e+00 0.O00e+00,
- 0. 00e+00 0.00e+00 0.00~e.00
- 0. 00e+00
- 0. 00e+00 0.00e+00 6.62e-02 2.62e-03 1.44e-01 8.76e+03 4.56e+02 0.0Oe+00 7.77e-01 0.OOe+00 0.0Oe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 O.OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00 0 OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe4OO 0.OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.0Oe+O0 1.44e-01 1.44e-01 8.76e+03 8.76e+03 4.56e+02 4.56e+02 0.OOe+00 0.OOe+00 2.12e-01 1.42e+00 9.44e+02 O.OOe+00 1.27e+02 0.OOe+00 0.OOe+00 2.71e+02 0.OOe+00 6.09e+02 0.OOe+00 0.OOe+00 0.OOe+0O 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 2.33e+01 0.OOe+00 3.62e+04 0.OOe+00 6.04e+01 0.OOe+00 0.OOe+00 0.OOe+00 0.00e+00 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+OO 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 0.OOe+0O0O.OOe+00 0.OOe+00 0.OOe+0O 0.OOe+00 0.OOe+00
-0.OOe+00 0.00e+00 0.OOe+00 0.OOe+00 0.00e+00 0.OOe+00 0.OOeOO 0.OOe+00 0.OOe+00 0.00e+00 9.47e-02 0.00e+00
-3.76e-03 0.OOe+00 1.94e+02 0.00e+00 2.23e+02 0.00e+00 3.10e-01 1.08e-02 2.25e-01 6.99e-03 1.45e+01 0.OOe+00 1.44e-01 8.76e+03 4.56e+02 5.38e+04 7.43e+01 2.83e+03 1.52e+04 8-.89e+01 2.19e+03 4.13e+02 1.15e+03 1.53e+02
- 2. 01e+03 4.52e+02 1.01e+04 6.28e+03 0.OOe+00 0.OOe+00 0.OOe+00 6.78e+03 1.47e+01 1.60e+00 1.21e+03 5.40e+03 1.25e+03 4.04e+03 2.30e+03 1.58e+03 1.47e+01 2.05e+03 3.34e+03 6.90e+01
-3.97e+02 3.82e+05 8.65e+01 1.22e+01 4.20e-02 1.49e+02 0.00e+00 1.44e-01.
0.00e*00 8.76e+03 0.00e+00 0.00e+O0 0.00e+00 0.00e+00 0.00e+00
'O. e+00
'O. e+00 0.00e+00
,0
.0e+00 0'
.TOe+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00
- 0. 00e+00 o0.00e+00
.0.700e+00 0.00e+00 0.O00e+00 0.00e+00 0.00e+00 0.00e+00
- 0. 00e+00 0.00e+00 0.00~e+00
- 0. 00e+00 0.00e+00 0.00e+00
- 0. 00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00
- 0. 00e+00 0.00e+00 0.00~e+O0 4.56e+02 7.50e+04 1.40e+00 8.97e+02 2.37et*01 1.49e+02
- 1. 05e+03 2.17e+02 6.14e+02 1.44e+03 9.60e+00 5.82e+00 3.57e+04 9.20e+00 S. 65e+01 6.S4e+0l 3.01e+00 6.48e+04 2.08e+02
- 1. 64e.02 S. 90e+02
-1.
02e+05 2.14e403.
98.54e+00 2.16e-02 3.17e-O01 2.73e-04 2.03e-03 6.16e S5.89e-02 1.55e-03 1.48e+02 2.59e+i01 3.54e-01 1.68e-01 2.21e+00 2.07e+02 0.OOe+00 1.05e+02 0.00e+00 2.14e-02 0.OOe+00 1.32e-02 0.OOe+00 0.OOe+00 0.OOe+00 (1)Ingestion dose factor (for bone) used in calculation of Dose Commitment Factor for P-32 derived in accordance with information supplied in Reference 3.17. The teen and child bone dose ingestion dose factors were derived by the ratio of the adult bone ingestion dose factors in Reg.
Guide 1.109 and ^The Importance of P-32 in Nuclear Reactor Liquid Effluents," Branagan, E. F.,
Nichols, C.R., and Willis, C. A., USNRC, 6/82 (Ref 3.17).
Page 5 of 8
Attachment B ODCM-QA-005 Revision 2 Page 24 of 48 DOSE COMMITMENT FACTORS FOR THE FISH PATHWAY I
(Ref. 3.15)
Release Type:
Units:
Age Group:
Pathway:
Nuclide Bone Liquid
((mrem/hr)/( QCi/ml))
CHILD Fresh Water Fish - Sport (FFSP)
Liver Thyroid Kidney Lung GI-Lli Skin TB RU-105 RU-106 AG-llOM TE-125M TE-127 TE-127M TE-129 TE-129M TE-131 TE-131M TE-132 I-130 I-131 I-132 I-133 1-134 1-135 CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141 BA-142 LA-140 LA-142 CE-141 CE-143 CE-144 PR-143 PR-144 ND-147 W-187 NP-239 5.07e-01 0.OOe+00 0.OOe+00 9.20e+01 0.OOe+00 0.OOe+00 9.75e-01 6.59e-01 0.OOe+00 3.59e+03 9.72e+02 1.Ole+03 1.48e+02 4.00e+01 1.03e+02 9.O9e+03 2.45e+03 2.17e+03 4.22e+01 1.18e+01 3.01e+01 1.53e+04 4.28e+03 4.94e+03 2.61e+01 7.96e+00 2.00e+01 2.27e+03 7.83e+02 1.61e+03 3.18e+03 1.41e+03 2.05e+03 3.45e+01 6.96e+01 7.67e+03 2.03e+02 2.04e+02 6.75e+04 9.44e+00 1.73e+01 8.05e+02 6.99e+01 8.64e+01 1.60e+04 4.94e+00 9.18e+00 2.11e+02 2.06e+01 3.72e+01 3.29e+03 3.68e+05 6.04e+05 0.00e+00 3.70e+04 1.02e+05 0.OOe+0O 5.14e+05 4.92e+05 0.00e+00 3.59e+02 4.99e+02 0.OOe+00 1.30e+00 6.95e-04 0.OOe+00 2.61e+02 2.29e-01 0.OOe+00 6.29e-01 3.52e-04 0.OOe+00 2.75e-01 1.98e-04 0.OOe+O0 1.99e-01 6.94e-02 0.OOe+00 1.03e-02 3.28e-03 0.OOe+00 3.12e-02 1.56e-02 0.OOe+00 5.50e-03 2.98e+00 0.OOe+00 1.64e+00 5.13e-01 0.00e+00 7.73e-01 2.32e-01 0.OOe+00 2.54e-03 7.85e-04 0.OOe+00 5.49e-01 4.44e-01 0.OOe+00 4.05e+02 2.40e+02 0.OOe+0O 4.13e-02 2.97e-03 O.OOe+0O 4.46e+00 1.24e+02 1.23e+00
- 0.
OOe+00 4.22e+02 2.59e+04 1.23e+02 4.50e+04 7.90e+01 7.58e+03 1.31e+04 1.04e+02 3.35e+02 2.65e+01 1.44e+02 1.40e+01 5.70e+01 1.87e+05 5.41e+04 1.60e+05 3.51e+02 6.07e-04 7.46e-02' 3.05e-04
- 1. 60e-04 0.OOe+00 0.00e+00
- 6. 83e-03 1.25e-03
- 2. 84e-01 1.26e-01 4.15e-04 2.44e-01 0.OOe+OO 8.57e-03
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. 00e+00
- 0. OOe+00 0.OOe+00
- 0. OOe+0O
- 0. OOe+00 6.72e+04
- 8. 07e+03
- 5. 77e+04 3.78e+01 4.09e-04
- 1.37e-01 2.07e-03 1.16e-04 0.OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 3.31e+02 1.43e+03 7.83e+01 3.46e+03 S. 79e+03 7.36e+03 2.62e+03
- 1. 87e+04 1.37e+02
- 3. 18e+04 1.42e+04 3.26e+01 1.82e+01 2.04e+01 3.48e+01 6.09e+00 2.83e+01 3.26e+03 3.57e+03 3.08e+03 2.30e+02 7.52e+01 1.32e+02 3.59e-01 3.59e-03
- 1. 94e+03 6.51e+02 1.94e+01 4.37e+01 1.34e+02 8.34e+02 1.69e+00 7.04e+02 3.37e+04 2.19e+02 0.OOe+00 0.OOe+OO 0.OOe+00 0.OOe+O0 0.OOe+OO 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+OO 0.OOe+0O 0.OOe+0O 0.OOe+OO
- 0. OOe+OO 0.OOe+OO 0.OOe+00 0.OOe+O0 0.OOe+00 0.OOe+00 0.OOe+00 O. OOe+0O 0.OOe+00 0.OOe+0O 0.OOe+00 0.OOe+00 0.OOe+0O 0.OOe+00
- 0. OOe+0O
- 0. OOe+00 0.OOe+OO 0.OOe+O0 0.OOe+00
- 0. OOe+00
- 0. OOe+0O 0.OOe+0O
- 0. OOe+00 1.84e-01 1.15e+01 5.26e-01 4.78e+02 3.18e+01 1.08e+03 1.OOe+0O 2.38e+03 7.77e+00 8.34e+02 1.70e+03 3.S9e+01 1.16e+02 7.98e+00 3.27e+01 4.22e+00 1.76e+01 1.27e+05 6.58e+04 7.27e+04 3.16e+02 3.78e-02 1.53e+01 2.05e-02 1.54e-02 2.34e-02 1.03e-03 2.31e-03 4.32e-04 8.73e-02 3.83e-02 1.28e-04 3.44e-02 1.08e+02 2.08e-03 Page 6 of 8
Attachment B ODCM-QA-005 Revision 2 Page 25 of 48 DOSE COMMITMENT FACTORS FOR THE FISH PATHWAY (Ref. 3.15)
Release Type:
Units:
Age Group:
Pathway:
Liquid
((mrem/hr)/(pCi/ml))
INFANT Fresh Water Fish -
Sport (FPSP)
Nuclide Bone
, Liver Thyroid Kidney Lung GI-Lli Skin TB,
7_
H-3 C-14 NA-24 P-32 CR-51 MN-54 MN-56 FE-55 FE-59 CO-58 CO-60 NI-63 NI-65 CU-64 ZN-65 ZN-69 BR-83 BR-84 BR-85B RB-86 RB-88 RB-89 SR-89 SR-90 SR SR-92 Y-90 Y-91 Y-91M Y-92 Y ZR-95 ZR-97 NB-95 MO-99 TC-99M TC-101 RU-103
- o. ooe+00 O. OOe+O0
,,O.OOe+OO O.OOe+OO o.OOe+OO O.OOe+OO o.00e+OO O.OOe+00 O.OOe+00 O. OOe+0 0 O.OOe+O0 O.OOe+00 O.OOe+00 O.00e+00 O.OOe+0O O. OOe+OO O. 00e+00 O.0Oe+0O O.O00e+OO O. OOe+00
- 0. OOe+OO o.OOe+0O
- 0. OOe+00 O.00e+00 O.00e+00 0.OOe+00 O.OOe+0O O.O0e+0O O.OOe+00 O.OOe+00 O.OOe+OO 0.OOe+00 O.OOe+00 O.OOe+00 O. 00e+00 o.00e+00 O. 00e+00 O.OOe+OO
- 0.
OOe+00 0.OOe+00
- 0.
OOe+00
- 0.
OOe+00 0.00e+00 0.OOe+O0 0.OOe+O0
- 0.
OOe+00 0.00e+00
.0.OOe+00 D0.OOe+00-0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+O0 0.OOe+O0 0.OOe+00
)'0.OOe+00 0.OOe+00 0.00e+000.OOe+00 0.OOe+0O'0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.Oe+00 0.OOe+00 0.OOe+00 0.00e+00 0.OOe+00 0.OOe+O0 0.OOe+00 0.OOe+O0 0.OOe+O0 0.0Oe+O0 0.OOe+O0 0.OOe+O0
- 0. OOe+O0 0.OOe+000.OOe+000.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+00 '0.00e+00 0.OOe+O0 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+O0 0.OOe+000.OOe+00 0.OOe+00 O.OOe+O0 0.OOe+00 0.OOe+00 0.OOe+00'.OOe+O0 0.00e+00 0.OOe+00 O.'00e+00 O.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00'0.00e+00 0. OOe+00 O.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+O0 0.OOe+00 '0.OOe+00 0.OOe+0O 0O.00e+O0 O.00e+00 0.OOe+00 0.OOe+00 O.OOe+O0 0.OOe+00 0.00e+00 0.OOe+00 O.OOe+00 0.'OOe+00 0.OOe+00 0.OOe+00 0.OOe+O0 O.'00e+00 0.OOe+00 0.OOe+00 '0.OOe+O0 O.OOe+00 0.00e+000.OOe+OO 'O.'OOe+O0 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+O0 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00'0.OOe+00 O.OOe+00 0.OOe'+00 0.OOe+00 0.OOe+00 0.OOe+O0 0.OOe+00 0.0Oe+000.OOe+00 0.OOe+O0 O.OOe+00 0.OOe+00 0.0e+00'O.00e+O0' 0.OOe+00 0.00e+00 0.OOe+00 0.OOe+00 0.OOe+00 O.00e+00 0.OOe+00 O.OOe+00 0.OOe+O0 O.OOe+O0 0.OOe+00 0.OOe+O0 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0 OOe+00 0.OOe+00
'O.OOe+00 O. OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 O.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.0Oe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.0Oe+00
- 0. OOe+00
'0.OOe+O0 0.OOe+00 0.OOe+00 0.OOe+00 0.00e+O0 0.OOe+00 O0OOe+00
,O.00e+00 0.OOe+O0 0.OOe+O0
'O.
OOe+00 0.OOe+00 0.00e+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+O0 O. OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 O.O0e+00O
- 0. OOe+00
- 0. OOe+00 O.OOe+00 0.OOe+00.
'O.
OOe+00
- 0. 00e+00 O. OOe+OO O. 00e4-00 0.OOe+0O 0.OOe+00
- 0. OOe+O0 0.OOe+00 0.OOe+00 0.OOe+O0 O. OOe+O0
- 0. 00e+O00
- 0. OOe+0O
- 0. OOe+00 0.OOe+00-0.OOe+00'
- 0. OOe+00'-
0.OOe+O0
- 0. OOe+00
- 0. OOe+00 0.OOe+00
- 0. ooe+00 O.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+0O
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+0O 0.OOe+00 0.OOe+0O O.OOe+O00O.OOe+00 0.OOe+OO0'.OOe+O0 0.OOe+OO 0.OOe+0O 0.OOe+00'0.OOe+00 O.OOe+00 0.OOe+0O O.OOe+00 0.OOe+00 0.OOe+0O 0.OOe+O0 Page 7 of 8
Attachment B
. ODCM-QA-005 Revision 2 Page 26 of 48 DOSE COMMITMENT FACTORS FOR THE FISH PATHWAY I
(Ref. 3.15)
Release Type:
Units:
Age Group:
Pathway:
Liquid
((mrem/hr) / fpci/ml) )
INFANT Fresh Water Fish - Sport (FFSP)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-lO5 RU-106 AG-llOM TE-125M TE-127 TE-127M TE-129 TE-129M TE-131 TE-131M TE-132 1-130 1-131 I-132 1-133 1-134 1-135 CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141 BA-142 LA-140 LA-142 CE-141 CE-143 CE-144 PR-143 PR-144 ND-147 W-7187 NP-239 O. 00e+0 O. Ooe+O-o.00e+01 0.00e+01
- o. 00e+01 O.Oe+0O O.OOe+O(
O.OOe+0(
O.OOe+0(
o.OOe+OC O. ooe+Oa O.ooe+OC
- 0. 00e+OC o.ooe+OC O. 00e+0O O.OOe+0O O.OOe+00 0.OOe+00 O. 00e+00 O.00e+00 O.OOe+00 O.OOe+OO O.OOe+00
- o. ooe+00 o.OOe+00 O.OOe+OO O.OOe+00 O.OOe+00 O. OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 0.00e+OO O.00e+0O 0.OOe+00 0 0.OOe+00 0.OOe+00 O 0.OOe+00 0.OOe+00 O O.OOe+00 0.OOe+O0 O 0.OOe+00 0.ooe+00 O 0.OOe+00 0.OOe+00 0 O.OOe+00 0.OOe+00 0.OOe+000.OOe+00 O 0.OOe+00'0.OOe+00 O 0.OOe+00 0.OOe+00 0.ooe+00 0.Ooe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 I 0.OOe+00 0.OOe+00 0 O.OOe+00 0.OOe+00 I 0.OOe+00 0.OOe+00 0 O.OOe+00 O.OOe+00 0.°°e+00 0,00e+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.ooe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 I 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.DOe+00 I 0.OOe+00 0.Ooe+00 I 0.OOe+00 0.OOe+00 I 0.OOe+00 0.OOe+00 C 0.OOe+00 0.OOe+00 C 0.OOe+00 0.OOe+00 (
0.OOe+0O 0.OOe+00 C 0.OOe+00 0.OOe+0O C 0.ooe+0o 0.OOe+O0 O. OOe+00 0.OOe+0O 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+Oo 0.OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00
- o. 00e+00
- 0. ooe+00
- 0. 00e+00
- 0. ooe+0o
- 0. 00e+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00 0.00e+00
- 0. OOe+0O
- 0. OOe+OO O. OOe+O0
- 0. OOe+00 O.OOe+00 O. OOe+00 D. OOe-OO 0.OOe+00 0.OOe+0O OOe+00
).OOe+00 O.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+00 0.0 0e+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0. OOe+O0 O.OOe+0O
- 0. OOe+00 0.OOe+00 0.OOe+00 0.00e+00
- o. 00e+00
- 0. ooe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.0 0e+00
- 0. OOe+00 0.OOe+00
- 0. OOe+O0 0.0Oe+OO 0.OOe+00 0.0Oe+00 0.OOe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00 0.0O0e+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 O.OOe+00 0.OOe+00 0.OOe+O0
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+O0
- 0. OOe+00
- 0. 00e+00
- 0. OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00 0.00e+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+O0 0.OOe+00
- 0. OOe+00 0.OOe+O0
- 0. OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+0O 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+0O 0.OOe+00 0.OOe+00 0.OOe+0O 0.OOe+00 0.00e+00 0.ooe+00 0.ooe+oo 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+O0 O. OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+0O 0.OOe+0O 0.OOe+0O 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+00 0.OOe+00 0.OOe+00 O. OOe;00
- 0. OOe+00 0.OOe+00 0. OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 O. OOe+00
- 0. OOe+00
- 0. 00e+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+0O O.OOe+00 O.OOe+00
- 0. OOe+00 0.OOe+00 O. OOe+0O
- 0. OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 O.OOe+00 O.OOe+0O O.OOe+00 0.OOe+00 0.OOe+00 N
Page 8 of 8
Attachment C ODCM-QA-005 Revision 2 Page 27 of 48 DOSE COMMITMENT FACTORS FOR THE SHORELINE PATHWAY I
(Ref. 3.15)
Release Type:
Liquid Dose Factor:
((mrem/hr)/(ACi/ml))
Age Group:
ADULT Pathway:
Shoreline sediment (SHDp)
Nuclide Bone Liver -
Thyroid Kidney Lung GI-Lli Skin TB H-3 C-14 NA-24 P-32 CR-51 MN-54 MN-56 FE-55 FE-59 CO-58 CO-60 NI-63 NI-65 CU-64 ZN-65 ZN-69 BR-83 BR-84 BR-85 RB-86 RB-88 RB-89 SR-89 SR-90 SR-91 SR-92 Y-90 Y-91 Y-91M Y-92 Y-93 ZR-95 ZR-97 NB-95 MO-99 TC-99M TC-101 RU-103 o.o0e+00 O.OOe+00 0.OOe+Ot 0.00e+00 0.00e+OO O.OOe+Ot 4.27e-01 4.27e-01 4.27e-0:
0.00e+00 0.OOe+00 0.00e+OC 1.67e-01 1.67e-01 1.67e-0' 4.96e+01 4.96e+01 4.96e+O:
3.23e-02 3.23e-02 3.23e-02 0.ooe+OO 0.00e+00O0.OOe+OC 9.73e+00 9.73e+00 9.73e+OC 1.35e+Ol 1.35e+01 1.35e+01 7.67e+02 7.67e+02 7.67e+02 0.ooe+OO 0.OOe+00 0.OOe+OC 1.06e-02 1.06e-02 1.06e-02 2.17e-02 2.17e-02 2.17e-02 2.67e+01 2.67e+01 2.67e+01 0.0Oe+00 0.OOe+00 0.OOe+00 1.75e-04 1.75e-04 1.75e-04 7.27e-03 7.27e-03 7.27e-03 0.OOe+00 0.00e+00 0.OOe+00 3.21e-01 3.21e-01 3.21e-01 1.19e-03 l.19e-03 1.19e-03 4.40e-03 4.40e-03 4.40e-03 7.73e-04 7.73e-04 7.73e-04 o.OOe+00 0.OOe+00 0.OOe+00 7.67e-02 7.67e-02 7.67e-02 2.78e-02 2.78e-02 2.78e-02 1.6le-04 1.61e-04 1.61e-04 3.84e-02-3.84e-02 3.84e-02 3.59e-03 3.59e-03 3.59e-03
-6.45e-03 6.45e-03 6.45e-03 6.56e-03 6.56e-03 6.56e-03 8.73e+00 8.73e+00 8.73e+00
,.06e-01 1.06e-01 1.06e-01' 4.89e+00 4.89e+00 4.89e+00 1.43e-01 1.43e-01 1.43e-01 6.59e-03 6.59e-03 6.59e-03 7.27e-04 7.27e-04 7.27e-04 3.87e+00 3.87e+00 3.87e+00 I0. O0e+00 I0.00e+00
- 4.27e-01 I0.00e+00 1.67e-01 4.96e+01 3.23e-02
- 0. 00e+00 9.73e+00 1.35e+01 7.67e4-02 0.00e+00 1.06e-02 2.17e-02 2.67e+01
- 0. 00e+00 1.75e-04 7.27e-03
- 0. ooe+00 3.21e-01
- 1. 19e-03 4.40e-03 7.73e-04 0.00e+00
-7.
67e-02 2.78e-02 1.61e-04
- 3. 84e-02 3.59e-03 6.45e-03 6.56e-03 S. 73e+00
- 1. 06e-01 0.00e+00 0.00e+00 4.27e-01
- 0. O0e+00 1.67e-01 4.96ei-01 3.23e-02
- 0. 00e+0OO 9.73e+00 1.35e+01.
- 7. 67e+02 0.00e+00
- 0. OOe+00 0.OOe+00 4.27e-01
- 0. OOe+00 1.67e-01 4.96e+01 3.23e-02
- 0. OOe+00 9.73e+00
'1.35e+01
- 7. 67e+02 0.OOe+00 1.06e-02' ~1.06e-02 2.17e-02 2A.7e-02 2.67e+01-2.67e+01 0.00e+00 0.00e+00 1.75e-04.1.75e-04 7.27e-03
- 0. OOe+00 3.21e-01 1.19e-03 4.40e-03 7.73e-04
- 0. OOe+00 7.67e-02 2.78e-02
- 1. 61e-04 3.84e-02
'3.59e-03' 6.45e-03 6.56e-03 8.73e+00 1.06e-01 7.27e-03
- 0. OOe+00
.3.21e-01 1.19e-03 4.40e-03 7.73e-04 0.OOe+00 7.67ez02 2.78e-02 1.61e-04 3.84e-02 3.59e-03 6.45e-'03 6.56e-03 8.73e+00 1.06e-01 4.89e+00 1.43e--01 6.59e-03 7.27e-04 3.87e+00 0.OOe+00 0.OOe+00 4.96e-01 0.OOe+00 1.97e-01 5.81e+01 3.81e-02
- 0. 00e+00 1.15e+01 1.59e+01 9.07e+02 0.OOe+00 1.23e-02 2.46e-02 3.07e+01 0.OOe+00 2.53e-04 8.47e-03 0.OOe+00 3.67e-01 1.35e-03 5.28e-03' 9.O0e-04 O. OOe+00 9.OOe-02 3.09e-02 1.90e-04 4.32e-02 4.15e-03 7.67e-03 9.00e-03 1.Ole+01 1.23e-01 5.75e+00 1.65e-01 7.53e-03 B. 07e-04 4.52e+00
- 0. OOe+00 0.OOe+00 4.27e-01 0.OOe+O0 1.67e-01 4.96e+01 3.23e-02 0.OOe+00 9.73e+00 1.35e+01 7.67e+02 0.OOe+00 1.06e-02 2.17e-02 2.67e+01 0.OOe+00 1.75e-04 7.27e-03 0.OOe+00 3.21e-01 1.19e-03 4.40e-03 7.73e-04 0.OOe+00 7.67e-02 2.78e-02 1.61e-04 3.84e-02 3.59e 6.45e-03 6.56e-03 8.73e+00 1.06e-01 4.89e+00 1.43e-01 6.59e-03 7.27e-04 3.87e+00 4.89e+00 4.89e+00 1.43e-01 1.43e-01 6.59e-03 6.59e-03 7.27e-04 7.27e-04 3.87e+00 3.87e+00 Page 1 of 8
Attachment C ODCM-QA-005 Revision 2 Page 28 of 48 DOSE COMMITMENT FACTORS FOR THE SHORELINE PATHWAY I
(Ref. 3.15)
Release Type:
Liquid Units:
((mrem/hr)/(pci/ml))
Age Group:
ADULT Pathway:
Shoreline Sediment (SHDp)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-105 RU-106 AG-llOM TE-125M TE-127 TE-127M TE-129 TE-129M TE-131 TE-131M TE-132 1-130 I-131 I-132 I-133 1-134 I-135 CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141 BA-142 LA-140 LA-142 CE-141 CE-143 CE-144 PR-143 PR-144 ND-147 W-187 NP-239 2.28e-02 1.51e+Ol 1.23e+02 5.55e-0 2
- 1. 07e-0 4 3.28e-03 9.40e-04 7.07e-01 1.05e-0 3
- 9. 07e-02 2.45e+02 9.40'e+00 3.68e+02 1'.29e-0 2
- 3. 79e-03 7.33e-01 1.49e-03 1.6le-03
- 6. 87e-01 2.72e-02
- 4. 89e-01 8.27e-02
- 2. 49e+00 o.O00e+00 6.57e-OS 3.01e-01
- 8. 40e-02 6.12e-02 2.28e-02 2.28i-02 1.51e+01 1.51e+01 1.23e+02 1.23e+02 5.55e-02 5.55e-02 1.07e-04 1.07e-04 3.28e-03 3.28e-03 9.40e-04 9.40e-04
'7.07e-01 7;07e-01 1.05e-03 1.05e-03 2.87e-01 2.87e-01 1.51e-01 1.51e-01 1.97e-01 1.97e-01 6.16e-01 6.16e-01 4.45e-02 4.45e-02 8.80e-02 8.80e-02 1.60e-02 1.60e-02 9.07e-02 9.07e-02 2.45e+02 2.45e+02 5.40e+00 5.40e+O0 3.68e+02 3.68e+02 1.29e-02 1.29e-02 3.79e-03 3.79e.03 7.33e-01 7.33e-01 1.49e-03 1.49e-03 1.61e-03 1.61e-03 6.87e-01 6.87e-01 2.72e-02 2.72e-02 4.89e-01 4.B9e-01 8.27e-02 8.27e-02 2.49e+00 2.49e+00 0.OOe+00 0.OOe+00 6.57e-05 6.57e-05 3.01e-01 3.01e-01 8.40e-02 8.40e-02 6.12e-02 6.12e-02 2.28e-02 1.51e+01 1.23e+02 5.55e-02 1.07e-04 3.28e-03 9.40e-04 7.07e-01 1.05e-03 2.87e-01 1.51e-01 1.97e-01 6.16e-01 4.45e-02 8.80e-02 1.60e-02 9.07e-02 2.45e+02 5.40e+00 3.68e+02 1.29e-02 3.79e-03 7.33e-01 1.49e-03 1.6le-03 6.87e-01 2.72e-02 4.89e-01 8.27e-02 2.49e+00 0.OOe+00 6.57e-05 3.01e-01 8.40e-02 6.12e-02 2.28e-02 2.28e-02 1.51e+01 1.51e+01 1.23e+02 1.23e+02 5.55e-02 1.07e-04 3.28e-03 9.40e-04 7.07e-01 1.05e-03 2.87e-01 1.51e-01 1.97e-01 6.16e-01 4.45e-02 8.80e-02 1.60e-02 9.07e-02 2.45e+02 5.40e+00 3.68e+02 1.29e-02 3.79e-03 7.33e-01 1.49e-03 1.61e-03 6.87e-01 2.72e-02 4.89e-01 8.27e-02 2.49e+00 0.OOe+00 6.57e-05
- 3. Ole-01 8.40e-02 6.12e-02 5.55e-02 1.07e-04 3.28e-03 9.40e-04 7.07e-01 1.05e-03 2.87e-01 1.51e-01 1.97e-01 6.16e-01 4.45e-02 8.80e-02 1.60e-02 9.07e-02 2.4Se+02 5.40e+00 3.68e+02 1.29e-02 3.79e-03 7.33e-01 1.49e-03 1.61e-03 6.87e-01 2.72e-02 4.89e-01 8.27e-02 2.49e+00
- 0. OOe+00 6.57e-05 3.01e-01 8.40e-02 6.12e-02' 2.58e-02 1.81e+01 1.43e+02 7.60e-02 1.17e-04 3.87e-03 l.lle-03 8.27e-01 1.23e+00 3.39e-01 1.78e-01 2.39e-01 7.47e-01 5.24e-02 1.07e-01 1.90e-02 1.05e-01 2.87e+02 6.12e+00 4.29e+02 1.47e-02 4.26e-03 8.40e-01 1.70e-03 1.83e-03 7.80e-01 3.26e-02 5.Sle-01 9.40e-02 2.88e+00 0.OOe+Ofr 7.53e-05 3.6le-01 9.80e-02 7.07e-02 2.28e-02 1.51e+01 1.23e+02 5.55e-02
- 1. 07e-04 3.28e-03 9.40e-04 7.07e-01
- 1. 05e-03 2.87e-01 1.51e-01 1.97e-01 6.16e-01 4.45e-02
- 8. 80e-02 1.60e-02 9.07e-02 2.45e+02 5.40e+00 3.68e+02 1.29e-02 3.79e-03 7.33e-01 1.49e-03 1.61e-03 6.87e-01 2.72e-02 4.89e-01 8.27e-02 2.49e+00 0.OOe+00 6.57e-05
- 3. Ole-01 8.40e-02 6.12e-02 Page 2 of 8
Attachment C ODCM-QA-005 Revision 2 Page 29 of 48 DOSE COMMITMENT FACTORS FOR THE SHORELINE PATHWAY I
(Ref. 3.15) -
Release Type:
Units:
Age Group:
Pathway:
Liquid
((mrem/hr) / (pCi/ml))
TEEN Shoreline Sediment (SHDp)
I II I
I Nuclide - Bone Liver H-3 O.OOe+OO O.OOe+OO C-14 0.OOe+OO 0.OOe+OO NA-24 2.39e+00 2.39e+00 P-32 O.OOe+OO O.
OOe+OO CR-51 9.33e-01.9.33e-O1 MN-54 2.77e+02,2.77e+02 MN-56 1.80e-01.1.8Oe-0l FE-55
-O.OOe+OO,0.OOe+OO FE-59 5.45e+01 5.45e+01 CO-58
-7.60e+01 7.60e+01' CO 4.29e+03 '4.29e+03 NI-63 O.OOe+OO O.OOe+OO NI-65 5.93e-0 2 5.93e-02 CU-64 1.21e-01 1.21e-ol' ZN-65 1.49e+02 1.49e+02 ZN-69 0.OOe+OO O.OOe+oo' BR-83 9.73e-04 9.73e-04' BR-84 4.05e-02 4.05e-02 BR-85 0.OOe+OO O.OOe+oO RB-86 1.79e+00 1.79e+00' RB-88 6.61e-03 6.61e703 RB-89 2.45e-02 2.45e,02 SR-89 4.33e-03 4.33e-03 SR-90 O.OOe+OO O.OOe+OO SR-91 4.29e-01 4.29e-01 SR-92 1.55e-01 I.55e-01 Y-90 9.-Oe-04 9.OOe-04 Y-91 2.15e-01 2.15e-01 Y-91M 2.Ole-02 2.O1e-02 Y-92 3.6le-02 3.6le-02 Y-93 3.67e-02 3.67e-02-.
ZR-95 4.89e+01 4.89e+01, ZR-97 5.91e-01 5.91e-O1'!
NB-95 2.73e+01 2.73e+01 ;
MO-99 8.OOe-O1 B.00e-01l rC-99M 3.68e-,02 3.68e-02 rc-101 4.07e-03 4.07e-03 4 RU-103 2.17e+01 2.17e+01 O
Thyroid
- Kidney, Lung GI-Lli Skin TB O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O. OOe+OO 0.00 ~+OO O. O0e+OO 0.O0e+OO 0.O0e+OO O. Oe+OO 0.0O0e+OO 2.39e+00 2.39e+00 2.39e+00 2.39e+00 2.77e+00 2.39e+00 O.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO O.00e+OO O.O0e+OO 9.33e-01 9.33e-01 9.33e-01 9.33e-01 l.lOe+OO 9.33e-01 2.77e+02 2.77e+02 2.77e+02 2.77e+02 3.25e+02 2.77e+02 1.80e-01 1.80e-01 1.80e-01 1.80e-01 2.13e-01 1.80e-01 O.OOe+OO O.OOe+OO O.OOe+OO' O.OOe+OO O.OOe+OO O.OOe+OO 5.45e+01 5.45e+01' 5.45e+O1 5.45e+01' 6.41e+01 5.45e+01 7.60e+01 7.60e+01'7.60e+O0 7.60e+01 8.87e+01 7.60e+01 4.29e+03 4.29e+03 4.29e+03 4.29e+03 5.05e+03'4.29e+03 O.OOe+OO O.OOe+00 0.OOe+OO O.OOe+OO O.OOe+OO O.OOe+OO 5.93e-02 5.93e-02 5.93e-02 5.93e-02 6.87e-02 5.93e-02 1.21e-01 1.49e+02 O.OOe+OO
'9.73e-04
- 4. 05e-02 O. OOe+O0
'1.79e+00 6.61e-03 2.45e-02 4.33e-,03
- 0. OOe+OO 4.29e-01 1.55e-01 1.2le-01 1.49e+02 0.00e+O0 9.73e-04 4.05e-02 O.O. e+00
- i. 79e+00 6.6ie-03 2.45e-02 4.33e-03 o0.00e+00 4.29e-01 1.55e-01 1.2le-01 1.49e+02 9.00e-04' 9.00e-04 O.OOe+OO 9.73e-04 4.05e-02 0.OOe+OO 1.79e+00 6.61e-03 2.45e-02 4.33e-03 O.OOe+OO 4.29e-01.
1.55e-01'
- 9. OOe-04 2.15e-01
- 2. Oe-02 3.6le-02 3.67e-02 4.89e+01 5.91e-01 2.73e+01 8.00e-0.1 3.68e-02 4.07e-03 2.17e+01 1.21e-01 1.37e-01 1.21e-01 1.49e+02 1.72e+02 1.49e+02 0.OOe+00 '0.OOe+O0 O.OOe+OO
.9.73e' 04'1.41e-03 9.73e-04 4.05e-02 4.72e-02 4.05e-02 0.OOe+00 O.OOe+0 0.OOe+00' 1.79e+00 2.05e+00'1.79e+00 6.61e-03 7.53e-03 6.61e-03 2.45e-02 2.95e-02 2.45e-02 4'.33e-03 5.02e-03 4.33e-03 0.OOe+00 0.OOe+00 O.OOe+O0 4.29e-01 5.02e-01 4.29e-01 1.55e-01 1.73e-01 I.55e-01 9.00e-04 1.06e-03 9.00e-04 2.15e-01 2.41e-01 2.15e-01 2.01e-02. 2.32e-02 2.01e-02 3.6le-02 4.28e-02 3.61e-02 3.67e-02 5.01e-02 3.67e-02
'4.89e+01 5.67e+01 '4.89e+01 S.91e-01 6.87e'-01 5.91e-01 2.73e+01 3.21e+01 '2.73e+01 8.00e-01 9.27e-01 8.00e-01 3.68e-02 '4.21e-02 3.68e-02 4.07e-03 4.52e-03 '4.07e-03 2.17e+01 2.53e+01 2.17e+01 2.15~e-01 2.03e-02 3.6le-02 3.67e-02 4.89e+01.
5.9lie-01 2.73e+0i B. 00e-01, 3.68~e-02
- 1. 07e-03 Z. 17e+01
- 27. i5e-O01 2.01e-02 3.6lie-02 3.6E7e-02
- 4. 89e+OJ.
5.9le-01 2.73e-+0i 8.00e-0i 3.68e-02 4.07e-03 2.17e+O1 Page 3 of 8
Attachment C ODCM-QA-005 Revision 2 Page 30 of 48 DOSE COMMITMENT FACTORS FOR THE SHORELINE PATHWAY I
(Ref. 3.15)
Release Type:
Units:
Age Group:
Pathway:
Liquid
((mrem/hr)/(ACi/ml))
TEEN Shoreline Sediment (SHDp)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-105 RU-106 AG-llOM TE-125M TE-127 TE-127M TE-129 TE-129M TE-131 TE-131M TE-132 1-130 I-131 I-132 1-133 I-134 I-135 CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141 BA-142 LA-140 LA-142 CE-141 CE-143-CE-144 PR-143 PR-144 ND-147 W-187 NP-239 1.27e-O 8.47e+0 6.87e+0 3.10e-0 5.95e-0,
- 1. 83e-0 5.24e-0 3.95e+0(
- 5. 83e-0:
1.61e+OC 8.47e-0:
1.lOe+OC 3.44e+0C 2.49e-03 4.90e-0O 8.93e-02
- 5. 05e-02 1.37e+03 3.01e+01
- 2. 05e+03 7.20e-02 2.11e-02
- 4. 10e+00 8.33e-03 8.93e-03
'3.84e+00 1.52e-01
-2.73e+00 4.62e-01 1.39e+01 0.00e+00 3.67e-04 1.68e+00 4.70e-01 3.42e-01 1 1.27e-0:
1 8.47e+0:
2 6.87e+0 1 3.10e-0:
I 5.95e-04 2 1.83e-OZ 3 5.24e-03 3.95e+0C 3 5.83e-03 1.61e+OC 8.47e-01 D 1.lOe+OO I 3.44e+00 2.49e-01 L 4.90e-01 8.93e-02
- 5. 05e-01 1.37e+03 3.01e+01
- 2. 05e+03 7.20e-02 2.11e-02
-4. 10e+00 8.33e-03 8.93e-03
- 3. 84e+00 1.52e-01 2'.73e+00
- 4. 62e-01 1.39e+01 0.0Oe+00 3.67e-04 1.68e+00 4.70e-01 3.42e-01 L 1.27e-01 L 8.47e+01 2 6.87e+02 L 3.10e-01 i 5.95e-04 21.83e-02 3 5.24e-03 3.95e+00 5.83e-03 I1. Gle.00 8.47e-01 I 1.lOe+00 I 3.44e+00 2.49e-01 4.90e-01 8.93e-02
'5. 05e-01 1.37e+03
- 3. 01e+01
- 2. 05e+03 7.20e-02 2.11e-02
- 4. 10e+00 8.33e-03 8.93e-03 3.84e+00 1.52e-01 2.73e+00
- 4. 62e-01 1.39e+01 0.OOe+00 3.67e-04
- 1. 68e+00 4.70e-01 3.42e-01 L 1.27e-01 L.47e+01 6.87e+02 3.10e-01 L5.95e-04 1.83e-02 5.24e-03 3.95e+00 5.83e-03 1.61e+00 8.47e!01 1.lOe+00 3.44e+00 2.49e-01 4.90e-01 8.93e-02 5.0se-01 1.37e+03
- 3. 01e+01
- 2. 05e+03
- 7. 20e-02
- 2. 11e-02 4.10e+00 8.33e-03
- 8. 93e-03 3.84e+00 1.52e-01 2.73e+00 4.62e-01 1.39e+01 O.OOe+00 3.67e-04
- 1. 68e+00 4.70e-01 3.42e-01 1.27e-01 8.47e+01 6.87e+02 3.10e-01 5.95e-04 1.83e-02 5.24e-03 3.95e+00 5.83e-03
- 1. 61e+00 8.47e-01 1.lOe+0O 3.44e+00 2.49e-01 4.90e-01 8.93e-02 5.05e-01 1.37e+03
- 3. 01e+01
- 2. 05e+03 7.20e-02
- 2. lle-02 4.10e+00 1.27e-01 8.47e+01 6.87e+02 3.10e-01 5.95e-04
- 1. 83e-02 5.24e-03 3.95e+00 5.83e-03 1.61e+00 8.47e-01 1.lOe+00 3.44e+00 2.49e-01 4.90e-01
- 8. 93e-02
- 5. 05e-01 1.37e+03 3.01e+01
- 2. 05e+03 7.20e-02 2.11e-02 4'. 10e+00 1.44e-01
- 1. 01e+~02 S. 00e+02 4.25e-01 9.55e-04 2.17e-02 6.20e-03 4.62e+O0 6.B7e+00 1.89e+00 9.93e-01 1.34e+O0 4.17e+00 2.93e-01
- 5. 9Se-01 1.06e-01 5.89e-01
- 1. 60e+03 3.42e+01 2.39e+03 8.20e-02 2.38e-02 4.69e+00 9.47e-03
- 1. 02e-02 4.35e+00
- 1. 82e-01 3.08e+00 5.25e-01
- 1. 61e+01 O.O00e+00 4.21e-04 2.Ol1e+O0 5.46e-01 3.95e-01 1.27e-01 8.47e+01 6.87e+02 3.10e-01 5.95e-04 1.83e-02 5.24e-03 3.95e+00 5.83e-03
- 1. 61e+00 8.47e-01 1.lOe+O0 3.44e+00 2.49e-01 4.90e-01 8.93e-02 5.05e-01 1.37e+03 3.01e+01 2.05e+03 7.20e-02 2.11e-02 4.10e+00 8.33e-03 8.93e-03 3.84e+00 1.52e-01 2.73e+00 4.62e-01 1.39e+01 O.OOe+0O 3.67e-04 1.68e+00 4.70e-01 3.42e-01 8.33e-03-8.33e-03 8.93e-03 8.93e-03 3.84e+00 3.84e+00 1.52e-01 2.73e+00 4.62e-01 1.39e+01 0.0Oe+0O 3.67e-04 1.68e+00 4.70e-01 3.42e-01 1.52e-01 2.73e+00 4.62e-01 1.39e+01 0.oo e+00
- 3. 67e-04
- 1. 68e+00 4.70e-01 3.42e-01 Page 4 of 8
Attachment C ODCM-QA-005 Revision 2 Page 31 of 48 DOSE COMMITMENT FACTORS FOR THE SHORELINE PATHWAY I
(Ref. 3.15)
Release Type:
Units:
Age Group:
Pathway:
Liquid
((mrem/hr) / (pCi/ml))
CHILD Shoreline Sediment (SHDp)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli, Skin TB H-3 C-14 NA-24 P-32 CR-51 MN-54 MN-56 FE-55 FE-59 Co-s5 CO-60 NI-63 NI-65 CU-64 ZN-65 ZN-69 BR-83 BR-84 BR-85 RB-86 RB-88 RB-89 SR-89 SR-90 SR-91 SR-92 Y-90 Y-91 Y-91M Y-92 Y-93 ZR-95 ZR-97 NB-95 MO-99 TC-99M TC-101 RU-103 o.O0e+00 0.OOe+OO 0.OOe+O0 o.ooe+OOO.OOe+00 O.OOe+OO 4.99e-0l'4.99e-01 4.99e-01 0.0Oe+OO 0.00e+OO 0.OOe+OO 1.'95e-o0 1.95e-01 1.95e-01 5.79e+01 5.79e+01 5.79e+01 3.77e-02 -3.77e-02 3.77e-02 O.00e+OO 0.OOe+OO 0.00e+0o 1.14e+°l 1.-14e+01 1.14e+01 1.58e+Oi 1.58e+01 1.58e+01 9.00e+02 9.00e+02 9.00e+02 0o.00e+0O 0.OOe+00 0.00e+00 1.24e-02 1.24e-02 1.24e-02 2.53e-02 2.53e-02 2.53e-02 3.12e+01 3.12e+01 3.12e+01 o.0Oe+OO O.OOe+00 0.OOe+O0 2.03e-0 4 2.03e-04 2.03e-04 8.47e-0 3 -8.47e-03 8.47e-03 o.ooe+00 0.OOe+00 0.OOe+00 3.75e-01 3.75e-01 3.75e-01 1.38e-03 1.38e-03 1.38e-03 5.13e-03 5.13e-03 5.13e-03 9.07e-0 4 9.07e-04 9.07e-04 o.00e+0 0 O.00e+0O O.OOe+00 g.00e-02 9.00e-02 9.00e-02 3.24e-02 3.24e-02 3.24e-02 1.87e-04 1.87e-04 1.87e-04 4.48e-02 4.48e-02 4.48e-02 4.19e-03 4.19e-03 4.19e-03
'7.53e-03 7.53e-03,7.53e-03 7.67e-03 7.67e-03 7.67e-03 1.02e+01 1.02e+01 1.02e+01 1.23e-01 1.23e-01.1.23e-01 5.71e+00S5.71e+00 5.71e+00 1.67e-01 1.67e-01 1.67e-01 7.67e-03 7.67e-03 7.67e-03 8.47e-04 8.47e-04 8.47e-04 4.52e+00 4.52e+00 4.52e+00 0.00e+OO 0.OOe+0O 0.00e+00 0.OOe+O0 0.OOe+0O 0.OOe+OO 4.99e-01 4.99e-01'4.99e-01 0.00e+0O O.OOe+00 0.OOe+0O 1.95e-01 1.95e-01 1.95e-01 5.79e+01 5.79e+01 5.79e+01 3.77e-02 3.77e-02 3.77e-02 0.OOe+00 O.OOe+OO 0.OOe+O0 1.14e+01 1.14e+01 1.14e+01 1.58e+01 1.58e+01 1.58e+01 9.00e+02 9.00e+02 9.00e+02 0.OOe+OO O.OOe+00 0.OOe+O0 1.24e-02 1.24e-02 1.24e-02 2.53e-02 2.53e-02-2.53e-02 3.12e+01 3.12e+01 3.12e+01 O.OOe+0O 0.OOe+OO 0.00e+OO 2.03e-04 2.03e-04 2.03e-04 8.47e-03 8.47e-03 8.47e-03 O.OOe+OO 0.OOe+00 0.OOe+O0 3.75e-01 3.75e-01 3.75e-01 1.38e-03 1.38e-03 1.38e-03 5.13e-03 5.13e-03 5.13e-03 9.07e-04 9.07e-04 9.07e-04 0.OOe+OO O.OOe+00 0.OOe+OO 9.00e-02 9.00e-02 9.00e-02 3.24e-02 3.24e-02 3.24e-02 1.87e-04 1.87e-04 1.87e-04 4.48e-02 4.48e-02 4.48e-02 4.19e-03 4.19e-03 4.19e-03 7.53e-03 7.53e-03 7.53e-03 7.67e-03 7.67e-03 7.67e-03 1.02e+01 1.02e+01 1.02e+01 1.23e-01'1.23e-01'1.23e-;01 5.71e+00 5.71e+00 5.71e+00 1.67e-01 1.67e-01 1.67e-01 7.67e-03 7.67e-03 7.67e-03 8.47e-04 8.47e-04 8.47e-04 4.52e+00 4.52e+00 4.52e+00 O0.OOe+0O 0.OOe+00 O.O0e+OO S.79e-01 0.OOe+00 2.30e-01
'6.80e+01 4.45e-02 0.QOe+00 1.34e+01 1.85e+01 1.05e+03 0.OOe+00 1.44e-02 2.87e-02 3.59e+01 O. OOe+OO 2.95e-04 9.87e-03 O. OOe+00 4.29e-,01 1.58e-03 6.16e-03 1.05e-03 0.OOe+00 1.OSe-001 3.61e-02 2.21e-04 5.04e-02 4.85e-03 8.93e-03
'1.05e-02
- 1. 19e+01 1.44e-01 6.73e+00 1.93e-01 8.80e-03 9.47e-04 5.27e+00 0.O0e+OO 4.99e-01 O.OOe+00 1.95e-01 5.79e+01 3.77e-02
- 0. OOe+OO 1.14e+01 1.58e+01 9.00e+02 0.OOe+00 1.24e-02 2.53e-02 3.12e+01 0.OOe+00 2.03e-04
-8.47e-03 0.OOe+00 3.75e-01 1.38e-03 5.13e-03 9.07e-04
- 0. OOe+00 9.OOe-02 3.24e-02 1.87e-04 4.48e-02 4.19e 7.53e-03 7.67e-03 1.02e+01 1.23e-01 5.71e+00 1.67e-01 7.67e-03 8.47e-04 4.52e+00 Page 5 of 8
IN Attachment C ODCM-QA-005 Revision 2 Page 32 of 48 DOSE COMMITMENT FACTORS FOR THE SHORELINE PATHWAY I
(Ref. 3.15)
Release Type:
Units:
Age Group:
Pathway:
Nuclide Bone Liquid
((mrem/hr)/(pCi/ml))
CHILD Shoreline Sediment (SHDp)
Liver Thyroid Kidney Lung GI-Lli Skin TB RU-105 RU-106 AG-llOM TE-125M TE-127 TE-127M TE-129 TE-129M TE-131 TE-131M TE-132 I-130 1-131 1-132 I-133 I-134 I-135 CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141 BA-142 LA-140 LA-142 CE-141 CE-143 CE-144 PR-143 PR-144 ND-147 W-187 NP-239 2.66e-02
- 1. 76e+U1 1.43e+02 6.48e-02 1.24e-04 3.83e-03
- 1. 09e-03 8.27e-01 1.22e-03 3.35e-01 1.77e-01 2.30e-0l 7.2Oe-Ol 5.20e-02
- 1. 03e-01 1.87e-02 1.05e-01 2.87e+02 6.30e+OO 4.29e+02 1.50e-02 4.42e-03 8.60e-01 1.74e-03 1.87e-03 8.00e-01 3.17e-02 5.71e-01 9.67e-02 2.90e+00 0.0Oe+OO 7.67e-05 3.51e-01
- 9. 80e-02 7.13e-02 2.66e-02 1.76e+01 1.43e+02 6.48e-02 1.24e-04 3.83e-03 1.09e-03 8.27e-01 1.22e-03 3.35e-01 1.77e-01 2.30e-01 7.20e-01 5.20e-02
- 1. 03e-01'
- 1. 87e-02 1.0se-01
- 2. 87e+02 6.30e+00 4.29e+02 1.50e-02 4.42e-03 8.60e-01 1.74e-03 1.87e-03 8.OOe-01 3.17e-02 5.71e-01 9.67e-02 2.90e+00 0.0Oe+O0 7.67e-05 3.51e-01 9.80e-02 7.13e-02 2.66e-02 1.76e+01 1.43e+02 6.48e-02 L1.24e-04 3.83e-03 1.09e-03 8.27e-01 1.22e-03 3.35e-01 1.77e-01 2.30e-01 7.20e-01 5.20e-02 1.03e-01 1.87e-02 1.05e-01 2.87e+02 6.30e+00 4.29e+02 1.50e-02 4.42e-03 8.60e-01 1.74e-03 1.87e-03 8.00e-01 3.17e-02 5.71e-01 9.67e-02 2.90e+00 0.OOe+00 7.67e-05 3.51e-01 9.80e-02 7.13e-02 2.66e-02 1.76e+01 1.43e+02 6.48e-02 1.24e-04 3.83e-03 l.09e-03 8.27e-01 1.22e-03 3.35e-01 1.77e-01 2.30e-01 7.20e-01 5.20e-02 1.03e-01 1.87e-02
- 1. 05e-01
- 2. 87e+02 6.30e+00 4.29e+02 1.50e-02 4.42e-03 8.60e-01O 1.74e-03
- 1. 87e-03
- 8. OOe-01 3.17e-02 5.71e-01 9.67e-02 2.90e+00
- 0. OOe+OO 7.67e-05 3.51e-01 9.80e-02 7.13e-02 2.66e-02 1.76e+01 1.43e+02 6.48e-02 1.24e-04 3.83e-03 l.09e-03 8.27e-01 1.22e-03 3.35e-01 1.77e-01 2.30e-01 7.20e-01 5.20e-02 1.03e-01 1.87e-02 1.05e-01 2.87e+02 6.30e+00 4.29e+02 1.50e-02 4.42e-03 8.60e-01 1.74e-03 1.87e-03 8.00e-01 3.17e-02 5.71e-01 9.67e-02 2.90e+00 0.OOe+00 7.67e-05 3.51e-01
- 9. 80e-02 7.13e-02 2.66e-02 1.76e+01 1.43e+02 6.48e-02 1.24e-04 3.83e-03
- 1. 09e-03 8.27e-01 1.22e-03 3.35e-01
- 1. 77e-01 2.30e-01 7.20e-01 5.20e-02
- 1. 03e-01
- 1. 87e-02
- 1. O5e-01
- 2. 87e+02 6.30e+00 4.29e+02 1.50e-02 4.42e-03
- 8. 60e-01 1.74e-03
- 1. 87e-03
- 8. OOe-01 3.17e-02 S. 71e-01 9.67e-02 2.90e+00
- 0. OOe+00 7.67e-05 3.51e-01
- 9. 80e-02 7.13e-02 3.01e-02 2.11e+01 1.67e+02 8.87e-02 1.37e-04 4.52e-03 1.29e-03 9.67e-01 1.44e+00 3.95e-01 2.08e-01 2.79e-01 8.73e-01 6.12e-02 1.25e-01 2.21e-02 1.23e-01 3.34e+02 7.13e+00
- 5. 01e+02 1.71e-02 4.97e-03 9.80e-01 1.99e-03 2.13e-03 9.07e-01 3.Ble-02 6.43e-01 1.lOe-01 3.36e+00 0.00e+00 8.80e-05 4.21e-01 1.14e-01 8.27e-02
- 2. 66e-02 1.76e+01 1.43e+02 6.48e-02 1.24e-04 3.83e-03 1.09e-03 8.27e-01 1.22e-03 3.35e-01 1.77e-01 2.30e-01 7.20e-01 S.20e-02 1.03e-01 1.87e-02 1.0se-01 2.87e+02 6.30e+00 4.29e+02 I.Sde-02 4.42e-03 S. 60e-01 1.74e-03
- 1. 87e-03 8.00e-01 3.17e-02 S.71e-01 9.67e-02 2.90e+00 0.00e+00 7.67e-OS 3.Sle-01.
9.80e-02 7.13e-02 I
Page 6 of 8
Attachment C ODCM-QA-005 Revision 2 Page 33 of 48 DOSE COMMITMENT FACTORS FOR THE SHORELINE PATHWAY I
(Ref. 3.15)
Release Type:
Units:
Age Group:
Pathway:
Liquid
({mrem/hr)/ (pCi/ml))
INFANT Shoreline Sediment (SHDp)
?..-,IJ A R -n Liver Thyroid Kidney Lung GI-Lli Skin TB MUL; sJ.
H-3 C-14 NA-24 P-32 CR-51 MN-54 MN-56 FE-55 FE-59 CO-58 CO-60 NI-63 NI-65 CU-64 ZN-65 ZN-69 BR-83 BR-84 BR-85 RB-86 RB-88 RB-89 SR-89 SR-90 SR-91 SR-92 Y-90 Y-91 Y-91M Y-92 Y-93 ZR-95 ZR-97 NB-95 MO-99 TC-99M TC-101 RU-103 O.OOe+OO 0.OOe+00 O.OOe+OO 0.OOe+0O o.O0e+OO O.OOe+oO o.ooe+OO O.OOe+Oo O.0Oe+0O O.OOe+oo 0.0Oe+0O O.OOe+oO 0.OOe+0O 0.OOe+OO 0.0Oe+O 0O.OOe+00 O.OOe+OO 0.OOe+O0 0.OOe+OO O.OOe+00 0.OOe+0O 0.OOe+OO o.oOe+OO O.00e+00 o.OOe+OO 0.OOe+oo 0.OOe+OO 0.OOe+0o 0.OOe+OO O.OOe+oo o.OOe+OO 0.OOe+o0 o.0Oe+OO 0.OOe+O0 o.oOe+OO O.OOe+0o O.OOe+0OOO.OOe+oo o.0Oe+OO O.OOe+00
- o. ooe+00 o.OOe+O0 o.ooe+0O 0.OOe+oo O.OOe+00 0.OOe+OO o.0Oe+OO 0.OOe+o0 o.oOe+OO 0.OOe+00 0.0Oe+OO O.OOe+oO 0.00e+00 0.Ooe+0o o.OOe+OO O.OOe+o0 O.OOe+00 O.OOe+o0 O.0Oe+0O O.OOe+0O 0
O.00e+00 0.OOe+O0 0.ooe+00 O.OOe+O0 0.0Oe+0O O.OOe+O I 0.oOe+OOO.OOe+Oo I o.OOe+0O O.OOe+OO o.ooe+OO 0.OOe+OO t o.OOe+OO O.OOe+0O.(
0.ooe+00 0.OOe+oo C 0.OOe+OO0.00e+OO O.OOe+00 0.OOe+00 O.00e+OO O.OOe+OO O.OOe+O0 O.OOe+OO O.OOe+OO 0.OOe+00 0.OOe+00 0.OOe+OO O.oOe+OO O.OOe+0O 0.00e+00 0.OOe+OO O.OOe+00 O.OOe+OO O.OOe+0O O.OOe+O0 0.OOe+00 0.OOe+O0 0.OOe+OO 0.OOe+OO O.OOe+0O O.OOe+OO O.0Oe+OO
- 0. OOe+00 0.OOe+O0
- 0. OOe+O0 O.0Oe+00 O.OOe+OO O.OOe+O0 O.0Oe+00
.OOe+00 O.OOe+00 O.00e+O0 O.OOe+OO O.OOe+0O
- 0.
OOe+00 0.OOe+OO O.OOe+OO
- 0.
OOe+OO 0.OOe+OO 0.OOe+0O
- 0.
OOe+OO 0.OOe 0+O0 O.OOe+00
- l. OOOe+00 o0.00e+00 0.OOe+O0 O.OOe+0O 0.OOe+OO O.
O.Oe+OO
- 0. Oe+OO
- 0.
OOe+O0
.OOe+OO O.OOe+O0 0.OOe+00
- 0. OOe+OO 0.oOe+00
- 0. 00e+00 O.OOe+00 O. OOe+00
- 0. OOe+00 O. OOe+OO 0.OOe+0O 0.OOe+OO
- 0. OOe+00 0'. Oe+00
- 0. OOe+0O 0.OOe+0O O. OOe+OO 0.OOe+O0
- 0. OOe+OO 0.OOe+0O I
0.OOe+00 0.00e+O0 O.00e+00 O.00e+00 0.00e+00
- 0. OOe+00 O.OOe+00 O.OOe+0O 0.OOe+OO 0.OOe+00 0.OOe+OO 0.OOe+O0 0.OOe+00 0.OOe+OO 0.0Oe+00 O.OOe+0O OOOe+0O 0.OOe+00 O.OOe+OO O.OOe+OO O.OOe+OO O. OOe+0O O.OOe+0O O.00e+00 0.OOe+0O 0.OOe+0O 0.oOe+00 0.OOe+00 O.OOe+00 0.OOe+0O O. OOe+O0 O. 00e+00 0.OOe+00 O. 00e+OO O.00e+00 0.OOe+0O O0OOe+0O
- 0. OOe+00 0.OOe+00 0.oOe+00 0.OOe+00 O.00e+O0 O.00e+OO 0.00e+00 O. 00e+00 0.OOe+0O O.OOe+00 0.OOe+00 O.OOe+00 O.OOe+00 O.OOe+0O O.oOe+00 O.00e+O0 O.00e+0O O.OOe+OO
-0.OOe+0O O.OOe+0O O. OOe+00 O. OOe+00 O. OOe+0O O. OOe+OO
- 0. 00e+00
- 0. OOe+00 O. 00e+00
- 0. OOe+00 0.OOe+00 O. 0Oe+00 O. 00e+00 0.OOe+00 O. OOe+00 0.OOe+0O 0.OOe+0O 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+O0 O.OOe+00 0.OOe+00 0.OOe+00 0.OOe+0O 0.OOe+00 0.OOe+00 0.OOe+0O 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+0O 0.OOe+00 0.OOe+00 0.00e+00 0.OOe+00 0.OOe+00 0.OOe+0O 0.OOe+0O 0.OOe+00 0.OOe+00 0.OOe+O0 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+O0 0.OOe+0O O.OOe+00 0.OOe+OO 0.OOe+0O 0.OOe+OO 0.OOe+00 0.ooe+OO O.00e+00 0.OOe+00-0.OOe+00 0.OOe+000.OOe+0OO 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+OO 0.OOe+0O 0.OOe+O0 0.O0e+00 0.OOe+00 0.OOe+0O 0.OOe+00 0.OOe+0O 0.OOe+00 O.OOe+0O 0.OOe+00 0.OOe+O0 0.OOe+00 0.00e+00 0.OOe+0O 0.OOe+o0 0.OOe+00 0.OOe+00 0.00e+00 0.OOe+00 0.00e+00 0.OOe+00 0.OOe+00 0.00e+Oo 0.OOe+00 0.OOe+00 0.OOe+OO 0.OOe+O0 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 Page 7 of 8
Attachment C ODCM-QA-005 Revision 2 Page 34 of 48 DOSE COMMITMENT FACTORS FOR THE SHORELINE PATHWAY (Ref. 3.15)
Release Type:
Units:
Age Group:
Pathway:
Liquid
((mrem/hr)/(
(Ci/ml))
INFANT Shoreline Sediment (SHDp)
Nuclide Bone Liver Thyroid Kidney Lung GI-Lli Skin TB RU-105 RU-106 AG-llOM TE-125M TE-127 TE-127M TE-129 TE-129M TE-131 TE-131M TE-132 1-130 I-131 I-132 1-133 1-134 1-135 CS-134 CS-136 CS-137 CS-138 BA-139 BA-140 BA-141 BA-142 LA-140 LA-142 CE-141 CE-143 CE-144 PR-143 PR-144 ND-147 W-187 NP-239
- 0. OOe+00
- 0. 00e+O0 0.OOe+O0
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00
- 0. ooe+00 0.00e+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00 0.O0e+00 0.0Oe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+0O
- 0. OOe+00 0.OOe+00
- 0. OOe+O0 0.OOe+00 0.00e+00 0.OOe+00 0.OOe+00 4 0.OOe+00 I 0.OOe+00 I 0.OOe+00 (
0.OOe+00 (
0.OOe+00 C 0.OOe+00 C 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+O0 0.OOe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00 0.00e+00 0.0Oe+00 0.0Oe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.0Oe+00 0.00e+00 0.OOe+00 0.OOe+00 0.00e+00 0.OOe+00 0.OOe+00 O.OOe+O0 O.00e+00 I O.00e+00 I O.00e+00
).OOe+00
).OOe+00 C O,00e+00 C 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+O0
- 0. 00e+00 0.00e+00 0.00e+00 0.00e+00 0.O00e+00 0.O00e+00 0.00e+00 0.O00e+00 0.O00e+00 0.00e+00 0.00e+00 0.00e+00 0.O00e+00 o0.00e+00 0.00e+00 0.00e+00 0.O00e+00 0.00e+00 0.00e+00
- 0. 00e+00 0.O00e+00 D. 00e+O0 D. 00e+00 D.O0e+00 D.00e+00
- 3. 00e+00
)
.00e+00
).00e+00
).00e+00
).00e+00 0.OOe+00
- 0.
OOe+00 0.00e+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 O.OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.00e+00 O. 00e+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.00e+00 0.OOe+00 0.OOe+00 0.00e+00 O.OOe+00 0.OOe+00 0.OOe+00 0.00e+O0
- 0. OOe+00 0.OOe+00 0.OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. 00e+00 0.OOe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00
- 0. 00e+00 0.OOe+00 0. OOe+00 0.00e+00
- 0. OOe+00 0.00e+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. 00e+00
- 0. OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. 00e+00
- 0. 00e+00 0.OOe+00 0.OOe+00 0.ooe+00 0.OOe+00 0.OOe+00 0.OOe+00
- 0. ooe+00
- 0. OOe+00 0.ooe+00
- 0. 00e+00
- 0. 00e+00 0.00e+00
- 0. OOe+00
- 0. ooe+00 0.OOe+00 0.OOe+00
- 0. ooe+00
- 0. OOe+00 0.ooe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. 0Oe+00
- 0. OOe+00 0.OOe+00
- 0. OOe+00
- 0. OOe+00
- 0. 00e+00
- 0. OOe+00
- 0. OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+00 0.OOe+OO
- 0. OOe+00
- 0. OOee+OO
- 0. OOe+00 0.OOe+OO
- 0. OOe+00 O. 00e+00
- 0. 00e+00
- 0. ooe+00
- 0. OOe+00
- 0. OOe+O0
- 0. OOe+0O
- 0. ooe+00 0.OOe+00 O. 00e+00
- 0. ooe+00
- 0. OOe+00
- 0. ooe+00
- 0. OOe+00
- 0. OOe+00
- 0. 0Oe+00
- 0. OOe+00
- 0. ooe+00
- 0. OOe+00
- 0. 00e+00 0.OOe+00 0.OOe+00
- 0. ooe+00 O. 00e+00
- 0. 00e+00
- 0. 00e+0O
- 0. OOe+00
- 0. 00e+00
- 0. 00e+00
- 0. ooe+00 0.00e+O0 0.00e+00 0.00e+00 0.O00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00
- 0. O0e+00 0.O00e+00 O. 00e+00 0.00e+00 0.00e+00 0.00e+00
- 0. 00e+00
- 0. 00e+00
- 0. O0e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00e+00 0.00~e+00 0.O00e+00 0.00e+00 0.00e+00
- 0. 00e+00
- 0. O0e+00 0.O00e+00 0.00e+00 0.00e+00 0.00e+00 Page 8 of 8
Attachment D ODCM-QA-005 Revision 2 Page 35 of 48 RADIOACTIVE DECAY CONSTANTS (Ref. 3.13)
I Isotope Half -life Period Decay Isotope Half-life Period Decay (S.N.H.D.Y)
Constant (S.,.E.D.Y)
Constant (Er-i)
(Hr-i) 1 H-3 12.28 Y
- 6.44E 38 Ru-103 39.35
-D 7.34E-04 2 C-14 5730 y
1.38E-08 39 Ru-105 4.44 H
1.56E-01 3 Na-24 15 H
4.62E-02 40 Ru-106 368.2 D
7.84E06 41P-32 14.29 D.
2.02E-03 41 Aq-110m -
-249.85 D 1
.16E-04 5 Cr-51 27.704 D
-1.04E-03 42 Te-125m 58 D
4.98E-04 6 Mn-54 312.7
-D 9.24E-05 43 Te-127m
. 109 D
2.65E-04 7 Mn-56 2.5785 H
2.69E-01 44 Te-127 9.35 H
7.41E-02 E Fe-55
.2.7 Y
2.93E-05 45 Te-129m 33.6 D
8.60E-04 9 Fe-59
- 44.
D 6.47E-04 46 Te-129 69.6 N
5.98E-01 lC Co-58 70.8 D
4.08E-04 47 Te-131m 30 H
2.31E-02 Il Co-60
- 5.
Y 1.50E-05 48 Te-131 25 N
1.66E+00 12 Ni-63 100.1 Y
7.90E-07 495Te-132 78.2 H
8.86E-03 13 Ni-65 2.52 H
2.75E-01 S0 1-130 12.36 H
5.61E-02 14 Cu-64 12.701 H
. 5.46E-02 51 1-131
- 8.04
- D 3.59E-03 15 Zn-65 244.4 D
l.lBE-04 52 I-132
. 2.3 H
3.01E-01 16 Zn-69 55.6 M
7.47E-01 -_53 I-133 20.8 H
3.33E-02 17 Br-83 2.39 H
2.90E-01 54 I-134 52.6 M
7.89E-01 18 Br-84 31.8 M
1.31E+00 55 3I-3 6.61 H
1.05E-01 19 Br-85
- 172 S
1.45E+01 5 Cs-134
-- 2.062 Y
3.84E-05 2C Rb-86 18.66 D
1.55E-03 57 Cs-136 13.16 D
2.19E-03 21 Rb-88 17.8 M
2.33E+00 S8 Cs-137 30.17 Y
2.62E-06 22 Rb-89
,15.44 M
2.69E+00
.5 Cs-138 32.2 N
1.29E+00 23 Sr-89 50.55 D
5.71E-04 60 Ba-139 83.1 M
4.99E-01 24 Sr-90 28.6 Y
2.77E-06 61 Ba-140 12.789 D
2.26E-03 25Sr-91 9.5 H
7.30E-02 62 Ba-141 18.27 M
2.27E+00 26 Sr-92 2.71 H
2.56E-01 63 Ba-142 10.7 M
3.88E+00 27 Y-90 64.1 H
1.08E-02 64 La-140 40.22 E
1.72E-02 28 Y-91m 49.71 8.35E-01 65 La-142 95.4 M
4.35E-01 29 Y-91 58.51 D4.94-04 66Ce-141 32.5 D
8.89E-04 30 Y-92 3.54 H
1.96E-01 67 Ce-143 33 H
2.10E-02 31 Y-93 10.1 H
6.86E-02 6ECe-144 284.3 D
1.02E-04 32 Zr-95 64.021 D
4.51E-04 69 Pr-143 13.56 D
2.13E-03 33 Zr-97 16.9 H
4.10E-02 70 Pr-144 17.28 M
2.40E+00 34 Nb-95 35.06 D
8.24E-04 71lNd-147 10.98 D
2.63E-03 35 Mo-99 66.02 H
1.05E-02 72 W-187 23.83 H
2.91E-02 36 Tc-99m 6.02 H
1.15E-01 73 Np-239 2.355 D
1.23E-02 37 Tc-101 14.2 M
2.92E+00 =
Page 1 of I
Attachment E ODCM-QA-005 Revision 2 Page 36 of 48 DILUTION FACTORS AND TRANSIT TIMES FOR SSES EFFLUENTS TO DANVILLE, PA (Ref. 3.12 Appendix E-17, E-18)
I RIVER DEPTH RIVER DEPTH RIVER LEADING MEAS.
AT ENPV.
LAB HEAS.
AT XCR DISCHARGE EDGE DILUTION (FEET)
(INCHES)
(CFS)
(HOURS)
FACTOR 1.5 144 500 68.7 136.4 1.6 145 530 67.8 140.1 1.8 148 600 66.3 147.3 2
150 670 64.8 155.5 2.2 152 730 63.3 164.5 2.4 155 780 61.8 173.9 2.5*
156*
825*
61.1*
179.1*
2.6 157 870 60.3 184.5 2.8 160 930 58.8 195.7 3
162 1000 57.2 208.3 3.2 164 1200 52.7 250.6 3.4 167 1400 48.2 291.5 3.5*
168*
1500*
45.9*
280.9*
3.6 169 1600 43.5 271.0 3.8 172-1800 -
39.0 250.6
-4 174 2000 35.5 250.6 4.2 176 2280 35.2 254.5 4.4 179 2560 34.7 259.1 4.5*
180*
2730*
34.5*
261.4*
4.6 181 2900 34.2 263.9 4.8 184 3300 33.7 270.3 5
186 3700 33.0 277.8 5.2 188 4140 32.3 284.1 5.4 191 4580 31.7 292.4 5.5*
192*
4820*
31.4*
297.2*
5.6 193 5060 31.0 302.1 5.8 196 5580 30.2 312.5 6
198 6100 29.5 323.6 6.2 200 6780 28.5 339.0 6.4 203 7460 27.5 354.6 6.5*
204*
7890*
26.9*
366.3*
6.6 205 8320 26.2.
378.8
_ ~
- Interpolated value Page 1 of 2
Attachment E ODCM-QA-005 Revision 2 Page 37 of 48 DILUTION FACTORS AND TRANSIT TIMES FOR SSES EFFLUENTS TO DANVILLE. PA (Ref. 3.12 Appendix E-17, E-18)
I RIVER DEPTH RIVER DEPTH RIVER LEADING MEAS. AT ENV. LAB MMAD.
AT MCM DISCEARGE EDGE DILUTION (FEET)
(INCHES)
(CF8)
(HOURS)
FACTOR 6.8 208
.9360 24.7 413.2 7
210 10400 23.0 456.6 7.5 216 12500 20.0 588.2 8
222 14900
-16.5 869.6 8.5 228 17500 15.3 980.4 9
234 20700 14.7 1071.8 9.5 240 24000 14.2 1173.7 10 246 27000 13.5 1285.3 10.5 252 30100 13.0 1373.6 11 258 34570 12.2 1567.4 11.5 264 38730 11.3 1795.3 12 270 42530 10.7 2057.6 12.5 276 46490 10.0 -
2398.1 13 282 50630 10.05 2597.4 13.5 288 54940 10.0
-2832.9 14 294 59430 9.8 3067.5 14.5 300 64090 9.8 3311.3 15 306 68930 9.8 3558.7 15.5*
312*
-74030*
-9.8*
3802.3*
16 318
- -79130 9.8 4081.6 16.5*
324*
84580*
9.8*
4347.8*
17 330 90030 9.7 4651.2 17.5*
336*
95830*
9.7*
4926.1*
18 342 101630 9.7 5235.6 18.5*
348*
107780*
9.7*
5540.2*'
19 354 113930 9.7 5882.4 19.5*
360*
120430*
9.6*
6192.0*
20 366 126930 9.5 6535.9 20.5*
372*
133780*
9.5*
6872.9*
21 378 140630 9.5 7246.4 21.5*
.384*
147830*
9.4*
7604.6*
22 390 155030 9.3 8000.0
- Interpolated value Page 2 of 2
Attachment F ODCM-QA-005 Revision 2 Page 38 of 48 a
SITE SPECIFIC INFORMATION I
Minimum Cooling Tower Blowdown Flow:
Shorewidth Factor.
Sediment exposure time:
5000 gpm (Ref. 3.14) 0.2 (Ref. 3.8 Table A-2) 131,400 hour0.00463 days <br />0.111 hours <br />6.613757e-4 weeks <br />1.522e-4 months <br /> (Ref. 3.8, Equation A-4)
I USAGE FACTORS (Ref. 3.8)
PATHWAY INFANT CHILD I
TEEN ADULT 0Fish (kg/VT) 0 6.9 16 21
[Potable Water (liter/V) 330 510 510 730 Shoreline hr 0
14 67 12 DILUTION FACTORS (DF)
(Ref. 3.12, Table 3 and Appendix E)
I I
PATHWAY LOCATION DF Fish Outfall 15.9 Potable Water Danville 388*
Shoreline Outfall 15.9 I
I *For estimating purposes (interpolated value frorn Ref. 3.12 Appendix E-17).
at Danville, Pa., for various river levels located in Attachment E.
Actual dilution factors TRANSIT TIMES (Ta)
(Ref. 3.1 0)
I PATHWAY Fish Potable Water Shoreline lLOCATION Outfall Danville Ouffall lTp (hr) 25I 25.8
- I I
- For estimating purposes. Actual river transit times at Danville, Pa., for various river levels located in Attachment E.
- Includes one hour transit from outfall plus 24 hours2.777778e-4 days <br />0.00667 hours <br />3.968254e-5 weeks <br />9.132e-6 months <br /> to consumption.
Page 1 of 1
Attachment G ODCM-QA-005 Revision 2 Page 39 of 48 CONSOLIDATED DOSE CALCULATION The following equation consolidates the methodology'as described in Section 6.0 (Regulatory Guide 1.109 methodology). The equation utilizes a dose commitment factor, which incorporates Regulatory Guide 1.109 parameters specific to each exposure pathway. The resultant dose commitment factor correlates dose to the radionuclide concentration received via the applicable exposure pathway.
The dose due to radionuclides released in liquid effluent to unrestricted areas during a specified time period via the potable water, fish and shoreline pathways is determined by the following:
Ra=DCFaoj
- e
- 1 hour/3600 sec Ra~j DFp F Where:
Fp, Dose to organ j of individuals of age group a from nuclide i in the pathway
- p. (mrem)
DCFaI
=
Dose Commitment Factor for organ j of individuals of age group a from nuclide i in the pathway p. (mrem*mVpClthr)
- Dose Commitment Factors listed in Attachments A (Potable Water
'Pathway), B (Fish Pathway) and C (Shoreline Pathway) (Ref. 3.15).
Q.
=
Activity Released of nuclide I (pCi)
=
Radioactive decay constant of nuclide i (Attachment D) (hf')
tp=
Total time elapsed between release of the nuclides and ingestion of food or water (Attachment F) (hr).
DFp Dilution Factor (default values in Attachment F, actual values based on current river depth at Main Control Room taken from Attachment E).
F
=
Flow rate in the liquid effluent (cooling tower blowdown flow in musec)
The dilution factor, DFp, has been substituted for the. mixing ratio, 1iMp, in the above equation.
Page 1 of 2
Attachment G ODCM-OA-005 Revision 2 Page 40 of 48 PathwaV Dose Commitment Factor Derivation A dose commitment factor (DCF) for each pathway is derived which incorporates standard parameters outlined in Section 6.0. The calculation of the individual dose commitment factors is as follows:
Potable water DCF.w = 1.14e5
- UV Dad Fish DCFaO = 1.14e5
- Up
- Bp
- Da#
Shoreline Where:
DCF.p, =1.14e5*100*Dj
- W*UT
- T1 [l-'b]
- 1. 14e5 = unit conversion (pCi*mL*yr)/(pCi*L*hr)
DCFa; = (mrem*mL)/1(Ci*hr)
=
Equilibrium bioaccumulation factor for nuclide i in pathway p, expressed as the ratio of the concentration in biota (pCGVkg) to the radionuclide concentration in water (pCi/liter), i.e., liter/kg (Ref. 3.8 Table A-1)
DajN uap
=
Dose factor specific to a given age group a, radionuclide 1, pathway p, and organ j, which can be used to calculate the radiation dose from ingestion of a radionuclide or from standing on contaminated ground (Ref. 3.8 Table E-6, E-1 1 through E-14) (mremnpCi ingested or mrem/hr per pC/m2)
=
Usage factor that specifies the intake rate or exposure rate for an individual of age group a associated with pathway p (Attachment F) (kg/yr, Vyr or hr/yr)
=
Radioactive decay constant of nuclide i (Attachment D) (hr-1)
\\
W
=
shoreline width factor (Attachment F) (dimensionless) th
=
Period of time shoreline is exposed to contaminated water (Attachment F) (hr)
T
=
Radioactive half-life of nuclide i (days).
I Page 2 of 2
Attachment H ODCM-QA-005 Revision 2 Page 41 of 48 MAXIMUM HYPOTHETICAL COMPOSITE DOSE FACTORS (Ref. 3.16)
I Composite Dose Factors:
Dose Factor Units:
Location:
Maximum Hypothetical Adult (Page 1 of 2) mrem/Ci Released Danville (Water Ing.)/Outfall (Fish and Shoreline)IFIXED DILUTION Usage (Uap) (kg/yr. FISH) =
-Usage (Uap) (hr/yr SHORE) =
Dilution (1/Mp:FISH) =
Transit time (tf) hrs. =
Transit time (tp) hrs. =
21
-.-.Usage (Uap) (kg/yr: WATER) =
12 Dilution (1/Mp:SHORE) =
15.9
-Dilution (1/Mp:WATER) =
25
- Transit time (tw) hrs. = -
- 1 e Transit time (tb) hrs. =
730 15.9 321 25.8 131400 Isotope Bone Liver T. Body Thyroid Kidney Lung GZ-LL Skin-,
1 H-3 O.OOE+00 3.59E-05 3.59E-05 3.59E-05 3.59E-05 3.59E-05 3.59E-05 0.003+00 2 C-14 1.70E+00 3.41E-01 3.41E-01 3.41E-01 3.41E-01 3.41E-01 3.41E-01 O.OOE+00 3 Na-24 7.09.E-03 7.09E-03 7.12E-03 7.09E-03 7.09E-03 7.09E-03 7.09E-03 2.58E-05 4 P-32
- 7.18E+01 4.46E+00 2.77E+00 O.OOE+00 O.OOE+00 O.OOE+0O 8.07E+00 O.OOE+00 5 Cr-51 0.OOE+00 O.OOE+00 7.72E-05 4.07E-05 1.50E-05 9.04E-05 1.71E-02 1.07E-05 6 Mn-54 O.OOE+00 2.39E-01 4.82E-02 O.OOE+00 7.10E-02 O.OOE+OO 7.31E-01 3.17E-03 7 Mn-56 0.OOE+00 7.25E-06 2.63E-06 O.OOE+00 9.21E-06 O.OOE+00 2.31E-04
-1.59E-06 8 Fe-55 3.64E-02 2.52E-02 5.87E-03 O.OOE+00 O.OOE+00 1.40E-02 1.44E-02 0.OOE+00 9Fe-59 5.66E-02 1.33E-01 t 5.15E-02 O.OOE+00 O.OOE+00 3.72E-02 4.43E-01 6.24E-04 10 Co-58s-O.OOE+00 4.97E-03 1.19E-02 O.OOE+00 0.00E+00 O.OOE+00 1.01E 8.64E-04 11 Co-60 0.00E+00 1.44E-02 7.37E-02 O.OOE+O0 0.OOE+00 O.OOE+00 2.71E-01 4.93E-02 12 Ni-63 1.72E+00 1.19E-01 5.78E-02 O.OOE+00 0.00E+00 O.OOE+00 2.49E-02 O.OOE+00 13 Ni-65 7.20E-06.9.35E-07 8.66E-07 O.OOE+00
- 0.
OOE+00 O.OOE+00 2.37E-05 S.11E-07 14 Cu-64 0.00E+00 1.43E-04 6.84E-05 O.OOE+00 3.61E-04 O.OOE+00 1.22E-02 1.27E-06 15 Zn-65.
1.26E+00 4.OOE+00 1.81E+00 O.OOE+00 2.68E+00 O.OOE+00 2.52E+00 1.67E-03 16 Zn-69 2.11E-11 4.03E-11 2.80E-12 O.OOE+00 2.62E-11 0.00E+00 6.06E-12 0.OOE+00 17 Br-83 F.00E+00 O.OOE+00 1.57E-06 O.OOE+00 O.OOE+300 0.OOE400 -2.26E-06 1.03E-08 18 Br-84 O.OOE+00 O.OOE+00 1.07E-07 O.OOE+00 O.OOE+00 0.00E+00 1.51E-22 -1.25E-07 19 Br-85.
o.OOE+0O O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 20 Rb-86 O.OOS+00 5.29E+00 2.47E+00 O.OOE+00 O.OOE+00 O.OOE+00 1.04E+00 2.00E-05 21 Rb-88 O.OOE+00 O.OOE+00 6.27E-09 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 7.17E-09 22 Rb-89 O.OOE+000 O.OOE+00 1.63E-08 O.OOE+00 O.OOE+00 O.OOE+00
-O.OOE+00 1.96E-08 23 Sr-89 1.25E+00 o.ooE+00 3.60E-02 0.OOE+00 O.OOE+00 O.OoE+00 2.01E-01 4.89E-08 24 Sr-90 3.13E+01 O.OOE+00 7.69E+00 O.OOE+00 O.
000E+00 O.OOE+00 9.05E-01 O.OOE+00 25 Sr-91 3.77E-03 O.OOE+00 1.56E-04 O.OOE+00 O.OOE+00 O.OOE+00 1.80E-02 4.55E-06 26 Sr-92 1.47E-05 O.OoE+00 1.81E-06 0.OOE+00 O.OOE+00 O.OOE+00 -2.91E-04
-1.30E-06 27 Y-90 2.55E-05 O.OOE+00 6.94E-07 O.OOE+00 O.OOE+00 O.OOE+00 2.71E-01 1.02E-08 28 Y-91m 2.64E-16 0.00E+00 8.49E-08 0.OOE+00 O.OOE+00 O.OOE+00 7.74E-16 9.83E-08 29 Y-91 4.85E-04 O.OOE+00 1.51E-05 0.OOE+00 O.OOE+00 O.OOE+00 2.67E-01 2.35E-06 30Y-92 2.18E-08 O.OOE+00 2.90E-07 O.OOE+00 O.OOE+00 O.OOE+00 3.82E-04 3.43E-07 31 Y-93 1.67E-06 0.0OE+00 3.80E-07 O.OOE+00 0.OOE+00 0.OOE+00 5.30E-02 4.56E-07 32 Zr-95 1.97E-05 6.31E-06 4.81E-04 O.OOE+00 9.90E-06 0.OOE+00 2.00E-02 S.S3E-04 33 Zr-97 3.90E-07 7.87E-08 5.57E-06 O.OOE+00 1.19E-07 0.OOE+00 2.44E-02 6.44E-06 34 Nb-95 2.38E-02 1.33E-02 7.39E-03 0.OOE+00 1.31E-02 O.OOE+00 -8.04E+01 3.13B-04 I
Page 1 of 6
Attachment H ODCM-QA-005 Revision 2 Page 42 of 48 MAXIMUM HYPOTHETICAL COMPOSITE DOSE FACTORS (Ref. 3.16)
Composite Dose Factors:
Dose Factor Units:
Location:
Maximum Hypothetical Adult (Page 2 of 2) mrem/Ci Released Danville (Water Ing.)/Ouffall (Fish and Shoreline)/FIXED DILUTION Isotope Bone Liver T.
Body Thyroid Kidney Lung G(I-LLI SKIN 35 Ho-99 O00O+00 5.06E-03 9.703-04 O.OOE+00 1.5E-02 O.OOE+00 1.17E-02 8.92E-06 36 Tc-99m 3.00E-08 8.47E-08 1.40E-06 O.OOE+00 1.29E-06 4.15E-08 S.01E-05 3.66E-07 37 Tc-101 0.00E+00 O.OOE+00 2.14E-09 0.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 2.37E-09 38 Ru-103 2.77E-04 0.03+00 3.30E-04 O.OOE+00 1.06E-03 O.OOE+00 3.24E-02 2.46E-04 39 Ru-105 4.67E-07
- 0. OOE+00 1.24E-06 O.OOE+00 6.03E-06 O.OOE+00 2.85E-04 1.20E-06 40 Ru-106 4.193-03
.OOE+OO 1.35E-03 O.OOE+00 8.09E-03 O.OOE+00 2.71E-01 9.87E-04 4l Ag-110m 8.36E-05 7.73E-05 6.74E-03 O.OOE+00 1.52E-04 O.OOE+00 3.16E-02 7.81E-03 42 Te-125m 1.39E-01 5.02E-02 1.86E-02 4.17E-02 5.63E-0I O.OOE+00 5.53E-01 4.14E-06 43 Te-127m
- 3. 52E-01 1.26E-01 4.29E-02 9.00E-02 1.43E+00 O.OOE+00 1.18E+00
- 2. 11E-07 44Te-127 9.02E-04 3.24E-04 1.95E-04 6.68E-04 3.67-03
- 0. OOE+00 7.12E-02 5.93E-09 45 Te-129rn 5.89E-01 2.20E-01 9.33E-02 2.02E-01 2.46E+00 0.OOE+00 2.97E+00 4.503-0 46 Te-129 1 613-03 6.05E-04 4.27E-04 1.23E-03 6.76E-03 O.OOE+00 1.21E-03 4.20E-05 47 Te-131m
- 5. 08E-02 2.49E-02 2.07E-02 3.94E-02 2.52E-01 O.003+00 2.47E+00 1.803-0 48 Te-131 9.69E-22 4.05E-22 1.08E-08 7.97E-22 4.24E-21 O.OOE+00 1.37E-22 1.28E-0 49 Te-132 1.06E-01 6.84E-02 6.42E-02 7.55E-02 6.58E-01 O.OOE+00 3.23E+00 9.623-06 50 I-130 4.043-04 1.19E-03 4.80E-04 1.01E-01 1.86E-03
. OOE+00 1.02E-03 1.23E-05 51 I-130 8.283-03 1.18E-02 6.82E-03 3.88E+00 2.03E-02 O.OOE+00 3.13E-03 4.06E-05 52 1-132 2.313-07 6.183-07 2.01E-06 2.16E-OS 9.85E-07 O.OOE+00 1.16E-07 2.11E-06 53 1-133 1.343-03 2.333-03 7.16E-04 3.43E-01 4.07E-03 0.OOE+00 2.10E-03 5.62E-06 54 I-134 5.953-13 1.62E-12 3.96E-07 2.803-11 2.573-2
- 0. OOE+00 1.41E-15 4.70E-07 55 1-135-6.96E-05 1.82E-04 7.17E-05 1.20E-02 2.92E-04 0.OOE+00 2.06E-04 5.17E-06 56 Cs-134 1.62E+01 3.86E+01 3.15E+01 O.OOE+00 1.25E+01 4.14E+00 6.75E-01 1.56E-02 57 Cs-136 1.61E+00 6.35E+00 4.57E+00 O. OOE+00 3.53E+00 4.84E-01 7.21E-01 3.32E-04 58 Cs-137 2.083+01 2.84E+01 1.86E+01 O.OOE+00 9.65E+00 3.21E+00 5.50E-01 2.34E-02 59 Cs-138 1.46E-1.6 2.87E-16 1.93E-07 O.OOE+00 2.11E-16 2.09E-17 1.23E-21 2.21E-07 60 Ba-139 2.463-10 1.75E-13 1.25E-07 O.OOE+00 1.64E-13 9.94E-14 4.36E-10 1.41E-07 61Ba-140 1.433-02 1.80E-05 9.77E-04 O.OOE+00 6.11E-06 1.03E-05 2.94E-02 4.56E-05 62 Ba-141 0.O0E+00 O.OOE+00 8.39E-09 0.OOE+00 0.OOE+00 O.OOE+00 0.00E+00 9.57E-09 63 Ba-142 O. 00E+0O0
- 0. OOE+00 1.81E-09
- 0. OOE+00 O. OOE+00 O.OOE+00
- 0. OOE+00 2.06E-09 64La-140 5.653-06 2.85E-06
.3.75E-05 O.OOE+00 O. OOE+00 O.OOE+00 2.09E-01 4.17E-05 65 La-142 8.263-12 3.763-12 9.60E-07 0.003+00 O.OOE+00 O.OOE+00 2.74E-08 1.15E-06 66Ce-141-3.253-06 2.193-06 2.68E-05 0.003+00 1.02E-06 O.OOE+00 8.39E-03 3.00E-05 67 Ce-143- -
3.423-07 2.53E-04 4.44E-06
- 0. 00E+00
- 1. 11E-07 0.OOE+00 9.46E-03 5.01E-06 68 Ce-144 1.73E04 7.22E-05 1.45E-04 0.OOE+00 4.28E-05
- 0. OOE+00 S.84E-02 1.57E-04 69 Pr-143 3.04E-05 1.22E-05 1.51E-06 O.OOE+00 7.03E-06 O.OOE+00 1.33E-01
- 0. OOE+00 70 Pr-144
- 0. 0+E0+0 O.OOE+00 3.24E-10 0.OOE+00 0.OOE+00 0.O0E+00 0.OOE+00 3.73E-10 71 Nd-147 2 05E05 2.37E-05 1.77E-05 O.OOE+00 1.39E-05 0.OOE+00 1.14E-01 1.96E-05 72W-187 7 79E-03 6.52E-03 2.28E-03
. OOE+00 0.003E+00
. OOE+00 2.13E+00 5.17E-06 73 Np-239 1.34-06 1.31E-07 3.363-06
- 0. OOE+00 4.10E-07 0.OO3E+O0 2.693-02 3.813-06 Page 2 of 6
Attachment H ODCM-QA-005 Revision 2 Page 43 of 48 MAXIMUM HYPOTHETICAL COMPOSITE DOSE FACTORS (Ref 3.16)
'111 I Composite Dose Factors:
Dose Factor Units:
Location:
Maximum Hypothetical Teen (Page 1 of 2) mrem/Ci Released Danville (Water Ing.)/Outfall (Fish and ShorelineYFIXED DILUTION Usage (Uap) (kglyr: FISH) =
16 Usage (Uap) (kg/yr. WATER) =
-Usage (Uap) (hrlyr SHORE) =
67 -
Dilution (1/Mp:SHORE) =
Dilution (1/Mp:FISH) =
15.9-
- Dilution (1/Mp-WATER) =
Transit time (tf) hrs. =
25
- Transit time (tw) hrs. =
Transit time (tp) hrs. =
1 Transit time (tb) hrs. =
510 15.9 321 25.8 131400 I
I I
T. Dody y.ioney I.eUfl
U.LAJJJ.L Thyroia 1
2 3
4 isotope H-3 C-14 Na-24 P-32 B'ne I
Liver T. Body Thyrola lxidmey LsungI
%*J-AA.
D iJL; 9 2
_ _ 1 T
1E-05 1 _
-el r n r
n n O0.
ooE+O0
- 1. 85E+QO 7.30E-L03 7.82E+0l n nnE+00 2.61E-O5 2.61E-05 2.61E-o5 2.blbE-UD Z.01E.-VD 3.
7 1 O 1 W. U g0nvU0
. :I_. A _
I 3.71E-01 3.71E- 01 3.71E-O1 3.71E- 01 3.71E-01 3.71E-0O O. OOE+O0 7.43E-03 7.3 OE-03 7.3 OE-03 7.30E-03 7.43E-03 7.30E-O3 7.30OE-03 7.3 OE-03 7.30,E-03
- 1. 44E-O+
I J.
.4 4
1 J.
4 -
.A
- 4. S4E.00 3 - 03E+00 0.OOE.Q0
- 0. OOE+00 4.84E+O0 3.-03E+OO O.OOE+O0 O. OOE+OO O.OOE+OO 6.57E+OO O.OOSB+O OI O E 0 1
_ - -I
. 2 1 E - 0 4 i f
3 T
O E - 0 5-O.OOE+O0 1.21E-04 3.9OE-O5 1.54E-05
- 1. OOE-04 1.1uzi-Ug
- 5. 98b-U 6 !1n-s4 O.OOE+00 2.35E-01 6.16E-02 O.OOE+O0 7.OOE-02 O.OOE+OO 4.81E-01 1.77E-02 7 M7n-56 O.ooE+OO 7.59E-06
.8.86E-06 O.OOE+OC 9.61E-06 O.OOE+0O 5.OOE-04 8.88E-06 8Fe-55
- 3.
a1~E02 2.70E-02 -6.30E-03 0
.OOE+00 O.OOE+00 *1.71E-02 1.17E-02 O.
OOE+O0
-F e-59 5.82E-02 1.36E-01 5.55E-02 O.OOE+00 O.OOE+00 4.29E-02 3.21E-01 3.49E-03 10 Co-So O.OOE+OO 4.93E-03 1.55E-02 O.OOE+00 O.OOE+00 O.OOE+OO
-6.79E-02 4.82E-03 11 Co-60 O.OOE+OO 1.44E-02 2.67E-011 O.OOE+O O.OOE+OO O.OOE+OO 1.87E-O O2.75E-01 n.-.
'r-
^
t1T._
1.-78E+UV
.L.. &C
-b-A
L
-ndiz o
i-
-i--
^
n n nt -nnn n
nnr+Oknrd l
-s 2 n.'
sE -OEI 13 1 4 Ni-65 Cu-64 7.77E-Uc O~oE+OO
- 1. 14+O
'I Z..3=J :-WU U. Quzat V. VVCt9VI V.OOE+00V
-7E 7.
I
.I _
E__A 2.50E-04 7.69E-Os O.oOE+OO 3.80OE-04 0.0oE+OO
- 1. 17E-02 7.08E-o6 I
J.
4 4
-F-I 3
- 1.
0.OOE+O0 2.54E.OO 3.-96E+O0
-1.86E+00 O.OOE+O0 2.54E+OO O.OOE+OO 1.68E+oo
,.bsu 16 Zn-69 2 25E-11 4.37E-11 3.06E-12 O.OOE+00 2.85E-11 0.OOE+0O 8.05E-11 0..OOE+C0 17Br-83 Oo+o O.OOE+00 1.74E-06 0.OOE+O0 0.OOE+00 O.OOE+0O O.OOE+OO 5.76E-08 1BBr-84 O.OoE+00 O.OOE+00 5.99E-07 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+OO 6.98E-07 19Br-85 O OE+oO O.OOE+Ot 0.OOE+00 O.OOE+00 O.oOE+00 O.OOE+00 0.OOE+0O 0.OOE+00 20Rb-86 a
Q.OOE+0o 5.70E+00 2.68E+0O O.OOE+00 0.OOE+O0 0.OOE+00 8.43E-01 1.12E-04 21 Rb-88 O.OOE+OO O.OOE+OC 3.50E-08 0.OOE+00 O.OOE+O0 0.OOE+0O 0.OOE+OO 4;.00E-O8 22 Rb-8s O.OOE+oo O.OOE+00 9.1lE-08 O.OOE+00 O.OOE+00 0.OOE+0O O.OOE+O0 1.09E-07 23 sr-89 1.36E+00 O.OOE+00 3.89E-02 o.OOE+O0 o.OOE+00 0.ooE+00 1.62E-01 2.73E-07 24 Sr-90 2.60E+01 0.OOE+00 6.43E+00 O.OOE+00 O.OOE+00 O.OOE+00 7.30E-01 O.OOE+00 25 Sr-91 4.07E-03 O.OOE+00 1.84E-04 O.OOE+00
- 0. OOE+0O O.OOE+00 1.85E-02 2.54E-05 26 sr-s2 1.58E-OS
- 0. OOE+00 7.22E-06 0.OOE+00
- 0. OOE+00 O.OOE+O0 4.03E-04 7.27E-06 27Y-90 2.76E-05 O.OOE+00 7.91E-07 O.OOE+00 0.OOE+00 O.OOE+00 2.27E-01 5.71E-0O 28 Y-T9m 2.84E-16 O.OOE+00 4.74E-07 O.oOE+00 0.00E+00 O.OOE+00 1.34E-14 5.49E-07 29 Y-91 5.24E-04 O.OOE+00 2.57E-05 O.OOE+00 O.OOE+00 O.OOE+00 2.15E-01 1.31E-05 30 Y-92 2.37E-08 O.OOE+00 1.61E-06 O.OOE+00 0.OOE+00 0.oOE+00 6.50E-04 1.92E-06 31Y-93 1.81E-06 O.OOE+00 1.91E-06 O.OOE+00 O.OOE+00 O.OOE+00 5.53E-02 2.55E-06 32 Zr-95 1.97E-05 6.23E-06 2.66E-03 O.OOE+00 9.15E-06 O.OOE+00 1.44E-02 3.09E-03 33 Zr-97 4.07E-07 8.06E-08 3.09E-05 O.OOE+00 1.22E-07 O.OOE+00 2.18E-02 3.60E-05 34 Nb-ss 2.40E-02 13E02 8.81E-03 O.OOE+00 1.29E-02 O.OOE+00 5.69E+01 1.75E-03 Page 3 of 6
Attachment H ODCM-QA-005 Revision 2 Page 44 of 48 MAXIMUM HYPOTHETICAL COMPOSITE DOSE FACTORS (Ref. 3.16)
I Composite Dose Factors:
Dose Factor Units:
Location:
Maximum Hypothetical Teen (Page 2 of 2) mrem/Ci Released Danville (Water Ing.)/Outfall (Fish and Shoreline)/FIXED DILUTION Isotope Bone Liver T. Body Thyroid Kidney Lung GI-LL l SXIN 35 Mo-99 F.
OOE+OO,5.33E-03 1.06E-03 O.OOE+00 1.22E-02 O.OOE+00 9.54E-03 4.98E-05 36Tc-99m 3.05S-08 8.50E-08 2.89E-06 O.OOE+00 1.27E-06 4.72E-08 5.58E-OS 2.04E-06 37 Tc-101 0.OOE+00 0.OOE+00 1.19E-08 0.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 1.33E-08 38 Ru-103 88E-04 O.OOE+00 1.30E-03 0.OOE+00 1.O1E-03 O.OOE+00 2.40E-02 1.37E-03 39 Ru-105 4.98E-07 O.OOE+00 6.11E-06 0.OOE+00 6.28E-06 O.OOE+00 4.02E-04 6.71E-06 40Ru-106 4.50E-03 O.OOE+00 5.16E-03 O.OOE+00 8.67E-03 O.OOE+00 2.16E-01 5.51E-03 41Ag-llOm 7.87E05 7.45E-05 3.74E-02 O.OOE+00 1.42E-04 O.OOE+00 2.09E-02 4.36E-02 42 Te-125m l.SlE-0l 5.43E-02 2.02E-02 4.21E-02 O.OOE+00 O.OOE+00 4.45E-01 2.31E-05 43 Te-127-3.83E-01 1.36E-01 4.55E-02 9.11E-02 1.55E+00 O.OOE+00 9.54E-01 1.lBE-06 44 Te-127 9.87E-04 3.50E-04 2.12E-04 6.81E-04 4.OOE-03 0.OOE+00 7.62E-02 3.31E-08 45 Te-129m 6.36E-01 2.36E-01 1.01E-01 2.05E-01 2.66E+00 0.OOE+00 2.39E+00 2.51E-04 46 Te-129 1.75E-03 6.52E-04 6.23E-04 1.25E-03 7.34E-03 O.OOE+00 9.56E-03 2.34E-04 47 Te-131m 5.46E-02 2.62E-02 2.1.9E-02 3.94E-02 2.73E-01 O.OOE+00 2.10E+00 1.01-04 48 Te-131 l.05E-21 4.31E-22 6.05E-08 8.05E-22 4.57E-21 O.OOE+00 8.58E-23 7.15E-05 49 Te-132
.111E-01 7.06E-02 6.65E-02 7.44E-02 6.77E-01 O.OOE+00 2.24E+00 5.37E-05 50 1-130 4.15E-04 1.20E-03 5.37E-04 9.80E-02 1.85E-03 O.OOE+00 9.24E-04 6.88E-05 51 I-131 8.80E-03 1.23E-02 6.80E-03 3.59E+00 2.12E-02 O.OOE+00 2.44E-03 2.26E-04 52 I-132 2.40E-07 6.29E-07 1.02E-05 2.12E-OS 9.91E-07 O.OOE+00 2.74E-07 1.18E-05 53 I-133 1.43E-03 2.43E-03 7.68E-04 3.40E-01 4.271E-03 O.OOE+00 1.84E-03 3.14E-05 54 1-134 6.22E-13 1.65E-12 2.21E-06 2.75E-11 2.60E-12 0.001+00 2.17E-14 2.63E-06 55 I-135 7.24E-05 1.86E-04 9.38E-05 1.20E-02 2.94E-04 0.00E+00 2.07E-04 2.89E-05 56 Cs-134 1.66E+01 3.91E+01 1.82E+01 O.OOE+00 1.24E+01 4.74E+00 4.86E-01 8.70E-02 57 Cs-136 1.62E+00 6.36E+00 4.27E+00 O.OOE+00 3.46E+00 5.45E-01 5.12E-01 1.86E-03 58 Cs-137 2.23E+01 2.96E+01 1.04E+01 0.00E+00 1.01E+01 3.91E+00 4.21E-01 1.31E-01 59 Cs-138 1.56E-16 2.99E-16 1.08E-06 O.OOE+00 2.21E-16 2.57E-17 1.36E-19 1.23E-06 60 Ba-139 2.64E-10 1.85E-13 7.00E-07 O.OOE+00 1.75E-13 1.28E-13 2.35E-09 7.88E-07 61 Ba-140 1.49E-02 1.82E-05 1.18E-03 O.OOE+00 6.17E-06 1.22E-05 2.29E-02 2.55E-04 62 Ba-141 0.OOE+OO O.OOE+00 4.69E-08 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 5.34E-08 63 Ba-142 0.0OE+OO O.OOE+00 1.01E-08 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 1.15E-08 64 La-140 5.96E-06 2.93E-06 2.06E-04 O.OOE+00 O.OOE+00 O.OOE+00 1.68E-01 2.33E-04 65 La-142 8.77E-12 3.89E-12 5.36E-06 0.00E+00 O.OOE+00 O.OOE+00 1.19E-07 6.431-06 66 Ce-141 3.331-06 2.22E-06 1.49E-04 O.OOE+00 1.05E-06 O.OOE+00 6.361-03 1.67E-04 67 Ce-143 3.52E-07 2.56E-04 2.47E-05 O.OOE+00 1.15E-07 O.OOE+00 7.70E-03 2.80E-05 68 Ce-144 1.78E-04 7.35E-05 7.66E-04 O.OOE+00 4.39E-05 O.OOE+00 4.47E-02 8.74E-04 69 Pr-143 3.28E-05 1.31E-05 1.63E-06 O.OOE+00 7.60E-06 O.OOE+00 1.08E-01 O.OOE+00 70 Pr-144 0.00E+00 O.OOE+00 1.81E-09 O.OOE+00 O.OOE+001
.00E+00 O.OOE++00 2.08E-09 71 Nd-147 2.321-05 2.52E-OS 9.26E-05 O.OOE+00 1.48E-05 O.OOE+00 9.09E-02 1.09E-04 72 W-187 8.42E-03 6.86E-03 2.43E-03 O.OOE+00 O.OOE+00 O.OOE+00 1.86E+00 2.89E-05 73 Np-239 1.49E-06 1.40E-07 1.85E-05 O.OOE+00 4.40E-07 O.OO+00 2.26E-02 2.13B-05 Page 4 of 6
Attachment H ODCM-QA-005 Revision 2 Page 45 of 48 MAXIMUM HYPOTHETICAL COMPOSITE DOSE FACTORS (Ref. 3.16)
I Composite Dose Factors:
Dose Factor Units:
Location:
Maximum Hypothetical Child (Page 1 of 2) mrem/Ci Released Danville (Water Ing.yOutfall (Fish and ShorelineYFIXED DILUTION Usage (Uap) (kglyr: FISH) =
Usage (Uap) (hr/yr: SHORE) =
Dilution (1/Mp:FISH) =
Transit time (tf) hrs. =
Transit time (tp) hrs.=
6.9 Usage (Uap) (kg/yr WATER) =
14 Dilution (1/Mp:SHORE) =
15.9 Dilution (1/Mp:WATER) =
25 Transit time (tw) hrs. =
I Transit time (tb) hrs. =
510 15.9 321 25.8 131400 Isotope Bone Liver T.
Body Tbyroid Kidney Lung GC-LL1 Skin 1H-3 O.OOE+OO 3.96E-05 3.96E-05 3.96E-05 3.96E-05 3.96E-0' 3.96E-05 0.003+00 2 C-14, 2.3SE+OC 4.77E-01 4.77E-01 4.77E-01 4.77E-01 4.773-01 4.77E-01 O.OOE+00 3Na-24 8.10S-03 8-10E-03 8.12E-03 8.10E-03 8.10E-03 8.10E-03 8.10E-03 3.01E-05 4 P-32 1.01E+02 4.72E+00 3.89E+00 O.OOE+00 0.OE+0O 0.003+00 2.79E+00 O.OOE+00 5 Cr-5 01+
O.OoE+0 O.E+OO 8.62305 4O20E-05 1.15E-Os 7.66E-05 4.01E-03 1.25E-05 6 Mn-54 O.3OE+00 1.84E-01 5.23E-02 O.OOE+00 5.17E-02 o.OOE+00 1.55E-01 3.69E-03 7 Mn-56 0.OOE+OO 6.95E-06 3.14E-06 0.OOE+00 8.41E-06 o.OOE+00 1.01E-03 1.853-06 8 Fe-55 5.10E-02
-2.71E-02 8.38E-03 O.OOE+00 O.OOE+00 1.53E-02 -5.01E-03 O.OOE+00
.79 Fe-59 7.21E- 0 1.17E-01 5.87E-02 O.OOE+00 O.OOE+00 3.38E-02 1.21E-01 7.28E-04 1O0Co-58 0.00E+00 4.OsE-03 1.34E-02 O.OOE+00 0.00E+00 o.OOE+00 2.393-02 I.O1E-03 1 Co-60 0.03OE+00 1.21E-02 8.47E-02 O.OOE+00 O.oOE+00 o.OOE+00 -6.73E-02 5.75E-02 l 2 Ni-63 2.39E+00 1.28E-01 8.12E-02 O.OOE+00 O.OOE+00 0.00E+00 -8.61E-03 0.OOE+00 13 Ni-65
- l.olE-OS 9.50E-07 1.07E-06 O.ooE+00 O.OOE+00 o.OOE+00 1.16E-04 5.96E-07 14 Cu-64 0.OOE+00 1.43E-04 8.79E-05 O.OOE+00 3.47E-04 o.OOE+00 6.733-03 1.48E-06 5 Zn-6s 1.17E+00 3.12E+00 1.94E+00 O.OOE+00 1.97E+00 O.OOE+00 5.48E-01 1.95E-03 16 Zn-65 2.95E-11 4.26E-11 3.4E-12 o.OOE+00 2.58E-11 0.00E400 2.68E-09 O.OOE+00 17 Br-83 0.OOE+00 0.OOE+00 2.21E-06 O.OOE+00 O.OOE+00 o.OOE+00 0.00E+00 1.20E-08 18 Br-84 0.00E+00 0.OOE+00 1.25E-07 O.OOE+00 O.OOE+00 o.OOE+O0 O.OO+00 -1.463-07 19 Br-85
.OOE+0OO O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 0.00E+00 0.003+00 0.OOE+00 20 Rb-86 O.0E+00 5.53E+00 3.40E+00 O.OOE+00 O.OOE+00 -o.OOE+00 3.56E-01 2.33E-05 21 Rb-88 0.O0E+00 0.OOE+00 7.31E-09 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 8.36E-09 22Rb-89 0.0OE+00 O.OOE+00 1.90E-08 O.OOE+00 O.OOE+00 0.00E+00 O.OOE+00 2.28E-08 23 Sr-89 1.8E+OO O.OOE+OO S.36E-02 O.OOE+OO O.OOE+00 o.OOE+00 7.26E-02 5.71E-08 24 Sr-90 2.45E+01 O.OOE+00 6.21E+00
.OOOE+0 O.OOE+00 0.OOE+00 3.30E-01 o.OOE+00 25Sr-91 5.55E-03
.0.OOE+00 2.14E-04 0.00E+00 O.OOE+00 O.OOE+00 1.22E-02 5.31E-06 26 Sr-92 2.13S-05 0.003+00 2.22E-06 O.OOE+00 O.OOE+00 O.OOE+00 4.03E-04 1.52E-06 27 Y-90 3.84E-05 0.OOE+OO 1.04E-06 O.OOE+00 O.OOE+00 O.OOE+00 1.09E-01 1.19E-08 28Y-91m 3.7EE-16 O.OOE+00 9.91E-08 O.OOE+00 O.OOE+00 O.OOE+00 7.40E-13 1.E13-07 29 Y-91 7.30E-04 O.OOE+00 2.20E-05 0.OOE+00 0.3OOE+00 O.OOE+00 9.72E-02 2.74E-06 30Y-92 3.243-08 0.OOE+00 3.38E-07 O.OOE+00 -O.OOE+00 0.OOE+00 9.37E-04 4.003-07 313Y-93 2.50E-06 O.00E+00 4.58E 0.OOE+00 O.OOE+00 O.OOE+00 3.73E-02 5.32E-07 32 ir-95 3.42E-05 7.51E-06 5.63E-04
- 0.
OOE+00 1'.08E-05
-0.00E+00 7.84E-03 6.45E-04 33 Zr-97 7.34E-07 1.06E-07 6.52E-06 0.003E+0 1.52E-07 0.OOE+00 1.61E-02 7.51E-06 34 Nb-95 2.83E-02 1.1OE-02 8.19E-03 O.OOE+00 1.04E-02 0.OOE+00 2.04E+01 3.65E-04 Page 5 of 6
-'U Attachment H ODCM-QA-005 Revision 2 Page 46 of 48 MAXIMUM HYPOTHETICAL COMPOSITE DOSE FACTORS (Ref. 3.16)
Composite Dose Factors:
Dose Factor Units:
Location:
Maximum Hypothetical Child (Page 2 of 2) mrem/Ci Released Danville (Water Ing.)/Ouffall (Fish and Shoreline)/FIXED DILUTION Isotope Bone Liver T.
Body Thyroid Kidney Lung GI-LLI SKI=l 3
M-99 O.OOE+OO 5.97E-03 1.49E-03 O.OOE+00 1.27E-02 0.OOE+00 4.94E-03 1.04E-05 36 Tc-99m 4.07E-08 7.99E-08 1.70E-06
- 0. OOE+00 1.16E-06 4.06E-08 4.55E-05 4.27E-07 37 Tc-l
- 0. 0OE+0OO. OOE+00 2.49E-09 O.OOE+00 O.OOE+00 O.OOE+00 O. OOE+00 2.77E-09 38 Ru-103 4.20E04
- 0. OOE+00 4.07E-04
- 0. OOE+00 1.06E-03 O.OOE+00 1.09E-02 2.87E-04 39 Ru-105 7.37E-07
- 0. OOE+00 1.50E-06 O.OOE+00 6.48E-06 O.OOE+00 4.81E-04 1.40E-06 40R-106 6.83E-03 O.OOE+00 1.81E-031
- 0. OOE+00 9.22E-03 O.OOE+00 1.06E-01
- 1. 1SE-03 4 Ag-llOm 1.37E04 9.26E-05 7.893-03 O.OOE+00 1.73E-04 O.OOE+00 1.103-02 9.11E-03 42Te-125m 1.95E-01 5.27E-02 2.59E-02 5.46E-02
- 0. OOE+00 O.OOE+00 1.88E-0O 4.83E-06 43 Te-127m 4.96E-01 1.34E-01 5.89E-02
- 1. 19E-01 1.41E+00 O.OOE+00 4.02E-01 2.46E-07 44 Te-127 1.27E-03 3.44E-04 2.73E-04 8.82E-04 3.63E-03 O.OOE+00 4.98E-02 6.91E-09
'45 Te-129m 8.24E-01 2.30E-01 1.28E-01 2.66E-01 2.42E+00 O. OOE+00
- l. OOE+00 5.25E-05 46 Te-129 2.27E-03 6.33E-04 5.79E-04 1.62E-03 6.63E-03
- 0. OOE+00 1.41E-01 4.90E-05 47 Te-131m 6.98E-02 2.413E-02 2.57E-02 4.97E-02 2.34E-01
- 0. OOE+00 9.79E-0O 2.10E-05 48 Te-131 1.34E-21 4.09E-22 1.26E-08 1.03E-21 4.06E-21 O.OOE+00 7.05E-21 1.49E-05 49 Te-132 1.40E-01 6.19E-02 7.48E-02 9.01E-02 5.75E-01
- 0. OOE+00 6.23E-01 1.12E-05 50 I-130 5.69E-04 1.lSE-03 6.04E-04 1.27E-01 1.72E-03 0.OOE+00 5.38E-04 1.44E-05 51 I-131 26-02 1.26E-02 7.213E-03 4.18E+00 2.07E-02
- 0. OOE+00 1.12E-03 4.73E-05 52 I-132 3.273-07 6.01E-07 2.37E-06 2.79E-05 9.20E-07
- 0. OOE+00 7.08E-07.
2.46E-06 53 1-133 2.05E-03 2.53E-03 9.62E-04 4.70E-01 4.22E-03 0.OOE+00 1.02E-03 6.55E-06 54-134 8.23E-13 1.53E-12 4.62E-07 3.52E-11 2.34E-12 O.OOE+OC 1.01l-12 5.493-07 55 1-135
- 1OOE-04 1.80E-04 9.03E-05 1.59E-02 2.76E-04 0.OOE+00 1.37E-04 6.03E-06 56Cs-134 2.01E+01 3.29E+01 6.96E+00 0.OOE+00 1.02E+01 3.66E+00 1.77E-01 1.82E-02 57 Cs-136 1.91E+00 5.25E+00 3.39E+00 0.OOE+00 2.79E+00 4.17E-01 1.843-01 3.88E-04 58 Cs-137 2.80E+01 2.68E+01 3.99E+00 0.OOE+00 8.75E+00 3.15E+00 1.68E-01 2.73E-02 59Cs-138 1.98E-16
- 2.75E-16 2.25E-07 0.00O+00 1.93E-16 2.08E-17 1.26E-16 2.57E-07 60 Ba-139 4.32E-10 2.31E-13 1.46E-07 O.OOE+00 2.01E-13 1.36E-13 2.49E-08 1.65E-07 61 Ba-140 2.57E-02 2.25E-05 1.55E-03 O.OOE+00 7.34E-06 1.34E-05 1.30E-02 5.32E-05 62 Ba-141 O.OOE+00 O.OOE+00 9.79E-09 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 1.12E-08 63 Ba-142 O.OOE+OO-0.OOE+00 2.11E-09 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 2.41E-09 64 La-140 8.04E-06 2.81E-06 4.39E-05 o.OOE+00 o.OOE+00 O.OOE+00 7.83E-02 4.86E-05 65 La-142 1.173-11 3.73E-12 1.12E-06 O.OOE+00 O.OOE+00 0.003+00 7.383-07 1.343-06 66 Ce-141
- 7. 74E-06 3.86E-06 3.16E-05 O.OOE+00 1.69E-06 O.OOE+00 4.82E-03 3.50E-05 67 Ce-143 8.14-07 4.41E-04 5.21E-06 O.OOE+00 1.85E-07 O.OOE+00 6.47E-03 5.85E-06 68 Ce-144 4.14E-04 1.30E-04 1.80E-04 O.OOE+00 7.19E-05 O.OOE+00 3.38E-02 1.83E-04 69 Pr-143
-4.57E-05 1.37E-05 2.27E-06 O.OOE+00 7.43E-06 O.OOE+00 4.93E-02 O.OOE+00 70 Pr-144 O.OOE+00 O.OOE+00 3.78E-10 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 4.35E-10 71 Nd-147 3.20E-05 2.60E-05 2.10E-05 O.OO+00 1.42E-05 O.OOE+00 4.11E-02 2.28E-OS 72 W-187 1.07E-02 6.333-03 2.84E-03 O.OE+00 O.OOE+00 O.OOE+00 8.89E-01 6.03E-06 73 Np-239 2.25E-06 1.62E-07 3.95E-06 0.0+E0+0 4.68E-07 0.00E+00 1.20E-02 4.45E-06 Page 6 of 6
Attachment I ODCM-QA-005 Revision 2 Page 47 of 48 MAXIMUM HYPOTHETICAL WATER INGESTION DOSE FACTORS -INFANT (Ref. 3.16)
I Water Ingestion Dose Factors:
Dose Factor Units:
Location:
Usage (Uap) (kg/yr. WATE Transit time (WATER) hrs.
Dilution (1/Mp:WATER) =
Maximum Hypothetical Infant (Page 1 of 2) mrem/Ci Released Danville Receiver/FIXED DILUTION R) =
330
=
25.8
~321 isotope Bone Liver T. Body Thyroid Kidney Lung -
GI-LL1 1 H-3 O.OOE+00 3.12E-05 3.12E-05 3.12E-05 3.12E-05 3.12E-05 3.12E-05 2 C-14 2.40E-03 5.13E-04 5.13E-04 5.13E-04 5.13E-04 5.13E-04 5.13E-04 3 Na-24 3.11E-04 3.-11E-04 3.11E-04 3.11E-04 3.11E-04 3.11E-04 3.11E-04 4
P-32 1.64E-01 9.63E-03 6.34E-03 O.OOE+00 0.OOE+00 O.OOE+00 2.21E-03 5 Cr-Sl 0.OOE+00 O.OOE+00 1.39E-06 9.08E-07 1.98E-07 1.77E-06 4.06E-05 6 Mn-54 O.OOE+00 2.01E-03 4.56E-04 O.OOE+00 4.46E-04 O.OOE+00 7.40E-04 7
Mn-56 0.OOE+00 8.07E-08 1.39E-08 O.OOE+00 6.93E-08 O.OOE+00 7.33E-06 F-5 1.41E-03 9.105-04 2.435-04 O.OOE+00 O.OOE+00 4.45E-04 1.16E-04
-Fe-59 3.07E-03 5.37E-03 2.11E-03 O.OOE+00 O.OOE+00 1.59E-03 2.56E-03 10 Co-58 O.OOE+00 3.61E-04 9.01E-04 0.OOE+00 O.OOE+00 O.OOE+O0 9.OOE-04 11 Co-60
.00E+0O 1.09E-03 2.59E-03 O.oOE+00 0.OOE+00 O.OOE+00 2.61E-03 12 Ni-63 6.43E-02 3.98E-03 2.23E-03 0.00E+00 0.OOE+00 0.OOE+00 1.98E-04 13 Ni-65 3.95E-07 4.47E-08 2.03E-08 O.OOE+00 O.OOE+00 O.OOE+00 3.40E-06 14 Cu O.OOE+00 1.51E-05 7.OOE-06 O.OOE+00 2.56E-05 0.OOE+00 3.10E-04 15 zn-65 1.86E-03 6.38E-03 2.94E-03 O.OOE+00 3.09E-03 0.OOE+00 5.39E-03 16 Zn-69 4.09E-14 7.36E-14 5.48E-15 O.OOE+O0 3.06E-14 0.OOE+00 6.00E-12 17 Br O.OOE+00 0.00E+00 2.07E-08 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 18 Br-84 O.OOE+00 O.OOE+00 9.19E-20 O.OOE+00 0.OOE+00 0.OOE+00 O.OOE+00 19 Br-85 O.OOE+00 O.OOE+00
- O.OOsE+O O.OOE+00 0.00E+00 0.00E+00 O.OOE+00 2 oRb-86 0.OOE+00 1.66E-02 8.19E-03 O.OOE+00 0.OOE+00 O.OOE+00 4.24E-04 21 Rb-88 O.OOE+00 O.OOE+00 0.0OOE+00 OoOE+00 O.OOE+00 O.OOE+00 O.OOE+00 22 Rb-89 o.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 O.OOE+00 0.OOE+00 O.OOE+00 23 sr-89 2.515-01 0.005+00 7.20E-03 O.OOE+00 0.00E+00 0.00E+00 5.16E-03 24 Sr-io
~~~1.88E+OC O.OOE+OO 4.78E-O1 O.E+C
.O+C OOEOO 23-;
24 Sr9 1.8+0O.0+0O.8-0E.0+00 0.005+00 0.005+00 2.345-02 25 Sr-91 7.72E-04 0.OOE+00 2.79E-OS 0.0OE+00 O.OOE+00 O.OOE+00 9.14E-04 2 Sr-92 2.65E O.OOE+00 9.85E-08 O.OOE+00 -
O.OOE+00 O.OOE+00 2.86E05 27 Y-90 6.67-06
.OOE+00 1.79E-07 O.OOE+00 O.OOE+00 O.OOE+00 9.21E-03 28 Y-91M 3.62E-17 O.OOE+00 1.23E-18 O.OOE+00 O.OOE+00 O.OOE+00 1.21E-13 29 Y-91 1.13E-04 O.OOE+00 3.01E-06 O.OOE+00 0.OOE+00 O.OOE+00 8.11E-03 30 Y-92 4.96E-09 O.OOE+00 1.40E-10 O.OOE+00 0.00E+00 O.OOE+00 9.47E-05 31 Y-93
~~~~4.20E-07 O.OOE+OO 1.14E-08 W.O+O OOEO
.O+O 33E0 31Y-93 4.0-7 000+0 1O5-8..0+00 0.005E+00 0.005+00 3.315-03 32 Zr-95 2.07E-05 5.03E-06 3.57E-06 O.OOE+00 5.42E-06 O.OOE+00 2.51E-03 33 Zr-97 5.21E07 8.94E-08 4.08E-08 O.OOE+00 9.01E-08 O.OOE+00 5.70E-03 34Nb-9S 4.17E-06 1.72E-06 9.93E-07 O.OOE+00 1.23E-06 0.OOE+00 1.45E-03 35Mo-99 0.005+00 2.63E-03 5.13E-04 O.OOE+00 3.93E-03 O.OOE+00 8.66E-04 Page 1 of 2
1B-Attachment I ODCM-QA-005 Revision 2 Page 48 of 48 MAXIMUM HYPOTHETICAL WATER INGESTION DOSE FACTORS - INFANT (Ref. 3.16)
I Water Ingestion Dose Factors: Maximum Hypothetical Infant (Page 2 of 2)
Dose Factor Units:
mrem/Ci Released Location:
Danville Receiver/FIXED DILUTION Isotope Bone Liver T. Body Thyroid lidney Lung GI-LL l
36 Tc-99m 9.98E-09 2.06E-08 2.65E-07 0.OOE+00 2.22E-07 1.08E-08 5.98E-06 37 Tc-101 O.OOE+00 O.OOE+00 O.OOE+00 0.aOE+00 O.OOE+00
- 0.
+00 O.OOE+00 38 Ru-103 1.47E-04 O.OOE+00 4.93E-05 O.00E+00 3.07E-04 O.OOE+00 1.79E-03 39 Ru-105 2.46E-07 O.OOE+00 8.27E-08 O.OOE+00 1.81E-06 O.OOE+00 9.77E-05 40 RU-106 2.44E-03 0.00O+00 3.05E-04 O.OOE+00 2.88E-03 O.OOE+00 1.85B-02 41 Ag-llOm 1.01E-04 7.35E-05 4.86E-05 O.OOE+00
- 1.05E-04 O.OOE+00 3.81E-03 42 Te-125m 2.33E-03 7.80E-04 3.15E-04 7.85E-04 O.OOE+00 O.OOE+00 1.11S-03 43 Te-127m B.893E-3 1.95E-03 7.13E-04 1.70E-03 1.45E-02 O.OOE+00 2.38E-03 44 Te-127 1.50E-05 5.02E-06 3.22E-06 1.22E-05 3.65E-05 O.OOE+00 3.153-04 45ITe-129F 9.92E-03 3.40E-03 1.53E-03 3.81E-03 2.48E-02 0.00E+00 5.92E-03 46 Te-129 2.82E-05 9.71E-06 6.58E-06 2.36E-05 7.01E O.OOE+00 2.25E-03 47 Te-131f 8.49E-04 3.42E-04 2.82E-04 6.93E-04 2.35E-03 O.OOE+00 5.76E-03 48Te-131 4.46E-24 1.65E-24 1.25E-24 3.98E-24 1.14E-23 O.OOE+00 1.80E-22 49Te-132 1.68E-03 8.31E-04 7.75E-04 1.23E-03 5.20E-03 O.OOE+00 3.07E-03 SO I-130 1.43E-04 3.15E-04 1.26E-04 3.53E-02 3.46E-04 O.OOE+00 6.75E-05 51 1-131 3.32E-03 3.91E-03 1.72E-03 1.28E+00 4.57E-03 O.OOE+00 1.40E-04 52 -132 7.07E-08 1.44E-07 5.11E-08 6.73E-06 -1.60E-07 O.OOE+00 1.16E-07 53 I-133 5.37E-o0 7.81E-04 2.29E-04 1.42E-01 9.19E-04 O.OOE+00 1.32E-04 54 1-134 1.27E-13 2.60E-13 9.25E-14 6.06E-12 2.91E-13 O.OO+00 2.69E-13 55 1-135 2.47E-05 4.91E-05 1.79E-05 4.40E-03 5.47E-05 O.OOE+00 1.78E-05 56 Cs-134 3.82E-02 7.12E-02 7.19E-03 O.OOE+00 1.83E-02 7..52E-03 1.94E-04 57 Cs-136 4.40E-03 1.29E-02 4.83E-03 O.OOE+00 5.16E-03 1.05E-03 1.96E-04 58 Cs-137 5.29E-02 6.20E-02 4.39E-03 O.OOE+00 1.66E-02 6.73E-03 1.94E-04 sTcs -138 1.76E-19 2.86E-19 1.39E-19 O.OOE+00 1.43E-19 2.23E-20 4.57E-19 60 Ba-139 2.26E-10 1.50E-13 6.55E-12 O.OOE+00 9.02E-14 9.09E-14 1.43E-08 61 Ba-140 1.64E-02 1.64E-05 8.43E-04 O.OOE+00
- 3.88E-06 1.OOE-05 4.02E-03 62 Ba-141 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 63 Ba-142 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOB+00 64 La-140 1.37E-06 5.41E-07 1.39E-07 O.OOE+00 O.OOE+00 O.OOE+00 6.3SE-03 65 La-142 1.49E-12 5.47E-13 1.31E-13 O.OOE+00 O.OOE+00 O.OOE+00 9.28E-08 66 Ce-141 7.80E-06 4.76E-06 S.60E-07 O.OOE+00 1.47E-06 O.OOE+00 2.46E-03 67 Ce-143 8.73E-07 5.79E-04 6.61E-08 O.OOE+00 1.69E-07 O.OOE+00 3.38E-03 68 Ce-144 3.01E-04 1.23E-04 1.69E-05 O.OOE+00 4.99E-05 O.OOE+00 1.73E-02 69 Pr-143 7.80E-06 2.92E-06 3.87E-07 O.OOE+00 1.08E-06 O.OOE+00 4.12E-03 70 Pr-144 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 O.OOE+00 o.OOE+00 71 Nd-147 5.243-06 5.383-06 3.30E-07 O.OOE+00 2.08E-06 O.OOE+00 3.41E-03 721W-187 4.32E-05 3.01E-05 1.04E-05 O.OOE+00 O.OOE+00 O.OOE+00 1.77E-03 73Np-239 8.20E-07 7734E-08 4.15E-08 O.OOE+00 1.46E-07 O.OOE+00 2.12E-03 Page 2 of 2
PROCEDURE CHANGE PROCESS FORM
- 4. PCAF NO. 2003- -72.
- 2. PAGE 1 OF 3
- 3. PROC. NO. ODCM-QA-006 REV. 1
-A.
-FORMS REVISED,R- _
R.,
R__
R R_,
R_,
R
- 5.
PROCEDURE TITLE
'TOTAL DOSE CALCULATIONS
- 6. REQUESTED CHANGE PERIODIC REVIEW 1
NO El YES INCORPORATE PCAFS 1 NO El YES #
REVISION El PCAF 3
DELETION-,
(CHEC.-ONFONLY)
- 7.
SUMMARY
OF/ REASON FOR CHANGE f
The change being rmade is the addition of the Nuclear Emergency Planning RECO MMENDED REVIEWS" section on the procedure cover page.
A x
This change to ODCM-QA-006 is an administrative correction and does not cfease the level of effluent control or the accuracy and/or reliability of dose calculations or sets detergnlnations as required by 10CFR20.1302, 40CFR190, 10CFR50.36a and 10CFR50 Appg. 1.
Continued E
- 8. DETERMINE COMMITTEE REVIEW REQUIREM (Refer to Section 6.1.4)
PORC REVIEW REQ'D?
1 3
- 9.
PORC MTG#
Mid I
,,AN BLOCKS 11 THRU 16 ARE ON PAGE 2 FOFeon
- 17.
Francis J. Hickey 1 4j0
- 18. COMMUNICATION OF CHANGE REQUIRED?
PREPARER DATE ZNO El YES (TYPE)
(Print or Type)
- 19.
SIGNATURE ATTESTS THAT RESPONSIBLE SUPERVISOR HAS CONDUCTED QADR AND TECHNICAL REVIEW UNLESS OTHERWISE
£,DOCUMENTED IN BLOCK 16 OR ATTACHED REVIEW FORMS.
E PIRVISOR DATE CROSS DISCIPLINE REVIEW (IF REQUIRED) HAS BEEN COMPLETED SPO AT BY SIGNATURE IN BLOCK 16 OR ATTACHED REVIEW FORMS.
- 20.
N/A FUM APPROVAL DATE
- 21. RESPONSIBLE APPROVER ENTER N/A IF FUM HAS APPROVAL AUTHORITY N/A INITIALS DATE iLAM NDAP-QA-0002-8, Rev. 8, Page 1 of 2 (Electronic Form) l l.
LML PROCEDURE CHANGE PROCESS FORM
- 1. PCAF NO.
J2003-U-/' 7
- 12. PAGE2OF 3
- 13. PROC. NO. ODCM-QA-006 REV. 1 I.-
=
1W 11. This question documents the outcome of the 50.59 and 72.48 Review required by NDAP-QA-0726.
b, c or d must be checked 'YES' and the appropriate form attached or referenced.
- a. This change is an Administrative Correction for which 50.59 and 72.48 are not 3 YES applicable.
- b. This change is a change to any surveillance, maintenance or administrative jj YES procedure for which 50.59 and 72.48 are not applicable.
- c. This change is bounded by a 50.59/72.48 Screen/Evaluation, therefore, no new 2
YES 50.59/72.48 Evaluation is required.
Screen/Evaluation No.
- d. 50.59 and/or 72.48 are applicable to this change and a 50.59/72.48 a
YES Screen/Evaluation is attached.
3 YES Change Request No.
- 13. Should this change be reviewed for potential effects on Training Needs or Material?
a] YES If YES, enter an Action Item @ NIMS/Action/Gen Work Mech/PICN
- 14.
Is a Surveillance Procedure Review Checklist required per NDAP-QA-0722?
[] YES
- 15. Is a Special, Infrequent or Complex Test/Evolution Analysis Form required per
[] YES NDAP-QA-0320? (SICT/E form does not need to be attached.)
Either 11a, Z WA 3 N/A 3 N/A Z N/A Z
NO Z
NO Z NO
- 16. Reviews may be documented below or by attaching Document Review Forms NDAP-QA-0101-1.
REVIEWED BY WITH DATE REVIEW NO COMMENTS QADR TECHNICAL REVIEW REACTOR ENGINEERING/NUCLEAR FUELS
- IST OF}
OPERATIONS NUCLEAR SYSTEMS ENGINEERING NUCLEAR MODIFICATIONS MAINTENANCE HEALTH PHYSICS NUCLEAR TECHNOLOGY CHEMISTRY OTHER Required for changes that affect, or have potential for affecting core reactivity, nuclear fuel, core power level indication or impact the thermal power heat balance. (5)
Required for changes to Section Xi Inservice Test Acceptance Criteria.
j&.
R 8,
FORM NDAP-OA-0002-8, Rev. 8, Page 2 of 2 (Electronic Forrn)
r 4 3 or 3 PROCEDURE COVER SHEET PPL SUSQUEHANNA, LLC NUCLEAR DEPARTMENT PROCEDURE ODCM-QA-006 Revision 1 TOTAL DOSE CALCULATIONS Page 1 of 6 QUALITY CLASSIFICATION:
APPROVAL CLASSIFICATION:
QA Program O Non-OA Program Plant C Non-Plant El Instruction EFFECTIVE DATE:
PERIODIC REVIEW FREQUENCY:.
NtA PERIODIC REVIEW DUE DATE:
NWA RECOMMENDED REVIEWS:
Nuclear Ehergency Planning Procedure Owner:
Francis J. Hickey Responsible Supervisor Chemistry Supervisor - SSES Responsible FUM:
Chemistry Supervisor - SSES Responsible Approver Vice President - Nuclear Operations I
I;.
I I
FORM NDAP-OA-0002-1, Rev. 3, Page 1 of 1
ODCM-QA-006 Revision 1 Page 2 of 6 PROCEDURE REVISION
SUMMARY
TITLE:
TOTAL DOSE CALCULATIONS Most of the revisions described below are editorial in nature. The changes made do not reduce or compromise the level of effluent control or the accuracy and/or reliability of dose calculations or setpoint determinations as required by 1 OCFR20.1302, 40CFR1 90, 1 OCFR50.36a and 1 OCFR50, Appendix I. Additionally, the changes outlined below: (1) do not alter the conduct of the radiological environmental monitoring program, (2) do not change the radioactive effluent controls and radiological environmental monitoring activities, and (3) do not change the information to be included in the Annual Radiological Environmental Operating and Radioactive Effluent Release Reports.
Various sections have been revised and/or deleted to incorporate the change in the computer program used by PPL Susquehanna, LLC in support of offsite dose assessment (LADTAP and GASPAR replaced by RETDAS) from routine liquid and gaseous effluents. This revision to ODCM-QA-006 does not change the dose assessment methodology, but deletes specific references to computer programs utilized to perform offsite dose assessment.
- 1. Removed redundant steps and gray shading incorporated for the transition to ITS.
- 2. Revised Sections 6.1, 6.2 and 6.3 to remove redundancy in defining the responsible personnel for performance of offsite dose calculations.
- 3. Deleted the Approval and Date stamp at the bottom of each page due to no longer required per ODCM-QA-002, Rev. 1.
- 4. Various sections revised to reflect SSES organizational changes.
ODCM-QA-006 Revision 1 Page 3 of 6 TABLE OF CONTENTS SECTION PAGE 1.0 PURPOSE 4
2.0 POLICY/DISCUSSION 4
3.0 REFERENCES
4 4.0 RESPONSIBILITIES 5
4.1 Chemistry Supervisor - SSES 5
5.0 DEFINITIONS 5
6.0 PROCEDURE 5
6.1 Waterbome Effluent 5
6.2 Airborne Effluent 5
6.3 Total Dose 6
7.0 RECORDS 6
,,0,,,-r ODCM-QA-006 Revision 1 Page 4 of 6 0
1.0 PURPOSE The purpose of this procedure is to provide the methodology and parameters to determine the total dose to a member of the public from the fuel cycle in the vicinity of the SSES site as required by 40CFR1 90.
It also ensures that radioactive effluents which result in calculated doses exceeding twice the objectives of 10CFR50, Appendix I, are identified, evaluated and reported.
This procedure constitutes part of the SSES Offsite Dose Calculation Manual (ODCM),
which is a licensing basis document.
2.0 POLICY/DISCUSSION 2.1 The cumulative dose to any member of the public due to radioactive releases from the SSES site is determined by summing the calculated doses to critical organs from airborne and liquid effluent sources.
2.2 For all dose calculations from airborne effluents, the deposition rate used in the analysis should be at the receiver location of the individual being evaluated, not the highest calculated annual average relative concentration or relative deposition rate for any area at or beyond the site boundary as given in Attachment B of ODCM-QA-004.
2.3 The direct radiation to any member of the public due to operations at SSES should be determined from the environmental monitoring program results.
2.4 The total dose to members of the public shall include any dose received from activities occurring within the site boundary. Use of realistic occupancy factors for determination of this dose is allowed.
3.0 REFERENCES
3.1 TR 3.11.3, Total Dose.
3.2 1 OCFR50 Appendix I, Numerical Guides for Design Objectives and Limiting Conditions for Operation to Meet the Criterion "As Low as is Reasonably Achievable" for Radioactive Material in Light-water Cooled Nuclear Power Reactor Effluents.
3.3 400FR1 90, Environmental radiation protection standards for nuclear power operations.
3.4 ODCM-QA-004, Airborne Effluent Dose Calculations.
3.5 ODCM-QA-005, Waterbome Effluent Dose Calculations.
ODCM-QA-006 Revision 1 Page 5 of 6 3.6 Regulatory Guide 1.109, Rev. 1, October, 1977, Calculation of Annual Doses to Man from Routine Releases of Reactor Effluents for the Purposes of Evaluating Compliance with 10 CFR 50, Appendix I.
4.0 RESPONSIBIlLITES 4.1 Chemistry Supervisor - SSES 4.1.1 Ensures adequacy and correctness of methodology to be used to determine the total dose to a member of the public from the fuel cycle.
4.1.2 Ensures dose calculations necessary for fulfillment of SSES Technical Requirements Surveillances are performed.
4.1.3 Ensures methodology and parameters to be used to determine the total dose to a member of the public from the fuel cycle are developed.
5.0 DEFINITIONS 5.1 MEMBER(S) OF THE PUBLIC - Shall include all persons who are not occupationally associated with the plant. This category does not include employees of the utility, its contractors, or vendors. Also excluded from this category are persons who enter the site to service equipment or to make deliveries. This category does include persons who use portions of the site for recreational, occupational, or other purposes not associated with the plant.
6.0 PROCEDURE 6.1 Waterborne Effluent The annual dose to critical organs of a maximally exposed individual for the liquid effluents shall be determined by using the methodology outlined in Section 6.1 of ODCM-QA-005.
ODCM-QA-006 Revision 1 Page 6 of 6 6.2 Airbome Effluent 6.2.1 The annual dose to critical organs of a real individual for the noble gases released in the gaseous effluents shall be determined by using Equation 3 of ODCM-QA-004 modified by replacing Ml with K for the whole-body dose and using Equation 4 modified by replacing N, by [L4 + (1.1 1 MX)(SF)]
for the skin dose. Values of 14, 4, and Mi are obtained from Attachment A of ODCM-QA-004.
D =3.17xlO 8 £ K. (XIQ) (Q )(S )
.(Eq. 1) g I
v iv F
D b =3.17x10 8 EL
[i +(1.1lMi d(SF )](X1/Q)V (Qiv )
(Eq. 2) 6.2.2 The annual dose to critical organs of a real individual for the radionuclides other than noble gases released in the gaseous effluents shall be determined by using Equation 6 of ODCM-QA-004.
6.3 Total Dose 6.3.1 The total dose to a member of the public shall be calculated by summing the direct dose determined by the environmental monitoring program', the airborne dose contribution at the point of interest determined per §6.2, and the total dose from liquid effluent determined per §6.1.
6.3.2 If the results of the calculated dose exceed twice the objectives of 10CFR50, Appendix I, it shall be determined whether the limits of 40CFR90 have been exceeded. If the 40CFR1 90 limits have been exceeded, a special report shall be prepared and submitted to the NRC within 30 days addressing the actions of TR 3.11.3.
7.0 RECORDS None.
odcm-qa.006(26)
PROCEDURE CHANGE PROCESS FORM AIIIIIIIIh
_e
- 1. PCAF NO.. 200322-3(p-
- 1. -2PAGE1 OF 3
- 3. PROC. NO. ODCM-QA-007 REV. 1
, 4. FORMS REVISED R,
, -RR_,
- _R R,
R R
- 5. PROCEDURE TITLE RADIOACTIVE WASTE TREATMENT SYSTEMS
- 6. REQUESTED CHANGE PERIODIC REVIEW 3 NO
[L YES INCORPORATE PCAFS 1 NO El YES #
REVISION
[J PCAF 3
DELETION El (CHEC E ONLY)
- 7.
SUMMARY
OF! REASON FOR CHANGE The change being made is the addition of the Nuclear Emergency Planning h RECOMMENDED REVIEWS" section on the procedure cover page.ge This change to ODCM-QA-007 is an administrative correction and does no se the level of effluent control or the accuracy and/or reliability of dose calculations or se zrdete¢,inations as required by 10CFR20.1302, 40CFR190, 1 OCFR50.36a and. 1 OCFR50 App Continued E
- 8.
DETERMINE COMMITTEE REVIEW REQUIREMENT X (Refer to Section 6.1.4)
PORC REVIEW REQ'D?
A3 wS9. PORCMTG#
_4_
9.POC TG BLOCKS 11 THRU 16 ARE ON PAGE 2bF FOR.)
- 17.
Francis J. Hickey I=-"13240
- 18. COMMUNICATION OF CHANGE REQUIRED?
PREPARER A
DATE NO
[M YES (TYPE).->
(Print or Type)
-t a
- 19.
aSIGNATURE ATTESTS THAT RESPONSIBLE SUPERVISOR HAS
<-^CONDUCTED QADR AND TECHNICAL REVIEW UNLESS OTHERWISE IA
- ^6 s:A,DOCUMENTED IN BLOCK 16 OR ATTACHED REVIEW FORMS.
RESPONSIBLESUPER VISOR DATE CROSS DISCIPLINE REVIEW (IF REQUIRED) HAS BEEN COMPLETED BY SIGNATURE IN BLOCK 16 OR ATTACHED REVIEW FORMS.
- 20.
N/A FUM APPROVAL DATE
- 21. RESPONSIBLE APPROVER ENTER N/A IF FUM HAS APPROVAL AUTHORITY N/A INITIALS DATE KORM NDAP-QA-0002-8, Rev. 8, Page 1 of 2 (Electronic Form)
DOCUMENT CONTROL SERVICES - SSES
PROCEDURE CHANGE PROCESS FORM
_s
-E PCAF NO.
.2003-49L. 12.
PAGE 2 OF 3
- 13. PROC. NO.
ODCM-OA-007 REV. 1
- 11. This question documents the outcome of the 50.59 and 72.48 Review required by NDAP-QA-0726. Either 18a, b, c or d must be checked 'YES' and the appropriate form attached or referenced.
- a. This change is an Administrative Correction for which 50.59 and 72.48 are not 3 YES W
N/A applicable.
- b. This change is a change to any surveillance, maintenance or administrative
[
YES A
N/A procedure for which 50.59 and 72.48 are not applicable.
- c. This change is bounded by a 50.59/72.48 Screen/Evaluation, therefore, no new E
YES z
N/A 50.59/72.48 Evaluation is required.
Screen/Evaluation No.
- d. 50.59 and/or 72.48 are applicable to this change and a 50.59172.48 0 YES 3 N/A Screen/Evaluation is attached.
3 YES Change Request No.
- 13. Should this change be reviewed for potential effects on Training Needs or Material?
fl YES 3 NO If YES, enter an Action Item @ NIMS/Action/Gen Work Mech/PICN
- 14. Is a Surveillance Procedure Review Checklist required per NDAP-OA-0722?
0 YES 3
NO
- 15.
Is a Special, Infrequent or Complex Test/Evolution Analysis Form required per
[
YES 3 NO NDAP-QA-0320? (SICT/E form does not need to be attached.)
- 16. Reviews may be documented below or by attaching Document Review Forms NDAP-OA-01 01 -1.
REVIEWED BY WITH DATE REVIEW NO COMMENTS OADR TECHNICAL REVIEW REACTOR ENGINEERING/NUCLEAR FUELS
- IST**
OPERATIONS NUCLEAR SYSTEMS ENGINEERING NUCLEAR MODIFICATIONS MAINTENANCE HEALTH PHYSICS NUCLEAR TECHNOLOGY CHEMISTRY OTHER
- Pne vira;I fnr channes that nffnt-nr hniv nnrtrntin fnr n n
rn~rtivitv n, r gl.n d aU ly
- 4 we
- 1vuiila IWI GXuv1WAly %VIVe IeUMUVILY, 11WUCLId IUM,%elt; u
PV WUUIe IOV0 indication or impact the thermal power heat balance. (5)
Required for changes to Section Xl Inservice Test Acceptance Criteria.
h FORM NDAP-QA-0002-8, Rev. 8, Page 2 of 2 (Electronic Form)
N
V U.
f64eA
-3 oF.)
PROCEDURE COVER SHEET PPL SUSQUEHANNA, L
NUCLEAR DEPARTMENT PROCEDURE RADIOACTIVE WASTE #IEAT~MkNT SYSTEMS ODCM-QA 007 Revision 1 Page 1 of 16 QUALITY CLASSIFICATION:
APPROVAL CLASSIFICATION 0 QA Program O Non-QA Program 0 Plant E Non-Plant El Instruction EFFECTIVE DATE:
9dOA__
PERIODIC REVIEW FREQUENCY:
N/A PERIODIC REVIEW DUE DATE:
NIA RECOMMENDED REVIEWS:-
Nuclear Rnergency Planning Procedure Owner Francis J. Hickey Responsible SupeMsor:
ChemistrySupervisor-SSES Responsible FUM:
Chemistry Supervisor - SSES Responsible Approver.
Vice President - Nuclear Operations fI C-A..,
FORM NDAP-QA-0002-1, Rev. 3, Page 1 of I
ODCM-QA-007 Revision 1 Page 2 of 16 PROCEDURE REVISION
SUMMARY
TITLE:
RADIOACTIVE WASTE TREATMENT SYSTEMS Most of the revisions described below are editorial in nature. The changes made do not reduce or compromise the level of effluent control or the accuracy and/or reliability of dose calculations or setpoint determinations as required by 10CFR20.1302, 40CFR190, 10CFR50.36a and 10CFR50, Appendix I. Additionally, the changes outlined below: (1) do not alter the conduct of the radiological environmental monitoring program, (2) do not change the radioactive effluent controls and radiological environmental monitoring activities, and (3) do not change the information to be included in the Annual Radiological Environmental Operating and Radioactive Effluent Release Reports.
- 1. Removed redundant steps and gray shading incorporated for the transition to ITS.
- 2. Added Attachment B, USSES Liquid Effluent Release Flowpath" and Attachment C, KSSES Gaseous Effluent Release Flowpath" to illustrate the general system flowpath for each release pathway (per EWR #389182).
- 3. Deleted the Approval and Date stamp at the bottom of each page due to no longer required per ODCM-QA-002, Rev. 1.
- 4. Revised Section 2.2.2f to clarify the radiological effluent technical specification guidance provided in NUREG-01 33 as well as the response provided in PPL AR No. 222585 (AR No. 222585 added as reference no. 3.20).
- 5. Deleted Section 2.4.3 due to inclusion into new Attachment C.
- 6. Various sections revised to reflect SSES organizational changes.
ODCM-QA-007 Revision 1 Page 3 of 16 TABLE OF CONTENTS SECTION PAGE 1.0 PURPOSE 4
2.0 POLICY/DISCUSSION 4
2.1 Liquid Waste Treatment 4
2.2 Definition of 'Appropriate Treatment' for Liquid Wastes 5
2.3 Liquid Effluent Monitoring Instrumentation 6
2.4 Gaseous Waste Treatment 6
2.5 Gaseous Effluent Monitoring Instrumentation 8
2.6 Solid Waste Treatment Including the Process Control Program (PCP) 8
3.0 REFERENCES
9 4.0 RESPONSIBILiTIES 10 4.1 Vice President - Nuclear Operations 10 4.2 General Manager - Nuclear Engineering 10 4.3 Chemistry Supervisor - SSES 10 5.0 DEFINITIONS 10 6.0 PROCEDURE 10 6.1 Liquid Waste Treatment 10 6.2 Gaseous Waste Treatment 11 6.3e Evaluating the Dose Impact of Changes to Waste Treatment Systems 11 7.0 RECORDS 12 ATTACHMENTS Attachment Paae A
Ventilation Exhaust Treatment Systems Which Require Offsite Vent 13 Evaluations When Bypassed, Degraded, or Otherwise Rendered Inoperable B
SSES Liquid Effluent Release Flowpath 14 I C SSES Gaseous Effluent Release Flowpath 15
U ODCM-QA-007 Revision 1 Page 4 of 16 1.0 PURPOSE The purpose of this procedure is to define the operability requirements of the radioactive waste treatment and effluent monitoring systems to keep effluent releases as low as is reasonably achievable. It also includes reporting requirements when changes are made to systems or when operability is not maintained in accordance with the Technical Requirements Manual (TRM).
This procedure constitutes part of the SSES Offsite Dose Calculation Manual (ODCM) which is a licensing basis document.
2.0 POLICY/DISCUSSION 2.1 Liquid Waste Treatment 2.1.1 The SSES Liquid Waste Management System consists of three processing sub-systems, liquid, chemical and laundry. Redundant and backup equipment, alternate process routes, interconnections and spare volumes are designed into the system to provide for operational and unanticipated surge waste volumes due to refueling, abnormal leakage rates, decontamination activities and equipment downtime, maintenance and repair. The system has piping connections to allow the installation of vendor-supplied equipment to provide specific treatment of off-normal wastes or to enhance the normal treatment capabilities as necessary.
Appropriate vendor-supplied equipment may also be used in place of installed equipment to allow for repair or replacement of components.
2.1.2 Low conductivity liquid wastes are processed in the Liquid Radwaste Treatment Sub-system (LRW). Liquid is collected in three pairs of LRW Collection tanks. Each pair of tanks has an approximate capacity of 28,000 gallons. Surge capacity is maintained with two pairs of LRW Surge Tanks also with a 28,000-gallon/pair capacity.
Liquids from these tanks are normally processed through two vertical centrifugal discharge precoat filters with 300 ft2 filter area at a 100 gpm normal flow rate. Liquid from the filters is then sentto a mixed bed demineralizer with a volume of 140 ft3 and normal flow rate of 100 gpm.
The demineralizer effluent is collected in three pairs of LRW Sample Tanks. Each pair of tanks has an approximate capacity of 28,100 gallons. The water is isolated in these tanks for analysis prior to recycle, reuse in the plant, or discharge to the Susquehanna River. Off-specification liquids can be recycled back to the Liquid Waste Management System for additional processing.
2.1.3 High conductivity wastes are collected in the Chemical Drain Tank and in specific sumps located in the Turbine and Radwaste Buildings. Liquid from these sources is collected in a Chemical Waste Tank of
ODCM-QA-007 Revision 1 Page 5 of 16 approximately 12,000 gallons capacity. This liquid can then be sent to any one of two pairs of Chemical Waste Neutralizing Tanks. Each pair has a capacity of 31,000 gallons. The liquid is then sent to a vendor-supplied Chemical Waste Processing Sub-system for radionuclide removal. The effluent from the Chemical Waste Processing Sub-system is routed to the Evaporator Distillate Sample Tank where it can be isolated for analysis prior to discharge. The capability exists to recycle the liquid for additional processing if necessary.
2.1.4 The Laundry Waste Sub-system collects water from washdown, laundry and decontamination facilities in one of two Laundry Drain Tanks. Each tank has a capacity of approximately 820 gallons and has an independent mechanical filter system. One tank is normally valved to receive waste while the other is valved for processing. Effluent from these tanks is routed to the Laundry Drain Sample Tank where it can be isolated for analysis prior to discharge. Off-specification liquid can be returned to the Chemical Waste Processing Sub-system.
2.1.5 A flow diagram of the Liquid Waste Management System is shown in Attachment B.
2.2 Definition of "ApproDriate Treatmentm for Liquid Wastes 2.2.1 TR 3.1 1.1.3 requires that the appropriate portions of the liquid waste treatment system be operable and be used to reduce radioactivity in
'liquid wastes prior to their release when projected doses from each reactor unit to unrestricted areas would exceed 0.06 mrem to the total body or 0.2 mrem to any organ in a 31 -day period.
2.2.2 Normal treatment, which is considered appropriate for each subsystem, is as follows:
- a.
Filtration is considered appropriate treatment for the Uquid Radwaste Laundry Processing Subsystem, which consists of high conductivity liquid wastes, such as those from equipment washdown and personnel decontamination facilities, or laundry.
- b.
The Mobile Liquid Processing System (a vendor-supplied system which is directed to the Distillate Sample Tank) comprises the Liquid Radwaste Chemical Processing Subsystem. Appropriate treatment options provided by this system consist of filtration and demineralization.
- c.
Demineralization and filtration are considered appropriate treatment for low conductivity/low organic contaminant liquid wastes entering the Liquid Radwaste Processing Subsystem (LRW collection tanks),
'U ODCM-QA-007 Revision 1 Page 6 of 16
- d.
Release with filtration alone is considered appropriate treatment for low conductivity/low organic contaminant liquid waste for batches which yield projected doses prior to treatment of less than or equal to 6.45E-04 mrem to the total body and 2.1 5E-03 mrem to any organ.
- e.
For batches of liquid radwaste which have no identified gamma activity above the Technical Requirements Manual Liquid Effluent LLD level (TR 3.1 1.1.1 Table 3.11.1.1-1), release without treatment is considered appropriate.
- f.
Projected dose threshold values used are derived by dividing the "per-unit" maximum projected doses without treatment (0.06 and 0.2 mrem) by 31 days and by 6, the maximum possible number of batches released per day. The uper-unit" threshold values are doubled (due to SSES is a two-unit site) to yield per-batch dose action levels. The two levels of uappropriate" treatment are in place so as not to require application of demineralization for treating low activity, high conductivity water (e.g., from Circulating or Service Water leakage). This would increase the overall efficiency of the solid radwaste program while ensuring calculated doses remain at a suitable fraction of 10CFR50 Appendix I design objectives and TR 3.11.1.2 limit (PLI-70360 and PLI-70612).
- g.
If liquid waste was discharged without treatment at levels exceeding TR 3.11.1.3, a special report shall be prepared and submitted to the NRC within 30 days which addresses the actions of TR 3.11.1.3.
2.3 Liquid Effluent Monitoring Instrumentation 2.3.1 Liquid radwaste monitoring instrumentation shall be maintained as specified in TR 3.11.1.4 and liquid process monitoring instrumentation shall be maintained as specified in TR 3.11.1.5. When monitoring instrumentation is not operable in accordance with the TRM, the required action of the. TRM shall be implemented as stated. If the inoperable condition was not corrected within the specified time frame, a report of the uncorrected condition shall be made in the Annual Effluent and Waste Disposal Report.
2.4 Gaseous Waste Treatment 2.4.1 The SSES Off Gas Treatment System operates with four steam jet air ejectors maintaining condenser vacuum. Noncondensible gases are passed through one of three recombiners (one for each reactor unit plus a common recombiner), reducing the amount of gases to be filtered and released. Gases pass through a two to nine minute holdup pipe before entering the Off Gas Treatment System, which consists of one 100
)
ODCM-QA-007 Revision 1 Page 7 of 16 percent capacity system per reactor unit. Each system consists of precoolers, chillers, reheaters, guard beds, and five charcoal absorbers and an outlet HEPA filter. Filtered air then exits to the Turbine Building vent.
2.4.2 The gaseous radwaste treatment system must be in operation whenever the main condenser air ejector system is in operation. This is the appropriate level of gaseous waste treatment.
2.4.3 Filtered exhaust systems serve selected areas of Zone I, II, and IlIl of the SSES Reactor Building. The Zone I and Zone II equipment compartment and Zone IlIl filtered exhaust systems each consist of two 100% capacity redundant fans and two 55% capacity filter trains. Each filter train has, in the direction of air flow, roughing filters, upstream HEPA filters, a charcoal filter bed, and downstream HEPA filters. Exhaust fan discharge is then routed to the atmosphere via the Reactor Building vents, where effluents are continuously sampled and monitored. -
2.4.4 The containment drywell is vented and purged via the Standby Gas Treatment System (SGTS) to ensure releases from the drywell are maintained as low as is reasonably achievable. This provides the appropriate level of treatment.,
2.4.5 The Turbine Building Filtered Exhaust System draws air from those areas of the building that are most likely to become contaminated. Two 100%
capacity fans serve each system, which contains two 50% capacity filter housings made up of a particulate prefilter, an upstream HEPA filter and a charcoal filter. Discharged air is released via the Turbine Building vents, which are continuously sampled and monitored.
2.4.6 The Radwaste Building Filtered Exhaust System draws potentially contaminated air from selected areas of the Radwaste Building. The system contains two 100% capacity fans and two 50% capacity filter housings, each containing a particulate filter bank and a HEPA filter.
Filtered air is discharged via the Unit 1 Turbine Building vent.
2.4.7 Ventilation exhaust systems must be drawing air through the HEPA and charcoal filters (where available) as the appropriate level of waste treatment.
2.4.8 In order to minimize the quantities of radioactivity in airbome effluents from the station, the ventilation exhaust treatment (filtered exhaust) systems are normally kept in service at SSES. A flow diagram of the Gaseous Waste Management System is shown in Attachment C.
2.4.9 As the need arises, these systems are periodically rendered inoperable for maintenance or testing activities. If any of the ventilation exhaust
ODCM-QA-007 Revision 1 Page 8 of 16 treatment systems in Attachment A are bypassed, degraded, or otherwise rendered inoperable, vent evaluations shall be performed in accordance with plant procedures. If the most recent 31 -day dose projection indicates that dose may exceed 0.3 mrem to any organ when averaged over the projected 31-day period, treatment systems rendered inoperable will be restored to operable status as quickly as is practicable.
2.4.10 When the Standby Gas Treatment System (SGTS) is not being used, a small amount of flow from the'SGTS vent remains. This residual flow originates in the battery rooms and SGTS Equipment Room in the control structure. Because there are no identifiable sources of radioactivity in these rooms, auxiliary particulate and iodine sample and noble gas grab sample at 4-hour intervals are not required from the SGTS vent when the SGTS continuous vent monitor is out of service, provided that
- a.
the Standby Gas Treatment System is not being used,
- b.
there are proper administrative controls in place to ensure that the required sampling will begin within 4 hours4.62963e-5 days <br />0.00111 hours <br />6.613757e-6 weeks <br />1.522e-6 months <br /> if the treatment system is operated.
2.4.11 If inoperable gaseous radwaste treatment systems are not returned to operation as required by TR 3.11.2.4.A, then a special report shall be prepared and submitted to the NRC within 30 days.
2.4.12 If gaseous effluents are discharged in excess of the limits of TR 3.11.2.5.A without treatment, then a special report shall be prepared and submitted to the NRC within 30 days.
2.5 Gaseous Effluent Monitoring Instrumentation Gaseous effluents shall be monitored as specified in TR 3.11.2.6. When monitoring instrumentation is not operable in accordance with the TRM, the required action of the TRM shall be implemented as stated. If the inoperable condition is not corrected in the specified time frame, a report of the uncorrected, condition shall be made in the Annual Effluent and Waste Disposal Report.
2.6 Solid Waste Treatment Including the Process Control Program (PCP) 2.6.1 The SSES Solid Radwaste System collects all wet wastes produced from the operation of other plant systems. A vendor-supplied system processes and packages the wastes into a waste form that meets all applicable federal, state, and local requirements for transportation, storage, and disposal. The Solid Radwaste Process Control Program (NDAP-QA-0646) contains the administrative controls for waste sampling, waste analysis, formulation for solidification or dewatering instructions, verification of solidification or dewatering, and reporting of process
ODCM-QA-007 Revision 1 Page9of 16 failures to ensure liquid waste is properly processed for disposal. In addition, the Process Control Program provides requirements for classifying waste in accordance with 1 OCFR61.
2.6.2 Changes in radioactive solid waste processing and operational changes shall be controlled, reviewed, and approved in accordance with NDAP-QA-0646.
2.6.3 Any changes to the Solid Radioactive Waste Process Control Program shall be provided in the Annual Radioactive Effluent and Waste Disposal Report.
3.0 REFERENCES
3.1 TR 3.6.1, Containment Venting or Purging 3.2 TR 3.11.1.3, [Radioactive Effluents] Liquid Waste Treatment System 3.3 TR 3.11.1.2, [Radioactive Effluents] Dose 3.4 TR 3.11.4.1, Table 3.11.4.1-3, Detection Capabilities for Environmental Sample Analysis Lower Limit of Detection (LLD) 3.5 TR 3.11.1.4, Liquid Radwaste Effluent Monitoring Instrumentation 3.6 TR 3.11.1.5, Radioactive Liquid Process Monitoring Instrumentation 3.7 TR 3.11.2.4, Gaseous Radwaste Treatment Systems 3.8 TR 3.11.2.5, Ventilation Exhaust Treatment Systems 3.9 TR 3.11.2.6, Radioactive Gaseous Effluent Monitoring Instrumentation 3.10 10CFR50.59, Changes, Tests and Experiments 3.11 1 OCFR20, Standards for Protection Against Radiation 3.12 FSAR Figure 11.2-8, Liquid Radwaste System Flow Diagram 3.13 FSAR Figure 11.3-1, Offgas System Process Flow Diagram 3.14 NDAP-QA-0646, Solid Radioactive Waste Process Control Program 3.15 NDAP-00-1203, Modification Identification and Scoping Process 3.16 ODCM-QA-005, Waterbome Effluent Dose Calculations
ODCM-QA-007 Revision 1 Page 10 of 16 3.17 ODCM-QA-009, Dose Assessment Policy Statements 3.18 PLI-70360, Memo from R. K. Barclay to R. A. Breslin, Calculation of Liquid Isotope Sampling Limits: Use of Atmospheric Demineralizer System, February 4,1992 3.19 PLI-70612, Memo from R. K. Barclay to R. A. Breslin, Atmospheric Demineralizer Effluent Results, March 4,1992 3.20 Action Request No. 222585.
4.0 RESPONSIBILITIES 4.1 Vice President - Nuclear Operations 4.1.1 Ensures that radioactive waste treatment systems are operated in compliance with the TROs stated in the Technical Requirements Manual and in accordance with this procedure.
[
4.2 General Manager-Nuclear Engineerinq 4.2.1 Provides modification engineering and support in accordance with NDAP-00-1203 for equipment and systems involved with the treatment or monitoring of radioactive effluents.
4.3 Chemistry Supervisor - SSES
-4.3.1 Ensures adequacy and correctness of operability requirements of the radioactive waste treatment systems presented in this procedure.
4.3.2 Ensures adequacy and correctness of pre-release liquid effluent dose assessments.
5.0 DEFINITIONS 5.1 LRW-Liquid Radwaste 5.2 RCA - Radiologically Controlled'Area 6.0 PROCEDURE 6.1 Liquid Waste Treatment 6.1.1 Chemistry shall perform a dose assessment using the methodology of ODCM-QA-005 prior to release in cases when a batch of liquid waste must be released with treatment less than that specified in Section 2.2, to ensure that the limits of TR 3.11.1.2 are not exceeded.
i
ODCM-QA-007 Revision 1 Page 1 of 16 6.2 Gaseous Waste Treatment 6.2.1 Dose projections shall be performed at least once per 31 days based on the most recently available effluent data. If it is known prior to performing the dose projection that a treatment system will be out of service, and if data exists which indicates how the lack of treatment will impact effluents, these factors will be considered when performing the dose projection.
6.3 Evaluating the Dose Impact of Changes to Waste Treatment Systems 6.3.1 The Annual Effluent and Waste Disposal Report shall include a discussion of any major changes to radwaste systems (liquid, gaseous and solid). Such discussion shall include the following:
- a.
a summary of the evaluation that led to the determination that the change could be made in accordance with 1 OCFR50.59,
- b.
sufficiently detailed information to fully support the change without supplemental information,
- c.
detailed descriptions of the equipment, components and processes involved and interfaces with other plant systems,
- d.
an evaluation which shows how the predicted releases of radioactive materials in liquid and gaseous effluents and/or quantity of solid waste differ from those previously predicted in the license application or subsequent amendments,
- e.
an evaluation of the change which shows the expected maximum exposures to an individual in the unrestricted area and to the general population that differ from those previously estimated in the license application or subsequent amendments,
- f.
a comparison of predicted releases of radioactive materials in liquid and gaseous effluents and in solid waste to the actual releases for the period prior to when the changes are to be made,
- 9.
an estimate of exposure to plant operating personnel as a result of the change, and documentation that the change was reviewed and approved by PORC.
6.3.2 If a modification to the liquid waste system results in positioning a radioactive liquid storage tank outside which is not surrounded by a liner, dike, or a wall capable of holding the contents of the tank and the tank does not have an overflow or surrounding area drains connected to the Liquid Radwaste Treatment System, then the tank contents shall be
ODCM-QA-007 Revision 1 Page 12 of 16 limited to less than 10 Curies (not including tritium and dissolved gas).
Chemistry will sample the tank per the TRM to ensure the contents are limited to 10 Curies. This is to ensure that a tank failure will not result in radioactivity in the nearest drinking water source in concentrations which exceed 1 OCFR20, Appendix B, Table 2, Col. 2.
7.0 RECORDS None.
odcm-qa-007(26)
^
~ttaCnlmen A
ODCM-QA-007 Revision 1 j
Page 13 of 16 VENTILATION EXHAUST TREATMENT SYSTEMS WHICH REQUIRE OFFSITE VENT EVALUATIONS WHEN BYPASSED, DEGRADED, OR OTHERWISE RENDERED INOPERABLE
-UPSTREAM-DOWNSTREAM-FILTER SYSTEM LOCATION--
DESIGNATION CHARCOALt-i DESIGNATiON'-5 Unit 1 Turbine Building I F157AIB 1 F158A/B N/A Unit 2 Turbine Building 2F157A/B 2F158A/B N/A Unit 1 Zone 1 Reactor Building 1 F255AIB 1 F257A/B 1 F258AIB Unit I Zone 3 Reactor Building 1F216A/B 1F217A/B IF218AIB-Unit 2 Zone 2 Reactor Building 2F255A/B 2F257A/B 2F258AIB Unit 2 Zone 3 Reactor Building 2F216A/B 2F217AIB 2F218AIB Radwaste Building Exhaust OF355A/B N/A N/A Radwaste Tank Vent OF358 OF359 N/A Radwaste Degasifier OF372 OF373 OF374 Control Structure Sample Room OF134 OF135 N/A Control Structure Rad Chem Lab OF137 OF138 N/A Control Structure Rad Chem Lab OF140 OF141 N/A-Control Structure Decon Area 0F143 OF144 N/A S&A Building OF716 N/A.
N/A Page 1 of I
Attachment B ODCM-QA-007 Revision 1 Page 14 of 16 W[
FROM EVAPORATOR HEATING
_u lSTEAM CONDENSATE RETURN TANK l
PRO1M PHASE SEPARATORS (DECANT)
R~OM RHI SYSTEM ISUPPRESSI10 P00L TRANSPIRE)
I RADWASTE UILDING DRAINS rl t
REACTOR WELL SEAL LEAK DRAIN I
'r REACTOR BUILDING DRAINS DRYWELL DRAINS
-I SSES LIQUID EFFLUENT RELEASE FLOWPATH I
4wIt TURBINE BUILDING DRAINS (M-161. M-162. M.163 AND M.164)
I{
RADWASTE BUILDING DRAINS P
LTC.t XADWAT2 XCYCU CONLL MCTION ANM suRGaA TANKSE OT 302A TlAU r OTW30IA THIU D T
T AWNA l
LUDW RADWASTE LIQUID XADWASTE F
0-302A *A5, 80 OT303A TMX rV COSAMPE ANK PUMPS PUMP LUI RAO T2SA2A BA C
EP.522A.a I
AA0WASTI STU3LOING SAPL STATION l
XWCU CMIMISAL DECO l
AUX E-ILlN BLOW DOW FUEL POOL CLEANUP SYSTEM CHEMICAL DECI RAIN TANN I
CMENtCALWASTE TANK 07-324 I
i -
- ON DRAINS (2) CO L-ItE SI: =
ETD 184 IN I
ANKs T
,w "HICAL W NEUTRALIZING TANKS ST,:133.OA :
I CH I I
A:
I CN6MtCAL WASTE I
I NEUTRALIZING TANK PUMPS I
KI I
_ +_
RA AST DISTILLATE EVAPORATORS SAMPLE TANK 09 302A S CT-21 III CNVAETRA70T CONC
.T.AT.
l l
0P3 227A.
CONDENSATE STORAGE TANKl DISFXCHASRGE PUPO-2 ED
_s l ERSONNEL DECONTAMINJ l
C(DETERGENTS)
-FLOOR DECOR (SOLUTIC R-EGULATED SHOP DRAII CASK CLEARING DR LAUNDRY DRAINS LAUNDRY DRAIN LAUNDRY TAM IS FILTV S
.211'1A.
UNDRY DRAIN OF-313 TANK PUMPS OF3134 LAUNDRY DRAIN BP-2 IIA MPLE TAN K PUMPS OP-329A. 5 II
,1 I II L.
(I) RADWASTE EVAPORATORS ARE NOT USED
- 12) CORD DENIM RESINS CURRENTLY NOT REGENERATED (3) CONTAMIINATED CLOTHING CURRENTLY NOT LAUN0DRED ONStTE Omar SUSQUEHANNA RIVER I
r-V.
Page 1 of 1
(9 (A
(chmentC ODCM-QA-007 Revision 1 Page 15 of 16 UNIT 1 UNIT 1 S
RM REACTOR BUILDING TURBINE BUILDING M
SSES GASECS EFFLUENT RELEASEfLOWPAJH EXHAUST VENT EXHAUST VENT UNIT I REACTOR BUILDINGPRMYCOLNDEASFR (M-175, M-176)
EH=
FILTR SYSTEM ZONE III FILTERED EXHAUST
-RADWASTE BUILDING (M-179)
TANK VENT FILTER EXHAUST
__________________________________UNIT 1 OFFGAS SYSTEM (M-171)
ZONE III UNFILTERED EXHAUST 1 r E
UNIt I MECHANICAL VACUUM PUMP (H-107)
N
=
SMOKEREMOVAL (2)
TYPICALOFl CONTROL STRUCTURE (M-178)
CONTROL FILTER UNIT (2)
ROOMS CONTROL ROOM.IYCIE NILTERED ROOMS BCONTROL ROOM TOILET RA XW4AUST ACCESS CONTROL AREA FN TOILET ACCESS AREA GENERAL ZONE I EO. COMP..
FILTERED EXHAUST SYSTEM ROOMS Page 1 of 2
U
- 0achrnent C ODCM-QA-007 Revision 1 Page 16 of 16 I
I Page ( of 2 C-